Outcomes Assessment in Cancer

Measures, Methods and Applications

Outcomes Assessment in Cancer
  • Edited by Joseph Lipscomb


    Edited by Carolyn C. Gotay


    Edited by Claire Snyder

  • Publisher: Cambridge University Press

    Online Publication Date:December 2009

    Online ISBN:9780511545856

    Hardback ISBN:9780521838900

    Paperback ISBN:9781107403161

  • Book DOI: http://dx.doi.org/10.1017/CBO9780511545856

    Subjects: Oncology

The U.S. National Cancer Institute established the Cancer Outcomes Measurement Working Group in 2001 to evaluate measurements of the important and diverse impacts of cancer on individuals and populations. The findings and recommendations of the working group's 35 internationally recognized members provide alternative approaches for comprehensively measuring the burden of cancer and the effectiveness of preventive and therapeutic interventions.


 Reviews:

"[T]he members of COMWG [Cancer Outcomes Measurement Working Group] are to be commended for providing readers with a thoughtful and detailed overview of where we are and where we need to go to '...strengthen our capacity to measure, evaluate, and improve the outcomes of cancer care.'"--Journal of the American Medical Association

"...important and timely...This book will be of particular interest to outcomes researchers and their students. However, its appeal is certainly not limited to this audience as anyone who is concerned with cancer-care outcomes and tehir assessment will find many of the chapters informative and useful." The New England Journal of Medicine,/i> David G. Pfister, M.D.

Reference Title: REFERENCES

Reference Type: reference-list

American Cancer Society (2004). Cancer Facts & Figures 2004. Atlanta, GA: ACS
Agency for Healthcare Research and Quality. “Outcomes research fact sheet: What is outcomes research.” Available at http://www.ahrq.gov/clinic/outfact.htm. Last accessed on September 9, 2004
National Cancer Institute. “Defining the emerging field of outcomes research.” Available at http://outcomes.cancer.gov/aboutresearch/defining.html/. Last accessed on September 9, 2004
Lipscomb, J., Donaldson, M. S., Hiatt, R. A. (2004). Cancer outcomes research and the arenas of application Journal of the National Cancer Institute Monograph 33:1–7
Braun (GmbH) Health Care Information Center. “History of Blood Pressure Measurement.” Available at http://www.braun.com/medical/bloodpressure/infocenter/background/history.html. Last accessed on January 30, 2004
Clancy, C. M., Eisenberg, J. M. (1998). Outcomes research: measuring the end results of health care Science 282(5387):245–6
National Cancer Institute. “The Nation's Investment in Cancer Research: a Plan and Budget Proposal for Fiscal Year 2005.” Available at http://plan.cancer.gov. Last accessed on September 13, 2004
National Cancer Institute. “Guidelines for the Conduct of Working Groups that Are Not Subject to the Federal Advisory Committee Act.” Available at http://deaintranet.nci.nih.gov/ncipolicy/non-faca-final.htm. Last accessed on September 12, 2004
Donaldson, M. S. (2004). Taking stock of health-related quality of life measurement in oncology practice in the United States Journal of the National Cancer Institute Monograph (Cancer Outcomes Research: the Arenas of Application). In press
Fayers, P. M., Machin, D. (2002). Quality of Life: Assessment, Analysis and Interpretation. Chichester: John Wiley & Sons Ltd
Spilker, B. (Ed.) (1996). Quality of Life and Pharmacoeconomics in Clinical Trials (2nd Edition). Philadelphia: Lippincott-Raven
Hambleton, this volume, Chapter 22
Reise, this volume, Chapter 21
Wilson, this volume, Chapter 23
Gotay, Lipscomb, this volume, Chapter 26
Ferrans, this volume, Chapter 2
Revicki, this volume, Chapter 27
Copley-Merriman et al., this volume, Invited Paper D
Lohr, K. N. (2002). Assessing health status and quality-of-life instruments: attributes and review criteria Quality of Life Research 11:193–205
Damiano A. M., Snyder, C. F., Strausser, B. et al. (1999). A review of health-related quality-of-life concepts and measures for Parkinson's disease Quality of Life Research 8:236–43
Erickson, this volume, Chapter 3
Feeny, this volume, Chapter 4
Ganz, Goodwin, this volume, Chapter 5
Litwin, Talcott, this volume, Chapter 6
Earle, Weeks, this volume, Chapter 7
Moinpour, Provenzale, this volume, Chapter 8
Barry, Dancey, this volume, Chapter 9
Mandelblatt, Selby, this volume, Chapter 10
Zebrack, Cella, this volume, Chapter 11
Ferrell, this volume, Chapter 12
Williams, this volume, Chapter 13
Darby, this volume, Chapter 14
Gustafson, this volume, Chapter 15
Snyder, this volume, Chapter 16
Fairclough, this volume, Chapter 17
Sloan, this volume, Chapter 18
Osoba, this volume, Chapter 19
Aaronson, this volume, Chapter 20
Hornbrook, this volume, Chapter 24
O'Brien, this volume, Chapter 25
Gotay, Lipscomb, Snyder, this volume, Chapter 28
Spilker, this volume, Invited Paper A
Willis, Reeve, Barofsky, this volume, Invited Paper C
McHorney, Cook, this volume, Invited Paper B

Reference Title: REFERENCES

Reference Type: reference-list

Johnson, J. R., Temple, R. (1985). Food and Drug Administration requirements for approval of new anticancer drugs Cancer Treatment Reports 69:1155–7
National Cancer Institute (1988). Clinical Trials Cooperative Group Program, Cancer Therapy Evaluation Program: Guidelines. Bethesda, MD, Division of Cancer Treatment, National Cancer Institute, February 29, 1988. Cited in: Varricchio, C. (1990). Relevance of quality of life to clinical nursing practice. Seminars in Oncology Nursing 6:255–9
Osoba, D. (1992). The quality of life committee of the clinical trials group of the National Cancer Institute of Canada: Organization and functions Quality of Life Research 1:211–8
Spilker, B., Revicki, D. (1996). Taxonomy of quality of life. In Quality of Life and Pharmacoeconomics in Clinical Trials (2nd Edition), ed. B. Spilker, pp. 25–31. Philadelphia, PA: Lippincott-Raven Publishers
Guyatt, G. H., Feeny, D. H., Patrick, D. L. (1993). Measuring health-related quality of life Annals of Internal Medicine 118:622–8
World Health Organization (1958). The First Ten Years of the World Health Organization. Geneva: World Health Organization
Spilker, B. (1996). Introduction. In Quality of Life and Pharmacoeconomics in Clinical Trials (2nd Edition), ed. B. Spilker, pp. 1–10. Philadelphia, PA: Lippincott-Raven Publishers
Aaronson, N., Ahmedzai, S., Bergman, B. et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality of life instrument for use in international clinical trials in oncology Journal of the National Cancer Institute 85:365–76
Shag, C., Ganz, P. A., Heinrich, R. (1991). Cancer Rehabilitation Evaluation System — Short Form (CARES-SF) Cancer 68:1406–13
Cohen, S., Mount, B., Strobel, M. et al. (1995). The McGill Quality of Life Questionnaire: A measure of quality of life appropriate for people with advanced disease Palliative Medicine 9:207–19
Leplege, A., Hunt, S. (1997). The problem of quality of life in medicine Journal of the American Medical Association 278:47–50
Padilla, G., Ferrell, B., Grant, M. et al. (1990). Defining the content domain of quality of life for cancer patients with pain Cancer Nursing 13:108–15
Grant, M., Ferrell, B., Schmidt, G. et al. (1992). Measurement of quality of life in bone marrow transplantation survivors Quality of Life Research 1:375–84
Ferrans, C., Powers, M. (1985). Quality of Life Index: development and psychometric properties Advances in Nursing Science 8:15–24
Ferrans, C. E. (1990). Development of a quality of life index for patients with cancer Oncology Nursing Forum 17:15–19
Ferrans, C., Powers, M. (1992). Psychometric assessment of the Quality of Life Index Research in Nursing and Health 15:29–38
Ferrell, B. R. (1996). The quality of lives: 1,525 voices of cancer Oncology Nursing Forum 26:907–16
Ferrell, B., Wisdom, C., Wenzl, C. (1989). QOL as an outcome variable in the management of cancer pain Cancer 63:2321–7
Ferrell, B., Grant, M., Padilla, G. (1991). Experience of pain and perceptions of quality of life: Validation of a conceptual model Hospice Journal 7:9–24
Ferrell, B., Grant, M., Schmidt, G. et al. (1992). The meaning of quality of life for bone marrow transplant survivors. Part 1: The impact of bone marrow transplant on QOL Cancer Nursing 15:153–60
Ferrell, B., Dow, K., Leigh, S. et al. (1995). Quality of life in long term cancer survivors Oncology Nursing Forum 22:915–22
Ferrans, C. (1996). Development of a conceptual model of quality of life Scholarly Inquiry for Nursing Practice: An International Journal 10:293–304
Ferrans, C. (1994). Quality of life through the eyes of survivors of breast cancer Oncology Nursing Forum 21:1645–51
Ferrans, C., Powers, M. (1993). Quality of life of hemodialysis patients American Nephrology Nurses Association Journal 20:575–81
Ferrans, C., Cohen, F., Smith, K. (1992). Quality of life of persons with narcolepsy Grief, Loss, and Care 5:23–32
Warnecke, R., Ferrans, C., Johnson, T. et al. (1996). Measuring quality of life in culturally diverse populations Journal of the National Cancer Institute Monographs 20:29–38
Anderson, J., Ferrans, C. (1997). The quality of life of persons with chronic fatigue syndrome Journal of Nervous and Mental Disease 106:359–67
Arzouman, J., Dudas, S., Ferrans, C. et al. (1991). Quality of life of patients with sarcoma post-chemotherapy Oncology Nursing Forum 18:889–94
Belec, R. (1992). Quality of life: Perceptions of long-term survivors of bone marrow transplantation Oncology Nursing Forum 19:31–7
Aaronson, N. K., Cull, A. M., Kaasa, S. et al. (1996). The European Organization for Research and Treatment of Cancer (EORTC) modular approach for quality of life assessment in oncology: An update. In Quality of Life and Pharmacoeconomics in Clinical Trials (2nd Edition), ed. B. Spilker, pp. 179–89. Philadelphia: Lippincott-Raven
Cella, D., Tulsky, D., Gray, G. et al. (1993). The Functional Assessment of Cancer Therapy (FACT) Scale: Development and validation of the general version Journal of Clinical Oncology 11:570–9
Cella, D., Bonomi, A., Lloyd, S. et al. (1995). Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument Lung Cancer 12:199–220
Osoba, D. (1994). Lessons learned from measuring health-related quality of life in oncology Journal of Clinical Oncology 12:608–16
Ganz, Goodwin, this volume, Chapter 5
Gotay, C. C. (1996). Trial-related quality of life: using quality-of-life assessment to distinguish among cancer therapies Journal of the National Cancer Institute Monographs 20:1–6
Chang, C., Cella, D. (1997). Equating health-related quality of life instruments in applied oncology settings Physical Medicine and Rehabilitation 11:397–406
Weitzner, M., Meyers, C., Byrne, K. (1996). Psychosocial functioning and quality of life in patients with primary brain tumors Journal of Neurosurgery 84:29–34
Fobair, P., Hoppe, R. T., Bloom, J. et al. (1986). Psychosocial problems among survivors of Hodgkin's disease Journal of Clinical Oncology 4:805–14
Kornblith, A. B., Anderson, J., Cella, D. F. et al. (1992). Hodgkin's disease survivors at increased risk for problems in psychosocial adaptation Cancer 70:2214–24
Schipper, H., Clinch, J., Olweny, C. (1996). Quality of life studies: Definitions and conceptual issues. In Quality of Life and Pharmacoeconomics in Clinical Trials (2nd Edition), ed. B. Spilker, pp. 11–23. Philadelphia, PA: Lippincott-Raven Publishers
Rhodes, V. A., McDaniel, R. W. (1997). Measuring nausea, vomiting, and retching. In Instruments for Clinical Health-Care Research, ed. M. Frank-Stromborg and S. J. Olsen, pp. 509–18. Sudbury, MA: Jones and Bartlett
Dougherty, C., Dewhurst, T., Nichol, P. et al. (1998). Comparison of three quality of life instruments in stable angina pectoris: Seattle Angina Questionnaire, Short Form Health Survey (SF-36), and Quality of Life Index — Cardiac Version III Journal of Clinical Epidemiology 51:569–75
Schlenk, E., Erlen, J., Dunbar-Jacob, J. et al. (1998). Health-related quality of life in chronic disorders: a comparison across studies using the MOS SF-36 Quality of Life Research 7:57–65
Campbell, A., Converse, P. E., Rodgers, W. L. (1976). The Quality of American Life: Perceptions, Evaluations, and Satisfactions. New York: Russell Sage
Day, H. and Jankey, S. G. (1996). Lessons from the literature: toward a holistic model of quality of life In Quality of Life in Health Promotion and Rehabilitation: Conceptual Approaches, Issues, and Applications, pp. 39–50. Thousand Oaks, CA: Sage
Frisch, M. B. (1998). Quality of life therapy and assessment in health care Clinical Psychology Science and Practice 5:19–40
Selby, P. (1993). Measurement of quality of life in cancer patients Journal of Pharmacy & Pharmacology 45 (Suppl. 1):384–6
Zissi, A., Barry, M. M., Cochrane, R. A. (1998). A mediational model of quality of life for individuals with severe mental health problems Psychological Medicine 28:1221–30
Diener, E., Suh, E. M., Lucas, R. E. et al. (1999). Subjective well-being: three decades of progress Psychological Bulletin 125:276–302
Sprangers, M. A. G., Schwartz, C. E. (1999). Integrating response shift into health-related quality of life research: a theoretical model Social Science and Medicine 48:1507–15
Feeny, this volume, Chapter 4
Frisch, M. B. (1993). The Quality of Life Inventory: a cognitive-behavioral tool for complete problem assessment, treatment planning, and outcome evaluation Behavior Therapy 16:42–4
Litwin, M. (1994). Measuring health related quality of life in men with prostate cancer Journal of Urology 152:1882–7
Gill, T., Feinstein, A. (1994). A critical appraisal of the quality of quality-of-life measurements Journal of the American Medical Association 272:619–26
Felce, D., Perry, J. (1995). Quality of life: its definition and measurement Research in Developmental Disabilities 16:51–74
Bloom, J. R. (1984). Response to J. E. Ware, Jr., Conceptualizing disease impact and treatment outcomes Cancer 53 (Suppl.):2323–6
Covinsky, K. E., Wu, A. W., Landefeld, S. et al. (1999). Health status versus quality of life in older patients: does the distinction matter? American Journal of Medicine 106:435–40
Patrick, D. L., Kinne, S., Engleberg, R. A. et al. (2000). Functional status and perceived quality of life in adults with and without chronic conditions Journal of Clinical Epidemiology 53:779–85
Barofsky, I. (2003). Patient's rights, quality of life, and health care system performance Quality of Life Research 12:473–84
Osoba, this volume, Chapter 19
Barofsky, I. (1996). Cancer: psychosocial aspects. In Quality of Life and Pharmacoeconomics in Clinical Trials (2nd Edition), ed. B. Spilker, pp. 993–1002. Philadelphia, PA: Lippincott-Raven
Ware, J. E. Jr., (1984). Conceptualizing disease impact and treatment outcomes Cancer 53 (Suppl.):2316–23
Wilson, I. B., Cleary, P. D. (1995). Linking clinical variables with health-related quality of life: a conceptual model of patient outcomes Journal of the American Medical Association 273:59–65
Patrick, D. L., Chiang, Y. P. (2000). Measurement of health outcomes in treatment effectiveness evaluations: conceptual and methodological challenges Medical Care 38 (Suppl. II):14–25
Smith, K. W., Avid, N. E., Assmann, S. F. (1999). Distinguishing between quality of life and health status in quality of life research: a meta-analysis Quality of Life Research 8:447–59
Fayers, P. M., Hand, D. J., Bjordal, K. et al. (1997). Causal indicators in quality of life research Quality of Life Research 6:393–406
Fayers, P. M., Hand, D. J. (2002). Causal variables, indicator variables, and measurement scales: an example from quality of life Journal of the Royal Statistical Society 165 (Part 2):1–21
Schipper, H., Clinch, J., McMurray, A. et al. (1984). Measuring the quality of life of cancer patients: the Functional Living Index — Cancer: Development and validation Journal of Clinical Oncology 2:472–83
Morrow, G., Lindke, J., Black, P. et al. (1992). Measurement of quality of life in patients: psychometric analysis of the Functional Living Index-Cancer (FLIC) Quality of Life Research 1:287–96
Clinch, J. (1996). The Functional Living Index-Cancer: ten years later. In Quality of Life and Pharmacoeconomics in Clinical Trials (2nd Edition), ed. B. Spilker, pp. 215–25. Philadelphia, PA: Lippincott-Raven Publishers
Ware, J. E. Jr.,, Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36) Medical Care 30:473–83
Stewart, A. L., Hays, R. D., Ware, J. E. (1988). The MOS short-form general health survey Medical Care 26:724–35
Spitzer, W., Dobson, A., Hall, J. et al. (1981). Measuring the quality of life of cancer patients: a concise QL-Index for use by physicians Journal of Chronic Disease 34:585–97
Cella, D. (1995). Measuring quality of life in palliative care Seminars in Oncology 22:73–81
Ebrahim, S. (1995). Clinical and public health perspectives and applications of health-related quality of life measurement Social Science and Medicine 41:1383–94
Revicki, D., Osoba, D., Fairclough, D. et al. (2000). Recommendations on health-related quality of life research to support labeling and promotional claims in the United States Quality of Life Research 9:887–900
Padilla, G. V., Grant, M. M., Ferrell, B. R. et al. (1996). Quality of Life — Cancer. In Quality of Life and Pharmacoeconomics in Clinical Trials (2nd Edition), ed. B. Spilker, pp. 301–8. Philadelphia, PA: Lippincott-Raven
Calman, K. C. (1987). Definitions and dimensions of quality of life. In The Quality of Life of Cancer Patients, ed. N. K. Aaronson and J. H. Beckmann, pp. 1–9. New York: Raven Press
Felce, D., Perry, J. (1996). Quality of Life in Health Promotion and Rehabilitation: Conceptual Approaches, Issues, and Applications. Thousand Oaks, CA: Sage
Patrick, D. L., Erickson, P. (1993). Health Status and Health Policy: Allocating Resources to Health Care. Oxford: Oxford University Press
Gotay, C., Korn, E., McCabe, M. et al. (1992). Quality-of-life assessment in cancer treatment protocols: Research issues in protocol development Journal of the National Cancer Institute 84:575–9
Roy, D. J. (1992). Measurement in the service of compassion Journal of Palliative Care 8:3–4
World Health Organization (1995). The World Health Organization Quality of Life Assessment (WHOQOL): Position paper from the World Health Organization Social Science and Medicine 41:1403–9
Karnofsky, D., Abelman, W., Craver, L. F. et al. (1948). The use of nitrogen mustards in the palliative treatment of carcinoma with particular reference to bronchogenic carcinoma Cancer 1:634–56
Gelber, R., Goldhirsch, A., Cavelli, F. (1991). Quality-of-life-adjusted evaluation of adjuvant therapies for operable breast cancer Annals of Internal Medicine 114:621–8

Reference Title: REFERENCES

Reference Type: reference-list

Brown, M. L., Lipscomb, J., Snyder, C. (2001). The burden of illness of cancer: economic cost and quality of life Annual Review of Public Health 22:91–113
Janknegt, R. (2001). Using health outcomes data to inform decision-making: formulary committee perspective Pharmacoeconomics 19(Suppl. 2):49–52
Lancry, P-J., O'Connor, R., Stempel, D. et al. (2001). Using health outcomes data to inform decision-making: healthcare payer perspective Pharmacoeconomics 19(Suppl. 2):39–47
Taylor, R. (2001). Using health outcomes data to inform decision-making: government agency perspective Pharmacoeconomics 19(Suppl. 2):33–8
Lipscomb, J., Snyder, C. F. (2002). The outcomes of cancer outcomes research: focusing on the National Cancer Institute's Quality-of-Care Initiative Medical Care 40(Suppl. 6):III3–III10
National Center for Health Statistics (2002). Health, United States, 2002 With Chartbook on Trends in the Health of Americans. Hyattsville, MD: National Center for Health Statistics
Gilson, B. S., Gilson, J. S., Bergner, M. et al. (1975). The Sickness Impact Profile: development of an outcome measure of health care American Journal of Public Health 65(12):1304–10
Bergner, M., Bobbitt, R. A., Carter, W. B. et al. (1981). The Sickness Impact Profile: development and final revision of a health status measure Medical Care 19(8):787–805
Stewart, A. L., Hays, R. D., Ware, J. E., Jr. (1988). The MOS Short-Form General Health Survey: reliability and validity in a patient population Medical Care 26(7):724–32
Ware, J. E., Jr., Sherbourne, C. D. (1992). The MOS 36-Item Short-Form Health Survey (SF-36): I. Conceptual framework and item selection Medical Care 30(6):473–83
Ware, J. E., Kosinski, M., Keller, S. D. (1996). A 12-Item Short-Form Health Survey (SF-12): Scale Construction and preliminary tests of reliability and validity. Boston, MA: Medical Outcomes Trust
Aaronson, N. K., Ahmedzai, S., Bergman, B. et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology Journal of the National Cancer Institute 85(5):365–76
Cella, D. F., Tulsky, D. S., Gray, G. et al. (1993). The Functional Assessment of Cancer Therapy Scale: development and validation of the general measure Journal of Clinical Oncology 11(3):570–9
Grassi, L., Indelli, M., Marzola, M. et al. (1996). Depressive symptoms and quality of life in home-care-assisted cancer patients Journal of Pain and Symptom Management 12(5):300–7
Klee, M. C., King, M. T., Machin, D. et al. (2000). A clinical model for quality of life assessment in cancer patients receiving chemotherapy Annals of Oncology 11(1):23–30
McWhinney, I. R., Bass, M. J., Donner, A. (1994). Evaluation of a palliative care service: problems and pitfalls British Medical Journal 309(6965):1340–2
Witteveen, P. O., Jacobs, H. M., van Groenestijn, M. A. C. et al. (1999). Assessment of the quality of life of patients with advanced and end-stage cancer or serious infections with a symptom-based or an impact-based instrument Supportive Care in Cancer 7(2):64–70
Erickson, P., Scott, J. (1993). The On-Line Guide to Quality-of-Life Assessment (OLGA): Resource for Selecting Quality-of-Life Assessments. In Quality of Life Assessment: Key Issues in the 1990s, ed. S. R. Walker, R. M. Rosser, pp. 221–32. Dordrecht, The Netherlands: Kluwer Academic Publishers
Feeny, this volume, Chapter 4
Patrick, D. L., Erickson, P. (1993). Health Status and Health Policy: Quality of Life in Health Care Evaluation and Resource Allocation. New York: Oxford University Press
Erickson, P. (2000). Assessment of the evaluative properties of health status instruments Medical Care 38(Suppl. 9):S95–9
Aaronson, this volume, Chapter 20
Snaith, R. P. (1987). The concepts and assessment of depression in oncology Journal of Psychosocial Oncology 5(3):133–9
Zigmond, A. S., Snaith, R. P. (1983). The Hospital Anxiety and Depression Scale Acta Psychiatrica Scandinavica 67(6):361–70
Maguire, P., Selby, P. (1989). Assessing the quality of life in cancer patients. British Journal of Cancer 60:437–40
Nystedt, M., Berglund, G., Bolund, C. et al. (2000). Randomized trial of adjuvant tamoxifen and/or goserelin in premenopausal breast cancer: self-rated physiological effects and symptoms Acta Oncologica 39(8):959–68
Howell, S. J., Radford, J. A., Adams, J. E. et al. (2001). Randomized placebo-controlled trial of testosterone replacement in men with mild Leydig Cell Insufficiency following cytotoxic chemotherapy Clinical Endocrinology 55(3):315–34
Razavi, D., Kormoss, N., Collard, A. et al. (1999). Comparative study of the efficacy and safety of trazodone versus clorazepate in the treatment of adjustment disorders in cancer patients: a pilot study Journal of International Medical Research 27(6):264–72
Ranson, M. R., Jayson, G., Perkins, S. et al. (1997). Single-agent paclitaxel in advanced non-small cell lung cancer: single-center phase II study using a 3-hour administration schedule Seminars in Oncology 24(4 Suppl. 12): 6–9
Smyth, J. F., Bowman, A., Perren, T. et al. (1997). Glutathione reduces the toxicity and improves quality of life of women diagnosed with ovarian cancer treated with cisplatin: results of a double-blind, randomised trial Annals of Oncology 8(6):569–73
Bleehen, N. M., Girling, D. J., Hopwood, P. et al. (1996). Randomised trial of four-drug vs less intensive two-drug chemotherapy in the palliative treatment of patients with small-cell lung cancer (SCLC) and poor prognosis British Journal of Cancer 73(3):406–13
Joffe, J. K., Banks, R. E., Forbes, M. A. et al. (1996). A Phase II study of interferon-alpha, interleukin-2 and 5-fluorouracil in advanced renal carcinoma: clinical data and laboratory evidence of protease activation British Journal of Urology 77(5):638–49
Seymour, M. T., Slevin, M. L., Kerr, D. J. et al. (1996). Randomized trial assessing the addition of interferon alpha-2a to fluorouracil and leucovorin in advanced colorectal cancer Journal of Clinical Oncology 14(8):2280–8
Harper-Wynne, C., English, J., Meyer, L. et al. (1999). Randomized trial to compare the efficacy and toxicity of cyclophosphamide, methotrexate and 5-fluorouracil (CMF) with methotrexate mitoxantrone (MM) in advanced carcinoma of the breast British Journal of Cancer 81(2):316–22
Hammerlid, E., Mercke, C., Sullivan, M. et al. (1997). A prospective quality of life study of patients with oral or pharyngeal carcinoma treated with external beam irradiation with or without brachytherapy Oral Oncology 33(3):189–96
Gregor, A., Cull, A., Stephens, R. J. et al. (1997). Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: results of a multicentre randomised trial European Journal of Cancer 33(11):1752–8
Griffiths, G. O., Parmar, M. K. B., Bailey, A. J. (1999). Physical and psychological symptoms of quality of life in the CHART randomized trial in head and neck cancer: short-term and long-term patient reported symptoms British Journal of Cancer 81(7):1196–205
Gaze, M. N., Kelly, C. G., Kerr, G. R. et al. (1997). Pain relief and quality of life following radiotherapy for bone metastases: a randomised trial of two fractionation schedules Radiotherapy and Oncology 45(2):109–16
Hjermstad, M. J., Loge, J. H., Evensen, S. A. et al. (1999). The course of anxiety and depression during the first year after allogeneic or autologous stem cell transplantation Bone Marrow Transplantation 24(11):1219–28
Loge, J. H., Abrahamsen, A. F., Ekeberg, O. et al. (2000). Fatigue and psychiatric morbidity among Hodgkin's disease survivors Journal of Pain and Symptom Management 19(2):91–9
Olweny, C. L. M., Juttner, C. A., Rofe, P. et al. (1993). Long-term effects of cancer treatment and consequences of cure: cancer survivors enjoy quality of life similar to their neighbours European Journal of Cancer 29A(6):826–30
Cull, A., Gregor, A., Hopwood, P. et al. (1994). Neurological and cognitive impairment in long-term survivors of small cell lung cancer European Journal of Cancer 30A(8):1067–74
Molassiotis, A., Boughton, B. J., Burgoyne, T. et al. (1995). Comparison of the overall quality of life in 50 long-term survivors of autologous and allogeneic bone marrow transplantation Journal of Advanced Nursing 22:509–16
Stromgren, A. S., Groenvold, M., Pedersen, L. et al. (2001). Does the medical record cover the symptoms experienced by cancer patients receiving palliative care? A comparison of the record and patient self-rating Journal of Pain and Symptom Management 21(3):189–96
Payne, S. A. (1992). A study of quality of life in cancer patients receiving palliative chemotherapy Social Science and Medicine 35(12):1505–9
Macbeth, F. R., Bolger, J. J., Hopwood, P. et al. (1996). Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status Clinical Oncology 8(3):167–75
Bratt, O., Damber, J.-E., Emanuelsson, M. et al. (2000). Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer European Journal of Cancer 36(2):235–41
Brandberg, Y., Bolund, C., Michelson, H. et al. (1993). Psychological reactions in public melanoma screening European Journal of Cancer 29A(6):860–3
Scaf-Klomp, W., Sanderman, R., van de Wiel, H. B. M. et al. (1997). Distressed or relieved? Psychological side effects of breast cancer screening in the Netherlands Journal of Epidemiology and Community Health 51(6):705–10
Brook, R. H., Ware, J. E., Jr., Rodgers, W. H. et al. (1983). Does free care improve adults' health? Results from a randomized controlled trial New England Journal of Medicine 309(23):1426–34
Tarlov, A. R., Ware, J. E., Jr., Greenfield, S. et al. (1989). The Medical Outcomes Study: an application of methods for monitoring the results of medical care Journal of the American Medical Association 262(7):925–30
Ware, J. E., Sherbourne, C. D., Davies, A. R. (1992). Developing and Testing the MOS 20-Item Short Form Health Survey: A General Population Application. In Measuring Functioning and Well-Being: The Medical Outcomes Study Approach, ed. A. L. Stewart, J. E. Ware, pp. 277–290. Durham, NC: Duke University Press
Ware, J. E., Jr., Snow, K. K., Kosinski, M. et al. (1993). SF-36 Health Survey: Manual and Interpretation Guide. Boston, MA: Health Institute
Brandberg, Y., Malm, M., Blomqvist, L. A. (2000). Prospective and randomized study, “SVEA,” comparing effects of three methods for delayed breast reconstruction on quality of life, patient-defined problem areas of life, and the cosmetic result Plastic and Reconstructive Surgery 105(1):66–74
McGuire, M. S., Grimaldi, G., Grotas, J. et al. (2000). The type of urinary diversion after radical cystectomy significantly impacts on the patient's quality of life Annals of Surgical Oncology 7(1):4–8
Veenstra, K. M., Sprangers, M. A. G., van der Eyken, J.-W. (2000). Quality of life in survivors with a Van Ness-Borggreve rotationplasty after bone tumour resection Journal of Surgical Oncology 73(4):192–7
Fujisawa, M., Isotani, S., Gotoh, A. et al. (2000). Health-related quality of life with orthotopic neobladder versus ileal conduit according to the SF-36 survey Urology 55(6):862–5
Neil-Dwyer, G., Lang, D. A., Davis, A. (2000). Outcome from complex neurosurgery: an evidence-based approach Acta Neurochirurgica 142(4):367–71
Naughton, C. K., Miller, D. C., Yan, Y. (2001). Impact of transrectal ultrasound guided prostate biopsy on quality of life: a prospective randomized trial comparing 6 versus 12 cores Journal of Urology 165(1):100–3
Rogers, S. N., Lowe, D., Humphris, G. (2000). Distinct patient groups in oral cancer: a prospective study of perceived health status following primary surgery Oral Oncology 36(6):529–38
de Boer, A. G. E. M., Onorbe Genovesi, P. I., Sprangers, M. A. G. et al. (2000). Quality of life in long-term survivors after curative transhiatal oesophagectomy for oesophageal carcinoma British Journal of Surgery 87(12):1716–21
Thompson-Fawcett, M. W., Richard, C. S., O'Connor, B. I. et al. (2000). Quality of life is excellent after a pelvic pouch for colitis-associated neoplasia Diseases of the Colon and Rectum 43(11):1497–502
Clark, P. E., Schover, L. R., Uzzo, R. G. et al. (2001). Quality of life and psychological adaptation after surgical treatment for localized renal cell carcinoma: impact of the amount of remaining renal tissue Urology 57(2):252–6
Davis, A. M., Devlin, M., Griffin, A. M. et al. (1999). Functional outcome in amputation versus limb sparing of patients with lower extremity sarcoma: a matched case-control study Archives of Physical Medicine and Rehabilitation 80(6):615–18
Janda, M., Gerstner, N., Obermair, A. et al. (2000). Quality of life changes during conformal radiation therapy for prostate carcinoma Cancer 89(6):1322–8
Sanchez-Ortiz, R. F., Broderick, G. A., Rovner, E. S. et al. (2000). Erectile function and quality of life after interstitial radiation therapy for prostate cancer International Journal of Impotence Research 12(Suppl. 3):S18–24
Beard, C. J., Propert, K. J., Rieker, P. P. et al. (1997). Complications after treatment with external-beam irradiation in early-stage prostate cancer patients: a prospective multiinstitutional outcomes study Journal of Clinical Oncology 15(1):223–9
Ganz, P. A., Greendale, G. A., Petersen, L. et al. (2000). Managing menopausal symptoms in breast cancer survivors: results of a randomized controlled trial Journal of the National Cancer Institute 92(13):1054–64
Hammerlid, E., Taft, C. (2001). Health-related quality of life in long-term head and neck cancer survivors: a comparison with general population norms British Journal of Cancer 84(2):149–56
Vickberg, S. M. J., Duhamel, K. N., Smith, M. Y. et al. (2001). Global meaning and psychological adjustment among survivors of bone marrow transplant Psycho-Oncology 10(1):29–39
Loge, J. H., Abrahamsen, A. F., Ekeberg, O. et al. (1999). Reduced health-related quality of life among Hodgkin's disease survivors: a comparative study with general population norms Annals of Oncology 10(1):71–7
Litwin, M. S., Shpall, A. I., Dorey, F. et al. (1998). Quality-of-life outcomes in long-term survivors of advanced prostate cancer American Journal of Clinical Oncology 21(4):327–32
QualityMetrics, Inc. Medical Outcomes Study instruments and measurement tools. Available at: www.qualitymetric.com. Last accessed October 17, 2002
Hyland, M. E. (2002). Recommendations from quality of life scales are not simple (letter) British Medical Journal 325:599
McNair, D. M., Lorr, M., Droppleman, L. F. (1971/1981). EITS Manual for the Profile of Mood States. San Diego, CA: Educational and Industrial Testing Service
Cella, D. F., Jacobsen, P. B., Orav, E. J. et al. (1987). A brief POMS measure of distress for cancer patients Journal of Chronic Diseases 40(10):939–42
Guadagnoli, E., Mor, V. (1989). Measuring cancer patients' affect: revision and psychometric properties of the Profile of Mood States (POMS) Journal of Consulting and Clinical Psychology 84:907–15
Shacham, S. (1983). A shortened version of the Profile of Mood States Journal of Personality Assessment 47(3):305–6
Bunevicius, R., Kazanavicius, G., Zalinkevicius, R. et al. (1999). Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism New England Journal of Medicine 340(6):424–9
Postma, T. J., Heimans, J. J., Luykx, S. A. et al. (2000). A phase II study of paclitaxel in chemonaive patients with recurrent high-grade glioma Annals of Oncology 11(4):409–43
Ahles, T. A., Silberfarb, P. M., Herndon II, J. et al. (1998). Psychologic and neuropsychologic functioning of patients with limited small-cell lung cancer treated with chemotherapy and radiation therapy with or without warfarin: a study by the Cancer and Leukemia Group B Journal of Clinical Oncology 16(5):1954–60
Heinonen, H., Volin, L., Uutela, A. et al. (2001). Quality of life and factors related to perceived satisfaction with quality of life after allogeneic bone marrow transplantation Annals of Hematology 80(3):137–43
Fife, B. L., Huster, G. A., Cornetta, K. G. et al. (2000). Longitudinal study of adaptation to the stress of bone marrow transplantation Journal of Clinical Oncology 18(7):1539–49
Nissen, M. J., Swenson, K. K., Ritz, L. J. et al. (2001). Quality of life after breast carcinoma surgery: a comparison of three surgical procedures Cancer 91(7):1238–46
Braslis, K. G., Santa-Cruz, C., Brickman, A. L. et al. (1995). Quality of life 12 months after radical prostatectomy British Journal of Urology 75(1):48–53
Jason, G. W., Pajurkova, E. M., Taenzer, P. A. et al. (1997). Acute effects on neuropsychological function and quality of life by high-dose multiple daily fractionated radiotherapy for malignant astrocytomas: assessing the tolerability of a new radiotherapy regimen Psycho-Oncology 6(2):151–7
Greenberg, D. B., Kornblith, A. B., Herndon, J. E. et al. (1997). Quality of life for adult leukemia survivors treated on clinical trials of cancer and leukemia Group B during the period 1971–1988: predictors for later psychologic distress Cancer 80(10):1936–44
Gotay, C. C., Muraoka, M. Y. (1998). Quality of life in long-term survivors of adult-onset cancers Journal of the National Cancer Institute 90(9):656–67
Haidet, P., Hamel, M. B., Davis, R. B. et al. (1998). Outcomes, preferences for resuscitation, and physician-patient communication among patients with metastatic colorectal cancer American Journal of Medicine 105(3):222–9
Paterson, D. L., Gayowski, T., Wannstedt, C. F. et al. (2000). Quality of life in long-term survivors after liver transplantation: impact of recurrent viral hepatitis C virus Hepatitis. Clinical Transplantation 4(1):48–54
Holland, J. C., Silberfarb, P., Tross, S. et al. (1986). Psychosocial research in cancer: the Cancer and Leukemia Group B (CALGB) experience. In Assessment of Quality of Life and Cancer Treatment, ed. V. Ventafridda, F. S. A. M. van Dam, R. Yancik et al., pp. 89–101. New York, NY: Elsevier Science Publishers
Spitzer, W. O., Dobson, A. J., Hall, J. et al. (1981). Measuring the quality of life of cancer patients: a concise QL-Index for use by physicians Journal of Chronic Diseases 34(12):585–97
Lipton, A., Theriault, R. L., Hortobagyi, G. N. et al. (2000). Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: long term follow-up of two randomized, placebo-controlled trials Cancer 88(5):1082–90
Berr, F., Wiedmann, M., Tannapfel, A. et al. (2000). Photodynamic therapy for advanced bile duct cancer: evidence for improved palliation and extended survival Hepatology 31(2):291–8
Mor, V., Stalker, M. Z., Gralla, R. et al. (1988). Day hospital as an alternative to inpatient care for cancer patients: a random assignment trial Journal of Clinical Epidemiology 41(8):771–85
Leo, E., Audisio, R. A., Belli, F. (1994). Total rectal resection and colo-anal anastomosis for low rectal tumours: comparative results in a group of young and old patients European Journal of Cancer 30A(8):1092–5
Knight, S. J., Chmiel, J. S., Kuzel, T. et al. (1998). Quality of life in metastatic prostate cancer among men of lower socioeconomic status: feasibility and criterion related validity of 3 measures Journal of Urology 160(5):1765–9
Hortobagyi, G. N., Theriault, R. L., Lipton, A. et al. (1998). Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate Journal of Clinical Oncology 16(6):2038–44
Riccardi, A., Tinelli, C., Brugnatelli, S. et al. (2000). Doubling of the epirubicin dosage within the 5-fluorouracil, epirubicin and cyclophosphamide regimen: a prospective, randomized, multicentric study on antitumor effect and quality of life in advanced breast cancer International Journal of Oncology 16(4):769–76
Theriault, R. L., Lipton, A., Hortobagyi, G. N. (1999). Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: a randomized, placebo-controlled trial Journal of Clinical Oncology 17(3):846–54
Roseveare, C. D., Patel, P., Simmonds, N. et al. (1998). Nutrition and survival in malignant oesophageal stenosis: a randomized controlled trial comparing modified Gianturco Z-Stents with plastic Atkinson tubes European Journal of Gastroenterology and Hepatology 10(8):653–7
Wu, C.-W., Hsieh, M.-C., Lo, Su-S. et al. (1997). Quality of life of patients with gastric adenocarcinoma after curative gastrectomy World Journal of Surgery 21(7):777–82
Wu, C.-W., Lo, S.-S., Shen, K.-H. et al. (2000). Surgical mortality, survival, and quality of life after resection for gastric cancer in the elderly World Journal of Surgery 24(4):465–72
Barr, H., Krasner, N., Raouf, A. et al. (1990). Prospective randomized trial of laser therapy only and laser therapy followed by endoscopic intubation for the palliation of malignant dysphagia Gut 31(1):252–8
Donnelly, S., Rybicki, L., Walsh, D. (2001). Quality of life measurement in the palliative management of advanced cancer Supportive Care in Cancer 9(5):361–5
Hinton, J. (1994). Can home care maintain an acceptable quality of life for patients with terminal cancer and their relatives? Palliative Medicine 8(3):183–96
Hinton, J. (1994). Which patients with terminal cancer are admitted from home care? Palliative Medicine 8(3):197–210
de Bruin, A. F., Buys, M., de Witte, L. P. et al. (1994). The Sickness Impact Profile: SIP68, a short generic version. First evaluation of the reliability and reproducibility Journal of Clinical Epidemiology 47(8):863–71
Dales, R. E., Belanger, R., Shamji, F. M. et al. (1994). Quality-of-life following thoracotomy for lung cancer Journal of Clinical Epidemiology 47(12):1443–9
Wu, A. W., Damiano, A. M., Lynn, J. et al. (1995). Predicting future functional status for seriously ill hospitalized adults: the SUPPORT prognostic model Annals of Internal Medicine 122(5):342–50
Tsevat, J., Cook, E. F., Green, M. L. et al. (1994). Health values of the seriously ill Annals of Internal Medicine 122(7):514–20
Durand-Zaleski, I., Earlam, S., Fordy, C. et al. (1998). Cost-effectiveness of systemic and regional chemotherapy for the treatment of patients with unresectable colorectal liver metastases Cancer 83(5):882–8
Earlam, S., Glover, C., Davies, M. et al. (1997). Effect of regional and systemic fluorinated pyrimidine chemotherapy on quality of life in colorectal liver metastasis patients Journal of Clinical Oncology 15(5):2022–9
Langius, A., Bjorvell, H., Lind, M. G. (1994). Functional status and coping in patients with oral and pharyngeal cancer before and after surgery Head and Neck 16(6):559–68
Hassan, S. J., Weymuller, Jr., E. A. (1993). Assessment of quality of life in head and neck cancer patients Head and Neck 15(6):485–96
Tenover, J. L., Pagano, G. A., Morton, A. S. et al. (1997). Efficacy and tolerability of finasteride in symptomatic benign prostatic hyperplasia: a primary care study Clinical Therapeutics 19(2):243–58
McLeod, R. S., Taylor, B. R., O'Connor, B. I. et al. (1995). Quality of life, nutritional status, and gastrointestinal hormone profile following the Whipple procedure American Journal of Surgery 169(1):179–85
Svedlund, J., Sullivan, M., Liedman, B. et al. (1997). Quality of life after gastrectomy for gastric carcinoma: controlled study of reconstructive procedures World Journal of Surgery 21(4):422–33
McDowell, I., Newell, C. (1987). Measuring Health: A Guide to Rating Scales and Questionnaires. New York: Oxford University Press
Patrick, D. L., Deyo, R. (1989). Generic and disease-specific measures in assessing health status and quality of life Medical Care 27:S217–23
Ganz, P. A., Schag, C. A. C., Lee, J. J. et al. (1992). The CARES: A generic measure of health-related quality of life for patients with cancer Quality of Life Research 1(1):19–29
Heinrich, R. L., Schag, C. A. C., Ganz, P. A. (1984). Living with cancer: the cancer inventory of problem situations Journal of Clinical Psychology 40:972–80
Schag, C. A. C., Heinrich, R. L., Ganz, P. A. (1983). Cancer inventory of problem situations: an instrument for assessing cancer patients' rehabilitation needs Journal of Psychosocial Oncology 1:11–24
Ganz, P. A., Schag, C. A. C., Cheng, H.-L. (1990). Assessing the quality of life — a study in newly-diagnosed breast cancer patients Journal of Clinical Epidemiology 43(1):75–86
Schag, C. A., Heinrich, R. L. (1990). Development of a comprehensive quality of life measurement tool: CARES Oncology 4:135–8
Schag, C. A. C., Ganz, P. A., Heinrich, R. L. (1991). Cancer Rehabilitation Evaluation System — Short Form (CARES-SF): a cancer specific rehabilitation and quality of life instrument Cancer 68(6):1406–13
Cramer, J. A., Arrigo, C., Van Hammee, G. et al. (2000). Comparison between the QOLIE-31 and Derived QOLIE-10 in a clinical trial of levetiracetam Epilepsy Research 41(1):29–38
Devinsky, O., Vickrey, B. G., Cramer, J. et al. (1995). Development of the quality of life in Epilepsy Inventory Epilepsia 36(11):1089–104
Frost, M. H., Suman, V. J., Rummans, T. A. et al. (2000). Physical, psychological and social well-being of women with breast cancer: the influence of disease phase Psycho-Oncology 9(3):221–31
Herth, K. (2000). Enhancing hope in people with a first recurrence of cancer Journal of Advanced Nursing 32(6):1431–41
Rustoen, T., Wiklund, I., Hanestad, B. R. et al. (1998). Nursing intervention to increase hope and quality of life in newly diagnosed cancer patients Cancer Nursing 21(4):235–45
Hawighorst-Knapstein, S., Schonefuss, G., Hoffmann, S. O. et al. (1997). Pelvic exenteration: effects of surgery on quality of life and body image — a prospective longitudinal study Gynecologic Oncology 66(3):495–500
Ganz, P. A., Schag, C. A. C., Lee, J. J. et al. (1992). Breast conservation versus mastectomy: is there a difference in psychological adjustment or quality of life in the year after surgery? Cancer 69(7):1729–38
Glimelius, B., Birgegard, G., Hoffman, K. et al. (1992). Improved care of patients with small cell lung cancer: nutritional and quality of life aspects Acta Oncologica 31(8):823–31
Litwin, M. S., Fine, J. T., Dorey, F. et al. (1997). Health related quality of life outcomes in patients treated for metastatic kidney cancer: a pilot study Journal of Urology 157(5):1608–12
Schag, C. A. C., Ganz, P. A., Wing, D. S. et al. (1994). Quality of life in adult survivors of lung, colon and prostate cancer Quality of Life Research 3:127–41
Wellisch, D. K., Centeno, J., Guzman, J. et al. (1996). Bone marrow transplantation vs. high-dose cytorabine-based consolidation chemotherapy for acute myelogenous leukemia: a long-term follow-up study of quality-of-life measures of survivors Psychosomatics 37(2):144–54
Ashing-Giwa, K., Ganz, P. A., Petersen, L. (1999). Quality of life of African-American and white long term breast carcinoma survivors Cancer 85(2):418–26
Gritz, E. R., Carmack, C. L., de Moor, C. et al. (1999). First year after head and neck cancer: quality of life Journal of Clinical Oncology 17(1):352–60
Sprangers, M. A. G., Cull, A., Groenvold, M. et al. (1998). The European Organization for Research and Treatment of Cancer approach to developing questionnaire modules: an update and overview Quality of Life Research 7:291–300
Aaronson, N. K., Cull, A. M., Kaasa, S. et al. (1996). The European Organization for Research and Treatment of Cancer (EORTC) modular approach to quality of life assessment in oncology: an update. In Quality of Life and Pharmacoeconomics in Clinical Trials (2nd Edition), ed. B. Spilker, pp. 179–89. Philadelphia, PA: Lippincott-Raven Publishers
Bjordal, K., Ahlmer-Elmqvist, M., Tollesson, E. et al. (1994). Development of a European Organization for Research and Treatment of Cancer (EORTC) questionnaire module to be used in quality of life assessments in head and neck cancer patients Acta Oncologica 33(8):879–85
Borghede, G., Sullivan, M. (1996). Measurement of quality of life in localized prostatic cancer patients treated with radiotherapy. Development of a prostate cancer-specific module supplementing the EORTC QLQ-C30 Quality of Life Research 5(2):212–22
Detmar, S. B., Aaronson, N. K. (1998). Quality of life assessment in daily clinical oncology practice: a feasibility study European Journal of Cancer 34(8):1181–6
Macquart-Moulin, G., Viens, P., Palangie, T. et al. (2000). High-dose sequential chemotherapy with recombinant granulocyte colony-stimulating factor and repeated stem-cell support for inflammatory breast cancer patients: does impact on quality of life jeopardize feasibility and acceptability of treatment? Journal of Clinical Oncology 18(4):754–64
Morant, R., Bernhard, J., Maibach, R. et al. (2000). Response and palliation in a phase II trial of gemcitabine in hormone-refractory metastatic prostatic carcinoma Annals of Oncology 11(2):183–8
Rauch, D. P., Maurer, C. A., Aebi, S. et al. (2001). Activity of gemcitabine and continuous infusion fluorouracil in advanced pancreatic cancer Oncology 60(1):43–8
Simons, J. P., Aaronson, N. K., Vansteenkiste, J. F. et al. (1996). Effects of medroxyprogesterone acetate on appetite, weight, and quality of life in advanced-stage non-hormone-sensitive cancer: a placebo-controlled multicenter study Journal of Clinical Oncology 14(4):1077–84
Hoffman, K., Glimelius, B. (1998). Evaluation of clinical benefit of chemotherapy in patients with upper gastrointestinal cancer Acta Oncologica 37(7–8):651–9
Osoba, D., Brada, M., Prados, M. D. et al. (2000). Effect of disease burden on health-related quality of life in patients with malignant gliomas Neuro-Oncology 2(4):221–8
Huan, S. D., Natale, R. B., Stewart, D. J. et al. (2000). Multicenter phase II trial of losoxantrone (DuP-941) in hormone-refractory metastatic prostate cancer Clinical Cancer Research 6(4):1333–6
Latreille, J., Pater, J., Johnston, D. et al. (1998). Use of dexamethasone and granisetron in the control of delayed emesis for patients who receive highly emetogenic chemotherapy Journal of Clinical Oncology 16(3):1174–8
Genre, D., Protiere, C., Macquart-Moulin, G. et al. (2002). Quality of life of breast cancer patients receiving high-dose-intensity chemotherapy: impact of length of cycles Supportive Care in Cancer 10(3):222–30
Greimel, E., Thiel, I., Peintinger, F. et al. (2002). Prospective assessment of quality of life of female cancer patients Gynecologic Oncology 85(1):140–7
Bjordal, K., Mastekaasa, A., Kaasa, S. (1995). Self-reported satisfaction with life and physical health in long-term cancer survivors and a matched control group European Journal of Cancer: Oral Oncology 31B(5):340–5
Joly, F., Henry-Amar, M., Arveux, P. et al. (1996). Psychosocial sequelae in Hodgkin's disease survivors: a French population-based case-control study Journal of Clinical Oncology 14(9):2444–53
Holzner, B., Kemmler, G., Kopp, M. et al. (2001). Quality of life in breast cancer patients — not enough attention for long-term survivors? Psychosomatics 42(2):117–23
Norum, J., Wist, E. A. (1996). Quality of life in survivors of Hodgkin's disease Quality of Life Research 5(3):367–74
Kallen, K.-J., Hofmann, M. A. K., Timm, A. et al. (2000). Weekly oxaliplatin, high-dose infusional 5-fluorouracil and folinic acid as palliative third-line therapy of advanced colorectal carcinoma Zeitschrift für Gastroenterologie 38(2):153–7
Langendijk, J. A., ten Velde, G. P. M., Aaronson, N. K. et al. (2000). Quality of life after palliative radiotherapy in non-small cell lung cancer: a prospective sudy International Journal of Radiation Oncology Biology and Physics 47(1):149–55
Radbruch, L., Sabatowski, R., Loick, G. et al. (2000). Constipation and the use of laxatives: a comparison between transdermal fentanyl and oral morphine Palliative Medicine 14(2):111–19
Doyle, C., Crump, M., Pintilie, M. et al. (2001). Does palliative chemotherapy palliate? Evaluation of expectations, outcomes, and costs in women receiving chemotherapy for advanced ovarian cancer Journal of Clinical Oncology 19(5):1266–74
Geels, P., Eisenhauer, E., Bezjak, A. et al. (2000). Palliative effect of chemotherapy: objective tumor response is associated with symptom improvement in patients with metastatic breast cancer Journal of Clinical Oncology 18(12):2395–405
Cella, D. F. (1997). FACIT MANUAL: Manual of the Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System, Version 4, Evanston, IL: Evanston Northwestern Healthcare and Northwestern University
Esper, P., Pienta, K., Cella, D. (1995). FACT-P: a new instrument for quality of life evaluation in prostate cancer (Abstract) Journal of Urology 153(Suppl. 4):239A
Carter, J. R., Chen, M. D., Fowler, J. M. et al. (1997). The effect of prolonged cycles of chemotherapy on quality of life in gynaecologic cancer patients Journal of Obstetrics and Gynaecological Research 23(2):197–203
Lutgendorf, S. K., Anderson, B., Rothrock, N. et al. (2000). Quality of life and mood in women receiving extensive chemotherapy for gynecologic cancer Cancer 89(6):1402–11
Sehlen, S., Hollenhorst, H., Lenk, M. et al. (2002). Only sociodemographic variables predict quality of life after radiotherapy in patients with head and neck cancer International Journal of Radiation Oncology Biology and Physics 52(3):779–83
Krupski, T., Petroni, G. R., Bissonette, E. A. et al. (2000). Quality-of-life comparison of radical prostatectomy and interstitial brachytherapy in the treatment of clinically localized prostate cancer Urology 55(5):736–42
Small, E. J., Meyer, M., Marshall, M. E. et al. (2000). Suramin therapy for patients with symptomatic hormone-refractory prostate cancer: results of a randomized phase III trial comparing suramin plus hydrocortisone to placebo plus hydrocortisone Journal of Clinical Oncology 18(7):1440–50
Poon, R. T.-P., Fan, S. T., Yu, W. C. et al. (2001). A prospective longitudinal study of quality of life after resection of hepatocellular carcinoma Archives of Surgery 136(6):693–9
Courneya, K. S., Friedenreich, C. M. (1997). Relationship between exercise pattern across the cancer experience and current quality of life in colorectal cancer survivors Journal of Alternative and Complementary Medicine 3(3):215–26
Schipper, H., Clinch, J., McMurray, A. et al. (1984). Measuring the quality of life of cancer patients: the Functional Living Index — Cancer: development and validation Journal of Clinical Oncology 2(5):472–83
Clinch, J. J. (1996). The Functional Living Index — Cancer: Ten years later. In Quality of Life and Pharmacoeconomics in Clinical Trials (2nd Edition), ed. B. Spilker, pp. 215–25. Philadelphia, PA: Lippincott-Raven Publishers
Remick, S. C., Sedransk, N., Haase, R. F. et al. (2001). Oral combination chemotherapy in conjunction with filgrastim (G-CSF) in the treatment of AIDS-related non-Hodgkin's lymphoma: evaluation of the role of G-CSF; quality-of-life analysis and long-term follow-up American Journal of Hematology 66(3):178–88
Osoba, D. (2000). Health-related quality-of-life assessment in clinical trials of supportive care in oncology Supportive Care in Cancer 8(2):84–8
Schliephake, H., Schmelzeisen, R., Schonweiler, R. et al. (1998). Speech, deglutition and life quality after intraoral tumour resection: a prospective study International Journal of Oral and Maxillofacial Surgery 27(2):99–105
Goss, P. E., Winer, E. P., Tannock, I. F. et al. (1999). Randomized phase III trial comparing the new potent and selective third-generation aromatase inhibitor vorozole with megestrol acetate in postmenopausal advanced breast cancer patients Journal of Clinical Oncology 17(1):52–63
Goss, P. E., Strasser, K., Marques, R. et al. (2000). Liarozole fumarate (R85246): in the treatment of ER negative, tamoxifen refractory or chemotherapy resistant postmenopausal metastatic breast cancer Breast Cancer Research and Treatment 64(2):177–88
Harvey, J., Cantrell, J. Jr.,, Campbell, M. et al. (2001). Mitoxantrone and paclitaxel combination chemotherapy in metastatic breast cancer Cancer Investigation 19(3):225–33
Goss, P. E., Oza, A., Goel, R. et al. (2000). Liarozole fumarate (R85246): a novel imidazole in the treatment of receptor positive postmenopausal metastatic breast cancer Breast Cancer Research and Treatment 59(1):55–68
Laufman, L. R., Bukowski, R. M., Collier, M. A. et al. (1993). A randomized, double-blind trial of fluorouracil plus placebo versus fluorouracil plus oral leucovorin in patients with metastatic colorectal cancer Journal of Clinical Oncology 11(10):1888–93
Clohisy, D. R., Le, C. T., Cheng, E. Y. et al. (2000). Evaluation of the feasibility of and results of measuring health-status changes in patients undergoing surgical treatment for skeletal metastases Journal of Orthopaedic Research 18(1):1
Ruckdeschel, J. C., Piantadosi, S. (1994). Quality of life in lung cancer surgical adjuvant trials Chest 106(Suppl. 6):324S–8S
de Haes, J. C. J. M., Pruyn, J. F. A., van Knippenberg, F. C. E. (1983). Complaint list for cancer patients: first experiences Nederlands Tijdschrift voor de Psychologie 38:403–22
de Haes, J. C. J. M., van Knippenberg, F. C. E., Neijt, J. P. (1990). Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist British Journal of Cancer 62(6):1034–8
Luteijn, F., Kok, A. R., Hamel, L. F. et al. (1979). Enige Ervaringe met en Klachtenlijst NederlandsTidjschrift voor Psychologie 34:167
Linssen, A. C. G., van Dam, F. S. A. M., Engelsman, E. et al. (1979). Leven met cytostatica Pharmaceutisch Weekblad 114:501
McCorkle, R., Young, K. (1978). Development of a symptom distress scale Cancer Nursing 1(5):373–8
O'Hanlon, D. M., Harkin, M., Karat, D. et al. (1995). Quality-of-life assessment in patients undergoing treatment for oesophageal carcinoma British Journal of Surgery 82(12):1682–5
Allen-Mersh, T. G., Earlam, S., Fordy, C. et al. (1994). Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases Lancet 344(8932):1255–60
Kramer, J. A., Curran, D., Piccart, M. et al. (2000). Randomised trial of paclitaxel versus doxorubicin as first-line chemotherapy for advanced breast cancer: quality of life evaluation using the EORTC QLQ-C30 and the Rotterdam Symptom Checklist European Journal of Cancer 36(12):1488–97
Kramer, J. A., Curran, D., Piccart, M. et al. (2000). Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in first-line chemotherapy in advanced breast cancer European Journal of Cancer 36(12):1498–506
Ranson, M., Davidson, N., Nicolson, M. et al. (2000). Randomized trial of paclitaxel plus supportive care versus supportive care for patients with advanced non-small-cell lung cancer Journal of the National Cancer Institute 92(13):1074–80
de Haes, J. C. J. M., Olschewski, M. (1998). Quality of life assessment in a cross-cultural context: use of the Rotterdam Symptom Checklist in a multinational randomised trial comparing CMF and Zoladex (Goserlin) treatment in early breast cancer Annals of Oncology 9(7):745–50
Erickson, P. (2001). Trends in population-based health-related quality of life: implications for interpretation of change Value in Health 4(6):418
Johnston, M., Pollard, B., Hennessey, P. (2000). Construct validation of the Hospital Anxiety and Depression Scale with clinical populations Journal of Psychosomatic Research 48(6):579–84
Velikova, G., Wright, P., Smith, A. B. et al. (2001). Self-reported quality of life of individual cancer patients: concordance of results with disease course and medical records Journal of Clinical Oncology 19(7):2064–73
Hopwood, P., Howell, A., Maguire, P. (1991). Screening for psychiatric morbidity in patients with advanced breast cancer: validation of two self-report questionnaires British Journal of Cancer 64:353–6
Skarstein, J., Aass, N., Fossa, S. D. et al. (2000). Anxiety and depression in cancer patients: relation between the Hospital Anxiety and Depression Scale and the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire Journal of Psychosomatic Research 49(1):27–34
Curran, S. L., Andrykowski, M. A., Studts, J. L. (1995). Short Form of the Profile of Mood States (POMS-SF): psychometric information Psychological Assessment 7(1):80–3
Mosconi, P., Cifani, S., Crispino, S. et al. (2000). The performance of the SF-36 Health Survey in patients with laryngeal cancer Head and Neck 22(2):175–82
Rogers, S. N., Lowe, D., Brown, J. S. et al. (1998). Comparison between the University of Washington Head and Neck Disease-Specific Measure and the Medical Short Form 36, EORTC-QLQ-C33, and EORTC Head and Neck 35 Oral Oncology 34(5):361–72
McHorney, C. A., Ware, J. E., Raczek, A. E. (1993). The MOS 36-Item Short-Form Health Status Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs Medical Care 31(3):247–63
McHorney, C. A., Ware, J. E., Lu, J. F. R. et al. (1994). The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions and reliability across diverse patient groups Medical Care 32(4):40–66
Ware, J. E., Kosinski, M., Bayliss, M. S. et al. (1995). Comparison of methods for the scoring and statistical analysis of the SF-36 health profile and summary measures: results from the Medical Outcomes Study Medical Care 33:A5264–A5279
Stewart, A. L., Greenfield, S., Hays, R. D. et al. (1989) Functional status and well-being of patients with chronic conditions: results from the Medical Outcomes Study Journal of the American Medical Association 262(7):907–13
Quality Metric, Inc. includes an online version of the instrument, annotated bibliography, on-line article searches, norms table downloads, open discussion groups, FAQs, and weekly SF e-mail newsletters. Available at http://www.sf36.com. Last accessed September 9, 2004
Sloan, J. A., Loprinzi, C. L., Kuross, S. A. et al. (1998). Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer Journal of Clinical Oncology 16(11):3662–73
Bergner, M., Bobbitt, R. A., Pollard, W. E. et al. (1976). The Sickness Impact Profile: validation of a Health Status Measure Medical Care 14(1):57–67
Carter, W. B., Bobbitt, R. A., Bergner, M. et al. (1976). Validation of an interval scaling: the Sickness Impact Profile Health Services Research 11(4):516–28
Pollard, W. E. M., Bobbitt, R. A., Bergner, M. et al. (1976). The Sickness Impact Profile: reliability of a health status measure Medical Care 14(2):146–55
Hunt, S. M., McKenna, S. P., McEwen, J. (1981). Reliability of a population survey tool for measuring perceived health problems: a study of patients with osteoarthrosis Journal of Epidemiology and Community Health 35:297–300
Hunt, S. M., McKenna, S. P., McEwen, J. et al. (1980). A quantitative approach to perceived health status: a validation study Journal of Epidemiology and Community Health 34(4):281–6
McKenna, S. P., McEwen, J., Hunt, S. M. et al. (1984). Changes in the perceived health of patients recovering from fractures Public Health (London) 98:97–102
Uyl-de Groot, C. A., Hagenbeek, A., Verdonck, L. F. et al. (1995). Cost-effectiveness of ABMT in comparison with CHOP chemotherapy in patients with intermediate- and high-grade malignant non-Hodgkin's lymphoma (NHL) Bone Marrow Transplantation 16(3):463–70
O'Toole, D., Ducreux, M., Bommelaer, G. I. et al. (2000). Treatment of carcinoid syndrome: a prospective crossover evaluation of lanreotide versus octreotide in terms of efficacy, patient acceptability, and tolerance Cancer 88(4):770–6
Hunt, S. M., McEwen, J. (1980). The development of a subjective health indicator Sociology of Health and Illness 2:231–46
Hunt, S. M., McEwen, J., McKenna, S. P. et al. (1984). Subjective health assessments and the perceived outcome of minor surgery Journal of Psychosomatic Research 28(2):105–14
Hunt, S. M., McEwen, J., McKenna, S. P. et al. (1982). Subjective health status of patients with peripheral vascular disease Practitioner 226(1363):133–6
Ferrans, C. E., Powers, M. J. (1985). Quality of Life Index: development and psychometric properties Advances in Nursing Science 8(1):15–24
Ferrans, C. E., Powers, M. J. (1992). Psychometric assessment of the Quality of Life Index Research in Nursing and Health 15(1):29–38
Ferrans, C. E. (1990). Development of a quality of life index for patients with cancer Oncology Nursing Forum 17(3 Suppl.):15–21
Schag, C. A. C., Heinrich, R. L., Aadland, R. L. et al. (1990). Assessing problems of cancer patients: psychometric properties of the Cancer Inventory of Problem Situations Health Psychology 9(1):83–102
Schag, C. A. C., Ganz, P. A., Polinsky, M. L. et al. (1993). Characteristics of women at risk for psychosocial distress in the year after breast cancer Journal of Clinical Oncology 11(4):783–93
Schag, C. A. C., Heinrich, R. L. (1989). The Cancer Rehabilitation Evaluation System (CARES) Manual. Los Angeles: CARES Consultants
Kemmler, G., Holzner, B., Kopp, M. et al. (1999). Comparison of two quality-of-life instruments for cancer patients: the Functional Assessment of Cancer Therapy-General and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30. Journal of Clinical Oncology 17(9):2932–40
Weitzner, M. A., Meyers, C. A., Gelke, C. K. et al. (1995). The Functional Assessment of Cancer Therapy (FACT) Scale: development of a brain subscale and revalidation of the General version (FACT-G) in patients with primary brain tumors Cancer 75(5):1151–61
Winstead-Fry, P., Schultz, A. (1997). Psychometric analysis of the Functional Assessment of Cancer Therapy-General (FACT-G) Scale in a rural sample Cancer 79(12):2446–52
Dow, K. H., Ferrell, B. R., Anello, C. (1997). Quality-of-life changes in patients with thyroid cancer after withdrawal of thyroid hormone therapy Thyroid 7(4):613–19
Knight, S. J., Chmiel, J. S., Sharp, L. K. et al. (2001). Spouse ratings of quality of life in patients with metastatic prostate cancer of lower socioeconomic status: an assessment of feasibility, reliability, and validity Urology 57(2):275–80
Morrow, G. R., Lindke, J., Black, P. (1992). Measurement of quality of life in patients: psychometric analyses of the Functional Living Index-Cancer (FLIC) Quality of Life Research 1:287–96
Butow, P., Coates, A., Dunn, S. et al. (1991). On the receiving end. IV: Validation of quality of life indicators Annals of Oncology 2(8):597–603
King, M. T., Dobson, A. J., Harnett, P. R. (1996). A comparison of two quality-of-life questionnaires for cancer clinical trials: the Functional Living Index-Cancer (FLIC) and the Quality of Life Questionnaire Core Module (QLQ-C30) Journal of Clinical Epidemiology 49(1):21–9
Buxton, J., White, M., Osoba, D. (1998). Patients' experiences using a computerized program with a touch-sensitive video monitor for the assessment of health-related quality of life Quality of Life Research 7(6):513–19
Osoba, D., Zee, B., Pater, J. et al. (1994). Psychometric properties and responsiveness of the EORTC Quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer Quality of Life Research 3(5):353–64
Hjermstad, M. J., Fossa, S. D., Bjordal, K. et al. (1995). Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire Journal of Clinical Oncology 13(5):1249–54
Bjordal, K., Kaasa, S. (1992). Psychometric validation of the EORTC Core Quality of Life Questionnaire, 30-Item Version, and a diagnosis-specific module for head and neck cancer patients Acta Oncologica 31(3):311–21
Niezgoda, H. E., Pater, J. L. (1993). A validation study of the domains of the Core EORTC Quality of Life Questionnaire Quality of Life Research 2(5):319–25
Ringdal, G. I., Ringdal, K. (1993). Testing the EORTC Quality of Life Questionnaire on cancer patients with heterogeneous diagnoses Quality of Life Research 2:129–40
Apolone, G., Filberti, A., Cifani, S. et al. (1998). Evaluation of the EORTC QLQ-C30 Questionnaire: a comparison with SF-36 Health Survey in a cohort of Italian long-survival cancer patients Annals of Oncology 9(5):549–57
Groenvold, M., Klee, M. C., Sprangers, M. A. G. et al. (1997). Validation of the EORTC QLQ-C30 Quality of Life Questionnaire through combined qualitative and quantitative assessment of patient-observer agreement Journal of Clinical Epidemiology 50(4):441–50
Ravaioli, A., Buda, P., Fava, C. et al. (1996). Assessment of the RSCL quality of life instrument during chemotherapy in an Italian setting Quality of Life Research 5(5):491–5

Reference Title: REFERENCES

Reference Type: reference-list

Erickson, this volume, Chapter 3
Drummond, M. F., O'Brien, B., Stoddart, G. et al. (1997). Methods for the Economic Evaluation of Health Care Programmes (2nd Edition). Oxford: Oxford University Press
O'Brien, this volume, Chapter 25
Neumann, P. J., Hermann, R. C., Kuntz, M. et al. (1999). Cost-effectiveness of donepezil in treatment of mild or moderate Alzheimer's disease Neurology 52:1138–45
Gold, M. R., Siegel, J. E., Russell, L. B. et al. (eds.) (1996). Cost-Effectiveness in Health and Medicine. New York: Oxford University Press
Furlong, W., Feeny, D., Torrance, G. W. et al. (1990). Guide to Design and Development of Health-State Utility Instrumentation. McMaster University Centre for Health Economics and Policy Analysis Working Paper No. 90–9
Torrance, G. W., Feeny, D., Furlong, W. (2001). Visual analogue scales: do they have a role in the measurement of preferences for health states? Medical Decision Making 21:329–34
Streiner, D. L., Norman, G. R. (1995). Health Measurement Scales. A Practical Guide to their Development and Use (2nd Edition). Oxford: Oxford University Press
Bennett, K. J., Torrance, G. W. (1996). Measuring health state preferences and utilities: rating scale, time trade-off, and standard gamble techniques. In Quality of Life and Pharmacoeconomics in Clinical Trials (2nd Edition), ed. B. Spilker, pp. 253–65. Philadelphia, PA: Lippincott-Raven Press
Llewellyn-Thomas, H. A., Sutherland, H. J., Thiel, E. C. (1993). Do patients' evaluations of a future health state change when they actually enter that state? Medical Care 31:1002–12
Feeny, D., Blanchard, C., Mahon, J. L. et al. (2001). Test-retest reliability and the interpretation of utility scores: evidence from elective total hip arthroplasty (abstract) Quality of Life Research 10:264
Laupacis, A., Bourne, R., Rorabeck, C. et al. (1993). The effect of elective total hip replacement upon health-related quality of life Journal of Bone and Joint Surgery 75-A:1619–26
Torrance, G., Feeny, D., Furlong, W. (2002). Health utility estimation Expert Review in Pharmacoeconomics Outcomes Research 2:99–108
Feeny, D., Barr, R. D., Furlong, W. et al. (1991). Quality of life of the treatment process in pediatric oncology: an approach to measurement. In The Effect of Cancer on Quality of Life, ed. D. Osoba, pp. 73–88. Boca Raton: CRC Press, Inc
Giesler, R. B., Ashton, C. M., Brody, B. et al. (1999). Assessing the performance of utility techniques in the absence of a gold standard Medical Care 37:580–98
Torrance, G. W. (1976). Social preferences for health states: an empirical evaluation of three measurement techniques Socio-Economic Planning Sciences 10:129–36
Green, C., Brazier, J., Deverill, M. (2000). Valuing health-related quality of life: a review of health state valuation techniques Pharmacoeconomics 17:151–65
Torrance, G. W. (1986). Measurement of health state utilities for economic appraisal — a review Journal of Health Economics 5:1–30
Torrance, G. W., Boyle, M. H., Horwood, S. P. (1982). Application of multi-attribute utility theory to measure social preferences for health states Operations Research 30:1042–69
O'Brien, B. J., Viramontes, J. L. (1994). Willingness to pay: a valid and reliable measure of health state preference? Medical Decision Making 14:289–97
van Agt, H. M. E., Essink-Bot, M.-L., Krabbe, P. F. et al. (1994). Test-retest reliability of health state valuations collected with the EuroQol Questionnaire Social Science and Medicine 39:1537–44
Gudex, C., Dolan, P., Kind, P. et al. (1996). Health state valuations from the general public using the visual analogue scale Quality of Life Research 5:521–31
Hays, R. D., Anderson, R., Revicki, D. (1993). Psychometric considerations in evaluating health-related quality of life measures Quality of Life Research 2:441–9
Revicki, D. A., Osoba, D., Fairclough, D. et al. (2000). Recommendations on health-related quality of life research to support labeling and promotional claims in the United States Quality of Life Research 9:887–900
McDowell, I., Newell, C. (1996). Measuring Health: A Guide to Rating Scales and Questionnaires (2nd Edition). New York: Oxford University Press
Bombardier, C., Ware, J., Russell, I. J. et al. (1986). Auranofin therapy and quality of life in patients with rheumatoid arthritis: results of a multicenter trial American Journal of Medicine 81:565–78
Feeny, D., Juniper, E. F., Ferrie, P. J. et al. (1998). Why not just ask the kids? Health-related quality of life in children with asthma. In Measuring Health-Related Quality of Life in Children and Adolescents: Implications for Research, Practice, and Policy, ed. D. Droter, pp. 171–85. Mahwah, NJ: Lawrence Erlbaum Associates
Juniper, E. F., Guyatt, G. H., Feeny, D. H. et al. (1997). Minimum skills required by children to complete health-related quality of life instruments for asthma: comparison of measurement properties European Respiratory Journal 10:2285–94
Patrick, D. L., Starks, H. E., Cain, K. C. et al. (1994). Measuring preferences for health states worse than death Medical Decision Making 14:9–18
von Neumann, J., Morgenstern, O. (1944). Theory of Games and Economic Behavior. Princeton: Princeton University Press
Torrance, G. W., Feeny, D. (1980). Utilities and quality-adjusted life years International Journal of Technology Assessment in Health Care 5:559–75
Feeny, D. H. (2000). A utility approach to assessing health-related quality of life Medical Care 38:II151–II154
Feeny, D. H., Torrance, G. W. (1989). Incorporating utility-based quality-of-life assessments in clinical trials: two examples Medical Care 27:S190–204
Torrance, G. W., Thomas, W. H., Sackett, D. L. (1972). A utility maximization model for evaluation of health care programs Health Services Research 7:118–33
Ness, R. M., Holmes, A. M., Klein, R. et al. (1999). Utility valuations for outcome states of colorectal cancer American Journal of Gastroenterology 94:1650–7
Hayman, J. A., Fairclough, D. L., Harris, J. R. et al. (1997). Patient preferences concerning the trade-off between the risks and benefits of routine radiation therapy after conservative surgery for early-stage breast cancer Journal of Clinical Oncology 15:1252–60
Albertsen, P. C., Nease, R. F., Potosky, A. L. (1998). Assessment of patient preferences among men with prostate cancer Journal of Urology 159:158–63
Chapman, G. B., Elstein, A. S., Kuzel, T. M. et al. (1999). A multi-attribute model of prostate cancer patients' preferences for health states Quality of Life Research 8:171–80
Chapman, G. B., Elstein, A. S., Kuzel, T. M. et al. (1998). Prostate cancer patients' utilities for health states: how it looks depends on where you stand Medical Decision Making 18:278–86
Bennett, C. L., Chapman, G., Elstein, A. S. et al. (1997). A comparison of perspectives on prostate cancer: analysis of the utility assessments of patients and physicians European Urology 32:86–8
Sommers, S. D., Ramsey, S. D. (1999). A review of quality-of-life evaluations in prostate cancer Pharmacoeconomics 16:127–40
Dominitz, J. A., Provenzale, D. (1997). Patient preferences and quality of life associated with colorectal cancer screening American Journal of Gastroenterology 92:2171–8
Ashby, J., O'Hanlon, M., Buxton, M. J. (1994). The time tradeoff technique: how do the valuations of breast cancer patients compare to those of other groups? Quality of Life Research 3:257–65
Jansen, S. T., Stiggelbout, A. M., Wakker, P. P. et al. (2000). Unstable preferences: a shift in valuation or an effect of the elicitation procedure? Medical Decision Making 20:62–71
Jansen, S. J. T., Stiggelbout, A. M., Nooij, M. A. et al. (2000). The effect of individually assessed preference weights on the relationship between holistic utilities and nonpreference-based assessment Quality of Life Research 9:541–57
Jansen, S. J. T., Kievit, J., Nooij, M. A. et al. (2001). Stability of patients' preferences for chemotherapy: the impact of experience Medical Decision Making 21:295–306
Jansen, S. J. T., Nooij, M. A., Overpelt, I. M. E. et al. (2001). Patients' preferences for adjuvant chemotherapy in early-stage breast cancer: is treatment worthwhile? British Journal of Cancer 84:1577–85
Perez, D. J., Williams, S. M., Christensen, E. A. et al. (2001). A longitudinal study of health related quality of life and utility measures in patients with advanced breast cancer Quality of Life Research 10:587–93
O'Connor, A., Boyd, N. F., Warde, P. et al. (1987). Eliciting preferences for alternative drug therapies in oncology: influence of treatment outcome description, elicitation technique and treatment experience on preferences Journal of Chronic Disease 40:811–8
Stiggelbout, A. M., Kiebert, G. M., Kievit, J. et al. (1995). The ‘utility’ of the time trade-off method in cancer patients: feasibility and proportional trade-off Journal of Clinical Epidemiology 48:1207–14
Grann, V. R., Panageas, K. S., Whang, W. et al. (1998). Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1-positive or BRCA2-positive patients Journal of Clinical Oncology 16:979–85
Grann, V. R., Jacobson, J. S., Sundarajan, V. et al. (1999). The quality of life associated with prophylatic treatments for women with BRCA1/2 mutations Cancer Journal from Scientific American 5:283–92
Hurny, C., van Wegberg, B., Bacchi, M. et al. (1998). Subjective health estimations (SHE) in patients with advanced breast cancer: an adapted utility concept for clinical trials British Journal of Cancer 77:985–91
Johnston, K., Brown, J., Gerard, K. et al. (1998). Valuing temporary and chronic health states associated with breast screening Social Science and Medicine 47:213–22
Hall, J., Gerard, K., Salkeld, G., Richardson, J. (1992). A cost utility analysis of mammography screening in Australia Social Science and Medicine 34:993–1004
Kuppermann, M., Shiboski, S., Feeny, D. et al. (1997). Can preference scores for discrete states be used to derive preference scores for an entire path of events? An application to prenatal diagnosis Medical Decision Making 17:42–55
Shiell, A., Seymour, J., Hawe, P. et al. (2000). Are preferences over health states complete? Health Economics 9:47–55
Mohide, E. A., Torrance, G. W., Streiner, D. L. et al. (1988). Measuring the wellbeing of family caregivers using the time trade-off technique Journal of Clinical Epidemiology 41:475–82
Gage, B. F., Cardinalli, A. B., Owens, D. K. (1996). The effects of stroke and stroke prophylaxis with aspirin or warfarin on quality of life Archives of Internal Medicine 156:1829–36
Tosteson, A. N. A., Kneeland, T. S., Nease, R. F. et al. (2002). Automated current health time trade-off assessments in women's health Value in Health 5:98–105
Saigal, C. S., Gornbein, J., Nease, R., Litwin, M. S. (2001). Predictors of utilities for health states in early stage prostate cancer Journal of Urology 166:942–6
Lenert, L., Kaplan, R. M. (2000). Validity and interpretation of preference-based measures of health-related quality of life Medical Care 38:II138–II150
Hutton, J., Brown, R., Borowitz, M. et al. (1996). A new decision model for cost-utility comparisons of chemotherapy in recurrent metastatic breast cancer Pharmacoeconomics 9:8–22
Launois, R., Reboul-Marty, J., Henry, B. et al. (1996). A cost-utility analysis of second-line chemotherapy in metastatic breast cancer: docetaxel versus paclitaxel versus vinorelbine Pharmacoeconomics 10:504–21
Brown, R. E., Hutton, J., Burrell, A. (2001). Cost-effectiveness of treatment options in advanced breast cancer in the UK Pharmacoeconomics 19:1091–102
Goodwin, P. J., Feld, R., Evans, W. K. et al. (1988). Cost-effectiveness of cancer chemotherapy: an economic evaluation of a randomized trial in small-cell lung cancer Journal of Clinical Oncology 6:1537–47
Leung, P. P., Tannock, I. F., Oza, A. M. et al. (1999). Cost-utility analysis of chemotherapy using paclitaxel, docetaxel, or vinorelbine for patients with anthracycline-resistant breast cancer Journal of Clinical Oncology 17:3082–90
Eckman, M. H. (2001). Patient-centered decision making: a view of the past and a look toward the future Medical Decision Making 21:441–7
Lee, S. J., Earle, C. C., Weeks, J. C. (2000). Outcomes research in oncology: history, conceptual framework, and trends in the literature Journal of the National Cancer Institute 92:195–204
Goel, V., Sawka, C. A., Thiel, E. C. et al. (2001). Randomized trial of a patient decision aid for choice of surgical treatment for breast cancer Medical Decision Making 21:1–6
Levine, M. N., Gafni, A., Markham, B. et al. (1992). A bedside decision instrument to elicit patient's preference concerning adjuvant chemotherapy for breast cancer Annals of Internal Medicine 117:53–8
Young, A., Topham, C., Turner, J., Wardle, J. et al. (1999). A patient preference study comparing raltitrexed (‘Tomudex’) and bolus or infusional 5-fluorouracil regimens in advanced colorectal cancer: influence of side-effects and administration attributes European Journal of Cancer 8:154–61
Stiggelbout, A. M., de Haes, J. C. J. M., Vree, R. et al. (1997). Follow-up of colorectal patients: quality of life and attitudes towards follow-up British Journal of Cancer 75:914–20
Cappelli, M., Surh, L., Humphreys, L. et al. (2001). Measuring women's preferences for breast cancer treatments and BRCA1/BRCA2 testing Quality of Life Research 10:595–607
Gelber, R. D., Cole, B. F., Goldhirsh, A. et al. (1996). Adjuvant chemotherapy plus tamoxifen compared with tamoxifen alone for postmenopausal breast cancer: meta-analysis of quality-adjusted survival Lancet 347:1066–71
Essink-Bot, M.-L., Stouthard, M. E. A., Bonsel, G. J. (1993). Generalizability of valuations on health states collected with the EuroQol questionnaire Health Economics 2:237–46
EuroQol Group (1990). EuroQol: a new facility for the measurement of health-related quality of life Health Policy 16:199–208
Dolan, P. (1997). Modeling valuations for EuroQol health states Medical Care 35:1095–108
Rabin, R., de Charro, F. (2001). EQ-5D: a measure of health status from the EuroQol Group Annals of Medicine 33:337–43
Feeny, D. H., Torrance, G. W., Furlong, W. J. (1996). Health Utilities Index. In Quality of Life and Pharmacoeconomics in Clinical Trials (2nd Edition), ed. B. Spilker, pp. 239–52. Philadelphia, PA: Lippincott-Raven Press
Feeny, D., Furlong, W., Torrance, G. W. et al. (2002). Multi-attribute and single-attribute utility functions for the Health Utilities Index Mark 3 System Medical Care 40:113–28
Furlong, W. J., Feeny, D. H., Torrance, G. W. et al. (2001). The Health Utilities Index (HUI) System for assessing health-related quality of life in clinical studies Annals of Medicine 33:375–84
Patrick, D. L., Bush, J. W., Chen, M. M. (1973). Methods for measuring levels of well-being for a health status index Health Services Research 8:228–45
Kind, P. (1996). The EuroQol Instrument: an index of health-related quality of life. In Quality of Life and Pharmacoeconomics in Clinical Trials (2nd Edition), ed. B. Spilker, pp. 191–201. Philadelphia, PA: Lippincott-Raven Press
Krabbe, P. F., Stouthard, M. E., Essink-Bot, M.-L. et al. (1999). The effect of adding a cognitive dimension to the EuroQol Multiattribute Health-Status Classification System Journal of Clinical Epidemiology 52:293–301
Brazier, J. E., Walters, S. J., Nicholl, J. P. et al. (1996). Using the SF-36 and EuroQol on an elderly population Quality of Life Research 5:195–204
Brazier, J. E., Harper, R., Munro, J. et al. (1999). Generic and condition-specific outcome measures for people with osteoarthritis of the knee Rheumatology 38:870–7
Dorman, P., Slattery, J., Farrell, B. (1998). Qualitative comparison of the reliability of health status assessments with the EuroQol and the SF-36 questionnaires after stroke Stroke 29:63–8
Essink-Bot, M.-L., Krabbe, P. F. M., Bonsel, G. J. et al. (1997). An empirical comparison of four generic health status measures: the Nottingham Health Profile, the Medical Outcomes Study 36-Item Short-Form Health Survey, the COOP/WONCA Charts, and the EuroQol Instrument Medical Care 35:522–37
Coons, S. J., Rao, S., Keininger, D. L. et al. (2000). A comparative review of generic quality-of-life instruments Pharmacoeconomics 17:13–35
Trippoli, S., Vaiani, M., Lucioni, C. et al. (2001). Quality of life and utility in patients with non-small cell lung cancer Pharmacoeconomics 19:855–63
Brazier, J., Jones, N., Kind, P. (1993). Testing the validity of the EuroQol and comparing it with the SF-36 health survey questionnaire Quality of Life Research 2:167–8
Lydick, E. (2000). Approaches to the interpretation of quality-of-life scales Medical Care 38:III 80–3
Essink-Bot, M-L., De Koning, H. J., Nijs, H. G. T. et al. (1998). Short-term effects of population-based screening for prostate cancer on health-related quality of life Journal of the National Cancer Institute 90:925–31
Houle, C., Berthelot, J.-M. (2000). A head-to-head comparison of the health utilities Mark 3 and the EQ-5D for the population living in private households in Canada Quality of Life Newsletter 24:5–6
Feeny, D., Furlong, W., Barr, R. D. et al. (1992). A comprehensive multiattribute system for classifying the health status of survivors of childhood cancer Journal of Clinical Oncology 10:923–8
Feeny, D., Furlong, W., Boyle, M. et al. (1995). Multi-attribute health status classification systems: Health Utilities Index Pharmacoeconomics 7:490–502
Torrance, G. W., Furlong, W., Feeny, D. et al. (1995). Multi-attribute preference functions: Health Utilities Index Pharmacoeconomics 7:503–20
Torrance, G. W., Feeny, D. H., Furlong, W. J. et al. (1996). Multi-attribute preference functions for a comprehensive health status classification system: Health Utilities Index Mark 2 Medical Care 34:702–22
Furlong, W., Feeny, D., Torrance, G. W. et al. (1998). Multiplicative Multi-attribute Utility Function for the Health Utilities Index Mark 3 (HUI3) System: A Technical Report. McMaster University Centre for Health Economics and Policy Analysis Working Paper No. 98-11
Barr, R. D., Furlong, W., Dawson, S. et al. (1993). An assessment of global health status in survivors of acute lymphoblastic leukemia in childhood American Journal of Pediatric Hematology/Oncology 15:284–90
Barr, R. D., Simpson, T., Whitton, A. et al. (1999). Health-related quality of life in survivors of tumours of the central nervous system in childhood — a preference-based approach to measurement in a cross-sectional study European Journal of Cancer 35:248–55
Whitton, A. C., Rhydderch, H., Furlong, W. et al. (1997). Self-reported comprehensive health status of adult brain tumor patients using the Health Utilities Index Cancer 80:258–65
Pickard, A. S., Topfer, L.-A., Feeny, D. H. (2004). A structured review of studies on health-related quality of life and economic evaluation in pediatric acute lymphoblastic leukemia Journal of the National Cancer Institute Monographs, in press
Ramsey, S. D., Andersen, M. R., Etzioni, R. et al. (2000). Quality of life in survivors of colorectal carcinoma Cancer 88:1294–1303
Grima, D. T., Torrance, G. W., Francis, G. et al. (2000). Cost and health related quality of life consequences of multiple sclerosis Multiple Sclerosis 6:91–8
Neumann, P. J., Kuntz, K. M., Leon, J. et al. (1999). Health utilities and health status in Alzheimer's disease: a cross-sectional study of subjects and caregivers Medical Care 37:27–32
Neumann, P. J., Sandberg, E. A., Araki, S. S. et al. (2000). A comparison of HUI2 and HUI3 utility scores in Alzheimer's disease Medical Decision Making 20:413–22
Bayoumi, A. M., Redelmeier, D. A. (1999). Economic methods for measuring the quality of life associated with HIV infection Quality of Life Research 8:471–80
Younossi, Z., Boparai, N., McCormick, M. et al. (2001). Assessment of utilities and health-related quality of life in patients with chronic liver disease American Journal of Gastroenterology 96:579–83
Grootendorst, P., Feeny, D., Furlong, W. (2000). Health Utilities Index Mark 3: evidence of construct validity for stroke and arthritis in a population health survey Medical Care 38:290–9
Boyle, M. H., Furlong, W., Feeny, D. et al. (1995). Reliability of the Health Utilities Index Mark III used in the 1991 Cycle 6 General Social Survey Health Questionnaire Quality of Life Research 4:249–57
Moore, A. D., Clarke, A. E., Danoff, D. S. et al. (1999). Can health utility measures be used in lupus research? A comparative validation and reliability study of 4 utility indices Journal of Rheumatology 26:1285–90
Le Gales, C., Costet, N., Gentet, J.-C. et al. (1999). Cross-cultural adaptation of a health status classification system in children with cancer. First results of the French adaptation of the Health Utilities Index Marks 2 and 3 International Journal of Cancer (Suppl.) 12:112–8
Barr, R. D., Petrie, C., Furlong, W. et al. (1997). Health-related quality of life during post-induction chemotherapy in children with acute lymphoblastic leukemia in remission: an influence of corticosteroid therapy International Journal of Oncology 11:333–9
Palmer, C. S., Niparko, J. K., Wyatt, R. et al. (1999). A prospective study of the cost-utility of the multichannel cochlear implant Archives of Otolaryngology — Head and Neck Surgery 125:1221–8
Krabbe, P. F. M., Hinderink, J. B., van den Broek, P. (2000). The effect of cochlear implant use in postlingually deaf adults International Journal of Technology Assessment in Health Care 16:864–73
Grossman, R., Mukherjee, J., Vaughan, D. et al. (1998). A one-year community-based health economic study of ciprofloxacin versus usual antibiotic treatment in acute exacerbations of chronic bronchitis Chest 113:131–41
Torrance, G. W., Walker, V., Grossman, R. et al. (1999). Economic evaluation of ciprofloxacin compared with usual antibacterial care for the treatment of acute exacerbations of chronic bronchitis in patients followed for 1 year Pharmacoeconomics 16:499–520
Suarez-Almazor, M. E., Kendall, C., Johnson, J. A. et al. (2000). Use of health status measures in patients with low back pain in clinical settings. Comparison of specific, generic, and preference-based instruments Rheumatology 39:783–90
Comerota, A. J., Throm, R. C., Mathias, S. D. et al. (2000). Catheter-directed thrombolysis for iliofemoral deep vein thrombosis improves health-related quality of life Journal of Vascular Surgery 32:130–7
Kaplan, R. M., Anderson, J. P. (1996). The General Health Policy Model: an integrated approach. In Quality of Life and Pharmacoeconomics in Clinical Trials (2nd Edition), ed. B. Spilker, pp. 309–22. Philadelphia, PA: Lippincott-Raven Publishers
Frosch, D., Porzsolt, F., Heicappell, R. et al. (2001). Comparison of German language versions of the QWB-SA and SF-36 evaluating outcomes for patients with prostate disease Quality of Life Research 10:165–73
Krahn, M., Ritvo, P., Irvine, J. et al. (2000). Construction of the Patient-Oriented Prostate Utility Scale (PORPUS): a multiattribute health status classification system for prostate cancer Journal of Clinical Epidemiology 53:920–30
Canadian Coordinating Office for Health Technology Assessment. (1997). Guidelines for Economic Evaluation of Pharmaceuticals: Canada, 2nd Edition. Ottawa: Canadian Coordinating Office for Health Technology Assessment
Ware, J. E., Sherbourne, C. D. (1992). The MOS 36-Item Short Form Health Survey (SF-36) Medical Care 30:473–83
Ware, J. E., Snow, K. K., Kosinski, M., Gandek, B. (1993). SF-36 Health Survey Manual and Interpretation Guide. Boston: New England Medical Center, The Health Institute
Ware, J. E., Jr. (1996). The SF-36 Health Survey. In Quality of Life and Pharmacoeconomics in Clinical Trials (2nd Edition), ed. B. Spilker, pp. 337–45. Philadelphia, PA: Lippincott-Raven Press
Brazier, J., Roberts, J., Deverill, M. (2002). The estimation of a preference-based measure of health status from the SF-36 Journal of Health Economics 21:271–92

Reference Title: REFERENCES

Reference Type: reference-list

Jemal, A., Tiwari, R. C., Murray, T. et al. (2004). Cancer statistics, 2004. CA: Cancer Journal for Clinicians 54:8–29
Howe, H. L., Wingo, P. A., Thun, M. J. et al. (2001). Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. Journal of the National Cancer Institute 93:824–42
Yancik, R., Ries, L. G., Yates, J. W. (1989). Breast cancer in aging women. A population-based study of contrasts in stage, surgery, and survival. Cancer 63:976–81
Yancik, R. (1997). Epidemiology of cancer in the elderly. Current status and projections for the future. Rays 22:3–9
Fisher, B., Costantino, J. P., Wickerham, D. L., Redmond, C. K. et al. (1998). Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. Journal of the National Cancer Institute 90:1371–88
National Institutes of Health (1990). Early stage breast cancer. Consensus Statement 8:1–19
National Institutes of Health (2001). National Institutes of Health Consensus Development Conference Statement: Adjuvant Therapy for Breast Cancer, November 1–3, 2000. Journal of the National Cancer Institute 93:979–89
Early Breast Cancer Trialists' Collaborative Group. (1998). Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 351:1451–67
Early Breast Cancer Trialists' Collaborative Group. (1998). Polychemotherapy for early breast cancer: an overview of the randomised trials. Lancet 352:930–42
Shapiro, C. L., Recht, A. (2001). Side effects of adjuvant treatment of breast cancer. New England Journal of Medicine 344:1997–2008
Priestman, T. J., Baum, M. (1976). Evaluation of quality of life in patients receiving treatment for advanced breast cancer. Lancet 1:899–900
Selby, P. J., Chapman, J. A., Etazadi-Amoli, J. et al. (1984). The development of a method for assessing the quality of life of cancer patients. British Journal of Cancer 50:13–22
Schag, C. C., Heinrich, R. L., Ganz, P. A. (1983). Cancer inventory of problem situations: an instrument for assessing cancer patients' rehabilitation needs. Journal of Psychosocial Oncology 1:11–24
Schipper, H., Clinch, J., McMurray, A. et al. (1984). Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation. Journal of Clinical Oncology 2:472–83
Schag, C. A., Heinrich, R. L. (1990). Development of a comprehensive quality of life measurement tool: CARES. Oncology 4:135–8
Spiegel, D., Bloom, J. R., Yalom, I. (1981). Group support for patients with metastatic cancer. A randomized prospective outcome study. Archives of General Psychiatry 38:527–33
Ganz, P. A., Coscarelli, A., Fred, C. et al. (1996). Breast cancer survivors: psychosocial concerns and quality of life. Breast Cancer Research and Treatment 38:183–99
Meyerowitz, B. E. (1980). Psychosocial correlates of breast cancer and its treatments. Psychological Bulletin 87:108–31
McNair, P. M., Lorr, M., Droppelman, L. EDITS Manual for Profile of Mood States. (1981). San Diego: Educational and Industrial Testing Service
Radloff, L. S. (1977). The CES-D Scale: A self-report depression scale for research in the general population. Applied Psychological Measurement 1:385–401
Coates, A., Gebski, V., Bishop, J. F. et al. (1987). Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies. New England Journal of Medicine 317:1490–5
Aaronson, N. K., Ahmedzai, S., Bergman, B. et al., for the EORTC Study Group on Quality of Life. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute 85:365–76
Cella, D. F., Tulsky, D. S., Gray, G. et al. (1993). The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. Journal of Clinical Oncology 11:570–9
Schag, C. A., Heinrich, R. L., Aadland, R. L. et al. (1990). Assessing problems of cancer patients: psychometric properties of the cancer inventory of problem situations. Health Psychology 9:83–102
Ganz, P. A., Schag, C. A., Lee, J. J. et al. (1992). The CARES: a generic measure of health-related quality of life for patients with cancer. Quality of Life Research 1:19–29
Schag, C. A., Ganz, P. A., Heinrich, R. L. (1991). Cancer Rehabilitation Evaluation System — short form (CARES-SF). A cancer specific rehabilitation and quality of life instrument. Cancer 68:1406–13
Levine, M. N., Guyatt, G. H., Gent, M. et al. (1988). Quality of life in stage II breast cancer: an instrument for clinical trials. Journal of Clinical Oncology 6:1798–1810
Sprangers, M. A., Groenvold, M., Arraras, J. I. et al. (1996). The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. Journal of Clinical Oncology 14:2756–68
Brady, M. J., Cella, D. F., Mo, F. et al. (1997). Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument. Journal of Clinical Oncology 15:974–86
National Institutes of Health (1985). Consensus conference. Adjuvant chemotherapy for breast cancer. Journal of the American Medical Association 254:3461–3
Feeny, this volume, Chapter 4
Erickson, this volume, Chapter 3
Ganz, P. A., Schag, A. C., Lee, J. J. et al. (1992). Breast conservation versus mastectomy. Is there a difference in psychological adjustment or quality of life in the year after surgery? Cancer 69:1729–38
Ganz, P. A., Schag, C. A., Cheng, H. L. (1990). Assessing the quality of life — a study in newly-diagnosed breast cancer patients. Journal of Clinical Epidemiology 43:75–86
Schag, C. A., Ganz, P. A., Polinsky, M. L. et al. (1993). Characteristics of women at risk for psychosocial distress in the year after breast cancer. Journal of Clinical Oncology 11:783–93
Lindley, C., Vasa, S., Sawyer, W. T. et al. (1998). Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer. Journal of Clinical Oncology 16:1380–7
Ingham, J., Seidman, A., Yao, T. J. et al. (1996). An exploratory study of frequent pain measurement in a cancer clinical trial. Quality of Life Research 5:503–7
Seidman, A. D., Portenoy, R., Yao, T. J. et al. (1995). Quality of life in phase II trials: a study of methodology and predictive value in patients with advanced breast cancer treated with paclitaxel plus granulocyte colony-stimulating factor. Journal of the National Cancer Institute 87:1316–22
Chu, L., Sutton, L. M., Peterson, B. L. et al. (1996). Continuous infusion 5-fluorouracil as first-line therapy for metastatic breast cancer. Journal of Infusional Chemotherapy 6:211–6
Edmonds, C. V., Lockwood, G. A., Cunningham, A. J. (1999). Psychological response to long-term group therapy: a randomized trial with metastatic breast cancer patients. Psycho-Oncology. 8:74–91
Goss, P. E. (1998). Pre-clinical and clinical review of vorozole, a new third generation aromatase inhibitor. Breast Cancer Research and Treatment 49 (Suppl. 1):S59–65
Kornblith, A. B., Hollis, D. R., Zuckerman, E. et al. (1993). Effect of megestrol acetate on quality of life in a dose-response trial in women with advanced breast cancer. The Cancer and Leukemia Group B. Journal of Clinical Oncology 11:2081–9
Riley, B. B., Perna, R., Tate, D. G. et al. (1998). Types of spiritual well-being among persons with chronic illness: their relation to various forms of quality of life. Archives of Physical Medicine and Rehabilitation 79:258–64
Tate, D. G., Riley, B. B., Perna, R. et al. (1997). Quality of life issues among women with physical disabilities or breast cancer. Archives of Physical Medicine and Rehabilitation 78:S18–25
Winer, E. P., Lindley, C., Hardee, M. et al. (1999). Quality of life in patients surviving at least 12 months following high dose chemotherapy with autologous bone marrow support. Psycho-Oncology 8:167–76
De Haes, J. C. J. M., Pruyn, J. F. A., van Knippenberg, F. C. E., klachtenlijst voor kankerpatienten, eerste ervaringen. (1983). Netherlands Tijdschrift voor de Psychologie en Haar Grensgebieden 38:403
Watson, M., Law, M., Maguire, G. P. et al. (1992). Further development of a quality of life measure for cancer patients: The Rotterdam Symptom Checklist (Revised). Psycho-Oncology 1:35–44
Bosnjak, S., Radulovic, S., Neskovic-Konstantinovic, Z. et al. (2000). Patient statement of satisfaction with antiemetic treatment is related to quality of life. American Journal of Clinical Oncology 23:575–8
Hall, A., A'Hern, R., Fallowfield, L. (1999). Are we using appropriate self-report questionnaires for detecting anxiety and depression in women with early breast cancer? European Journal of Cancer 35:79–85
Jansen, S. J., Stiggelbout, A. M., Nooij, M. A. et al. (2000). Response shift in quality of life measurement in early-stage breast cancer patients undergoing radiotherapy. Quality of Life Research 9:603–15
Clavel, M., Soukop, M., Greenstreet, Y. L. (1993). Improved control of emesis and quality of life with ondansetron in breast cancer. Oncology 50:180–5
de Haes, J. C., Olschewski, M. (1998). Quality of life assessment in a cross-cultural context: use of the Rotterdam Symptom Checklist in a multinational randomised trial comparing CMF and Zoladex (Goserlin) treatment in early breast cancer. Annals of Oncology 9:745–50
Soukop, M., McQuade, B., Hunter, E. et al. (1992). Ondansetron compared with metoclopramide in the control of emesis and quality of life during repeated chemotherapy for breast cancer. Oncology 49:295–304
Goldberg, J. A., Scott, R. N., Davidson, P. M. et al. (1992). Psychological morbidity in the first year after breast surgery. European Journal of Surgical Oncology 18:327–31
Kiebert, G. M., Hanneke, J., de Haes, C. J. et al. (1990). Effect of peri-operative chemotherapy on the quality of life of patients with early breast cancer. European Journal of Cancer 26:1038–42
Fulton, C. L. (1997). The physical and psychological symptoms experienced by patients with metastatic breast cancer before death. European Journal of Cancer Care (England) 6:262–6
Hopwood, P., Howell, A., Maguire, P. (1991). Psychiatric morbidity in patients with advanced cancer of the breast: prevalence measured by two self-rating questionnaires. British Journal of Cancer 64:349–52
Ramirez, A. J., Towlson, K. E., Leaning, M. S. et al. (1998). Do patients with advanced breast cancer benefit from chemotherapy? British Journal of Cancer 78:1488–94
Harper-Wynne, C., English, J., Meyer, L. et al. (1999). Randomized trial to compare the efficacy and toxicity of cyclophosphamide, methotrexate and 5-fluorouracil (CMF) with methotrexate mitoxantrone (MM) in advanced carcinoma of the breast. British Journal of Cancer 81:316–22
Joensuu, H., Holli, K., Heikkinen, M. et al. (1998). Combination chemotherapy versus single-agent therapy as first- and second-line treatment in metastatic breast cancer: a prospective randomized trial. Journal of Clinical Oncology 16:3720–30
Richards, M. A., Hopwood, P., Ramirez, A. J. et al. (1992). Doxorubicin in advanced breast cancer: influence of schedule on response, survival and quality of life. European Journal of Cancer 28A:1023–8
Buzdar, A. U., Jones, S. E., Vogel, C. L. et al. (1997). A phase III trial comparing anastrozole (1 and 10 milligrams), a potent and selective aromatase inhibitor, with megestrol acetate in postmenopausal women with advanced breast carcinoma. Arimidex Study Group. Cancer 79:730–9
Kramer, J. A., Curran, D., Piccart, M. et al. (2000). Randomised trial of paclitaxel versus doxorubicin as first-line chemotherapy for advanced breast cancer: quality of life evaluation using the EORTC QLQ-C30 and the Rotterdam symptom checklist. European Journal of Cancer 36:1488–97
Hopwood, P., Howell, A., Maguire, P. (1991). Screening for psychiatric morbidity in patients with advanced breast cancer: validation of two self-report questionnaires. British Journal of Cancer 64:353–6
Paci, E. (1992). Assessment of validity and clinical application of an Italian version of the Rotterdam Symptom Checklist. Quality of Life Research 1:129–34
Steginga, S., Occhipinti, S., Wilson, K. et al. (1998). Domains of distress: the experience of breast cancer in Australia. Oncology Nursing Forum 25:1063–70
Ganz, P. A., Schag, C. C., Polinsky, M. L. et al. (1987). Rehabilitation needs and breast cancer: the first month after primary therapy. Breast Cancer Research and Treatment 10:243–53
Ganz, P. A., Rowland, J. H., Desmond, K. et al. (1998). Life after breast cancer: understanding women's health-related quality of life and sexual functioning. Journal of Clinical Oncology 16:501–14
Ganz, P. A., Greendale, G. A., Petersen, L. et al. (2000). Managing menopausal symptoms in breast cancer survivors: results of a randomized controlled trial. Journal of the National Cancer Institute 92:1054–64
Ganz, P. A., Desmond, K. A., Leedham, B. et al. (2002). Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. Journal of the National Cancer Institute 94:39–49
Ganz, P. A., Lee, J. J., Sim, M. S. et al. (1992). Exploring the influence of multiple variables on the relationship of age to quality of life in women with breast cancer. Journal of Clinical Epidemiology 45:473–85
Ganz, P. A., Hirji, K., Sim, M. S. et al. (1993). Predicting psychosocial risk in patients with breast cancer. Medical Care 31:419–31
Frost, M. H., Arvizu, R. D., Jayakumar, S. et al. (1999). A multidisciplinary healthcare delivery model for women with breast cancer: patient satisfaction and physical and psychosocial adjustment. Oncology Nursing Forum 26:1673–80
Wyatt, G. K., Friedman, L. L. (1998). Physical and psychosocial outcomes of midlife and older women following surgery and adjuvant therapy for breast cancer. Oncology Nursing Forum 25:761–8
Rustoen, T., Moum, T., Wiklund, I. et al. (1999). Quality of life in newly diagnosed cancer patients. Journal of Advanced Nursing 29:490–8
Shimozuma, K., Ganz, P. A., Petersen, L. et al. (1999). Quality of life in the first year after breast cancer surgery: rehabilitation needs and patterns of recovery. Breast Cancer Research and Treatment 56:45–57
Rustoen, T., Wiklund, I., Hanestad, B. R. et al. (1998). Nursing intervention to increase hope and quality of life in newly diagnosed cancer patients. Cancer Nursing 21:235–45
Ganz, P. A., Rowland, J. H., Meyerowitz, B. E. et al. (1998). Impact of different adjuvant therapy strategies on quality of life in breast cancer survivors. Recent Results Cancer Research 152:396–411
Rowland, J. H., Desmond, K. A., Meyerowitz, B. E. et al. (2000). Role of breast reconstructive surgery in physical and emotional outcomes among breast cancer survivors. Journal of the National Cancer Institute 92:1422–9
Ashing-Giwa, K., Ganz, P. A., Petersen, L. (1999). Quality of life of African-American and white long term breast carcinoma survivors. Cancer 85:418–26
Frost, M. H., Suman, V. J., Rummans, T. A. et al. (2000). Physical, psychological and social well-being of women with breast cancer: the influence of disease phase. Psycho-Oncology 9:221–31
Aaronson, N. K., Ahmedzai, S., Bullinger, M. et al. (1987). The EORTC core quality of life questionnaire: Interim results of an international field study. In Effect of Cancer on Quality of Life, ed. D. Osoba, pp. 185–203. Boston: Yale University Press
Aaronson, N. K., Cull, A., Kaasa, S. et al. (1994). The European Organization for Research and Treatment of Cancer (EORTC) modular approach to quality of life assessment in oncology. International Journal of Mental Health 23:75–96
Kaasa, S., Bjordal, K., Aaronson, N. et al. (1995). The EORTC core quality of life questionnaire (QLQ-C30): validity and reliability when analysed with patients treated with palliative radiotherapy. European Journal of Cancer 31A:2260–3
Osoba, D., Zee, B., Pater, J. et al. (1994). Psychometric properties and responsiveness of the EORTC Quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer. Quality of Life Research 3:353–64
Niezgoda, H. E., Pater, J. L. (1993). A validation study of the domains of the core EORTC quality of life questionnaire. Quality of Life Research 2:319–25
McLachlan, S. A., Devins, G. M., Goodwin, P. J. (1999). Factor analysis of the psychosocial items of the EORTC QLQ-C30 in metastatic breast cancer patients participating in a psychosocial intervention study. Quality of Life Research 8:311–17
Chie, W. C., Huang, C. S., Chen, J. H. et al. (1999). Measurement of the quality of life during different clinical phases of breast cancer. Journal of Formosan Medical Association 98:254–60
Taenzer, P. A., Speca, M., Atkinson, M. J. et al. (1997). Computerized quality-of-life screening in an oncology clinic. Cancer Practice 5:168–75
Carlsson, M., Hamrin, E. (1996). Measurement of quality of life in women with breast cancer. Development of a Life Satisfaction Questionnaire (LSQ-32) and a comparison with the EORTC QLQ-C30. Quality of Life Research 5:265–74
Mercier, M., Bonneterre, J., Schraub, S. et al. (1998). The development of a French version of a questionnaire on the quality of life in cancerology (Functional Living Index-Cancer: FLIC). Bulletin du Cancer 85:180–6
King, M. T., Dobson, A. J., Harnett, P. R. (1996). A comparison of two quality-of-life questionnaires for cancer clinical trials: the functional living index—cancer (FLIC) and the quality of life questionnaire core module (QLQ-C30). Journal of Clinical Epidemiology 49:21–9
McLachlan, S. A., Devins, G. M., Goodwin, P. J. (1998). Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (QLQ-C30) as a measure of psychosocial function in breast cancer patients. European Journal of Cancer 34:510–17
McLachlan, S. A., Pintilie, M., Tannock, I. F. (1999). Third line chemotherapy in patients with metastatic breast cancer: an evaluation of quality of life and cost. Breast Cancer Research and Treatment 54:213–23
Osoba, D., Rodrigues, G., Myles, J. et al. (1998). Interpreting the significance of changes in health-related quality-of-life scores. Journal of Clinical Oncology 16:139–44
Wilson, K. A., Dowling, A. J., Abdolell, M. et al. (2000). Perception of quality of life by patients, partners and treating physicians. Quality of Life Research 9:1041–52
Apolone, G., Filiberti, A., Cifani, S. et al. (1998). Evaluation of the EORTC QLQ-C30 questionnaire: a comparison with SF-36 Health Survey in a cohort of Italian long-survival cancer patients. Annals of Oncology 9:549–57
Kemmler, G., Holzner, B., Kopp, M. et al. (1999). Comparison of two quality-of-life instruments for cancer patients: the Functional Assessment of Cancer Therapy—General and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30. Journal of Clinical Oncology 17:2932–40
Montazeri, A., Harirchi, I., Vahdani, M. et al. (2000). The EORTC breast cancer-specific quality of life questionnaire (EORTC QLQ-BR23): translation and validation study of the Iranian version. Quality of Life Research 9:177–84
Klee, M., Groenvold, M., Machin, D. (1997). Quality of life of Danish women: population-based norms of the EORTC QLQ-C30. Quality of Life Research 6:27–34
Macquart-Moulin, G., Viens, P., Palangie, T. et al. (2000). High-dose sequential chemotherapy with recombinant granulocyte colony-stimulating factor and repeated stem-cell support for inflammatory breast cancer patients: does impact on quality of life jeopardize feasibility and acceptability of treatment? Journal of Clinical Oncology 18:754–64
King, M. T., Kenny, P., Shiell, A. et al. (2000). Quality of life three months and one year after first treatment for early stage breast cancer: influence of treatment and patient characteristics. Quality of Life Research 9:789–800
Grunfeld, E., Mant, D., Yudkin, P. et al. (1996). Routine follow up of breast cancer in primary care: randomised trial. British Medical Journal 313:665–9
van Dam, F. S., Schagen, S. B., Muller, M. J. et al. (1998). Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. Journal of the National Cancer Institute 90:210–18
Cohen, L., Hack, T. F., de Moor, C. et al. (2000). The effects of type of surgery and time on psychological adjustment in women after breast cancer treatment. Annals of Surgical Oncology 7:427–34
Kornblith, A. B., Herndon, J. E., Zuckerman, E. et al. (2001). Social support as a buffer to the psychological impact of stressful life events in women with breast cancer. Cancer 91:443–54
Kramer, J. A., Curran, D., Piccart, M. et al. (2000). Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in first-line chemotherapy in advanced breast cancer. European Journal of Cancer 36:1498–506
Pater, J. L., Zee, B., Palmer, M. et al. (1997). Fatigue in patients with cancer: results with National Cancer Institute of Canada Clinical Trials Group studies employing the EORTC QLQ-C30. Supportive Care in Cancer 5:410–13
Curran, D., Aaronson, N., Standaert, B. et al. (2000). Summary measures and statistics in the analysis of quality of life data: an example from an EORTC-NCIC-SAKK locally advanced breast cancer study. European Journal of Cancer 36:834–44
Geels, P., Eisenhauer, E., Bezjak, A. et al. (2000). Palliative effect of chemotherapy: objective tumor response is associated with symptom improvement in patients with metastatic breast cancer. Journal of Clinical Oncology 18:2395–405
Kristensen, B., Ejlertsen, B., Groenvold, M. et al. (1999). Oral clodronate in breast cancer patients with bone metastases: a randomized study. Journal of Internal Medicine 246:67–74
Osoba, D., Burchmore, M. (1999). Health-related quality of life in women with metastatic breast cancer treated with trastuzumab (Herceptin). Seminars in Oncology 26:84–8
Kaufmann, M., Bajetta, E., Dirix, L. Y. et al. (2000). Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: results of a phase III randomized double-blind trial. The Exemestane Study Group. Journal of Clinical Oncology 18:1399–411
Nabholtz, J. M., Senn, H. J., Bezwoda, W. R. et al. and 304 Study Group (1999). Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. 304 Study Group. Journal of Clinical Oncology 17:1413–24
Norris, B., Pritchard, K. I., James, K. et al. (2000). Phase III comparative study of vinorelbine combined with doxorubicin versus doxorubicin alone in disseminated metastatic/recurrent breast cancer: National Cancer Institute of Canada Clinical Trials Group Study MA8. Journal of Clinical Oncology 18:2385–94
Hack, T. F., Cohen, L., Katz, J. et al. (1999). Physical and psychological morbidity after axillary lymph node dissection for breast cancer. Journal of Clinical Oncology 17:143–9
Kissane, D. W., Clarke, D. M., Ikin, J. et al. (1998). Psychological morbidity and quality of life in Australian women with early-stage breast cancer: a cross-sectional survey [see comments]. Medical Journal of Australia 169:192–6
Holzner, B., Kemmler, G., Kopp, M. et al. (2001). Quality of life in breast cancer patients — not enough attention for long-term survivors? Psychosomatics 42:117–23
Hakamies-Blomqvist, L., Luoma, M., Sjostrom, J. et al. (2000). Quality of life in patients with metastatic breast cancer receiving either docetaxel or sequential methotrexate and 5-fluorouracil. A multicentre randomised phase III trial by the Scandinavian breast group. European Journal of Cancer 36:1411–17
Joly, F., Espie, M., Marty, M., Heron, J. F. et al. (2000). Long-term quality of life in premenopausal women with node-negative localized breast cancer treated with or without adjuvant chemotherapy. British Journal of Cancer 83:577–82
Stanton, A. L., Danoff-Burg, S., Cameron, C. L. et al. (2000). Emotionally expressive coping predicts psychological and physical adjustment to breast cancer. Journal of Consulting and Clinical Psychology 68:875–82
Dow, K. H., Ferrell, B. R., Leigh, S. et al. (1996). An evaluation of the quality of life among long-term survivors of breast cancer. Breast Cancer Research and Treatment 39:261–73
Wenzel, L. B., Fairclough, D. L., Brady, M. J. et al. (1999). Age-related differences in the quality of life of breast carcinoma patients after treatment. Cancer 86:1768–74
Ritz, L. J., Nissen, M. J., Swenson, K. K. et al. (2000). Effects of advanced nursing care on quality of life and cost outcomes of women diagnosed with breast cancer. Oncology Nursing Forum 27:923–32
Nissen, M. J., Swenson, K. K., Ritz, L. J. et al. (2001). Quality of life after breast carcinoma surgery: a comparison of three surgical procedures. Cancer 91:1238–46
Richardson, M. A., Post-White, J., Grimm, E. A. et al. (1997). Coping, life attitudes, and immune responses to imagery and group support after breast cancer treatment. Alternative Therapies in Health and Medicine 3:62–70
Ware, J. E., Jr., Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care 30:473–83
McHorney, C. A., Ware, J. E., Jr., Raczek, A. E. (1993). The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Medical Care 31:247–63
McHorney, C. A., Ware, J. E., Jr., Lu, J. F. et al. (1994). The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Medical Care 32:40–66
Ganz, P. A., Greendale, G. A., Kahn, B. et al. (1999). Are older breast carcinoma survivors willing to take hormone replacement therapy? Cancer 86:814–20
Stein, K. D., Jacobsen, P. B., Hann, D. M. et al. (2000). Impact of hot flashes on quality of life among postmenopausal women being treated for breast cancer. Journal of Pain and Symptom Management 19:436–45
Burstein, H. J., Gelber, S., Guadagnoli, E. et al. (1999). Use of alternative medicine by women with early-stage breast cancer. New England Journal of Medicine 340:1733–9
Bloom, J. R., Stewart, S. L., Johnston, M., Banks, P. (1998). Intrusiveness of illness and quality of life in young women with breast cancer. Psycho-Oncology 7:89–100
Velanovich, V., Szymanski, W. (1999). Quality of life of breast cancer patients with lymphedema. American Journal of Surgery 177:184
Maunsell, E., Brisson, J., Deschenes, L. et al. (1996). Randomized trial of a psychologic distress screening program after breast cancer: effects on quality of life. Journal of Clinical Oncology 14:2747–55
Bower, J. E., Ganz, P. A., Desmond, K. A. et al. (2000). Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. Journal of Clinical Oncology 18:743–53
Broeckel, J. A., Jacobsen, P. B., Balducci, L. et al. (2000). Quality of life after adjuvant chemotherapy for breast cancer. Breast Cancer Research and Treatment 62:141–50
Andrykowski, M. A., Curran, S. L., Studts, J. L. et al. (1996). Psychosocial adjustment and quality of life in women with breast cancer and benign breast problems: a controlled comparison. Journal of Clinical Epidemiology 49:827–34
Jacobsen, P. B., Widows, M. R., Hann, D. M. et al. (1998). Posttraumatic stress disorder symptoms after bone marrow transplantation for breast cancer. Psychosomatic Medicine 60:366–71
Hann, D. M., Jacobsen, P. B., Martin, S. C. et al. (1997). Quality of life following bone marrow transplantation for breast cancer: a comparative study. Bone Marrow Transplantation 19:257–64
Wapnir, I. L., Cody, R. P., Greco, R. S. (1999). Subtle differences in quality of life after breast cancer surgery. Annals of Surgical Oncology 6:359–66
Stearns, V., Isaacs, C., Rowland, J. et al. (2000). A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors. Annals of Oncology 11:17–22
Hann, D. M., Jacobsen, P. B., Azzarello, L. M. et al. (1998). Measurement of fatigue in cancer patients: development and validation of the Fatigue Symptom Inventory. Quality of Life Research 7:301–10
Dorval, M., Maunsell, E., Deschenes, L. et al. (1998). Long-term quality of life after breast cancer: comparison of 8-year survivors with population controls. Journal of Clinical Oncology 16:487–94
McCaul, K. D., Sandgren, A. K., King, B. et al. (1999). Coping and adjustment to breast cancer. Psycho-Oncology 8:230–6
Carpenter, J. S., Andrykowski, M. A., Cordova, M. et al. (1998). Hot flashes in postmenopausal women treated for breast carcinoma: prevalence, severity, correlates, management, and relation to quality of life. Cancer 82:1682–91
Cordova, M. J., Andrykowski, M. A., Kenady, D. E. et al. (1995). Frequency and correlates of posttraumatic-stress-disorder-like symptoms after treatment for breast cancer. Journal of Consulting and Clinical Psychology 63:981–6
Zigmond, A. S., Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica 67:361–70
Groenvold, M., Fayers, P. M., Sprangers, M. A. et al. (1999). Anxiety and depression in breast cancer patients at low risk of recurrence compared with the general population: a valid comparison? Journal of Clinical Epidemiology 52:523–30
Watson, M., Greer, S., Rowden, L. et al. (1991). Relationships between emotional control, adjustment to cancer and depression and anxiety in breast cancer patients. Psychological Medicine 21:51–7
Razavi, D., Delvaux, N., Farvacques, C. et al. (1993). Prevention of adjustment disorders and anticipatory nausea secondary to adjuvant chemotherapy: a double-blind, placebo-controlled study assessing the usefulness of alprazolam. Journal of Clinical Oncology 11:1384–90
Wallace, L. M., Priestman, S. G., Dunn, J. A. et al. (1993). The quality of life of early breast cancer patients treated by two different radiotherapy regimens. Clinical Oncology (Royal College of Radiologists) 5:228–33
Spiegel, D., Morrow, G. R., Classen, C. et al. (1999). Group psychotherapy for recently diagnosed breast cancer patients: a multicenter feasibility study. Psycho-Oncology 8:482–93
Fukui, S., Kugaya, A., Okamura, H. et al. (2000). A psychosocial group intervention for Japanese women with primary breast carcinoma. Cancer 89:1026–36
Watson, M., Haviland, J. S., Greer, S. et al. (1999). Influence of psychological response on survival in breast cancer: a population-based cohort study. Lancet 354:1331–6
Millar, K., Jelicic, M., Bonke, B. et al. (1995). Assessment of preoperative anxiety: comparison of measures in patients awaiting surgery for breast cancer. British Journal of Anesthesia 74:180–3
Brezden, C. B., Phillips, K. A., Abdolell, M. et al. (2000). Cognitive function in breast cancer patients receiving adjuvant chemotherapy. Journal of Clinical Oncology 18:2695–701
Cimprich, B. (1999). Pretreatment symptom distress in women newly diagnosed with breast cancer. Cancer Nursing 22:185–94
Graydon, J. E. (1994). Women with breast cancer: their quality of life following a course of radiation therapy. Journal of Advanced Nursing 19:617–22
Miaskowski, C., Dibble, S. L. (1995). The problem of pain in outpatients with breast cancer. Oncology Nursing Forum 22:791–7
Romsaas, E. P., Malec, J. F., Javenkoski, B. R. et al. (1986). Psychological distress among women with breast problems. Cancer 57:890–5
Wolberg, W. H., Tanner, M. A., Romsaas, E. P. et al. (1987). Factors influencing options in primary breast cancer treatment. Journal of Clinical Oncology 5:68–74
Levy, S. M., Herberman, R. B., Lee, J. K. et al. (1989). Breast conservation versus mastectomy: distress sequelae as a function of choice. Journal of Clinical Oncology 7:367–75
Schwartz, A. L. (1999). Fatigue mediates the effects of exercise on quality of life. Quality of Life Research 8:529–38
Swain, S. M., Rowland, J., Weinfurt, K. et al. (1996). Intensive outpatient adjuvant therapy for breast cancer: results of dose escalation and quality of life. Journal of Clinical Oncology 14:1565–72
Bridge, L. R., Benson, P., Pietroni, P. C. et al. (1988). Relaxation and imagery in the treatment of breast cancer. British Medical Journal 297:1169–72
Pozo, C., Carver, C. S., Noriega, V. et al. (1992). Effects of mastectomy versus lumpectomy on emotional adjustment to breast cancer: a prospective study of the first year postsurgery. Journal of Clinical Oncology 10:1292–8
Wolberg, W. H., Romsaas, E. P., Tanner, M. A. et al. (1989). Psychosexual adaptation to breast cancer surgery. Cancer 63:1645–55
Bultz, B. D., Speca, M., Brasher, P. M. et al. (2000). A randomized controlled trial of a brief psychoeducational support group for partners of early stage breast cancer patients. Psycho-Oncology 9:303–13
McQuellon, R. P., Craven, B., Russell, G. B. et al. (1996). Quality of life in breast cancer patients before and after autologous bone marrow transplantation. Bone Marrow Transplantation 18:579–84
Broeckel, J. A., Jacobsen, P. B., Horton, J. et al. (1998). Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. Journal of Clinical Oncology 16:1689–96
Levy, S. M., Haynes, L. T., Herberman, R. B. et al. (1992). Mastectomy versus breast conservation surgery: mental health effects at long-term follow-up. Health Psychology 11:349–54
Interdisciplinary Group for Cancer Care Evaluation (GIVIO). Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. (1994). Journal of the American Medical Association 271:1587–92
Classen, C., Koopman, C., Angell, K. et al. (1996). Coping styles associated with psychological adjustment to advanced breast cancer. Health Psychology 15:434–7
Koopman, C., Hermanson, K., Diamond, S. et al. (1998). Social support, life stress, pain and emotional adjustment to advanced breast cancer. Psycho-Oncology 7:101–11
Ahles, T. A., Tope, D. M., Furstenberg, C. et al. (1996). Psychologic and neuropsychologic impact of autologous bone marrow transplantation. Journal of Clinical Oncology 14:1457–62
Classen, C., Butler, L. D., Koopman, C. et al. (2001). Supportive-expressive group therapy and distress in patients with metastatic breast cancer: a randomized clinical intervention trial. Archives of General Psychiatry 58:494–501
Edelman, S., Bell, D. R., Kidman, A. D. (1999). A group cognitive behaviour therapy programme with metastatic breast cancer patients. Psycho-Oncology 8:295–305
Tannock, I. F., Boyd, N. F., DeBoer, G. et al. (1988). A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancer. Journal of Clinical Oncology 6:1377–87
Butow, P., Coates, A., Dunn, S. et al. (1991). On the receiving end. IV: Validation of quality of life indicators. Annals of Oncology 2:597–603
Hurny, C., Bernhard, J., Gelber, R. D. et al. (1992). Quality of life measures for patients receiving adjuvant therapy for breast cancer: an international trial. The International Breast Cancer Study Group. European Journal of Cancer 28:118–24
Hurny, C., Bernhard, J., Bacchi, M. et al. (1993). The Perceived Adjustment to Chronic Illness Scale (PACIS): a global indicator of coping for operable breast cancer patients in clinical trials. Swiss Group for Clinical Cancer Research (SAKK) and the International Breast Cancer Study Group (IBCSG). Supportive Care in Cancer 1:200–8
Whelan, T. J., Levine, M., Julian, J. et al. (2000). The effects of radiation therapy on quality of life of women with breast carcinoma: results of a randomized trial. Ontario Clinical Oncology Group. Cancer 88:2260–6
Levine, M. N., Bramwell, V. H., Pritchard, K. I. et al. (1998). Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group. Journal of Clinical Oncology 16:2651–8
Fetting, J. H., Gray, R., Fairclough, D. L. et al. (1998). Sixteen-week multidrug regimen versus cyclophosphamide, doxorubicin, and fluorouracil as adjuvant therapy for node-positive, receptor-negative breast cancer: an Intergroup study. Journal of Clinical Oncology 16:2382–91
Bernhard, J., Hurny, C., Coates, A. S. et al. (1997). Quality of life assessment in patients receiving adjuvant therapy for breast cancer: the IBCSG approach. The International Breast Cancer Study Group [published erratum appears in Ann Oncol (1998) 9(2):231]. Annals of Oncology 8:825–35
Coates, A. S., Hurny, C., Peterson, H. F. et al. (2000). Quality-of-life scores predict outcome in metastatic but not early breast cancer. International Breast Cancer Study Group. Journal of Clinical Oncology 18:3768–74
Bull, A. A., Meyerowitz, B. E., Hart, S. et al. (1999). Quality of life in women with recurrent breast cancer. Breast Cancer Research and Treatment 54:47–57
Litwin, M. S., Hays, R. D., Fink, A. et al. (1995). Quality-of-life outcomes in men treated for localized prostate cancer. Journal of the American Medical Association 273:129–35
Guyatt, G. H., Kirshner, B., Jaeschke, R. (1992). Measuring health status: what are the necessary measurement properties? Journal of Clinical Epidemiology 45:1341–5
Goodwin, P. J., Black, J. T., Bordeleau, L. J. et al. (2003). Health-related quality of life measurement in randomized clinical trials in breast cancer — taking stock. Journal of the National Cancer Institute 95:263–81
Poulsen, B., Graversen, H. P., Beckmann, J. et al. (1997). A comparative study of post-operative psychosocial function in women with primary operable breast cancer randomized to breast conservation therapy or mastectomy. European Journal of Surgical Oncology 23:327–34
Curran, D., van Dongen, J. P., Aaronson, N. K. et al. (1998). Quality of life of early-stage breast cancer patients treated with radical mastectomy or breast-conserving procedures: results of EORTC Trial 10801. The European Organization for Research and Treatment of Cancer (EORTC), Breast Cancer Co-operative Group (BCCG). European Journal of Cancer 34:307–14
de Haes, J. C., van Oostrom, M. A., Welvaart, K. (1986). The effect of radical and conserving surgery on the quality of life of early breast cancer patients. European Journal of Surgical Oncology 12:337–42
Kemeny, M. M., Wellisch, D. K., Schain, W. S. (1988). Psychosocial outcome in a randomized surgical trial for treatment of primary breast cancer. Cancer 62:1231–7
Bates, T., Riley, D. L., Houghton, J. et al. (1991). Breast cancer in elderly women: a Cancer Research Campaign trial comparing treatment with tamoxifen and optimal surgery with tamoxifen alone. The Elderly Breast Cancer Working Party. British Journal of Surgery 78:591–4
Hurny, C., Bernhard, J., Coates, A. S. et al. (1996). Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancer. International Breast Cancer Study Group [published erratum appears in Lancet (1997) 350(9073):298]. Lancet 347:1279–84
Nystedt, M., Berglund, G., Bolund, C. et al. (2000). Randomized trial of adjuvant tamoxifen and/or goserelin in premenopausal breast cancer — self-rated physiological effects and symptoms. Acta Oncologica 39:959–68
Fairclough, D. L., Fetting, J. H., Cella, D. et al. (1999). Quality of life and quality adjusted survival for breast cancer patients receiving adjuvant therapy. Eastern Cooperative Oncology Group (ECOG). Quality of Life Research 8:723–31
Fraser, S. C., Dobbs, H. J., Ebbs, S. R. et al. (1993). Combination or mild single agent chemotherapy for advanced breast cancer? CMF vs epirubicin measuring quality of life. British Journal of Cancer 67:402–6
Kloke, O., Klaassen, U., Oberhoff, C. et al. (1999). Maintenance treatment with medroxyprogesterone acetate in patients with advanced breast cancer responding to chemotherapy: results of a randomized trial. Essen Breast Cancer Study Group. Breast Cancer Research and Treatment 55:51–9
Buzdar, A., Douma, J., Davidson, N. et al. (2001). Phase III, multicenter, double-blind, randomized study of Letrozole, an aromatase inhibitor, for advanced breast cancer versus megestrol acetate. Journal of Clinical Oncology 19:3357–66
Goss, P. E., Winer, E. P., Tannock, I. F. et al. (1999). Randomized phase III trial comparing the new potent and selective third-generation aromatase inhibitor vorozole with megestrol acetate in postmenopausal advanced breast cancer patients. North American Vorozole Study Group. Journal of Clinical Oncology 17:52–63
Bertsch, L. A., Donaldson, G. (1995). Quality of life analyses from vinorelbine (Navelbine) clinical trials of women with metastatic breast cancer. Seminars in Oncology 22:45–53
Stewart, D. J., Evans, W. K., Shepherd, F. A. et al. (1997). Cyclophosphamide and fluorouracil combined with mitoxantrone versus doxorubicin for breast cancer: superiority of doxorubicin. Journal of Clinical Oncology 15:1897–905
Riccardi, A., Tinelli, C., Brugnatelli, S. et al. (2000). Doubling of the epirubicin dosage within the 5-fluorouracil, epirubicin and cyclophosphamide regimen: a prospective, randomized, multicentric study on antitumor effect and quality of life in advanced breast cancer. International Journal of Oncology 16:769–76
Holten-Verzantvoort, A. T., Zwinderman, A. H., Aaronson, N. K. et al. (1991). The effect of supportive pamidronate treatment on aspects of quality of life of patients with advanced breast cancer. European Journal of Cancer 27:544–9
Hultborn, R., Gundersen, S., Ryden, S. et al. (1996). Efficacy of pamidronate in breast cancer with bone metastases: a randomized double-blind placebo controlled multicenter study. Acta Oncologica 35 (Suppl. 5):73–4
Pandya, K. J., Raubertas, R. F., Flynn, P. J. et al. (2000). Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: a University of Rochester Cancer Center Community Clinical Oncology Program study. Annals of Internal Medicine 132:788–93
Dixon, A. K., Wheeler, T. K., Lomas, D. J. et al. (1993). Computed tomography or magnetic resonance imaging for axillary symptoms following treatment of breast carcinoma? A randomized trial. Clinical Radiology 48:371–6
Marchioro, G., Azzarello, G., Checchin, F. et al. (1996). The impact of a psychological intervention on quality of life in non-metastatic breast cancer. European Journal of Cancer 32A:1612–15
Walker, L. G., Walker, M. B., Ogston, K. et al. (1999). Psychological, clinical and pathological effects of relaxation training and guided imagery during primary chemotherapy. British Journal of Cancer 80:262–8
Sandgren, A. K., McCaul, K. D., King, B. et al. (2000). Telephone therapy for patients with breast cancer. Oncology Nursing Forum 27:683–8
Goodwin, P. J., Leszcz, M., Ennis, M. et al. (2001). The effect of group psychosocial support on survival in metastatic breast cancer. New England Journal of Medicine 345:1719–26
Spiegel, D., Bloom, J. R., Kraemer, H. C. et al. (1989). Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet 2:888–91
Fogarty, L. A., Curbow, B. A., Wingard, J. R. et al. (1999). Can 40 seconds of compassion reduce patient anxiety? Journal of Clinical Oncology 17:371–9
Christensen, D. N. (1983). Postmastectomy couple counseling: an outcome study of a structured treatment protocol. Journal of Sex and Marital Therapy 9:266–75
Wengström, Y., Häggmark, C., Strander, H. et al. (1999). Effects of a nursing intervention on subjective distress, side effects and quality of life of breast cancer patients receiving curative radiation. Acta Oncologica 38:763–70
Helgeson, V. S., Cohen, S. (2001). Long-term effects of educational and peer discussion group interventions on adjustment to breast cancer. Health Psychology 20:387–92
Arathuzik, D. (1994). Effects of cognitive-behavioral strategies on pain in cancer patients. Cancer Nursing 17:207–14
Bordeleau, L., Szalai, J. P., Goodwin, P. J. et al. (2002). Quality of life (QOL) and psychosocial support in women with metastatic breast cancer (MBC): results of a multicenter randomized trial. Proceedings of the American Society of Clinical Oncology 21: A1424
Cunningham, A. J., Edmonds, C. V., Jenkins, G. P. et al. (1998). A randomized controlled trial of the effects of group psychological therapy on survival in women with metastatic breast cancer. Psycho-Oncology 7:508–17
Coates, A., Gebski, V., Signorini, D. et al. (1992). Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group. Journal of Clinical Oncology 10:1833–8
Simes, R. J., Coates, A. S. (2001). Patient preferences for adjuvant chemotherapy of early breast cancer: how much benefit is needed? Journal of the National Cancer Institute Monographs 30:146–52
Moinpour, C. M. (1996). Costs of quality-of-life research in Southwest Oncology Group trials. Journal of the National Cancer Institute Monographs 20:11–16
Bernhard, J., Cella, D. F., Coates, A. S. et al. (1998). Missing quality of life data in cancer clinical trials: serious problems and challenges. Statistics in Medicine 17:517–32
Ganz, P. A., Day, R., Ware, J. E., Jr. et al. (1995). Base-line quality-of-life assessment in the National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial. Journal of the National Cancer Institute 87:1372–82
Day, R., Ganz, P. A., Costantino, J. P. et al. (1999). Health-related quality of life and tamoxifen in breast cancer prevention: a report from the National Surgical Adjuvant Breast and Bowel Project P-1 Study. Journal of Clinical Oncology 17:2659–69
Osoba, this volume, Chapter 19
Lippman, M. E., Hayes, D. F. (2001). Adjuvant therapy for all patients with breast cancer? Journal of the National Cancer Institute 93:80–2
Kiebert, G. M., de Haes, J. C., van de Velde, C. J. (1991). The impact of breast-conserving treatment and mastectomy on the quality of life of early-stage breast cancer patients: a review. Journal of Clinical Oncology 9:1059–70
Fallowfield, L. (1997). Offering choice of surgical treatment to women with breast cancer. Patient Education and Counseling 30:209–14
Moyer, A. (1997). Psychosocial outcomes of breast-conserving surgery versus mastectomy: a meta-analytic review [published erratum appears in Health Psychology 1997 16(5):442]. Health Psychology 16:284–98
Ganz, P. A., Desmond, K. A., Belin, T. R. et al. (1999). Predictors of sexual health in women after a breast cancer diagnosis. Journal of Clinical Oncology 17:2371–80

Reference Title: REFERENCES

Reference Type: reference-list

Ganz, Goodwin, this volume, chapter 5
Flower F. J., Jr., Barry, M. J., Lu-Yao, G. et al. (1993). Patient-reported complications and follow-up treatment after radical prostatectomy. The National Medicare Experience: 1988–1990 (updated June 1993) Urology 42(6):622–9
Jemal, A., Thomas, A., Murray, T. et al. (2002). Cancer statistics, 2002. Ca: a Cancer Journal for Clinicians 52(1):23–47
Moinpour, C. M., Lovato, L. C., Thompson, I. M., Jr. et al. (2000). Profile of men randomized to the prostate cancer prevention trial: baseline health-related quality of life, urinary and sexual functioning, and health behaviors. Journal of Clinical Oncology 18(9):1942–53
Thompson, I. M., Klein, E. A., Lippman, S. M. et al. (2003). Prevention of prostate cancer with finasteride: U.S./European perspective European Urology 44: 650–5
Cormier, L., Valeri, A., Azzouzi, R. et al. (2002). Worry and attitude of men in at-risk families for prostate cancer about genetic susceptibility and genetic testing. Prostate 51(4):276–85
Cormier, L., Guillemin, F., Valeri, A. et al. (2002). Impact of prostate cancer screening on health-related quality of life in at-risk families. Urology 59(6):901–6
Essink-Bot, M. L., de Koning, H. J., Nijs, H. G. et al. (1998). Short-term effects of population-based screening for prostate cancer on health-related quality of life. Journal of the National Cancer Institute 90(12):925–31
Smith, D. S., Carvalhal, G. F., Schneider, K. et al. (2000). Quality-of-life outcomes for men with prostate carcinoma detected by screening. Cancer 88(6):1454–63
Potosky, A. L., Miller, B. A., Albertsen, P. C. et al. (1995). The role of increasing detection in the rising incidence of prostate cancer. Journal of the American Medical Association 273(7):548–52
Potosky, A. L., Feuer, E. J., Levin, D. L. (2001). Impact of screening on incidence and mortality of prostate cancer in the United States. Epidemiology Review 23(1):181–6
Rietbergen, J. B., Schroder, F. H. (1998). Screening for prostate cancer — more questions than answers [see comments]. Acta Oncologica 37(6):515–32
Perkins, J. J., Sanson-Fisher, R. W., Clarke, S. J. et al. (1998). An exploration of screening practices for prostate cancer and the associated community expenditure. British Journal of Urology 82(4):524–9
Litwin, M. S., Pasta, D. J., Stoddard, M. L. et al. (1998). Epidemiological trends and financial outcomes in radical prostatectomy among Medicare beneficiaries, 1991 to 1993 [published erratum appears in Journal of Urology (1998) 160(6 Pt 1):2164]. Journal of Urology 160(2): 445–8
Standaert, B., Denis, L. (1997). The European Randomized Study of Screening for Prostate Cancer: an update. Cancer 80(9):1830–4
Gohagan, J. K., Prorok, P. C., Hayes, R. B. et al. (2000). The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status. Controlled Clinical Trials 21(6 Suppl):251S–72S
Potosky, A. L., Reeve, B. B., Clegg, L. X. et al. (2002). Quality of life following localized prostate cancer treated initially with androgen deprivation therapy or no therapy. Journal of the National Cancer Institute 94(6):430–7
Pound, C. R., Partin, A. W., Eisenberger, M. A. et al. (1999). Natural history of progression after PSA elevation following radical prostatectomy Journal of the American Medical Association 281(17):1591–7
Smith, M. R., Finkelstein, J. S., McGovern, F. J. et al. (2002). Changes in body composition during androgen deprivation therapy for prostate cancer. Journal of Clinical Endocrinology and Metabolism 87(2):599–603
Smith, M. R., McGovern, F. J., Zietman, A. L. et al. (2001). Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer. New England Journal of Medicine 345(13):948–55
Harlan, L., Brawley, O., Pommerenke, F. et al. (1995). Geographic, age, and racial variation in the treatment of local/regional carcinoma of the prostate. Journal of Clinical Oncology 13(1):93–100
Talcott, J. A. (2002). Androgen deprivation as primary treatment for early prostate cancer: should we “just do something”? Journal of the National Cancer Institute 94(6):407–9
Tannock, I., Gospodarowicz, M., Meakin, W. et al. (1989). Treatment of metastatic prostatic cancer with low-dose prednisone: evaluation of pain and quality of life as pragmatic indices of response. Journal of Clinical Oncology 7(5):590–7
Tannock, I. F., Osoba, D., Stockler, M. R. et al. (1996). Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points. Journal of Clinical Oncology 14(6):1756–64
Small, E. J., Halabi, S., Ratain, M. J. et al. (2002). Randomized study of three different doses of suramin administered with a fixed dosing schedule in patients with advanced prostate cancer: results of intergroup 0159, cancer and leukemia group B 9480. Journal of Clinical Oncology 20(16):3369–75
Hussain, M., Fisher, E. I., Petrylak, D. P. et al. (2000). Androgen deprivation and four courses of fixed-schedule suramin treatment in patients with newly diagnosed metastatic prostate cancer: A Southwest Oncology Group Study. Journal of Clinical Oncology 18(5):1043–9
Greenlee, R. T., Hill-Harmon, M. B., Murray, T. et al. (2001). Cancer statistics, 2001. Ca: a Cancer Journal for Clinicians 51(1):15–36
Lu-Yao, G. L., Greenberg, E. R. (1994). Changes in prostate cancer incidence and treatment in USA. Lancet 343(8892):251–4
Lu-Yao, G. L., McLerran, D., Wasson, J. et al. (1993). An assessment of radical prostatectomy. Time trends, geographic variation, and outcomes. The Prostate Patient Outcomes Research Team. Journal of the American Medical Association 269(20):2633–6
Bubolz, T., Wasson, J. H., Lu-Yao, G. et al. (2001). Treatments for prostate cancer in older men: 1984–1997. Urology 58(6):977–82
Osoba, D. (1991). Measuring the Effect of Cancer on Quality of Life. Boca Raton: CRC Press
Patrick, D. L., Erickson, P. (1993). Assessing health-related quality of life for clinical decision-making. In Quality of Life Assessment: Key Issues in the 1990's, ed. S. R. Walker, R. M. Rosser, pp. 11–64. Dordrecht: Kluwer Academic Publishers
World Health Organization (WHO) (1948). Constitution of the World Health Organization, basic documents. Geneva: WHO
Fitzpatrick, J. M., Kirby, R. S., Krane, R. J. et al. (1998). Sexual dysfunction associated with the management of prostate cancer. European Urology 33(6):513–22
Holmberg, L., Bill-Axelson, A., Helgesen, F. et al. (2002). A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. New England Journal of Medicine 347(11):781–9
Steineck, G., Helgesen, F., Adolfsson, J. et al. (2002). Quality of life after radical prostatectomy or watchful waiting. New England Journal of Medicine 347(11):790–6
Albertsen, P. C., Aaronson, N. K., Muller, M. J. et al. (1997). Health-related quality of life among patients with metastatic prostate cancer. Urology 49(2):207–16
Krahn, M., Ritvo, P., Irvine, J. et al. (2000). Construction of the Patient-Oriented Prostate Utility Scale (PORPUS): a multiattribute health state classification system for prostate cancer. Journal of Clinical Epidemiology 53(9):920–30
Perczek, R. E., Burke, M. A., Carver, C. S. et al. (2002). Facing a prostate cancer diagnosis: who is at risk for increased distress? Cancer 94(11):2923–9
Patrick, D. L., Deyo, R. A. (1989). Generic and disease-specific measures in assessing health status and quality of life. Medical Care 27(3 Suppl):S217–32
McHorney, C. A., Ware, J. E., Jr., Raczek, A. E. (1993). The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Medical Care 31(3):247–63
McNair, D. M., Lorr, M., Droppleman, L. F. (1981). Profile of Mood States (2nd edn.) San Diego: Educational and Industrial Testing Service
Aaronson, N. K., Ahmedzai, S., Bergman, B. et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute 85(5):365–76
Cella, D. F., Tulsky, D. S., Gray, G. et al. (1993). The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. Journal of Clinical Oncology 11(3):570–9
Spitzer, W. O., Dobson, A. J., Hall, J. et al. (1981). Measuring the quality of life of cancer patients: a concise QL-index for use by physicians. Journal of Chronic Diseases 34(12):585–97
Schipper, H., Clinch, J., McMurray, A. et al. (1984). Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation. Journal of Clinical Oncology 2(5):472–83
Litwin, M. S., Hays, R. D., Fink, A. et al. (1998). The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Medical Care 36(7):1002–12
Wei, J. T., Dunn, R. L., Litwin, M. S. et al. (2000). Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 56(6):899–905
Stockler, M. R., Osoba, D., Corey, P. et al. (1999). Convergent discriminative and predictive validity of the Prostate Cancer Specific Quality of Life Instrument (PROSQOLI) assessment and comparison with analogous scales from the EORTC QLQ-C30 and a trial-specific module. European Organisation for Research and Treatment of Cancer. Core Quality of Life Questionnaire. Journal of Clinical Epidemiology 52(7):653–66
Dale, W., Campbell, T., Ignacio, L. et al. (1999). Self-assessed health-related quality of life in men being treated for prostate cancer with radiotherapy: instrument validation and its relation to patient-assessed bother of symptoms. Urology 53(2):359–66
Ganz, P. A., Schag, C. A., Lee, J. J. et al. (1992). The CARES: a generic measure of health-related quality of life for patients with cancer. Quality of Life Research 1(1):19–29
Akakura, K., Isaka, S., Akimoto, S. et al. (1999). Long-term results of a randomized trial for the treatment of Stages B2 and C prostate cancer: radical prostatectomy versus external beam radiation therapy with a common endocrine therapy in both modalities. Urology 54(2):313–18
Fransson, P., Damber, J. E., Tomic, R. et al. (2001). Quality of life and symptoms in a randomized trial of radiotherapy versus deferred treatment of localized prostate carcinoma. Cancer 92(12):3111–19
Auvinen, A., Vornanen, T., Tammela, T. L. et al. (2001). A randomized trial of the choice of treatment in prostate cancer: design and baseline characteristics. BJU International 88(7):708–15
Rosenberg, H. J., Rosenberg, S. D., Ernstoff, M. S. et al. (2002). Expressive disclosure and health outcomes in a prostate cancer population. International Journal of Psychiatry in Medicine 32(1):37–53
Moore, M. J., O'Sullivan, B., Tannock, I. F. (1988). How expert physicians would wish to be treated if they had genitourinary cancer. Journal of Clinical Oncology 6(11):1736–45
Fowler, F. J., Jr., McNaughton Collins, M., Albertsen, P. C. et al. (2000). Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. Journal of the American Medical Association 283(24):3217–22
McHorney, C. A., Ware, J. E., Jr., Lu, J. F. et al. (1994). The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Medical Care 32(1):40–66
Zigmond, A. S., Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica 67(6):361–70
Johansson, J. E., Wersall, P., Brandberg, Y. et al. (2001). Efficacy of epoetin beta on hemoglobin, quality of life, and transfusion needs in patients with anemia due to hormone-refractory prostate cancer — a randomized study. Scandinavian Journal of Neurology and Nephrology 35(4):288–94
Boccardo, F., Rubagotti, A., Barichello, M. et al. (1999). Bicalutamide monotherapy versus flutamide plus goserelin in prostate cancer patients: results of an Italian Prostate Cancer Project study. Journal of Clinical Oncology 17(7):2027–38
Fossa, S. D., Slee, P. H., Brausi, M. et al. (2001). Flutamide versus prednisone in patients with prostate cancer symptomatically progressing after androgen-ablative therapy: a phase III study of the European Organization for Research and Treatment of Cancer Genitourinary Group. Journal of Clinical Oncology 19(1):62–71
Fossa, S. D., Curran, D., Aaronson, N. K. et al. (2000). Quality of life of patients with newly diagnosed poor prognosis M1 prostate cancer undergoing orchiectomy without or with mitomycin C. Results from the EORTC Phase-III trial 30893. European Urology 37(5):541–51
Moinpour, C. M., Savage, M. J., Troxel, A. et al. (1998). Quality of life in advanced prostate cancer: results of a randomized therapeutic trial. Journal of the National Cancer Institute 90(20):1537–44
Sharp, L. K., Knight, S. J., Nadler, R. et al. (1999). Quality of life in low-income patients with metastatic prostate cancer: divergent and convergent validity of three instruments. Quality of Life Research 8(5):461–70
Jacobsen, S. J., Girman, C. J., Guess, H. A. et al. (1993). Natural history of prostatism: factors associated with discordance between frequency and bother of urinary symptoms. Urology 42(6):663–71
Clark, J. A., Talcott, J. A. (2001). Symptom indexes to assess outcomes of treatment for early prostate cancer. Medical Care 39(10):1118–30
Bokhour, B. G., Clark, J. A., Inui, T. S. et al. (2001). Sexuality after treatment for early prostate cancer: exploring the meanings of “erectile dysfunction.” Journal of General Internal Medicine 16(10):649–55
Clark, J. A., Wray, N., Brody, B. et al. (1997). Dimensions of quality of life expressed by men treated for metastatic prostate cancer. Social Science and Medicine 45(8):1299–309
Talcott, J. A., Manola, J., Clark, J. A. et al. (2003). Time course and predictors of symptoms after primary prostate cancer therapy Journal of Clinical Oncology 21:3979–86
Litwin, M. S., Flanders, S. C., Pasta, D. J. et al. (1999). Sexual function and bother after radical prostatectomy or radiation for prostate cancer: multivariate quality-of-life analysis from CaPSURE. Cancer of the Prostate Strategic Urologic Research Endeavor. Urology 54(3):503–8
Beard, C. J., Propert, K. J., Rieker, P. P. et al. (1997). Complications after treatment with external-beam irradiation in early-stage prostate cancer patients: a prospective multiinstitutional outcomes study. Journal of Clinical Oncology 15(1):223–9
Potosky, A. L., Harlan, L. C., Stanford, J. L. et al. (1999). Prostate cancer practice patterns and quality of life: the Prostate Cancer Outcomes Study. Journal of the National Cancer Institute 91(20):1719–24
Erickson, this volume, Chapter 3
Ware, J. E., Jr., Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care 30(6):473–83
Ware, J., Jr., Kosinski, M., Keller, S. D. (1996). A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Medical Care 34(3):220–33
Cella, D. F., Jacobsen, P. B., Orav, E. J. et al. (1987). A brief POMS measure of distress for cancer patients. Journal of Chronic Diseases 40(10):939–42
Penson, D. F., Stoddard, M. L., Pasta, D. J. et al. (2001). The association between socioeconomic status, health insurance coverage, and quality of life in men with prostate cancer. Journal of Clinical Epidemiology 54(4):350–8
Eton, D. T., Lepore, S. J., Helgeson, V. S. (2001). Early quality of life in patients with localized prostate carcinoma: an examination of treatment-related, demographic, and psychosocial factors. Cancer 92(6):1451–9
Bacon, C. G., Giovannucci, E., Testa, M. et al. (2002). The association of treatment-related symptoms with quality-of-life outcomes for localized prostate carcinoma patients. Cancer 94(3):862–71
Litwin, M. S., Lubeck, D. P., Stoddard, M. L. et al. (2001). Quality of life before death for men with prostate cancer: results from the CaPSURE database. Journal of Urology 165(3):871–5
Schapira, M. M., Lawrence, W. F., Katz, D. A. et al. (2001). Effect of treatment on quality of life among men with clinically localized prostate cancer. Medical Care 39(3):243–53
Davis, J. W., Kuban, D. A., Lynch, D. F. et al. (2001). Quality of life after treatment for localized prostate cancer: differences based on treatment modality. Journal of Urology 166(3):947–52
Schlenk, E. A., Erlen, J. A., Dunbar-Jacob, J. et al. (1998). Health-related quality of life in chronic disorders: a comparison across studies using the MOS SF-36. Quality of Life Research 7(1):57–65
Clark, J. A., Rieker, P., Propert, K. J. et al. (1999). Changes in quality of life following treatment for early prostate cancer. Urology 53(1):161–8
Potosky, A. L., Legler, J., Albertsen, P. C. et al. (2000). Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study. Journal of the National Cancer Institute 92(19):1582–92
Lubeck, D. P., Litwin, M. S., Henning, J. M. et al. (1997). Measurement of health-related quality of life in men with prostate cancer: the CaPSURE database. Quality of Life Research 6(5):385–92
Litwin, M. S., Hays, R. D., Fink, A. et al. (1995). Quality-of-life outcomes in men treated for localized prostate cancer. Journal of the American Medical Association 273(2):129–35
Litwin, M. S., Lubeck, D. P., Henning, J. M. et al. (1998). Differences in urologist and patient assessments of health related quality of life in men with prostate cancer: results of the CaPSURE database. Journal of Urology 159(6):1988–92
Lubeck, D. P., Litwin, M. S., Henning, J. M. et al. (1999). Changes in health-related quality of life in the first year after treatment for prostate cancer: results from CaPSURE. Urology 53(1):180–6
Janda, M., Gerstner, N., Obermair, A. et al. (2000). Quality of life changes during conformal radiation therapy for prostate carcinoma. Cancer 89(6):1322–8
Kim, S. P., Bennett, C. L., Chan, C. et al. (1999). QOL and outcomes research in prostate cancer patients with low socioeconomic status. Oncology (Huntington) 13(6):823–38
Kurtz, M. E., Kurtz, J. C., Stommel, M. et al. (1997). Loss of physical functioning among geriatric cancer patients: relationships to cancer site, treatment, comorbidity and age. European Journal of Cancer 33(14):2352–8
Litwin, M. S., Shpall, A. I., Dorey, F. et al. (1998). Quality-of-life outcomes in long-term survivors of advanced prostate cancer. American Journal of Clinical Oncology 21(4):327–32
Stier, D. M., Greenfield, S., Lubeck, D. P. et al. (1999). Quantifying comorbidity in a disease-specific cohort: adaptation of the total illness burden index to prostate cancer. Urology 54(3):424–9
Melmed, G. Y., Kwan, L., Reid, K. et al. (2002). Quality of life at the end of life: trends in patients with metastatic prostate cancer. Urology 59(1):103–9
Wei, J. T., Dunn, R. L., Sandler, H. M. et al. (2002). Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. Journal of Clinical Oncology 20(2):557–66
Lim, A. J., Brandon, A. H., Fiedler, J. et al. (1995). Quality of life: radical prostatectomy versus radiation therapy for prostate cancer. Journal of Urology 154(4):1420–5
Braslis, K. G., Santa-Cruz, C., Brickman, A. L. (1995). Quality of life 12 months after radical prostatectomy. British Journal of Urology 75(1):48–53
Bisson, J. I., Chubb, H. L., Bennett, S. et al. (2002). The prevalence and predictors of psychological distress in patients with early localized prostate cancer. British Journal of Urology International 90(1):56–61
Stone, P., Hardy, J., Huddart, R. et al. (2000). Fatigue in patients with prostate cancer receiving hormone therapy. European Journal of Cancer 36(9):1134–41
Kemmler, G., Holzner, B., Kopp, M. et al. (1999). Comparison of two quality-of-life instruments for cancer patients: The Functional Assessment of Cancer Therapy-General and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30. Journal of Clinical Oncology 17(9):2932–40
Fossa, S. D., Woehre, H., Kurth, K. H. et al. (1997). Influence of urological morbidity on quality of life in patients with prostate cancer. European Urology 31(Suppl. 3):3–8
Krupski, T., Petroni, G. R., Bissonette, E. A. et al. (2000). Quality-of-life comparison of radical prostatectomy and interstitial brachytherapy in the treatment of clinically localized prostate cancer. Urology 55(5):736–42
Lilleby, W., Fossa, S. D., Waehre, H. R. (1999). Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy. International Journal of Radiation Oncology, Biology, and Physics 43(4):735–43
Ben-Tovim, D., Dougherty, M. L., Stapleton, A. M. et al. (2002). Coping with prostate cancer: a quantitative analysis using a new instrument, the centre for clinical excellence in urological research coping with cancer instrument. Urology 59(3):383–8
Rosendahl, I., Kiebert, G. M., Curran, D. et al. (1999). Quality-adjusted survival (Q-TWiST) analysis of EORTC trial 30853: comparing goserelin acetate and flutamide with bilateral orchiectomy in patients with metastatic prostate cancer. European Organization for Research and Treatment of Cancer. Prostate 38(2):100–9
Wang, H., Huang, E., Dale, W. et al. (2000). Self-assessed health-related quality of life in men who have completed radiotherapy for prostate cancer: instrument validation and its relation to patient-assessed bother of symptoms. International Journal of Cancer 90(3):163–72
Borghede, G., Sullivan, M. (1996). Measurement of quality of life in localized prostatic cancer patients treated with radiotherapy. Development of a prostate cancer-specific module supplementing the EORTC QLQ-C30. Quality of Life Research 5(2):212–22
Knight, S. J., Chmiel, J. S., Kuzel, T. et al. (1998). Quality of life in metastatic prostate cancer among men of lower socioeconomic status: feasibility and criterion related validity of 3 measures. Journal of Urology 160(5):1765–9
Wilson, K. A., Dowling, A. J., Abdolell, M. et al. (2000). Perception of quality of life by patients, partners and treating physicians. Quality of Life Research 9(9):1041–52
Curran, D., Fossa, S., Aaronson, N. et al. (1997). Baseline quality of life of patients with advanced prostate cancer. European Organization for Research and Treatment of Cancer (EORTC), Genito-Urinary Tract Cancer Cooperative Group (GUT-CCG). European Journal of Cancer 33(11):1809–14
Joly, F., Brune, D., Couette, J. E. et al. (1998). Health-related quality of life and sequelae in patients treated with brachytherapy and external beam irradiation for localized prostate cancer. Annals of Oncology 9(7):751–7
Moore, M. J., Osoba, D., Murphy, K. et al. (1994). Use of palliative end points to evaluate the effects of mitoxantrone and low-dose prednisone in patients with hormonally resistant prostate cancer. Journal of Clinical Oncology 12(4):689–94
Fossa, S. D. (1994). Quality of life after palliative radiotherapy in patients with hormone-resistant prostate cancer: single institution experience. British Journal of Urology 74(3):345–51
Borghede, G., Karlsson, J., Sullivan, M. (1997). Quality of life in patients with prostatic cancer: results from a Swedish population study. Journal of Urology 158(4):1477–85
Dawson, N. A., Conaway, M., Halabi, S. et al. (2000). A randomized study comparing standard versus moderately high dose megestrol acetate for patients with advanced prostate carcinoma: cancer and leukemia group B study 9181. Cancer 88(4):825–34
Herr, H. W., O'Sullivan, M. (2000). Quality of life of asymptomatic men with nonmetastatic prostate cancer on androgen deprivation therapy. Journal of Urology 163(6):1743–6
Shrader-Bogen, C. L., Kjellberg, J. L., McPherson, C. P. et al. (1997). Quality of life and treatment outcomes: prostate carcinoma patients' perspectives after prostatectomy or radiation therapy. Cancer 79(10):1977–86
Heathcote, P. S., Mactaggart, P. N., Boston, R. J. et al. (1998). Health-related quality of life in Australian men remaining disease-free after radical prostatectomy. Medical Journal of Australia 168(10):483–6
Tefilli, M. V., Gheiler, E. L., Tiguert, R. et al. (1998). Quality of life in patients undergoing salvage procedures for locally recurrent prostate cancer. Journal of Surgical Oncology 69(3):156–61
Esper, P., Mo, F., Chodak, G. et al. (1997). Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument. Urology 50(6):920–8
Lee, W. R., Hall, M. C., McQuellon, R. P. et al. (2001). A prospective quality-of-life study in men with clinically localized prostate carcinoma treated with radical prostatectomy, external beam radiotherapy, or interstitial brachytherapy. International Journal of Radiation Oncology, Biology, and Physics 51(3):614–23
Lee, W. R., McQuellon, R. P., Case, L. D. et al. (1999). Early quality of life assessment in men treated with permanent source interstitial brachytherapy for clinically localized prostate cancer. Journal of Urology 162(2):403–6
Robinson, J. W., Saliken, J. C., Donnelly, B. J. et al. (1999). Quality-of-life outcomes for men treated with cryosurgery for localized prostate carcinoma. Cancer 86(9):1793–801
Monga, U., Kerrigan, A. J., Thornby, J. et al. (1999). Prospective study of fatigue in localized prostate cancer patients undergoing radiotherapy. Radiation Oncology Investigations 7(3):178–85
de Haes, J. C., van Knippenberg, F. C., Neijt, J. P. (1990). Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. British Journal of Cancer 62(6):1034–8
Gralnek, D., Wessells, H., Cui, H. et al. (2000). Differences in sexual function and quality of life after nerve sparing and nonnerve sparing radical retropubic prostatectomy. Journal of Urology 163(4):1166–70
Krongrad, A., Litwin, M. S., Lai, H. et al. (1998). Dimensions of quality of life in prostate cancer. Journal of Urology 160(3 Pt 1):807–10
Johnstone, P. A., Gray, C., Powell, C. R. (2000). Quality of life in T1-3N0 prostate cancer patients treated with radiation therapy with minimum 10-year follow-up. International Journal of Radiation Oncology, Biology, and Physics 46(4):833–8
Krongrad, A., Perczek, R. E., Burke, M. A. et al. (1997). Reliability of Spanish translations of select urological quality of life instruments. Journal of Urology 158(2):493–6
Barry, M. J., Fowler, F. J., Jr., O'Leary, M. P. et al. (1992). The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. Journal of Urology 148(5):1549–64
Clark, J. A., Wray, N. P., Ashton, C. M. (2001). Living with treatment decisions: regrets and quality of life among men treated for metastatic prostate cancer. Journal of Clinical Oncology 19(1):72–80
Giesler, R. B., Miles, B. J., Cowen, M. E. et al. (2000). Assessing quality of life in men with clinically localized prostate cancer: development of a new instrument for use in multiple settings. Quality of Life Research 9(6):645–65
Clark, J. A., Bokhour, B. G., Inui, T. S. et al. (2003). Measuring patients' perceptions of the outcomes of treatment for early prostate cancer. Medical Care 41: 923–36
Gray, A., Feldman, H. A., McKinlay, J. B. et al. (1991). Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. Journal of Clinical Endocrinology and Metabolism 73(5):1016–25
Feldman, H. A., Goldstein, I., Hatzichristou, D. G. et al. (1994). Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. Journal of Urology 151(1):54–61
O'Leary, M. P., Fowler, F. J., Lenderking, W. R. et al. (1995). A brief male sexual function inventory for urology [see comments]. Urology 46(5):697–706
Rosen, R. C., Riley, A., Wagner, G. et al. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 49(6):822–30
Small, E. J., Meyer, M., Marshall, M. E. et al. (2000). Suramin therapy for patients with symptomatic hormone-refractory prostate cancer: results of a randomized phase III trial comparing suramin plus hydrocortisone to placebo plus hydrocortisone. Journal of Clinical Oncology 18(7):1440–50
Seo, P. H., D'Amico, A. V., Clark, J. A. et al. (2004). Assessing a prostate cancer brachy therapy technique using early patient-reported symptoms: a potential early indicator for technology assessment? Clinical Prostate Cancer 3:38–42
Wilt, T. J., Brawer, M. K. (1994). The Prostate Cancer Intervention Versus Observation Trial: a randomized trial comparing radical prostatectomy versus expectant management for the treatment of clinically localized prostate cancer. Journal of Urology 152 (5 Pt 2):1910–14
Fowler, F. J., Jr., Barry, M. J., Lu-Yao, G. et al. (1996). Outcomes of external-beam radiation therapy for prostate cancer: a study of Medicare beneficiaries in three surveillance, epidemiology, and end results areas. Journal of Clinical Oncology 14(8):2258–65
Talcott, J. A., Rieker, P., Clark, J. A. et al. (1998). Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study. Journal of Clinical Urology 16(1):275–83
Hamilton, A. S., Stanford, J. L., Gilliland, F. D. et al. (2001). Health outcomes after external-beam radiation therapy for clinically localized prostate cancer: results from the Prostate Cancer Outcomes Study. Journal of Clinical Oncology 19(9):2517–26
Walsh, P. C., Marschke, P., Ricker, D. et al. Patient-reported urinary continence and sexual function after anatomic radical prostatectomy. Urology 55(1):58–61
Litwin, M. S., Melmed, G. Y., Nakazon, T. (2001). Life after radical prostatectomy: a longitudinal study. Journal of Urology 166(2):587–92
Hanlon, A. L., Watkins Bruner, D., Peter, R. et al. (2002). Quality of life study in prostate cancer patients treated with three-dimensional conformal radiation therapy: comparing late bowel and bladder quality of life symptoms to that of the normal population. International Journal of Radiation Oncology, Biology, and Physics 49(1):51–9
Pietrow, P. K., Parekh, D. J., Smith, J. A., Jr. et al. (2001). Health related quality of life assessment after radical prostatectomy in men with prostate specific antigen only recurrence. Journal of Urology 166(6):2286–90
Hagedoorn, M., Sneeuw, K. C., Aaronson, N. K. (2002). Changes in physical functioning and quality of life in patients with cancer: response shift and relative evaluation of one's condition. Journal of Clinical Epidemiology 55(2):176–83
Sloan, J. A., Cella, D., Frost, M. et al. (2002). Assessing clinical significance in measuring oncology patient quality of life: introduction to the symposium, content overview, and definition of terms. Mayo Clinic Proceedings 77(4):367–70
Guyatt, G. H., Osoba, D., Wu, A. W. et al. (2002). Methods to explain the clinical significance of health status measures. Mayo Clinic Proceedings 77(4):371–83
Cella, D., Bullinger, M., Scott, C. et al. Group vs individual approaches to understanding the clinical significance of differences or changes in quality of life. Mayo Clinic Proceedings 77(4):384–92

Reference Title: REFERENCES

Reference Type: reference-list

Greenlee, R. T., Murray, T., Bolden, S. et al. (2000). Cancer statistics, 2000 Ca: Cancer Journal for Clinicians 50:7–33
DeVita, V. T. Jr., Hellman, S., Rosenberg, S. A. (1993). Cancer: Principles and Practice of Oncology. Philadelphia, PA: J.B. Lippincott Co
Reis, L. A. G., Kosary, C. L., Hankey, B. F. et al. (1999). SEER Cancer Statistics Review, 1973–1996. Bethesda, MD: National Cancer Institute
Hopwood, P., Stephens, R. J. (1995). Symptoms at presentation for treatment in patients with lung cancer: implications for the evaluation of palliative treatment British Journal of Cancer 71:633–6
Thatcher, N., Hopwood, P., Anderson, H. (1997). Improving quality of life in patients with non-small cell lung cancer: research experience with gemcitabine European Journal of Cancer 33:S8–13
Hollen, P. J., Gralla, R. J. (1996). Comparison of instruments for measuring quality of life in patients with lung cancer Seminars in Oncology 23:31–40
Hopwood, P. (1996). Quality of life assessment in chemotherapy trials for non-small cell lung cancer: are theory and practice significantly different? Seminars in Oncology 23:60–4
Manegold, C., Schwarz, R. (1996). Quality of life and supportive care in the treatment of NSCLC Chest 109:113S–14S
Johnson, D. H. (2000). Evolution of cisplatin-based chemotherapy in non-small cell lung cancer: a historical perspective and the eastern cooperative oncology group experience Chest 117:133S–7S
Chang, A. Y., Kim, K., Boucher, H. et al. (1998). A randomized phase II trial of echinomycin, trimetrexate, and cisplatin plus etoposide in patients with metastatic nonsmall cell lung carcinoma: an Eastern Cooperative Oncology Group Study (E1587) Cancer 82:292–300
Crawford, J., O'Rourke, M., Schiller, J. H. et al. (1996). Randomized trial of vinorelbine compared with fluorouracil plus leucovorin in patients with stage IV non-small-cell lung cancer Journal of Clinical Oncology 14:2774–84
Li, B., Yu, J., Suntharalingam, M. et al. (2000). Comparison of three treatment options for single brain metastasis from lung cancer International Journal of Cancer 90:37–45
White, S. C., Cheeseman, S., Thatcher, N. et al. (2000). Phase II study of oral topotecan in advanced non-small cell lung cancer Clinical Cancer Research 6:868–73
Hopwood, P., Harvey, A., Davies, J. et al. (1998). Survey of the administration of quality of life (QL) questionnaires in three multicentre randomised trials in cancer. The Medical Research Council Lung Cancer Working Party the CHART Steering Committee European Journal of Cancer 34:49–57
Sarna, L. (1993). Correlates of symptom distress in women with lung cancer Cancer Practice 1:21–8
Sarna, L. (1993). Women with lung cancer: impact on quality of life Quality of Life Research 2:13–22
Sarna, L., Brecht, M. L. (1997). Dimensions of symptom distress in women with advanced lung cancer: a factor analysis Heart Lung 26:23–30
Movsas, B., Scott, C., Sause, W. et al. (1999). The benefit of treatment intensification is age and histology-dependent in patients with locally advanced non-small cell lung cancer (NSCLC): a quality-adjusted survival analysis of radiation therapy oncology group (RTOG) chemoradiation studies International Journal of Radiation Oncology, Biology, and Physics 45:1143–9
Erickson, this volume, Chapter 3
Hendriks, J., Van Schil, P., van Meerbeeck, J. et al. (1996). Short-term survival after major pulmonary resections for bronchogenic carcinoma Acta Chirurgica Belgica 96:273–9
Taenzer, P., Bultz, B. D., Carlson, L. E. et al. (2000). Impact of computerized quality of life screening on physician behaviour and patient satisfaction in lung cancer outpatients Psycho-Oncology 9:203–13
Lutz, S. T., Huang, D. T., Ferguson, C. L. et al. (1997). A retrospective quality of life analysis using the Lung Cancer Symptom Scale in patients treated with palliative radiotherapy for advanced nonsmall cell lung cancer International Journal of Radiation Oncology, Biology, and Physics 37:117–22
Bernhard, J., Hurny, C., Bacchi, M. et al. (1996). Initial prognostic factors in small-cell lung cancer patients predicting quality of life during chemotherapy. Swiss Group for Clinical Cancer Research (SAKK) British Journal of Cancer 74:1660–7
Joss, R. A., Alberto, P., Hurny, C. et al. (1995). Quality versus quantity of life in the treatment of patients with advanced small-cell lung cancer? A randomized phase III comparison of weekly carboplatin and teniposide versus cisplatin, adriamycin, etoposide alternating with cyclophosphamide, methotrexate, vincristine and lomustine. Swiss Group for Clinical Cancer Research (SAKK) Annals of Oncology 6:41–8
Montazeri, A., Milroy, R., Hole, D. et al. (1998). Anxiety and depression in patients with lung cancer before and after diagnosis: findings from a population in Glasgow, Scotland Journal of Epidemiology and Community Health 52:203–4
Cullen, M. H., Billingham, L. J., Woodroffe, C. M. et al. (1999). Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life Journal of Clinical Oncology 17:3188–94
Helsing, M., Bergman, B., Thaning, L. et al. (1998). Quality of life and survival in patients with advanced non-small cell lung cancer receiving supportive care plus chemotherapy with carboplatin and etoposide or supportive care only. A multicentre randomised phase III trial. Joint Lung Cancer Study Group European Journal of Cancer 34:1036–44
Gridelli, C., Frontini, L., Perrone, F. et al. (2002). Gemcitabine plus vinorelbine in advanced non-small cell lung cancer: a phase II study of three different doses. Gem Vin Investigators British Journal of Cancer 83:707–14
Aaronson, N. K., Cull, A. M., Kaasa, S., Sprangers, M. A. G. (1996). The European Organization for Research and Treatment of Cancer (EORTC) modular approach to quality of life assessment in oncology: an update. In Quality of Life and Pharmacoeconomics in Clinical Trials (2nd Edition), ed. B. Spilker, pp. 179–89. Philadelphia, PA: Lippincott-Raven
Cella, D. F., Bonomi, A. E. (1996). The Functional Assessment of Cancer Therapy (FACT) and Functional Assessment of HIV Infection (FAHI) quality of life measurement system. In Quality of Life and Pharmacoeconomics in Clinical Trials (2nd Edition), ed. B. Spilker, pp. 203–14. Philadelphia, PA: Lippincott-Raven
European Organization for Research and Treatment of Cancer. QLQ-C30 (core). http://www.eortc.be/home/qol/ Accessed September 10, 2004
Bergman, B., Aaronson, N. K., Ahmedzai, S. et al. (1994). The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life European Journal of Cancer 30A:635–42
Bergman, B., Sullivan, M., Sorenson, S. (1992). Quality of life during chemotherapy for small cell lung cancer. II. A longitudinal study of the EORTC Core Quality of Life Questionnaire and comparison with the Sickness Impact Profile Acta Oncologica 31:19–28
Herndon, J. E., Fleishman, S., Kosty, M. P. et al. (1997). A longitudinal study of quality of life in advanced non-small cell lung cancer: Cancer and Leukemia Group B (CALGB) 8931 Controlled Clinical Trials 18:286–300
Kosmidis, P. (1996). Quality of life as a new end point Chest 109:110S-2S
Aaronson, N. K., Ahmedzai, S., Bergman, B. et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology Journal of the National Cancer Institute 85:365–76
Osoba, D., Zee, B., Pater, J. et al. (1994). Psychometric properties and responsiveness of the EORTC Quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer Quality of Life Research. 3:353–64
Osoba, D., Murray, N., Gelmon, K. et al. (1994). Quality of life, appetite, and weight change in patients receiving dose-intensive chemotherapy Oncology (Huntington) 8:61–5
Geddes, D. M., Dones, L., Hill, E. et al. (1990). Quality of life during chemotherapy for small cell lung cancer: assessment and use of a daily diary card in a randomized trial European Journal of Cancer 26:484–92
Zieren, H. U., Muller, J. M., Hamberger, U. et al. (1996). Quality of life after surgical therapy of bronchogenic carcinoma European Journal of Cardiovascular Therapy 10:233–7
Cella, D. F., Tulsky, D. S., Gray, G. S. B. et al. (1993). The Functional Assessment of Cancer Therapy Scale: development and validation of the general measure Journal of Clinical Oncology 11:570–9
Cella, D. F., Tulsky, D. S., Gray, G. S. B. et al. Functional Assessment of Chronic Illness Therapy. http://www.facit.org. Accessed September 10, 2004
Cella, D. F., Bonomi, A. E., Lloyd, S. R. et al. (1995). Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument Lung Cancer 12:199–220
Bonomi, P., Kim, K., Fairclough, D. et al. (2000). Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial Journal of Clinical Oncology 18:623–31
Colon-Otero, G., Niedringhaus, R. D., Hillman, S. H. et al. (2001). A phase II trial of edatrexate, vinblastine, adriamycin, cisplastin, and filgrastim (EVAC/G-CSF) in patients with non-small-cell carcinoma of the lungs: a North Central Cancer Treatment Group Trial American Journal of Clinical Oncology 24:551–5
Hollen, P. J., Gralla, R. J., Kris, M. G. et al. (1993). Quality of life assessment in individuals with lung cancer: testing the Lung Cancer Symptom Scale (LCSS) European Journal of Cancer 29A(Suppl. 1):S51–8
Hollen, P. J., Gralla, R. J., Kris, M. G. et al. (1994). Quality of life during clinical trials: conceptual model for the Lung Cancer Symptom Scale (LCSS) Supportive Care in Cancer 2:213–22
Hollen, P. J., Gralla, R. J., Kris, M. G. et al. (1994). Measurement of quality of life in patients with lung cancer in multicenter trials of new therapies. Psychometric assessment of the Lung Cancer Symptom Scale Cancer 73:2087–98
Hollen, P. J., Gralla, R. J., Kris, M. G. et al. (1999). Normative data and trends in quality of life from the Lung Cancer Symptom Scale (LCSS) Supportive Care in Cancer 7:140–8
Hollen, P. J., Gralla, R. J., Liepa, A. M. et al. (2001). Validation of a quality of life instrument for patients with pleural mesothelioma: Lung Cancer Symptom Scale Proceedings of the American Society for Clinical Onology 20 (Abstract 1579)
Lung Cancer Symptom Scale. http://www.lcss-ql.com/. Accessed September 10, 2004
Hollen, P. J., Gralla, R. J., Cox, C. et al. (1997). A dilemma in analysis: issues in the serial measurement of quality of life in patients with advanced lung cancer Lung Cancer 18:119–36
Dales, R. E., Belanger, R., Shamji, F. M. et al. (1994). Quality-of-life following thoracotomy for lung cancer Journal of Clinical Epidemiology 47:1443–9
Langendijk, J. A., ten Velde, G. P., Aaronson, N. K. et al. (2002). Quality of life after palliative radiotherapy in non-small cell lung cancer: a prospective study International Journal of Radiation Oncology, Biology, and Physics 47:149–55
Schaafsma, J., Coy, P. (2000). Response of global quality of life to high-dose palliative radiotherapy for non-small-cell lung cancer International Journal of Radiation Oncology, Biology, and Physics 47:691–701
Lutz, S., Norrell, R., Bertucio, C. et al. (2001). Symptom frequency and severity in patients with metastatic or locally recurrent lung cancer: a prospective study using the Lung Cancer Symptom Scale in a community hospital Journal of Palliative Medicine 4:157–65
Hickish, T. F., Smith, I. E., Nicolson, M. C. et al. (1998). A pilot study of MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in small-cell lung cancer British Journal of Cancer 77:1966–70
Shevlin, P. M., Muers, M. F., Peake, M. D. et al. (1998). Modified ICE study: a phase II study of an intensive, modified ICE regimen (ifosfamide, carboplatin and etoposide) in patients with better prognosis, small cell lung cancer Lung Cancer 21:115–26
Frasci, G., Comella, P., Panza, N. et al. (1998). Carboplatin-oral etoposide personalized dosing in elderly non-small cell lung cancer patients. Gruppo Oncologico Cooperativo Sud-Italia European Journal of Cancer 34:1710–14
Tester, W. J., Jin, P. Y., Reardon, D. H. et al. (1997). Phase II study of patients with metastatic nonsmall cell carcinoma of the lung treated with paclitaxel by 3-hour infusion Cancer 79:724–9
Roychowdhury, D. F., Desai, P., Zhu, Y. W. (1997). Paclitaxel (3-hour infusion) followed by carboplatin (24 hours after paclitaxel): a phase II study in advanced non-small cell lung cancer Seminars in Oncology 24:S12.
Han, J. Y., Kim, H. K., Choi, B. G. et al. (1998). Quality of life (QOL) assessment of MIP (mitomycin, ifosfamide and cisplatin) chemotherapy in advanced non-small cell lung cancers (NSCLC) Japanese Journal of Oncology 28:749–53
Gridelli, C., Perrone, F., Gallo, C. et al. (1999). Single-agent gemcitabine as second-line treatment in patients with advanced non small cell lung cancer (NSCLC): a phase II trial Anticancer Research 19:4535–8
Kosmas, C., Tsavaris, N. B., Polyzos, A. et al. (2000). A phase II study of paclitaxel-ifosfamide-cisplatin combination in advanced nonsmall cell lung carcinoma Cancer 89:774–82
Socinski, M. A., Steagall, A., Gillenwater, H. (1999). Second-line chemotherapy with 96-hour infusional paclitaxel in refractory non-small cell lung cancer: report of a phase II trial Cancer Investigation 17:181–8
Pujol, J. L., Monnier, A., Berille, J. et al. (1994). Phase II study of nitrosourea fotemustine as single-drug chemotherapy in poor-prognosis non-small-cell lung cancer British Journal of Cancer 69:1136–40
Maasilta, P. K., Rautonen, J. K., Mattson, M. T. et al. (1990). Quality of life assessment during chemotherapy for non-small cell lung cancer European Journal of Cancer 26:706–8
Quantin, X., Riviere, A., Daures, J. P. et al. (2000). Phase I-II study of high dose epirubicin plus cisplatin in unresectable non-small-cell lung cancer: searching for the maximal tolerated dose American Journal of Clinical Oncology 23:192–6
Buccheri, G., Ferrigno, D. (2000). Vinorelbine in elderly patients with inoperable nonsmall cell lung carcinoma: a phase II study Cancer 88:2677–85
Hurny, C., Bernhard, J., Joss, R. et al. (1993). “Fatigue and malaise” as a quality-of-life indicator in small-cell lung cancer patients. The Swiss Group for Clinical Cancer Research (SAKK) Supportive Care in Cancer 1:316–20
Tishelman, C., Degner, L. F., Mueller, B. (2000). Measuring symptom distress in patients with lung cancer. A pilot study of experienced intensity and importance of symptoms [published erratum appears in Cancer Nursing (2000)23(3):163] Cancer Nursing 23:82–90
The Elderly Lung Cancer Vinorelbine Italian Study Group (1999). Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer Journal of the National Cancer Institute 91:66–72
Regan, J., Yarnold, J., Jones, P. W. et al. (1991). Palliation and life quality in lung cancer: how good are clinicians at judging treatment outcome? British Journal of Cancer 64:396–400
Gralla, R. J., Hollen, P. J., Rittenberg, C. N. et al. (1999). Measuring quality of life (QL) in lung cancer clinical trials: Determining the frequency of QL assessment Proceedings of the American Society for Clinical Oncology 18 (Abstract 2235)
Hurny, C., Bernhard, J., Joss, R. et al. (1992). Feasibility of quality of life assessment in a randomized phase III trial of small cell lung cancer — a lesson from the real world — the Swiss Group for Clinical Cancer Research SAKK Annals of Oncology 3:825–31
Bergman, B., Sullivan, M., Sorenson, S. (1991). Quality of life during chemotherapy for small cell lung cancer. I. An evaluation with generic health measures Acta Oncologica 30:947–57
Hopwood, P., Stephens, R. J., Machin, D. (1994). Approaches to the analysis of quality of life data: experiences gained from a medical research council lung cancer working party palliative chemotherapy trial Quality of Life Research 3:339–52
Kosty, M. P., Fleishman, S. B., Herndon, J. E. et al. (1994). Cisplatin, vinblastine, and hydrazine sulfate in advanced, non-small-cell lung cancer: a randomized placebo-controlled, double-blind phase III study of the Cancer and Leukemia Group B Journal of Clinical Oncology 12:1113–20
Giaccone, G., Splinter, T. A., Debruyne, C. et al. (1998). Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group Journal of Clinical Oncology 16:2133–41
Earl, H. M., Rudd, R. M., Spiro, S. G. et al. (1991). A randomised trial of planned versus as required chemotherapy in small cell lung cancer: a Cancer Research Campaign trial British Journal of Cancer 64:566–72
Ahles, T. A., Silberfarb, P. M., Rundle, A. C. et al. (1994). Quality of life in patients with limited small-cell carcinoma of the lung receiving chemotherapy with or without radiation therapy, for cancer and leukemia group B Psychotherapy and Psychosomatics 62:193–9
Macbeth, F. R., Bolger, J. J., Hopwood, P. et al. (1996). Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status. Medical Research Council Lung Cancer Working Party Clinical Oncology (Royal College of Radiology) 8:167–75
Bailey, A. J., Parmar, M. K., Stephens, R. J. (1998). Patient-reported short-term and long-term physical and psychologic symptoms: results of the continuous hyperfractionated accelerated radiotherapy (CHART) randomized trial in non-small-cell lung cancer. CHART Steering Committee Journal of Clinical Oncology 16:3082–93
Anderson, H., Hopwood, P., Stephens, R. J. et al. (2000). Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer—a randomized trial with quality of life as the primary outcome. UK NSCLC Gemcitabine Group. Non-Small Cell Lung Cancer British Journal of Cancer 83:447–53
Agteresch, H. J., Dagnelie, P. C., van der Gaast, A. et al. (2000). Randomized clinical trial of adenosine 5′-triphosphate in patients with advanced non-small-cell lung cancer Journal of the National Cancer Institute 92:321–8
Shepherd, F. A., Dancey, J., Ramlau, R. et al. (2000). Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy Journal of Clinical Oncology 18:2095–103
Roszkowski, K., Pluzanska, A., Krzakowski, M. et al. (2000). A multicenter, randomized, phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy-naive patients with metastatic or non-resectable localized non-small cell lung cancer (NSCLC) Lung Cancer 27:145–57
Ranson, M., Davidson, N., Nicolson, M. et al. (2000). Randomized trial of paclitaxel plus supportive care versus supportive care for patients with advanced non-small-cell lung cancer Journal of the National Cancer Institute 92:1074–80
Souhami, R. L., Spiro, S. G., Rudd, R. M. et al. (1997). Five-day oral etoposide treatment for advanced small-cell lung cancer: randomized comparison with intravenous chemotherapy Journal of National Cancer Institute 89:577–80
Gower, N. H., Rudd, R. M., Ruiz de Elvra, M. C. et al. (1995). Assessment of ‘quality of life’ using a daily diary card in a randomised trial of chemotherapy in small-cell lung cancer Annals of Oncology 6:575–80
Fayers, P. M., Bleehen, N. M., Girling, D. J. et al. (1991). Assessment of quality of life in small-cell lung cancer using a Daily Diary Card developed by the Medical Research Council Lung Cancer Working Party British Journal of Cancer 64:299–306
Frasci, G., Lorusso, V., Panza, N. et al. (2000). Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer Journal of Clinical Oncology 18:2529–36
ten Bokkel, H., Bergman, B., Chemaissani, A. et al. (1999). Single-agent gemcitabine: an active and better tolerated alternative to standard cisplatin-based chemotherapy in locally advanced or metastatic non-small cell lung cancer Lung Cancer 26:85–94
Rowland, K. M. J., Loprinzi, C. L., Shaw, E. G. et al. (1996). Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer: a North Central Cancer Treatment Group study Journal of Clinical Oncology 14:135–41
Loprinzi, C. L., Goldberg, R. M., Su, J. Q. et al. (1994). Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancer Journal of Clinical Oncology 12:1126–9
Thatcher, N., Girling, D. J., Hopwood, P. et al. (2000). Improving survival without reducing quality of life in small-cell lung cancer patients by increasing the dose-intensity of chemotherapy with granulocyte colony-stimulating factor support: results of a British Medical Research Council Multicenter Randomized Trial. Medical Research Council Lung Cancer Working Party Journal of Clinical Oncology 18:395–404
Crino, L., Scagliotti, G. V., Ricci, S. et al. (1999). Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project Journal of Clinical Oncology 17:3522–30
Cardenal, F., Lopez-Cabrerizo, M. P., Anton, A. et al. (1999). Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer Journal of Clinical Oncology 17:12–18
Kosmidis, P., Mylonakis, N., Fountzilas, G. et al. (1997). Paclitaxel (175 mg/m2) plus carboplatin versus paclitaxel (225 mg/m2) plus carboplatin in non-small cell lung cancer: a randomized study Seminars in Oncology 24:S12
Glimelius, B., Birgegard, G., Hoffman, K. et al. (1992). Improved care of patients with small cell lung cancer. Nutritional and quality of life aspects Acta Oncologica 31:823–31
Fairclough, this volume, chapter 17
Gelber, R. D., Goldhirsch, A., Cole, B. F. et al. (1996). A quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of adjuvant radiation therapy and chemotherapy for resectable rectal cancer Journal of the National Cancer Institute 88:1039–45
Goldhirsch, A., Gelber, R. D., Simes, R. J. et al. (1989). Costs and benefits of adjuvant therapy in breast cancer: A quality-adjusted survival analysis Journal of Clinical Oncology 7:36–44
Patrick, D. L., Starks, K. C., Cain, R. F. et al. (1994). Measuring preferences for health states worse than death Medical Decision Making 14:9–18
Hyodo, I., Eguchi, K., Takigawa, N. et al. (1999). Psychological impact of informed consent in hospitalized cancer patients. A sequential study of anxiety and depression using the hospital anxiety and depression scale Supportive Care in Cancer 7:396–9
Hopwood, P., Stephens, R. J. (2000). Depression in patients with lung cancer: prevalence and risk factors derived from quality-of-life data Journal of Clinical Oncology 18:893–903
Faller, H., Bulzebruck, H., Drings, P. et al. (1999). Coping, distress, and survival among patients with lung cancer Archives of General Psychiatry 56:756–62
McCarthy, E. P., Phillips, R. S., Zhong, Z. (2000). Dying with cancer: patients' function, symptoms, and care preferences as death approaches Journal of the American Geriatric Society 48:S110–21
Claessens, M. T., Lynn, J., Zhong, Z. et al. (2000). Dying with lung cancer or chronic obstructive pulmonary disease: insights from SUPPORT. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments Journal of the American Geriatric Society 48:S146–53
Schag, C. A., Ganz, P. A., Wing, D. S. et al. (1994). Quality of life in adult survivors of lung, colon and prostate cancer Quality of Life Research 3:127–41
Degner, L. F., Sloan, J. A. (1995). Symptom distress in newly diagnosed ambulatory cancer patients and as a predictor of survival in lung cancer Journal of Pain and Symptom Management 10:423–31
Ganz, P. A., Lee, J. J., Siau, J. (1991). Quality of life assessment. An independent prognostic variable for survival in lung cancer Cancer 67:3131–5
Ruckdeschel, J. C., Piantadosi, S. (1994). Quality of life in lung cancer surgical adjuvant trials Chest 106:324S–8S
Abratt, R., Viljoen, G. (1995). Assessment of quality of life by clinicians — experience of a practical method in lung cancer patients South African Medical Journal 85:896–8
Buccheri, G. F., Ferrigno, D., Tamburini, M. et al. (1995). The patient's perception of his own quality of life might have an adjunctive prognostic significance in lung cancer Lung Cancer 12:45–58
Langendijk, H., Aaronson, N. K., de Jong, J. M. et al. (2000). The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy Radiotherapy and Oncology 255:19–25
Burris, H. A., Moore, M. J., Andersen, J. S. et al. (1997). Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial Journal of Clinical Oncology 15:2403–13
Vansteenkiste, J. F., Vandebroek, J. E., Nackaerts, K. L. et al. (2001). Clinical-benefit response in advanced non-small-cell lung cancer: A multicentre prospective randomized phase II study of single agent gemcitabine versus cisplatin-vindesine Annals of Oncology 12:1221–30

Reference Title: REFERENCES

Reference Type: reference-list

National Cancer Institute. Colorectal Screening. http://www.cancer.gov/cancerinfo/pdq/screening/colorectal/healthprofessional. Last accessed September 11, 2004
Mandel, J. S., Bond, J. H., Church, T. R. et al. (1993). Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study New England Journal of Medicine 328:1365–71
Selby, J. V., Friedman, G. D., Quesenberry, Jr., C. P. et al. (1992). A case-control study of screening sigmoidoscopy and mortality from colorectal cancer New England Journal of Medicine 326:653–7
Newcomb, P. A., Norfleet, R. G., Storer, B. E. et al. (1992). Screening sigmoidoscopy and colorectal cancer mortality Journal of the National Cancer Institute 84:1572–5
Muller, A. D., Sonnenberg, A. (1995). Protection by endoscopy against death from colorectal cancer Archives of Internal Medicine 155:1741–8
National Cancer Institute. Colon cancer treatment. http://www.cancer.gov/cancerinfo/pdq/treatment/colon. Last accessed September 11, 2004
Ries, L. A. G., Eisner, M. P., Kosary, C. L. et al. (eds). (2002). SEER Cancer Statistics Review, 1973–1999. Bethesda, MD: National Cancer Institute, http://seer.cancer.gov/csr/1973_1999. Accessed September 11, 2004
Aaronson, N. K., Ahmedzai, S., Bergman, B. et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology Journal of the National Cancer Institute 85:365–76
Kaasa, S., Mastekaasa, A., Stokke, I. et al. (1988). Validation of a quality of life questionnaire for use in clinical trials for treatment of patients with inoperable lung cancer European Journal of Cancer and Clinical Oncology 24:691–701
Glimelius, B., Hoffman, K., Olafsdottir, M. et al. (1989). Quality of life during cytostatic therapy for advanced symptomatic colorectal carcinoma: a randomized comparison of two regimens European Journal of Cancer and Clinical Oncology 25:829–35
Adang, E. M., Engel, G. L., Konsten, J. et al. (1993). Quality of life after dynamic graciloplasty for fecal incontinence: first results Thoracic Surgery 8:122–4
Renner, K., Rosen, H. R., Novi, G. et al. (1999). Quality of life after surgery for rectal cancer: do we still need a permanent colostomy? Diseases of the Colon and Rectum 42:1160–7
Björvell, H., Hylander, B. (1989). Functional status and personality in patients on chronic dialysis Journal of Internal Medicine 226:319–24
Forsberg, C., Bjorvell, H., Cedermark, B. (1996). Well-being and its relation to coping ability in patients with colo-rectal and gastric cancer before and after surgery Scandinavian Journal of Caring Science 10:35–44
Schipper, H., Clinch, J., McMurray, A. et al. (1984). Measuring the quality of life of cancer patients: The Functional Living Index-Cancer: Development and validation Journal of Clinical Oncology 2:472–83
Morrow, G. R., Lindke, J., Black, P. (1992). Measurement of quality of life in patients: psychometric analyses of the Functional Living Index-Cancer (FLIC) Quality of Life Research 1:287–96
de Haes, J. C. J. M., van Oostrom, M. A., Welvaart, K. (1986). The effect of radical and conserving surgery on the quality of life of early breast cancer patients. European Journal of Surgical Oncology 12:337–42
de Haes, J. C. J. M., Raatgever, J. W., van der Burg, M. E. L. et al. (1987). Evaluation of the quality of life of patients with advanced ovarian cancer treated with combination chemotherapy. In The Quality of Life of Cancer Patients, ed. N. K. Aaronson, J. Beckman, pp. 215–26. New York: Raven Press
de Haes, J. C. J. M., van Knippenberg, F. C. E., Neijt, J. P. (1990). Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist British Journal of Cancer 62:1034–38
de Haes, J. C. J. M., Olschewski, M. (1998). Quality of life assessment in a cross-cultural context: use of the Rotterdam Symptom Checklist in a multinational randomised trial comparing CMF and Zoladex (Goserlin) treatment in early breast cancer Annals of Oncology 9:745–50
Spitzer, W. O., Dobson, A. J., Hall, J. et al. (1983). Measuring the quality of life of cancer patients. A concise QL- Index for use by physicians Journal of Chronic Disease 34:585–97
EuroQoL Group (1990). EuroQoL — a new facility for the measurement of health-related quality of life Health Policy 16:199–208
Kind, P. (1996). The EuroQoL instrument: an index of health-related quality of life. In Quality of Life and Pharmacoeconomics in Clinical Trials (2nd Edn), ed. B. Spilker, pp. 191–201. Philadelphia, PA: Lippincott-Raven
Zigmund, A. S., Snaith, R. P. (1983). The Hospital Anxiety and Depression Scale Acta Psychiatrica Scandinavica 67:361–70
Hunt, S. M., McEwen, J., McKenna, S. P. (1986). Measuring Health Status. London: Croom Helm
Hunt, S. M., McKenna, S. P. (1991). The Nottingham Health Profile User's Manual. Manchester: Galen Research and Consultancy
McEwen, J., McKenna, S. P. (1996). Nottingham Health Profile. In Quality of Life and Pharmacoeconomics in Clinical Trials (2nd Edition), ed. B. Spilker, pp. 281–86. Philadelphia, PA: Lippincott-Raven
Lorr, M., McNair, D. M. (1982). Profile of Mood States: Bi-polar Form. San Diego: Educational and Industrial Testing Service
Shacham, S. (1983). A shortened version of the Profile of Mood States Journal of Personality Assessment 47:305–6
Bergner, M., Bobbitt, R. A., Carter, W. B. et al. (1981). The Sickness Impact Profile: development and final revision of a health status measure Medical Care 19:787–805
Damiano, A. M. (1996). The Sickness Impact Profile. In Quality of Life and Pharmacoeconomics in Clinical Trials (2nd Edition), ed. B. Spilker, pp. 347–54. Philadelphia, PA: Lippincott-Raven
Erickson, this volume, Chapter 3
Fayers, P., Aaronson, N., Bjordal, K. et al., on behalf of the EORTC Quality of Life Group. (2001). EORTC QLQ-C30 Scoring Manual (3rd Edition). Brussels: EORTC
Fayers, P., Weeden, S., Curran, D. (1998). EORTC QLQ-C30 Reference Values. Brussels: EORTC Study Group on Quality of Life
Sprangers, M. A., Cull, A., Bjordal, K. et al., for the EORTC Study Group on Quality of Life (1993). The European Organization for Research and Treatment of Cancer approach to quality of life assessment: Guidelines for developing modules Quality of Life Research 2:287–95
Sprangers, M. A. G. (1999). Quality-of-life assessment in colorectal cancer patients: evaluation of cancer therapies Seminars in Oncology 26:691–6
Aaronson, N. K., Cull, A. M., Kaasa, S. et al. (1996). The European Organization for Research and Treatment of Cancer (EORTC) Modular Approach to Quality of Life Assessment in Oncology: An update. In Quality of Life and Pharmacoeconomics in Clinical Trials (2nd Edition), ed. B. Spilker, pp. 179–89. Philadelphia, PA: Lippincott-Raven
Sprangers, M. A. G., te Velde, A., Aaronson, N. K. on behalf of the European Organization for Research and Treatment of Cancer Study Group on Quality of Life (1999). The construction of the EORTC colorectal cancer-specific quality of life questionnaire module (QLQ-CR38) European Journal of Cancer 35:238–47
Sailer, M., Debus, E. S., Fuchs, K.-H. (2000). How useful is the EORTC QLQ-CR38 in the pre- and post-operative evaluation of patients with rectal cancer? Quality of Life Research Newsletter 25:13–14
Cella, D. F., Tulsky, D. S., Gray, G. et al. (1993). The Functional Assessment of Cancer Therapy scale: development and validation of the general measure Journal of Clinical Oncology 11:570–9
Cella, D. (1997). FACIT Manual. Manual of the Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System. Version 4. Evanston, IL: Center on Outcomes, Research and Education (CORE)
Ward, W. L., Hahn, E. A., Mo, F. et al. (1999). Reliability and validity of the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) quality of life instrument Quality of Life Research 8:181–95
Courneya, K. S., Friedenreich, C. M. (1997). Relationship between exercise pattern across the cancer experience and current quality of life in colorectal cancer survivors Journal of Alternative and Complementary Medicine 3:215–26
Allal, A. S., Bieri, S., Peloni, A. et al. (2002). Sphincter-sparing surgery after preoperative radiotherapy for low rectal cancers: feasibility, oncologic results and quality of life outcomes British Journal of Cancer 82:1131–7
Cronbach, L. J. (1951). Coefficient alpha and the internal structure of tests Psychometrika 16:297–334
Borras, J. M., Sanchez-Hernandez, A., Navarro, M. et al. (2001). Compliance, satisfaction, and quality of life of patients with colorectal cancer receiving home chemotherapy or outpatient treatment: a randomised controlled trial British Medical Journal 322:1–5
Bernhard, J., Hürny, C., Maibach, R., Herrmann, R. et al., for the Swiss Group for Clinical Cancer Research (SAKK). (1999). Quality of life as subjective experience: reframing of perception in patients with colon cancer undergoing radical resection with or without adjuvant chemotherapy Annals of Oncology 10:775–82
Ulander, K., Jeppsson, B., Grahn, G. (1997). Quality of life and independence in activities of daily living preoperatively and at follow-up in patients with colorectal cancer Supportive Care in Cancer 5:402–9
Whynes, D. K., Neilson, A. R. (1997). Symptoms before and after surgery for colorectal cancer Quality of Life Research 6:61–6
Barsevick, A. M., Pasacreta, J., Orsi, A. (1995). Psychological distress and functional dependence in colorectal cancer patients Cancer Practice 3:105–10
Padilla, G. V., Grant, M. M., Lipsett, J. et al. (1992). Health quality of life and colorectal cancer Cancer 70:1450–6
Scieszka, M., Zielinski, M., Machalski, M. et al. (2000). Quality of life in cancer patients treated by chemotherapy Neoplasma 47:396–9
Anthony, T., Jones, C., Antoine, J. et al. (2001). The effect of treatment for colorectal cancer on long-term health-related quality of life Annals of Surgical Oncology 8:44–9
McHorney, C. A., Ware, Jr., J. E., Raczek, A. E. (1993). The MOS 36-item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs Medical Care 31:247–63
Langius, A., Björvell, H., Antonovsky, A. (1992). The Sense of Coherence concept and its relation to personality traits in Swedish samples Scandinavian Journal of Caring Science 6:165–71
Antonovsky, A. (1987). Unraveling the Mystery of Health: How People Manage Stress and Stay Well. San Francisco, CA: Jossey-Bass Publishers
Garufi, C., Brienza, S., Pugliese, P. et al. (2000). Overcoming resistance to chronomodulated 5-fluorouracil and folinic acid by the addition of chronomodulated oxaliplatin in advanced colorectal cancer patients Anticancer Drugs 11:495–501
Garufi, C., Dogliotti, L., D'Attino, R. M. et al. (2001). Irinotecan and chronomodulated infusion of 5-fluorouracil and folinic acid in the treatment of patients with advanced colorectal carcinoma: a phase I study Cancer 91:712–20
Hauns, B., Häring, B., Köhler, S. et al. (2001). Phase II study of combined 5 fluorouracil/Ginkgo biloba extract (GBE 761 ONC) therapy in 5-fluorouracil pretreated patients with advanced colorectal cancer Phytotherapy Research 15:34–8
Henry, B., Becouarn, Y., Aussage, P. (1999). Clinical benefits of stabilization with second line chemotherapy in patients with metastatic colorectal cancer Oncology Hematology 32:145–54
Fordy, C., Glover, C., Davies, M. M. et al. (1998). Hepatic arterial floxuridine as second-line treatment for systemic fluorouracil-resistant colorectal liver metastases British Journal of Cancer 78:1058–60
Cunningham, D., Zalcberg, J. R., Rath, U. et al. (1996). Final results of a randomised trial comparing ‘Tomudex’ (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer. “Tomudex” Colorectal Cancer Study Group Annals of Oncology 7:961–5
Cunningham, D., Glimelius, B. on behalf of the V301 Study Group. (1999). A phase III study of irinotecan (CPT-11) versus best supportive care in patients with metastatic colorectal cancer who have failed 5-fluorouracil therapy. V301 Study Group Seminars in Oncology 26:6–12
de Gramont, A., Figer, A., Seymour, M. et al. (2000). Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer Journal of Clinical Oncology 18:2938–47
Douillard, J. Y., Cunningham, D., Roth, A. D. et al. (2000). Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial Lancet 355:1041–7
Hill, M., Norman, A., Cunningham, D. et al. (1995). Impact of protracted venous infusion fluorouracil with or without interferon alfa-2b on tumor response, survival, and quality of life in advanced colorectal cancer Journal of Clinical Oncology 13:2317–23
Ross, P., Norman, A., Cunningham, D. et al. (1997). A prospective randomised trial of protracted venous infusion 5-fluorouracil with or without mitomycin C in advanced colorectal cancer Annals of Oncology 8:995–1001
Rougier, P., Van Cutsem, E., Bajetta, E. et al. (1998). Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer Lancet 352:1407–12
Saltz, L. B., Cox, J. V., Blanke, C. et al. (2000). Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group New England Journal of Medicine 343:905–14
Van Cutsem, E., Blijham, G. H. on behalf of the V302 Study Group. (1999). Irinotecan versus infusional 5-fluorouracil: a phase III study in metastatic colorectal cancer following failure on first-line 5-fluorouracil Seminars in Oncology 26:13–20
Norum, J., Vonen, B., Olsen, J. A. et al. (1997). Adjuvant chemotherapy (5-fluorouracil and levamisole) in Dukes' B and C colorectal carcinoma: a cost-effectiveness analysis Annals of Oncology 8:65–70
Allen-Mersh, T. G., Earlam, S., Fordy, C. et al. (1994). Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases Lancet 344:1255–60
Allen-Mersh, T. G., Glover, C., Fordy, C. et al. (2000). Randomized trial of regional plus systemic fluorinated pyrimidine compared with systemic fluorinated pyrimidine in treatment of colorectal liver metastases European Journal of Surgical Oncology 26:468–73
Cocconi, G., Cunningham, D., Van Cutsem, E. et al. (1998). Open, randomized, multicenter trial of raltitrexed versus fluorouracil plus high-dose leucovorin in patients with advanced colorectal cancer. Tomudex Colorectal Cancer Study Group Journal of Clinical Oncology 16:2943–52
Earlam, S., Glover, C., Davies, M. et al. (1997). Effect of regional and systemic fluorinated pyrimidine chemotherapy on quality of life in colorectal liver metastasis patients Journal of Clinical Oncology 15:2022–9
Seymour, M. T., Slevin, M. L., Kerr, D. J. et al. (1996). Randomized trial assessing the addition of interferon alpha-2a to fluorouracil and leucovorin in advanced colorectal cancer. Colorectal Cancer Working Party of the United Kingdom Medical Research Council Journal of Clinical Oncology 14:2280–8
Sobrero, A., Zaniboni, A., Frassineti, G. L. et al. (2000). Schedule specific biochemical modulations of 5-fluorouracil in advanced colorectal cancer: A randomized study. GISCAD, IOR and collaborating centers Annals of Oncology 11:1413–20
Caudry, M., Bonnel, C., Floquet, A. et al. (1995). A randomized study of bolus fluorouracil plus folinic acid versus 21-day fluorouracil infusion alone or in association with cyclophosphamide and mitomycin C in advanced colorectal carcinoma American Journal of Clinical Oncology 18:118–25
Loprinizi, C. L., Juross, S. A., O'Fallon, J. R. et al. (1994). Randomized placebo-controlled evaluation of hydrazine sulfate in patients with advanced colorectal cancer Journal of Clinical Oncology 12:1121–5
Smyth, J. F., Hardcastle, J. D., Denton, G. et al. (1995). Two phase III trials of tauromustine (TCNU) in advanced colorectal cancer Annals of Oncology 6:948–9
Laufman, L. R., Bukowski, R. M., Collier, M. A. et al. (1993). A randomized, double-blind trial of fluorouracil plus placebo versus fluorouracil plus oral leucovorin in patients with metastatic colorectal cancer Journal of Clinical Oncology 11:1888–93
Scheithauer, W., Rosen, H., Kornek, G.-V. et al. (1993). Randomized comparison of combination 4 chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer British Medical Journal 306:752–5
Sullivan, B. A., McKinnis, R., Laufman, L. R. (1995). Quality of life in patients with metastatic colorectal cancer receiving chemotherapy: a randomized, double-blind trial comparing 5-FU versus 5-FU with leucovorin Pharmacotherapy 15:600–7
Glimelius, B., Hoffman, K., Graf, W. et al. (1994). Quality of life during chemotherapy in patients with symptomatic advanced colorectal cancer Cancer 73:556–62
Leichman, C. G., Fleming, T. R., Muggia, F. M. et al. (1995). Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study Journal of Clinical Oncology 13:1303–11
Moinpour, C. M., Triplett, J. S., McKnight, B. et al. (2000). Challenges posed by non-random missing quality of life data in an advanced-stage colorectal cancer clinical trial Psycho-Oncology 9:340–54
Moinpour, C. M., Savage, M., Hayden, K. A. et al. (1995). Quality of Life Assessment in Cancer Clinical Trials. In Quality of Life in Behavioral Medicine Research, ed. J. E. Dimsdale, A. Braun, pp. 79–95. Hillsdale, NJ: Lawrence Erlbaum Associates
Feeny, D., Furlong, W., Boyle, M. et al. (1995). Multi-attribute health status classification systems: Health Utilities Index Pharmacoeconomics 7:490–502
Tobin, E. (2001). Report on Focus Group Research. Conducted for NCI's COMWG with cancer patients and survivors by Cancer Care Strategies. September, 2001. Completed under contract to the National Cancer Institute by E. Tobin
Zebrack, Cella, this volume, Chapter 11
Bernhard, J., Cella, D. F., Coates, A. S. et al. (1998). Missing quality of life data in cancer clinical trials: serious problems and challenges Statistics in Medicine 17:517–32
Hogan, J. W., Laird, N. M. (1997). Mixture models for the joint distribution of repeated measures and event times Statistics in Medicine 16:239–57
Fairclough, this volume, Chapter 17
Sprangers, M. A. G., Taal, B. G., Aaronson, N. K. et al. (1995). Quality of life in colorectal cancer. Stoma vs. nonstoma patients Diseases of the Colon and Rectum 38:361–9
Camilleri-Brennan, J., Steele, R. J. C. (1998). Quality of life after treatment for rectal cancer British Journal of Surgery 85:1036–43
Wils, J., Sahmoud, T., Sobrero, A. et al. (1998). Evaluation of clinical efficacy of new medical treatments in advanced colorectal cancer. Results of a workshop organized by the EORTC GITCCG Tumori 84:335–47
Sobrero, A., Belvedere, O., Ramello, M. et al. (2001). Endpoints of medical treatment of colorectal cancer Tumori 87(Suppl. 1):S63–4
Allen, M., Cunningham, D., Schmitt, C. (1998). The importance of stabilization as an endpoint in the treatment of metastatic colorectal carcinoma: recent quality of life studies Anti-Cancer Drugs 9:783–90
Cull, A., Groenvold, M., on behalf of the EORTC Quality of Life Study Group. (1998). EORTC Quality of Life Study Group Translation Procedure. ISBN: 2-930064-15–3. Brussels: EORTC
Beck, A. T., Steer, R. A. (1987). Beck Depression Inventory (BDI) Manual. San Antonio: Harcourt Brace Jovanovich
Benoliel, J. Q., McCorkle, R., Young, K. (1983). The development of a social dependency scale Research in Nursing and Health 3:3–10
McCorkle, R. M., Benoliel, J. Q., Donaldson, G. et al. (1989). A randomized clinical trial of home nursing care for lung cancer patients Cancer 57:358–64
Priestman, T., Baum, M. (1976). Evaluation of quality of life in patients receiving treatment for advanced breast cancer Lancet 24:899–900
Coates, A., Gebski, V., Bishop, J. F. et al. (1987). Improving the quality of life during chemotherapy for advanced breast cancer New England Journal of Medicine 317:1633–7
Ware, Jr., J. E., Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection Medical Care 30:473–83
McHorney, C. A., Ware, Jr., J. E., Lu, J. F. R., Sherbourne, C. D. (1994). The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups Medical Care 32:40–66
Ware, Jr., J. E., Snow, K. K., Kosinski, M. et al. (1993). SF-36 Health Survey Manual and Interpretation Guide. Boston, MA: New England Medical Center, The Health Institute

Reference Title: REFERENCES

Reference Type: reference-list

Donovan, K., Sanson-Fisher, R., Redman, S. (1989). Measuring quality of life in cancer patients. Journal of Clinical Oncology 7:959–68
Scott, C. B. (1998). Issues in quality of life assessment during cancer therapy. Seminars in Radiation Oncology 8:5–9
Carlsson, M., Strang, P., Bjurstrom, C. (2000). Treatment modality affects long-term quality of life in gynaecological cancer. Anticancer Research 20(1B):563–8
Langenhoff, B. S., Krabbe, P. F., Wobbes, T. et al. (2001). Quality of life as an outcome measure in surgical oncology. British Journal of Surgery 88:643–52
Cox, J., Stetz, J., Pajak, T. (1995). Toxicity criteria of the radiation therapy oncology group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). International Journal of Radiation Oncology, Biology, and Physics 31:1341–6
Paszat, L., Mackillop, W., Groome, P. et al. (1998). Mortality from myocardial infarction after adjuvant radiotherapy for breast cancer in the surveillance, epidemiology, and end-results cancer registries. Journal of Clinical Epidemiology 16:2625–31
National Cancer Institute (2001). CancerNet PDQ Cancer Information Summary. Breast Cancer Treatment (for health professionals). http://www.cancer.gov/cancerinfo/pdq/treatment/breast/healthprofessional. Last accessed September 11, 2004
National Cancer Institute (2001). CancerNet PDQ Cancer Information Summary. Colon Cancer Treatment (for health professionals). http://www.cancer.gov/cancerinfo/pdq/treatment/colon/healthprofessional. Last accessed September 11, 2004
National Cancer Institute (2001). CancerNet PDQ Cancer Information Summary. Rectal Cancer Treatment (for health professionals). http://www.cancer.gov/cancerinfo/pdq/treatment/rectal/healthprofessional. Last accessed September 11, 2004
National Cancer Institute (2001). CancerNet PDQ Cancer Information Summary. Non-small Cell Lung Cancer Treatment (for health professionals). http://www.cancer.gov/cancerinfo/pdq/treatment/non-small-cell-lung/healthprofessional. Last accessed September 11, 2004
National Cancer Institute (2002). CancerNet PDQ Cancer Information Summary. Small Cell Lung Cancer Treatment (for health professionals). http://www.cancer.gov/cancerinfo/pdq/treatment/small-cell-lung/healthprofessional. Last accessed September 11, 2004
National Cancer Institute (2001). CancerNet PDQ Cancer Information Summary. Prostate Cancer Treatment (for health professionals). http://www.cancer.gov/cancerinfo/pdq/treatment/prostate/healthprofessional. Last accessed September 11, 2004
Smets, E. M., Garssen, B., Bonke, B. et al. (1995). The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. Journal of Psychosomatic Research 39:315–25
Smets, E. M., Garssen, B., Cull, A. et al. (1996). Application of the multidimensional fatigue inventory (MFI-20) in cancer patients receiving radiotherapy. British Journal of Cancer 73:241–5
Smets, E. M., Visser, M. R., Garssen, B. et al. (1998). Understanding the level of fatigue in cancer patients undergoing radiotherapy. Journal of Psychosomatic Research 45:277–93
Ahsberg, E., Furst, C. J. (2001). Dimensions of fatigue during radiotherapy — an application of the Swedish Occupational Fatigue Inventory (SOFI) on cancer patients. Acta Oncologia 40:37–43
Hopwood, P. (1993). The assessment of body image in cancer patients. European Journal of Cancer 29A:276–81
Klee, M. C., King, M. T., Machin, D. et al. (2000). A clinical model for quality of life assessment in cancer patients receiving chemotherapy. Annals of Oncology 11(1):23–30
Broecke, J. A., Jacobsen, P. B., Balducci, L. et al. (2000). Quality of life after adjuvant chemotherapy for breast cancer. Breast Cancer Research and Treatment 62(2):141–50
van Dam, F. S., Schagen, S. B., Muller, M. J. et al. (1998). Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. Journal of the National Cancer Institute 90:210–18
Schagen, S. B., van Dam, F. S., Muller, M. J. et al. (1999). Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer 85:640–50
Brezden, C. B., Phillips, K. A., Abdolell, M.(2000). Cognitive function in breast cancer patients receiving adjuvant chemotherapy. Journal of Clinical Oncology 18:2695–701
Hurny, C., Bernhard, J., Coates A. (1998). Quality of life assessment in the International Breast Cancer Study Group: past, present, and future. Recent Results in Cancer Research 152:390–5
Hurny, C., Bernhard, J., Coates, A. S. et al. (1996). Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancer. International Breast Cancer Study Group. Lancet 347:1279–84
Fairclough, D. L., Fetting, J. H., Cella, D. et al. (1999). Quality of life and quality adjusted survival for breast cancer patients receiving adjuvant therapy. Eastern Cooperative Oncology Group (ECOG). Quality of Life Research 8:723–31
Douillard, J. Y., Cunningham, D., Roth, A. D. et al. (2000). Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 355(9209):1041–7
Cunningham, D., Pyrhonen, S., James, R. D. et al. (1998). Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer. Lancet 352(9138):1413–18
Rougier, P., Van Cutsem, E., Bajetta, E. et al. (1998). Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer. Lancet 352(9138):1407–12
Osoba, D., Tannock, I. F., Ernst, D. S. et al. (1999). Health-related quality of life in men with metastatic prostate cancer treated with prednisone alone or mitoxantrone and prednisone. Journal of Clinical Oncology 17:1654–63
Cullen, M. H., Billingham, L. J., Woodroffe, C. M. et al. (1999). Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life. Journal of Clinical Oncology 17:3188–94
Shepherd, F. A., Dancey, J., Ramlau, R. et al. (2000). Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy. Journal of Clinical Oncology 18:2095–103
Hakamies-Blomqvist, L., Luoma, M., Sjostrom, J. et al. (2000). Quality of life in patients with metastatic breast cancer receiving either docetaxel or sequential methotrexate and 5-fluorouracil. A multicentre randomised phase III trial by the Scandinavian breast group. European Journal of Cancer 36:1411–17
Kramer, J. A., Curran, D., Piccart, M. et al. (2000). Randomised trial of paclitaxel versus doxorubicin as first-line chemotherapy for advanced breast cancer: quality of life evaluation using the EORTC QLQ-C30 and the Rotterdam symptom checklist. European Journal of Cancer 36:1488–97
Harper-Wynne, C., English, J., Meyer, L. et al. (1999). Randomized trial to compare the efficacy and toxicity of cyclophosphamide, methotrexate and 5-fluorouracil (CMF) with methotrexate mitoxantrone (MM) in advanced carcinoma of the breast. British Journal of Cancer 81:316–22
Cella, D., Tulsky, D., Gray, G. et al. (1993). The Functional Assessment of Cancer Therapy Scale: Development and validation of the general measure. Journal of Clinical Oncology 11:570–9
Brundage, M., Pater, J., Zee, B. (1993). Assessing the reliability of two toxicity scales: implications for interpreting toxicity data. Journal of the National Cancer Institute 85:1138–48
Pavy, J. J., Denekamp, J., Letschert, J. et al. (1995). Late effects toxicity scoring: the SOMA Scale. International Journal of Radiation Oncology, Biology, and Physics 31:1043–7
Rubin, P., Constine, L., Fajardo, L. et al. (1995). Overview: Late effects of normal tissues (LENT) scoring system. International Journal of Radiation Oncology, Biology, and Physics 31:1041–2
Trotti, A., Byhardt, R., Stetz, J. et al. (2000). Common toxicity criteria: Version 2.0. An improved reference for grading the acute effects of cancer treatment: Impact on radiotherapy. International Journal of Radiation Oncology, Biology, and Physics 47:13–47
Franklin, H., Simonetti, G., Dubbelman, A. et al. (1994). Toxicity grading systems. A comparison between the WHO scoring system and the Common Toxicity Criteria when used for nausea and vomiting. Annals of Oncology 5:113–17
Anacak, Y., Yalman, D., Ozsaran, Z. et al. (2001). Late radiation effects to the rectum and bladder in gynecologic cancer patients: the comparison of LENT/SOMA and RTOG/EORTC late-effects scoring systems. International Journal of Radiation Oncology, Biology, and Physics 50:1107–12
Bruner, D., Wasserman, T. (1995). The impact on quality of life by radiation late effects. International Journal of Radiation Oncology, Biology, and Physics 31:1353–5
Youngblood, M., Williams, P. D., Eyles, H. et al. (1994). A comparison of two methods of assessing cancer therapy-related symptoms. Cancer Nursing 17:37–44
Williams, P. D., Ducey, K. A., Sears, A. M. et al. (2001). Treatment type and symptom severity among oncology patients by self-report. International Journal of Nursing Studies 38:359–67
Munro, A. J., Potter, S. (1996). A quantitative approach to the distress caused by symptoms in patients treated with radical radiotherapy. British Journal of Cancer 74:640–7
Johnson, D. J., Casey, L., Noriega, B. (1994). A pilot study of patient quality of life during radiation therapy treatment. Quality of Life Research 3:267–72
Trotti, A., Johnson, D. J., Gwede, C. et al. (1998). Development of a head and neck companion module for the quality of life-radiation therapy instrument (QOL-RTI). International Journal of Radiation Oncology, Biology, and Physics 42:257–61
Brown, V., Sitzia, J., Richardson, A. et al. (2001). The development of the Chemotherapy Symptom Assessment Scale (C-SAS): a scale for the routine clinical assessment of the symptom experiences of patients receiving cytotoxic chemotherapy. International Journal of Nursing Studies 38(5):497–510
Kurihara, M., Shimizu, H., Tsuboi, K. et al. (1999). Development of quality of life questionnaire in Japan: quality of life assessment of cancer patients receiving chemotherapy Psycho-Oncology 8(4):355–63
Sitzia, J., Dikken, C., Hughes, J. (1997). Psychometric evaluation of a questionnaire to document side-effects of chemotherapy. Journal of Advanced Nursing 25(5):999–1007
Fallowfield, L. J., Leaity, S. K., Howell, A. et al. (1999). Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT-B. Breast Cancer Research and Treatment 55(2):189–99
Aaronson, N., Ahmedzai, S., Bergman, B. et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute 85:365–76

Reference Title: REFERENCES

Reference Type: reference-list

Strain, J. J. (1990). The evolution of quality of life evaluations in cancer therapy Oncology 4:22–7
Heithoff, K. A. (1990). Effectiveness and Outcomes in Health Care: Proceedings of an Invitational Conference by the Institute of Medicine, Division of Health Care Services. Washington, DC: National Academy Press
Holland, J. C. (1986). Assessment of Quality of Life and Cancer Treatment. Brookline, MA: Cancer and Leukemia Group B (CALGB)
Mandelblatt, J., Armetta, C., Yabroff, Y. et al. (2004). A descriptive review of the literature on breast cancer outcomes:1990–2000 Journal of the National Cancer Institute, in press
Patrick, D. L., Erickson, P. (1993). Health Status and Health Policy: Quality of Life in Health Care Evaluation and Resource Allocation. New York, NY: Oxford University Press
Johnston, K., Brown, J., Gerard, K. et al. (1998). Valuing temporary and chronic health states associated with breast screening Social Science and Medicine 47(2):213–22
Dickersin, K. (1994). Identifying relevant studies for systematic reviews British Medical Journal 309:1286–91
Greenwald, P. (2001). From carcinogenesis to clinical interventions for cancer prevention Toxicology 166:37–45
Osborne, M., Boyle, P., Lipkin, M. (1997). Cancer prevention Lancet 2(Suppl.):27–30
Moinpour, C., Lovato, L., Thompson, I., Ware J. et al. (2000). Profile of men randomized to the prostate cancer prevention trial: baseline health-related quality of life, urinary and sexual functioning and health behaviors Journal of Clinical Oncology 18(1942):1953
Fallowfield, L., Fleissig, A., Edwards, R. et al. (2001). Tamoxifen for the prevention of breast cancer: psychosocial impact on women participating in two randomized controlled trials Journal of Clinical Oncology 19(7):1885–92
Ganz, P. A., Day, R., Ware, J. E. et al. (1995). Base-line quality-of-life assessment in the National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial Journal of the National Cancer Institute 87(18):1372–82
Stewart, A. L., Ware, J. E. (eds) (1992). Measuring Functioning and Well-Being: The Medical Outcomes Study Approach. Durham, NC: Duke University Press
Goldberg, D. P., Hillier, V. F. (1979) A scaled version of the General Health Questionnaire Psychology Medicine 9(1):139–45
Spielberger, C. D. (1983). Manual for the State-Trait Anxiety Inventory STAI(form Y) “Self evaluation questionnaire.” Palo Alto, CA: Consulting Psychologists Press
Wallston, K. A. (1978). Development of the Multidimensional Health Locus of Control (MHLC) Scales Health Education Monograph 6(2):160–70
Andresen, E. M., Malmgren, J. A., Carter, W. B. et al. Screening of depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale) American Journal of Preventive Medicine 10:77–84
Barry, M. J. (1995). Measuring disease-specific health status in men with benign prostatic hyperplasia. Measurement Committee of the American Urological Association Medical Care 33(4(Suppl.)):AS145–55
Barry, M. J., Fowler, F. J., O'Leary, M. P. et al. (1992). The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association Journal of Urology 148(5):1549–57
Sherbourne, C. D. (1992). Social functioning: sexual problems measures. In Measuring Functioning and Well-being: The Medical Outcomes Study Approach, eds. A. L. Stewart, J. E. Ware, Jr., pp. 194–204. Durham, NC: Duke University Press
Thirlaway, K. (1996). The Sexual Activity Questionnaire: a measure of women's sexual functioning Quality of Life Research 5(1):81–90
Hunter, M. (1992). The Women's Health Questionnaire. A measure of mid-aged women's perceptions of their emotional and physical health Psychology and Health 7:15–54
Strickler, R. (2000). Raloxifene and estrogen effects on quality of life in healthy postmenopausal women: a placebo-controlled randomized trial Obstetrics and Gynecology 96(3):359–65
Epstein, R. S., Deverka, P. A., Chute, C. G. et al. (1992). Validation of new quality of life questionnaire for benign prostatic hyperplasia Journal of Clinical Epidemiology 45:1431–45
Hudmon, K., Lover, R., Chamberlain, R. (1999). Perceived benefits and barriers to participation in a phase I/II colon cancer prevention trial Journal of Cancer Education 14:83–7
Day, R., Ganz, P. A., Costantino, J. P. et al. (1999). Health-related quality of life and tamoxifen in breast cancer prevention: a report from the National Surgical Adjuvant Breast and Bowel Project P-1 Study Journal of Clinical Oncology 17(9):2659–69
Thirlaway, K., Fallowfield, L., Cuzick, J. (1996). Anxiety in women “at risk” of developing breast cancer British Journal of Cancer 73:1422–4
Cummings, S. R., Eckert, S., Krueger, K. A. et al. (1999). The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation Journal of the American Medical Association 281(23):2189–97
Fisher, B., Costantino, J. P., Wickerham, D. L. et al. (1998). Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study Journal of the National Cancer Institute 90(18):1371–88
Ware, J. E., Jr., Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36): Conceptual framework and item selection Medical Care 30(6):473–81
Roberts, R. E., Vernon, S. W. (1983). The center for epidemiologic studies depression scale: Its use in a community sample American Journal of Psychiatry 140(1):41–6
Radloff, L. S. (1977). The CES-D Scale: a self-report depression scale for research in the general population Applied Psychological Measurement 1:385–401
Dunn, B. K., Ford, L. G. (2001). From adjuvant therapy to breast cancer prevention: BCPT and STAR Breast Journal 7(3):144–57
Levine, M., Moutquin, J. M., Walton, R. et al. (2001). Chemoprevention of breast cancer. A joint guideline from the Canadian Task Force on Preventive Health Care and the Canadian Breast Cancer Initiative's Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer Canadian Medical Association Journal 164(12):1681–90
Fabian, C. J. (2001). Breast cancer chemoprevention: beyond tamoxifen Breast Cancer Research 3(2):99–103
Thompson, I. M. J., Kouril, M., Klein, E. A. et al. (2001). The prostate cancer prevention trial: current status and lessons learned Urology 57(4 (Suppl.)):230–4
Kaplan, S., Garvin, D., Gilhooly, P. et al. (2000). Impact of baseline symptom severity on future risk of benign prostatic hyperplasia-related outcomes and long-term response to finasteride Urology 56(4):610–16
Clark, L. C., Dalkin, B., Krongrad, A. et al. (1998). Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial British Journal of Urology 81:730–4
Clark, L. C., Combs, G. F., Turnbull, B. W. et al. (1996). Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group Journal of the American Medical Association 276:1957–63
Kazis, L. E., Ren, X. S., Lee, A. et al. (1999). Health status in VA patients: results from the Veterans Health Study American Journal of Medical Quality 14(1):28–38
Baron, J. A. (2000). Nonsteroidal anti-inflammatory drugs and cancer prevention Annual Review of Medicine 51:511–23
Kune, G. A. (1988). Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study Cancer Research 48(15):4399–404
Clapper, M. L. (2001). Chemoprevention of colorectal cancer Current Opinion in Oncology 13:307–13
Baron, J. A. (1999). Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group American College of Physicians Journal Club 131(2):39
Schiffman, M. H., Bauer, H. M., Hoover, R. N. et al. (1993). Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia Journal of the National Cancer Institute 85:958–64
Lerman, C., Hughes, C., Croyle, R. T. et al. (2000). Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing Preventive Medicine 31(1):75–80
Freyer, G., Dazord, A., Schlumberger, M. et al. (1999). Psychosocial impact of genetic testing in familial medullary-thyroid carcinoma: a multicentric pilot-evaluation Annals of Oncology 10(1):87–95
Smith, K. R., West, J. A., Croyle, R. T. et al. (1999). Familial context of genetic testing for cancer susceptibility: moderating effect of siblings' test results on psychological distress one to two weeks after BRCA1 mutation testing Cancer Epidemiology, Biomarkers and Prevention 8(4 Pt 2):385–92
Evans, D. G., Blair, V., Greenhalgh, R. et al. (1994). The impact of genetic counselling on risk perception in women with a family history of breast cancer British Journal of Cancer 70(5):934–8
Biesecker, B. B., Boehnke, M., Calzone, K. et al. (1993). Genetic counseling for families with inherited susceptibility to breast and ovarian cancer Journal of the American Medical Association 269(15):1970–4
Billings, P. B. J. (1992). Genetic testing in the workplace: a view from the USA Trends in Genetics 6:198–202
Ritvo, P., Robinson, G., Irvine, J. et al. (2000). Psychological adjustment to familial genetic risk assessment: differences in two longitudinal samples Patient Education and Counseling 40(2):163–72
Tercyak, K. P., Lerman, C., Peshkin, B. N. et al. (2001). Effects of coping style and BRCA1 and BRCA2 test results on anxiety among women participating in genetic counseling and testing for breast and ovarian cancer risk Health Psychology 20(3):217–22
Hatcher, M. B., Fallowfield, L., A'Hern, R. (2001). The psychosocial impact of bilateral prophylactic mastectomy: prospective study using questionnaires and semistructured interviews British Medical Journal 322(7278):76
McNair, P. M., Lorr, M., Droppelman, L. (1971). EITSManual for the Profile of Mood States. San Diego, CA: Educational and Industrial Testing Service
Schwartz, M. D., Lerman, C., Miller, S. M. et al. (1995). Coping disposition, perceived risk, and psychological distress among women at increased risk for ovarian cancer Health Psychology 14(3):232–5
Diefenbach, M. A. (1993). Scales for assessing perceptions of health hazard susceptibility Health Education and Research 8(2):181–92
Audrain, J., Rimer, B., Cella, D. et al. (1998). Genetic counseling and testing for breast-ovarian cancer susceptibility: what do women want? Journal of Clinical Oncology 16(1):133–8
Schwartz, M. D., Peshkin, B. N., Hughes. C. et al. (2002). The impact of BRCA1/BRCA2 mutation testing on psychological distress in a clinic-based sample Journal of Clinical Oncology 20(2):514–20
Lerman, C., Narod, S., Schulman, K. et al. (1996). BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes Journal of the American Medical Association 275(24):1885–92
Lerman, C., Hughes, C., Lemon, S. J. et al. (1998). What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing Journal of Clinical Oncology 16(5):1650–4
Zigmond, A. S., Snaith, R. P. (1983). The hospital anxiety and depression scale Acta Psychiatrica Scandanavica 67:361–70
Lodder, L., Frets, P. G., Trijsburg, R. W. et al. (2001). Psychological impact of receiving a BRCA1/BRCA2 test result American Journal of Medical Genetics 98(1):15–24
Zung, W. W., King, R. E. (1983). Identification and treatment of masked depression in a general medical practice Journal of Clinical Psychiatry 44(10):365–8
Wagner, T. M., Moslinger, R., Langbauer, G. et al. (2000). Attitude towards prophylactic surgery and effects of genetic counselling in families with BRCA mutations. Austrian Hereditary Breast and Ovarian Cancer Group British Journal of Cancer 82(7):1249–53
Folkman, S. (1980). An analysis of coping in a middle-aged community sample Journal of Health and Social Behavior 21(3):219–39
Hopwood, P. (2001). A body image scale for use with cancer patients European Journal of Cancer 37(2):189–97
Derogatis, L. R., Lipman, R. S., Rickels, K. et al. (1974). The Hopkins symptoms checklist (HSCL): a measure of primary symptom dimensions Psychological Measurements in Psychopharmacology 7:79–110
Derogatis, L. R., Melisaratos, N. (1983). The Brief Sympton Inventory: an introductory report Psychological Medicine 13(3):595–605
Derogatis, L. R. (1977). SCL-90 Administration scoring and procedures. Manual-I to the (revised) version. Baltimore, MD: Johns Hopkins University School of Medicine
Dorval, M., Patenaude, A. F., Schneider, K. A. et al. (2000). Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: findings from p53 and BRCA1 testing programs Journal of Clinical Oncology 18(10):2135–42
Coyne, J. C., Benazon, N. R., Gaba, C. G. et al. (2000). Distress and psychiatric morbidity among women from high-risk breast and ovarian cancer families Journal of Consulting Clinical Psychiatry 68(5):864–74
Miller, S. M. (1987). Monitoring and blunting: validation of a questionnaire to assess styles of information seeking under threat Journal of Personality and Social Psychology 52:345–53
Scheier, M. F., Carver, C. S. (1985). Optimism, coping, and health: assessment and implications of generalized outcome expectancies Health Psychology 4(3):219–47
Horowitz, M., Wilner, N., Alvarez, W. (1979). Impact of Event Scale: a measure of subjective stress Psychosomatic Medicine 41(3):209–18
Grilli, R., Mainini, F., Penna, A. et al. (1993). Inappropriate Halsted mastectomy and patient volume in Italian hospitals American Journal of Public Health 83(12):1762–4
Goldberg, D. P., Williams, P. (1988). A Users Guide to the General Health Questionnaire. Windsor: NFER-Nelson
Sherbourne, C. D., Stewart, A. L. (1991). The MOS Social Support Survey Social Sciences and Medicine 32:705–15
First, M. B., Spitzer, R. L., Gibbon, M. et al. (1995). Structured Clinical Interview for DSM—IV Axis I Disorders — Patient Edition (SCID-I-P, Version 2.0). New York: Biometrics Research Dept., New York State Psychiatric Institute
Plon, S. E., Peterson, L. E., Friedman, L. C. et al. (2000). Mammography behavior after receiving a negative BRCA1 mutation test result in the Ashkenazim: a community-based study Genetics in Medicine 2(6):307–11
Metcalfe, K. A., Liede, A., Hoodfar, E. et al. (2000). An evaluation of needs of female BRCA1 and BRCA2 carriers undergoing genetic counselling Journal of Medical Genetics 37(11):866–74
Frost, M. H., Schaid, D. J., Sellers, T. A. et al. (2000). Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy Journal of the American Medical Association 284(3):319–24
Payne, D. K., Biggs, C., Tran, K. N. et al. (2000). Women's regrets after bilateral prophylactic mastectomy Annals of Surgical Oncology 7(2):150–4
Collins, V., Halliday, J., Warren, R. et al. (2000). Cancer worries, risk perceptions and associations with interest in DNA testing and clinic satisfaction in a familial colorectal cancer clinic Clinical Genetics 58(6):460–8
Croyle, R. T., Smith, K. R., Botkin, J. R. et al. (1997). Psychological responses to BRCA1 mutation testing: preliminary findings Health Psychology 16(1):63–72
Lynch, H. T., Lynch, J., Conway, T. et al. (1994). Psychological aspects of monitoring high risk women for breast cancer Cancer 74(3 Suppl.):1184–92
Lynch, H. T., Watson, P., Tinley, S. et al. (1999). An update on DNA-based BRCA1/BRCA2 genetic counseling in hereditary breast cancer Cancer Genetics and Cytogenetics 109(2):91–8
Women's use of coping strategies while waiting for genetic testing results (2000). Poster session presented at the annual meeting of the American Society of Preventive Oncology. Bethesda, MD
Lerman, C., Schwartz, M. (1993). Adherence and psychological adjustment among women at high risk for breast cancer Breast Cancer Research and Treatment 28(2):145–55
Kash, K. M., Holland, J. C., Halper, M. S. et al. (1992). Psychological distress and surveillance behaviors of women with a family history of breast cancer Journal of the National Cancer Institute 84(1):24–30
Lerman, C., Caputo, C., Brody, D. (1990). Factors associated with inadequate cervical cancer screening among lower income primary care patients Journal of the American Board of Family Practice 3(3):151–6
Lidbrink, E., Levi, L., Pettersson, I. et al. (1995). Single-view screening mammography: psychological, endocrine and immunological effects of recalling for a complete three-view examination European Journal of Cancer 31A(6):932–3
Lazarus, R. S. (1974). Psychological stress and coping in adaptation and illness International Journal of Psychiatry and Medicine 5(4):321–33
Wardle, J., Pope, R. (1992). The psychological costs of screening for cancer Journal of Psychosomatic Research 36(7):609–24
Olsson, P., Armelius, K., Nordahl, G. et al. (1999). Women with false positive screening mammograms: how do they cope? Journal of Medical Screening 6(2):89–93
Skrabanek, P. (1985). False premises and false promises of breast cancer screening Lancet 2(8450):316–20
Aro, A. R., Pilvikki Absetz, S., van Elderen, T. M. et al. (2000). False-positive findings in mammography screening induces short-term distress — breast cancer-specific concern prevails longer European Journal of Cancer 36(9):1089–97
Aro, A. R., Absetz-Ylostalo, P., Eerola, T. et al. (1996). Pain and discomfort during mammography European Journal of Cancer 32A(10):1674–9
Bennetts, A., Irwig, L., Oldenburg, B. et al. (1995). PEAPS-Q: A questionnaire to measure the psychosocial effects of having an abnormal pap smear. Psychosocial Effects of Abnormal Pap Smears Questionnaire Journal of Clinical Epidemiology 48(10):1235–43
Bennett, A. K. (1995). Overview of 1995 PIAA Breast Cancer Study Missouri Medicine 92(10):624–6
Wolfe, C., Doherty, I., Raju, K. S. et al. (1992). First steps in the development of an information and counselling service for women with an abnormal smear result European Journal of Obstetrics, Gynecology and Reproductive Biology 45(3):201–6
Tomaino-Brunner, C., Freda, M. C., Damus, K. et al. (1998). Can precolposcopy education increase knowledge and decrease anxiety? Journal of Obstetrics, Gynecology and Neonatal Nursing 27(6):636–45
Nugent, L. S., Tamlyn-Leaman, K., Isa, N. et al. (1993). Anxiety and the colposcopy experience Clinical Nursing Research 2(3):267–77
Gath, D. H., Hallam, N., Mynors-Wallis, L. et al. (1995). Emotional reactions in women attending a UK colposcopy clinic Journal of Epidemiology and Community Health 49(1):79–83
Somerset, M. (1998). Intervening to reduce anxiety for women with mild dyskaryosis: do we know what works and why? Journal of Advanced Nursing 28(3):563–70
Palmer, A. G., Tucker, S., Warren, R. et al. (1993). Understanding women's responses to treatment for cervical intra-epithelial neoplasia British Journal of Clinical Psychology 32(Pt 1):101–12
Marteau, T. M. (1990). Screening in practice: reducing the psychological costs British Medical Journal 301(6742):26–8
Sutton, S., Saidi, G., Bickler, G. et al. (1995). Does routine screening for breast cancer raise anxiety? Results from a three wave prospective study in England Journal of Epidemiology and Community Health 49(4):413–18
Brett, J., Austoker, J., Ong, G. (1998). Do women who undergo further investigation for breast screening suffer adverse psychological consequences? A multi-centre follow-up study comparing different breast screening result groups five months after their last breast screening appointment Journal of Public Health Medicine 20(4):396–403
Ong, G., Austoker, J., Brett, J. (1997). Breast screening: adverse psychological consequences one month after placing women on early recall because of a diagnostic uncertainty. A multicentre study Journal of Medical Screening 4(3):158–68
Essink-Bot, M. L., de Koning, H. J., Nijs, H. G. et al. (1998). Short-term effects of population-based screening for prostate cancer on health-related quality of life Journal of the National Cancer Institute 90(12):925–31
Diefenbach, M. A. (1999). Specific worry about breast cancer predicts mammography use in women at risk for breast and ovarian cancer Health Psychology 18(5):532–6
Andrykowski, M. A., Curran, S. L., Studts, J. L. et al. (1996). Psychosocial adjustment and quality of life in women with breast cancer and benign breast problems: a controlled comparison Journal of Clinical Epidemiology 49(8):827–34
Lampic, C., Thurfjell, E., Bergh, J. et al. (2001). Short- and long-term anxiety and depression in women recalled after breast cancer screening European Journal of Cancer 37(4):463–9
Bull, A., Mountney, L., Sanderson, H. (1991). Stage distribution of breast cancer: a basis for the evaluation of breast screening programmes British Journal of Radiology 64(762):516–19
Scaf-Klomp, W., Sanderman, R., van de Wiel, H. B. et al. (1997). Distressed or relieved? Psychological side effects of breast cancer screening in The Netherlands Journal of Epidemiology and Community Health 51(6):705–10
Gilbert, F. J., Cordiner, C. M., Affleck, I. R. et al. (1998). Breast screening: the psychological sequelae of false-positive recall in women with and without a family history of breast cancer European Journal of Cancer 34(13):2010–14
Bell, S., Porter, M., Kitchener, H. et al. (1995). Psychological response to cervical screening Preventive Medicine 24(6):610–16
Thiis-Evensen, E., Wilhelmsen, I., Hoff, G. S. et al. (1999). The psychologic effect of attending a screening program for colorectal polyps Scandinavian Journal of Gastroenterology 34(1):103–9
Beck, A. T., Steer, R. A. (1993). Beck Depression Inventory Manual. San Antonio, TX: Harcourt Brace
Northouse, L. L., Jeffs, M., Cracchiolo-Caraway, A. et al. (1995). Emotional distress reported by women and husbands prior to a breast biopsy Nursing Research 44(4):196–201
Snaith, R. P. (1976). The Leeds scales for the self-assessment of anxiety and depression British Journal of Psychiatry 128:156–65
Steggles, S., Lightfoot, N., Sellick, S. M. (1998). Psychological distress associated with organized breast cancer screening Cancer Prevention and Control 2(5):213–20
Taylor, K. L., DiPlacido, J., Redd, W. H. et al. (1999). Demographics, family histories, and psychological characteristics of prostate carcinoma screening participants Cancer 85(6):1305–12
Watson, D., Clark, L. A., Tellegen, A. (1988). Development and validation of brief measures of positive and negative affect: the PANAS scales Journal of Personality and Social Psychiatry 54(6):1063–70
Lauver, D. R., Kruse, K., Baggot, A. (1999). Women's uncertainties, coping, and moods regarding abnormal Papanicolaou results Journal of Womens Health and Gender-Based Medicine 8(8):1103–12
Sjoberg, L. (1979). The measurement of mood Scandinavian Journal of Psychology 20(1):1–18
Taylor, J. A. (1953). A personality scale of manifest anxiety Journal of Abnormal Social Psychology 48:285–90
Kerner, J. F., Yedidia, M., Padgett, D. et al. (2003). Realizing the promise of breast cancer screening: clinical follow-up after abnormal screening among black women. Preventive Medicine 37:92–101
Billings, A. G. (1981). The role of coping responses and social resources in attenuating the stress of life events Journal of Behavioral Medicine 4(2):139–57
Rosenberg, M. (1965). Society and the Adolescent Self Image. Princeton, NJ: Princeton University Press
Abi Rafi, A. (1965). The Maudsley Personality INVENTORY: a cross-cultural study British Journal of Social and Clinical Psychology 4(4):266–8
Cooper, P., Osborn, M., Gath, D. H. (1982). Evaluation of a modified self-report measure of social adjustment British Journal of Psychiatry 141:68–75
Miller, S. M., Roussi, P., Altman, D. et al. (1994). Effects of coping style on psychological reactions of low-income, minority women to colposcopy Journal of Reproductive Medicine 39(9):711–18
Deiner, E., Emmons, R., Larsen, R., Griffin, S. (1985). The satisfaction with life scale Journal of Personality Assessment 49:71–5
Smilkstein, G., Zimlich, R. (1990). A stress scale validation study. An instrument for psychosocial stressor assessment. New York, NY: Oxford University Press
Boer, H. Psychosocial effects of breast cancer screening. University of Twente 1993. Dissertation
Lau, R. R., Jr. (1981). Refinements in the measurement of health-specific locus-of-control beliefs Medical Care 19(11):1147–58
Kellner, R. (1987). Psychological measurements in somatization and abnormal illness behavior Advances in Psychosomatic Medicine 17:101–18
Walker, L. G., Cordiner, C., Gilbert, F. J. (1994). How distressing is attendance for routine breast screening Psycho-Oncology 3:299–304
Dean, C., Roberts, M. M., French, K. et al. (1986). Psychiatric morbidity after screening for breast cancer Journal of Epidemiology and Community Health 40(1):71–5
Ellman, R., Angeli, N., Christians, A. et al. (1989). Psychiatric morbidity associated with screening for breast cancer British Journal of Cancer 60(5):781–4
Cockburn, J., De Luise, T., Hurley, S. et al. (1992). Development and validation of the PCQ: a questionnaire to measure the psychological consequences of screening mammography Social Science and Medicine 34(10):1129–34
Lowe, J. B., Balanda, K. P., Del Mar, C. et al. (1999). Psychologic distress in women with abnormal findings in mass mammography screening Cancer 85(5):1114–18
Spanier, G. B. (1976). Measuring dyadic adjustment: new scales for assessing the quality of marriage and similar dyads Journal of Marriage and Family 38:15–28
Eysenck, H. J., Eysenck, S. B. G. (1963). The Eysenck Personality Inventory. London: University of London Press
Mishel, M. H. (1981). The measurement of uncertainty in illness Nursing Research 30(5):258–63
Veit, C. T., Ware, J. E., Jr. (1983). The structure of psychological distress and well-being in general populations Journal of Consulting Clinical Psychology 51:730–42
Lerman, C., Miller, S. M., Scarborough, R. et al. (1991). Adverse psychologic consequences of positive cytologic cervical screening American Journal of Obstetrics and Gynecology 165(3):658–62
Stillman, M. J. (1977). Women's health beliefs about breast cancer and breast self-examination Nursing Research 26(2):121–7
Fallowfield, L. J., Rodway, A., Baum, M. (1990). What are the psychological factors influencing attendance, non-attendance and re-attendance at a breast cancer screening centre Journal of the Royal Society of Medicine 83(9):547–551
Slenker, S. E., Grant, M. C. (1989). Attitudes, beliefs, and knowledge about mammography among women over forty years of age Journal of Cancer Education 4(1):61–5
Naughton, C. K. (2001). Impact of transrectal ultrasound guided prostate biopsy on quality of life: a prospective randomized trial comparing 6 versus 12 cores Journal of Urology 165(1):100–3
EuroQOL Group. (1990). EuroQol — a new facility for the measurement of health related quality of life Health Policy 16:199–208
Volk, R. J., Cantor, S. B., Spann, S. J. et al. (1997). Preferences of husbands and wives for prostate cancer screening Archives of Family Medicine 6(1):72–6
Torrance, G. W. (1987). Utility approach to measuring health-related quality of life Journal of Chronic Disease 40:593–600
Gram, I. T., Lund, E., Slenker, S. E. (1990). Quality of life following a false positive mammogram British Journal of Cancer 62(6):1018–22
Dominitz, J. A., Provenzale, D. (1997). Patient preferences and quality of life associated with colorectal cancer screening American Journal of Gastroenterology 92(12):2171–8
de Haes, J. C., de Koning, H. J., van Oortmarssen, G. J. et al. (1991). The impact of a breast cancer screening programme on quality-adjusted life-years International Journal of Cancer 49(s):538–44
Orbell, S. (1996). Cognition and affect after cervical screening: the role of previous test outcome and personal obligation in future uptake expectations Social Science and Medicine 43(8):1237–43
Wilson, J. D., Hines, B. (2000). Nurse counselling for women with abnormal cervical cytology improves colposcopy and cytology follow up attendance rates Sexually Transmitted Infections 76(4):322
Paskett, E. D., Carter, W. B., Chu, J. et al. (1990). Compliance behavior in women with abnormal Pap smears. Developing and testing a decision model Medical Care 28(7):643–56
Reelick, N. F., de Haes, W. F., Schuurman, J. H. (1984). Psychological side-effects of the mass screening on cervical cancer Social Science and Medicine 18(12):1089–93
Pisano, E. D., Earp, J., Schell, M. et al. (1998). Screening behavior of women after a false-positive mammogram Radiology 208(1):245–9
Pisano, E. D., Earp, J. A., Gallant, T. L. (1998). Screening mammography behavior after a false positive mammogram Cancer Detection and Prevention 22(2):161–7
Gram, I. T., Slenker, S. E. (1992). Cancer anxiety and attitudes toward mammography among screening attenders, nonattenders, and women never invited American Journal of Public Health 82(2):249–51
Schwartz, L., Woloshin, S., Sox, H. et al. (2000). US women's attitudes to false-positive mammography results and detection of ductal carcinoma in situ: cross-sectional survey Original Research 173:307–9
Benedict, S., Williams, R. D., Baron, P. L. (1994). The effect of benign breast biopsy on subsequent breast cancer detection practices Oncology Nursing Forum 21(9):1467–75
Lindfors, K. K., O'Connor, J., Parker, R. A. (2001). False-positive screening mammograms: effect of immediate versus later work-up on patient stress Radiology 218(1):247–253
Lindholm, E., Berglund, B., Kewenter, J. et al. (1997). Worry associated with screening for colorectal carcinomas Scandinavian Journal of Gastroenterology 32(3):238–45
Mant, D., Fitzpatrick, R., Hogg, A. et al. (1990). Experiences of patients with false positive results from colorectal cancer screening British Journal of General Practice 40(339):423–5
Winawer, S. J., Miller, C., Lightdale, C. et al. (1987). Patient response to sigmoidoscopy. a randomized, controlled trial of rigid and flexible sigmoidoscopy Cancer 60(8):1905–8
Drossman, D. A., Brandt, L. J., Sears, C. et al. (1996). A preliminary study of patients' concerns related to GI endoscopy American Journal of Gastroenterology 91(2):287–91
McCarthy, B. D., Moskowitz, M. A. (1993). Screening flexible sigmoidoscopy: patient attitudes and compliance Journal of General Internal Medicine 8(3):120–5
Pedersen, K. V., Carlsson, P., Varenhorst, E. et al. (1990). Screening for carcinoma of the prostate by digital rectal examination in a randomly selected population British Medical Journal 300(6731):1041–4
Myers, R. E., Hyslop, T., Wolf, T. A. et al. (2000). African-American men and intention to adhere to recommended follow-up for an abnormal prostate cancer early detection examination result Urology 55(5):716–20
Lauver, D., Rubin, M. (1991). Women's concerns about abnormal Papanicolaou test results Journal of Obstetrics, Gynecology, and Neonatal Nursing 20(2):154–9
Quilliam, S. (1989). Emotional aspects of positive smears Health Visit 62(10):308–9
Wardle, J., Sutton, S., Williamson, S. et al. (2000). Psychosocial influences on older adults' interest in participating in bowel cancer screening Preventive Medicine 31(4):323–34
Auvinen, A. (1996). Prospective evaluation plan for randomised trials of prostate cancer screening. The International Prostate Cancer Screening Trial Evaluation Group Journal of Medical Screening 3(2):97–104
Kramer, B. S. (1993). Prostate cancer screening: what we know and what we need to know Annals of Internal Medicine 119(9):914–23
Carvalhal, G. F., Smith, D. C., Ramos, C. et al. (1999). Correlates of dissatisfaction with treatment in patients with prostate cancer diagnosed through screening Journal of Urology 162(1):113–18
Stewart-Brown, S. F. A. (1997). Screening could seriously damage your health British Medical Journal 1314(7080):533–4
Cockburn, J., Staples, M., Hurley, S. F. et al. (1994). Psychological consequences of screening mammography Journal of Medical Screening 1(1):7–12
Gerard, K., Salkeld, G., Hall, J. (1990). Counting the costs of mammography screening: first year results from the Sydney study Medical Journal of Australia 152(9):466–71
Rimer, B. K., Bluman, L. G. (1997). The psychosocial consequences of mammography Journal of the National Cancer Institute Monographs 22:131–8
Fletcher, S. W. (1999). False-positive screening mammograms: good news, but more to do Annals of Internal Medicine 131(1):60–2
Sickles, E. A. (1991). Periodic mammographic follow-up of probably benign lesions: results in 3,184 consecutive cases Radiology 179(2):463–8
Breen, N., Wagener, D. K., Brown, M. L. et al. (2001). Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys Journal of the National Cancer Institute 93(22):1704–13
Olivotto, I. A., Kan, L., Coldman, A. J. (1998). False positive rate of screening mammography New England Journal of Medicine 339(8):560
Elmore, J. G., Barton, M. B., Moceri, V. M. et al. (1998). Ten-year risk of false positive screening mammograms and clinical breast examinations New England Journal of Medicine 338(16):1089–96
Lidbrink, E., Elfving, J., Frisell, J. et al. (1996). Neglected aspects of false positive findings of mammography in breast cancer screening: analysis of false positive cases from the Stockholm trial British Medical Journal 312(7026):273–6
Lipkus, I. M., Halabi, S., Strigo, T. S. et al. (2000). The impact of abnormal mammograms on psychosocial outcomes and subsequent screening Psycho-Oncology 9(5):402–10
Veit, C. T., Ware, J. E., Jr. (1983). The structure of psychological distress and well-being in general populations Journal of Consulting Clinical Psychology 51(5):730–42
Fallowfield, L. (1990). The Quality of Life: The Missing Measurement in Health Care. New York, NY: Oxford University Press
Mould, T. A., Rodgers, M. E., Singer, A. (1995). The psychological reaction of women to a colposcopy clinic British Journal of Obstetrics and Gynecology 102(5):428–9
Campion, M. J., Brown, J. R., McCance, D. J. et al. (1988). Psychosexual trauma of an abnormal cervical smear British Journal of Obstetrics and Gynecology 95(2):175–81
Pisano, E. D. (1998). Screening behavior of women after a false-positive mammogram Radiology 208(1):245–9
Miller, A. B. (1993). Canadian National Breast Screening Study: public health implications Canadian Journal of Public Health 84(1):14–16
Lerman, C. E. (1993). Psychosocial impact of cancer screening Oncology (Huntington) 7(4):67–72
Gotay, C. C. (1984). The experience of cancer during early and advanced stages: the views of patients and their mates Social Science and Medicine 18(7):605–13
Weil, J. G. (1997). Positive findings of mammography may lead to suicide British Medical Journal 314(7082):754–5
Fentiman, I. S. (1988). Pensive women, painful vigils: consequences of delay in assessment of mammographic abnormalities Lancet 1(8593):1041–2
McCarthy, B. D. (1997). Screening mammography use: the importance of a population perspective American Journal of Preventive Medicine 12(2):91–5
Kerner, J. F., Mandelblatt, J. S., Silliman, R. A. et al. (2001). Screening mammography and breast cancer treatment patterns in older women Breast Cancer Research and Treatment 69(1):81–91
Burman, M. L. (1999). Effect of false-positive mammograms on interval breast cancer screening in a health maintenance organization Annals of Internal Medicine 131(1):1–6
Stidley, C. A., Tollestrup, K., Frost, F. et al. (2001). Mammography utilization after a benign breast biopsy among Hispanic and non-Hispanic women Cancer 91(9):1716–23
Bull, A. R., Campbell, M. J. (1991). Assessment of the psychological impact of a breast screening programme British Journal of Radiology 64(762):510–15
McCaul, K. D., Schroeder, D. M., Reid, P. A. (1996). Breast cancer worry and screening: some prospective data Health Psychology 15(6):430–3
Feeny, this volume, Chapter 4
Gold, M. R., Siegel, J. E., Russell, L. B. et al. (1996). Cost-Effectiveness in Health and Medicine. New York, NY: Oxford University Press
Olsson, P., Armelius, K., Nordahl, G. (1999). Women with false postivie screening mammograms: how do they cope? Journal of Medical Screening 6(2):89–93
Pater, J., Osoba, D., Zee, B. et al. (1998). Effects of altering the time of administration and the time frame of quality of life assessments in clinical trials: an example using the EORTC QLQ-C30 in a large anti-emetic trial Quality of Life Research 7(3):273–8
Katz, S. (1963). Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychological function Journal of the American Medical Association 185:914–19
Llewellyn-Thomas, H., Sutherland, H. J., Tibshirani, R. et al. (1982). The measurement of patients'values in medicine Medical Decision Making 2(4):449–62
Nord, E., Pinto, J. L., Richardson, J. et al. (1999). Incorporating societal concerns for fairness in numerical valuations of health programmes Health Economics 8(1):25–39
Dolan, P., Gudex, C. (1995). Time preference, duration and health state valuations Health Economics 4(4):289–99
Torrance, G. W. (1976). Toward a utility theory foundation for health status index models Health Services Research 11:349–69

Reference Title: REFERENCES

Reference Type: reference-list

Jemal, A., Thomas, A., Murray, T. et al. (2002). Cancer Statistics, 2002 CA: Cancer Journal for Clinicians 52:23–47
Clark, E. J., Stovall, E. L. (1996). Advocacy: the cornerstone of cancer survivorship Cancer Practice 4:239–44
Ferrell, B. R., Dow, K. H., Grant, M. (1995). Measurement of the quality of life in cancer survivors Quality of Life Research 4:523–31
Tross, S., Holland, J. (1990). Psychological sequelae in cancer survivors. In Handbook of Psycho-oncology, ed. J. C. Holland, J. H. Rowland, Chapter 7. New York, NY: Oxford University Press
Gotay, C. C., Muraoka, M. Y. (1998). Quality of life in long-term survivors of adult-onset cancers Journal of the National Cancer Institute 90:656–67
Andrykowski, M., Brady, M. J., Hunt, J. W. (1993). Positive psychosocial adjustment in potential bone marrow transplant recipients: Cancer as a psychosocial transition Psycho-Oncology 2:261–76
Cella, D. F., Tross, S. (1986). Psychological adjustment to survival from Hodgkin's disease Journal of Consulting and Clinical Psychology 54:616–22
Collins, R. L., Taylor, S. E., Skokan, L. A. (1990). A better world or a shattered vision? Changes in life perspectives following victimization Social Cognition 8:263–85
Fromm, K., Andrykowski, M. A., Hunt, J. (1996). Positive and negative psychosocial sequelae of bone marrow transplantation: implications for quality of life assessment Journal of Behavioral Medicine 19:221–40
Wilson, S. E., Andersen, M. R., Meischke, H. (2000). Meeting the needs of rural breast cancer survivors: What still needs to be done? Journal of Women's Health and Gender-Based Medicine 9:667–77
Zebrack, B. J. (2000). Quality of life in long-term survivors of leukemia and lymphoma Journal of Psychosocial Oncology 18:39–59
Curbow, B., Somerfield, M. R., Baker, F. et al. (1993). Personal changes, dispositional optimism, and psychological adjustment to bone marrow transplantation Journal of Behavioral Medicine 16:423–43
McMillen, J. C., Fisher, R. H. (1998). The perceived benefit scales: Measuring perceived positive life changes after negative events Social Work Research 22:173–87
Miller, W. R., C'deBaca, J. (1994). Quantum change: toward a psychology of transformation. In Can Personality Change? ed. T. F. Heatherton, J. L. Weinberger, pp. 253–81. Washington, DC: American Psychological Association
Affleck, G., Tennen, H. (1996). Construing benefits from adversity: adaptational significance and dispositional underpinnings Journal of Personality 64:899–922
Allswede, J. S. (1991). Perceptions of personal change reported by people with leukemia or lymphoma. Unpublished doctoral dissertation, University of Michigan, Ann Arbor, MI
Davis, S. H., Chesler, M. A., Chesney, B. (1990). Coping with cancer: life changes reported by patients and significant others dealing with leukemia and lymphoma. In The Working Paper Series, #427. Ann Arbor, MI: Center for Research on Social Organization, University of Michigan
Taylor, S. E., Lichtman, R. R., Wood, J. V. (1984). Attributions, beliefs about control, and adjustment to breast cancer Journal of Personality and Social Psychology 46:489–502
O'Leary, V., Alday, C. S., Ickovics, J. R. (1998). Models of Life Change in Posttraumatic Growth. In Models of Life Change and Posttraumatic Growth, eds. V. O'Leary, C. S. Alday, J. R. Ickovics, pp. 127–51. Mahwah, NJ: Lawrence Erlbaum Publishers
Park, C. L., Cohen, L. H., Murch, R. L. (1996). Assessment and prediction of stress-related growth Journal of Personality 64:71–105
Tedeschi, R. G., Calhoun, L. G. (1996). The Posttraumatic Growth Inventory: measuring the positive legacy of trauma Journal of Traumatic Stress 9:455–71
Carver, C. S. (1998). Resilience and thriving: issues, models, and linkages Journal of Social Issues 54:245–66
Cohen, L. H., Cimbolic, K., Armeli, S. R. (1998). Quantitative assessment of thriving Journal of Social Issues 54:323–35
Dow, K. H. (1990). The enduring seasons in survival Oncology Nursing Forum 17:511–16
Massey, S., Cameron, A., Ouellette, S. et al. (1998). Qualitative approaches in the study of thriving: what can be learned? Journal of Social Issues 54:337–55
Park, C. L. (1998). Stress-related growth and thriving through coping: the roles of personality and cognitive processes Journal of Social Issues 54:267–77
Wyatt, G. K., Friedman, L. L. (1996). Development and testing of a quality of life model for long-term female cancer survivors Quality of Life Research 5:387–94
National Cancer Institute Office of Cancer Survivorship. Prevalence by Cancer Site. Available at http://cancercontrol.cancer.gov/ocs/. Last accessed September 11, 2004
Holzner, B., Kemmler, G., Kopp, M. et al. (2001). Quality of life in breast cancer patients — not enough attention for long-term survivors? Psychosomatics 42:117–23
Saleeba, A., Weitzner, M. A., Meyers, C. A. (1996). Subclinical psychological distress in long-term survivors of breast cancer: a preliminary communication Journal of Psychosocial Oncology 14:83–93
Dorval, M., Maunsell, E., Deschenes, L. et al. (1998). Long-term quality of life after breast cancer: comparison of 8-year survivors with population controls Journal of Clinical Oncology 16:487–94
Omne-Ponten, M., Holmberg, L., Sjoden, P. O. (1994). Psychosocial adjustment among women with breast cancer stages I and II: six-year follow-up of consecutive patients Journal of Clinical Oncology 12:1778–82
Ferrell, B. R., Grant, M., Funk, B. et al. (1998). Quality of life in breast cancer. Part II: Psychological and spiritual well-being Cancer Nursing 21:1–9
Ferrell, B. R., Grant, M., Funk, B. et al. (1996). Quality of life in breast cancer Cancer Practice 4:331–40
Halttunen, A., Hietanen, P., Jallinoja, P. et al. (1992). Getting free of breast cancer. An eight-year perspective of the relapse-free patients Acta Oncologica 31:307–10
Bower, J. E., Ganz, P. A., Desmond, K. A. et al. (2000). Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life Journal of Clinical Oncology 18:743–53
Northouse, L. L., Caffey, M., Deichelbohrer, L. et al. (1999). The quality of life of African American women with breast cancer Research in Nursing and Health 22:449–60
Shimozuma, K., Ganz, P. A., Petersen, L. et al. (1999). Quality of life in the first year after breast cancer surgery: rehabilitation needs and patterns of recovery Breast Cancer Research and Treatment 56:45–57
Maunsell, E., Brisson, C., Dubois, L. et al. (1999). Work problems after breast cancer: an exploratory qualitative study Psycho-Oncology 8:467–73
Ganz, P. A., Desmond, K. A., Leedham B. et al. (2002). Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study Journal of the National Cancer Institute 94:39–49
Ganz, P. A., Coscarelli, A., Fred, C. et al. (1996). Breast cancer survivors: psychosocial concerns and quality of life Breast Cancer Research and Treatment 38:183–99
Vinokur, A. D., Threatt, B. A., Caplan, R. D. et al. (1989). Physical and psychosocial functioning and adjustment to breast cancer. Long-term follow-up of a screening population Cancer 63:394–405
Lee, C. O. (1997). Quality of life and breast cancer survivors. Psychosocial and treatment issues Cancer Practice 5:309–16
Carpenter, J. S., Brockopp, D. Y., Andrykowski, M. A. (1999). Self-transformation as a factor in the self-esteem and well-being of breast cancer survivors Journal of Advanced Nursing 29:1402–11
Sarna, L. (1998). Lung cancer. In Psycho-oncology, ed. J. C. Holland, pp. 340–8. New York: Oxford University Press
Montazeri, A., Gillis, C. R., McEwen, J. (1998). Quality of life in patients with lung cancer: a review of literature from 1970 to 1995 Chest 113:467–81
Fossella, F., DeVore, R., Kerr, R. et al. (2000). Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small cell lung cancer previously treated with platinum-containing chemotherapy regimens Journal of Clinical Oncology 18:2354–62
Gatzemeier, U., von Pawel, J., Gottfried, M. et al. (2000). Phase III comparative study of high-dose cisplatin versus a combination of paclitaxel and cisplatin in patients with advanced non-small-cell lung cancer Journal of Clinical Oncology 18:3390–9
Gregor, A., Cull, A., Stephens, R. et al. (1997). Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: results of a multicenter randomized trial European Journal of Cancer 33:1752–8
Helsing, M., Bergman, B., Thaning, L. et al. (1998). Quality of life and survival in patients with advanced non-small cell lung cancer receiving supportive care plus chemotherapy with carboplatin and etoposide or supportive care only. A multicentre randomized phase III trial European Journal of Cancer 34:1036–44
Herndon, J. E., Fleishman, S., Kosty, M. P. et al. (1997). A longitudinal study of quality of life in advanced non-small cell lung cancer: Cancer and Leukemia Group B (CALGB) 8931 Controlled Clinical Trials 18:286–300
Langendijk, J., Aaronson, N., ten Velde, G. et al. (2000). Pretreatment quality of life of inoperable non-small cell lung cancer patients referred for primary radiotherapy Acta Oncologica 39:949–58
Thongprasert, S. (1998). Lung cancer and quality of life Australia and New Zealand Journal of Medicine 28:397–9
Hopwood, P., Stephens, R. (2000). Depression in patients with lung cancer: prevalence and risk factors derived from quality-of-life data Journal of Clinical Oncology 18:893–903
Eton, D. T., Lepore, S. J. (2002). Prostate cancer and health-related quality of life: a review of the literature Psycho-Oncology 11:307–26
Litwin, M. S., Hays, R. D., Fink, A. et al. (1995). Quality-of-life outcomes in men treated for localized prostate cancer Journal of the American Medical Association 273:129–35
Lubeck, D. P., Litwin, M. S., Henning, J. M. et al. (1999). Changes in health-related quality of life in the first year after treatment for prostate cancer: results from CaPSURE Urology 53:180–6
Potosky, A., Legler, J., Albertsen, P. et al. (2000). Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study Journal of the National Cancer Institute 92:1582–92
Shrader-Bogen, C. L., Kjellberg, J. L., McPherson, C. P. et al. (1997). Quality of life and treatment outcomes: prostate carcinoma patients' perspectives after prostatectomy or radiation therapy Cancer 79:1977–86
Fowler, Jr., F. J., Barry, M. J., Lu-Yao, G. et al. (1996). Outcomes of external-beam radiation therapy for prostate cancer: a study of Medicare beneficiaries in three Surveillance, Epidemiology, and End Results areas Journal of Clinical Oncology 14:2258–65
Lim, A. J., Brandon, A. H., Fiedler, J. et al. (1995). Quality of life: radical prostatectomy versus radiation therapy for prostate cancer The Journal of Urology 154:1420–5
Yarbro, C. H., Ferrans, C. E. (1998). Quality of life of patients with prostate cancer treated with surgery or radiation therapy Oncology Nursing Forum 25:685–93
Litwin, M. S., McGuigan, K. A., Shpall, A. I. et al. (1999). Recovery of health related quality of life in the year after radical prostatectomy: early experience Journal of Urology 161:515–19
Stanford, J. L., Feng, Z., Hamilton, A. S. et al. (2000). Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study Journal of the American Medical Association 283:354–60
Da Silva, F. C., Fossa, S. D., Aaronson, N. K. et al. (1996). The quality of life of patients with newly diagnosed M1 prostate cancer: experience with EORTC clinical trial 30853 European Journal of Cancer 32A:72–7
Litwin, M. S., Shpall, A. I., Dorey, F. et al. (1998). Quality-of-life outcomes in long-term survivors of advanced prostate cancer American Journal of Clinical Oncology 21:327–32
Moinpour, C. M., Savage, M. J., Troxel, A. et al. (1998). Quality of life in advanced prostate cancer: results of a randomized therapeutic trial Journal of the National Cancer Institute 90:1537–44
Albertsen, P. C., Aaronson, N. K., Muller, M. J. et al. (1997). Health-related quality of life among patients with metastatic prostate cancer Urology 49:207–16
Cassileth, B. R., Soloway, M. S., Vogelzang, N. J. et al. (1992). Quality of life and psychosocial status in stage D prostate cancer. Zoladex Prostate Cancer Study Group Quality of Life Research 1:323–9
Esper, P., Mo, F., Chodak, G. et al. (1997). Measuring quality of life in men with prostate cancer using the Functional Assessment of Cancer Therapy-Prostate instrument Urology 50:920–8
Chodak, G., Sharifi, R., Kasimis, B. et al. (1995). Single-agent therapy with bicalutamide: a comparison with medical or surgical castration in the treatment of advanced prostate carcinoma Urology 46:849–55
Iversen, P., Tyrrell, C. J., Kaisary, A. V. et al. (1998). Casodex (bicalutamide) 150-mg monotherapy compared with castration in patients with previously untreated nonmetastatic prostate cancer: results from two multicenter randomized trials at a median follow-up of 4 years Urology 51:389–96
Tyrrell, C. J., Kaisary, A. V., Iversen, P. et al. (1998). A randomised comparison of ‘Casodex’ (bicalutamide) 150 mg monotherapy versus castration in the treatment of metastatic and locally advanced prostate cancer European Urology 33:447–56
Mannaerts, G. H., Schijven, M. P., Hendrikx, A. et al. (2001). Urologic and sexual morbidity following multimodality treatment for locally advanced primary and locally recurrent rectal cancer European Journal of Surgical Oncology 27:265–72
Ness, R. M., Holmes. A., Klein, R. et al. (1998). Outcome states of colorectal cancer: identification and description using patient focus groups American Journal of Gastroenterology 93:1491–7
Ulander, K., Jeppsson, B., Grahn, G. (1997). Quality of life and independence in activities of daily living preoperatively and at follow-up in patients with colorectal cancer Supportive Care in Cancer 5:402–9
Ramsey, S. D., Andersen, M. R., Etzioni, R. et al. (2000). Quality of life in survivors of colorectal carcinoma Cancer 88:1294–1303
Hays, R. D., Sherbourne, C. D., Mazel, R. M. (1993). The RAND 36-Item Health Survey 1.0 Health Economics 2:217–27
Ware, J. E., Sherbourne, C. D. (1992). A 36-item Short Form Health Survey (SF-36): I. Conceptual framework and item selection Medical Care 30:473–83
Ganz, P. A., Schag, C. A., Lee, J. J. et al. (1992). The CARES: a generic measure of health-related quality of life for cancer patients Quality of Life Research 1:19–29
Schag, C. A., Ganz, P. A., Heinrich R. L. (1991). Cancer Rehabilitation Evaluation System—Short Form (CARES-SF). A cancer specific rehabilitation and quality of life instrument Cancer 68:1406–13
Aaronson, N. K., Ahmedzai, S., Bergman, B. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international trials in oncology Journal of the National Cancer Institute 85:365–76
Ferrans, C. E., Power, M. J. (1995). Quality of life index: development and psychometric properties Annals of Nursing Science 8:15–24
Cella, D. F., Tulsky, D. S. (1993). Quality of life in cancer: definition, purpose, and method of measurement Cancer Investigation 11:327–36
Schipper, H., Clinch, J., McMurray, A. et al. (1984). Measuring the quality of life of cancer patients: The Functional Living Index-Cancer: Development and validation Journal of Clinical Oncology 2:472–83
Erickson, this volume, Chapter 3
Andersen, M. R., Urban, N. (1999). Involvement in decision-making and breast cancer survivor quality of life Annals of Behavioral Medicine 21:201–9
Ganz, P. A., Rowland, J. H., Desmond, K. et al. (1998). Life after breast cancer: understanding women's health-related quality of life and sexual functioning Journal of Clinical Oncology 16:501–14
Cordova, M. J., Andrykowski, M. A., Kenady, D. E. et al. (1995). Frequency and correlates of posttraumatic stress disorder like symptoms after treatment for breast cancer Journal of Consulting and Clinical Psychology 63:981–6
Polinsky, M. L. (1994). Functional status of long-term breast cancer survivors: demonstrating chronicity Health and Social Work 19:165–73
Stiggelbout, A. M., de Haes, J. C. J. M., Vree, R. et al. (1997). Follow-up of colorectal cancer patients: quality of life and attitudes toward follow-up British Journal of Cancer 75:914–20
Vickberg, S. M. J., Bovbjerg, D. H., DuHamel, K. N. et al. (2000). Intrusive thoughts and psychological distress among breast cancer survivors: global meaning as a possible protective factor Behavioral Medicine 25:152–60
Beard, C. J., Propert, K. J., Rieker, P. P. et al. (1997). Complications after treatment with external-beam irradiation in early-stage prostate cancer patients: a prospective multiinstitutional outcomes study Journal of Clinical Oncology 15:223–9
Brandeis, J., Litwin, M., Burnison, M., Reiter, R. (2000). Quality of life outcomes after brachytherapy for early stage prostate cancer Journal of Urology 163:851–7
Clark, J. A., Rieker, P., Propert, K. J. et al. (1999). Changes in quality of life following treatment for early prostate cancer Urology 53:161–8
Eton, D., Lepore, S., Helgeson, V. (2001). Early quality of life in localized prostate carcinoma: treatment-related, demographic, and psychosocial factors Cancer 92:1451–9
Hamilton, A., Stanford, J., Gilliland, F. et al. (2001). Health outcomes after external-beam radiation therapy for clinically localized prostate cancer: results from the Prostate Cancer Outcomes Study Journal of Clinical Oncology 19:2517–26
Janda, M., Gerstner, N., Obermair, A. et al. (2000). Quality of life changes during conformal radiation therapy for prostate carcinoma Cancer 89:1322–8
Litwin, M., McGuigan, K. (1999). Accuracy of recall in health-related quality-of-life assessment among men treated for prostate cancer Journal of Clinical Oncology 17:2882–8
Lubeck, D., Grossfeld, G., Carroll, P. (2001). The effect of androgen deprivation therapy on health-related quality of life in men with prostate cancer Urology 58:94–100
Madalinska, J., Essink-Bot, M., de Koning, H. et al. (2001). Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer Journal of Clinical Oncology 19:1619–28
Penson, D., Stoddard, M., Pasta, D. et al. (2001). The association between socioeconomic status, health insurance coverage, and quality of life in men with prostate cancer Journal of Clinical Epidemiology 54:350–8
Potosky, A., Knopf, K., Clegg, L. et al. (2001). Quality-of-life outcomes after primary androgen deprivation therapy: results from the Prostate Cancer Outcomes Study Journal of Clinical Oncology 19:3750–7
Schapira, M., Lawrence, W., Katz, D., McAuliffe, T., Nattinger, A. (2001). Effect of treatment on quality of life among men with clinically localized prostate cancer Medical Care 39:243–53
Mangione, C. M., Goldman, L., Orav, J. et al. (1997). Health-related quality of life after elective surgery: measurement of longitudinal changes Journal of General Internal Medicine 12:686–97
Ganz, P. A., Hirji, K., Sim, M. et al. (1993). Predicting psychosocial risk in patients with breast cancer Medical Care 31:419–31
Schag, C. A., Ganz, P. A., Wing, D. S. et al. (1994). Quality of life in adult survivors of lung, colon and prostate cancer Quality of Life Research 3:127–41
Kurtz, M. E., Wyatt, G., Kurtz, J. C. (1995). Psychological and sexual well-being, philosophical/spiritual views, and health habits of long-term cancer survivors Health Care Women International 16:253–62
Ashing-Giwa, K., Ganz, P. A., Petersen, L. (1999). Quality of life of African-American and White long-term breast carcinoma survivors Cancer 85:418–26
Canales, S., Ganz, P. A., Coscarelli, C. A. (1995). Translation and validation of quality of life instrument for Hispanic American cancer patients: methodological considerations Quality of Life Research 4:3–11
Cousson-Gelie, F. (2000). Breast cancer, coping and quality of life: a semi-prospective study European Review of Applied Psychology 50:315–20
Joly, F., Espie, M., Marty, M. et al. (2000). Long-term quality of life in premenopausal women with node-negative localized breast cancer treated with or without adjuvant chemotherapy British Journal of Cancer 83:577–82
Fossa, S. D., Woehre, H., Kurth, K. H. et al. (1997). Influence of urological morbidity on quality of life in patients with prostate cancer European Urology 31:3–8
Moore, M. J., Osoba, D., Murphy, K. et al. (1994). Use of palliative end points to evaluate the effects of mitoxantrone and low-dose prednisone in patients with hormonally resistant prostate cancer Journal of Clinical Oncology 12:689–94
Sneeuw, K., Albertsen, P., Aaronson, N. (2001). Comparison of patient and spouse assessments of health related quality of life in men with metastatic prostate cancer Journal of Urology 165:478–82
Stockler, M. R., Osoba, D., Goodwin, P. et al. (1998). Responsiveness to change in health-related quality of life in a randomized clinical trial: a comparison of the Prostate Cancer Specific Quality of Life Instrument (PROSQOLI) with analogous scales from the EORTC QLQ-C30 and a trial specific module. European Organization for Research and Treatment of Cancer Journal of Clinical Epidemiology 51:137–45
Anderson, H., Hopwood, P., Stephens, R. et al. (2000). Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer — a randomized trial with quality of life as the primary outcome British Journal of Cancer 83:447–53
Crino, L., Scagliotti, G., Ricci, S. et al. (1999). Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project Journal of Clinical Oncology 17:3522–30
Langendijk, H., Aaronson, N., de Jong, J. et al. (2000). The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy Radiotherapy and Oncology 55:19–25
Langendijk, J., ten Velde, G., Aaronson, N. et al. (2000). Quality of life after palliative radiotherapy in non-small cell lung cancer: a prospective study International Journal of Radiation Oncology, Biology, and Physics 47:149–55
Roskowski, K., Pluzanska, A., Krzakowski, M. et al. (2000). A multicenter, randomized, phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy-I patients with metastatic or non-resectable localized non-small cell lung cancer (NSCLC) Lung Cancer 27:145–57
Ringdal, G. I., Ringdal, K. (2000). A follow-up study of the quality of life in cancer patients with different prognoses Quality of Life Research 9:65–73
Pedro, L. W. (2001). Quality of life for long-term survivors of cancer Cancer Nursing 24:1–11
Sammarco, A. (2001). Perceived social support, uncertainty, and quality of life of younger breast cancer survivors Cancer Nursing 24:212–19
Weitzner, M. A., Meyers, C. A., Stuebing, K. K. et al. (1997). Relationship between quality of life and mood in long-term survivors of breast cancer treated with mastectomy Supportive Care in Cancer 5:241–8
Ramsey, S. D., Berry, K., Moinpour, C. et al. (2002). Quality of life in long term survivors of colorectal cancer American Journal of Gastroenterology 97:1128–34
Dow, K. H., Ferrell, B. R., Leigh, S. et al. (1996). An evaluation of the quality of life among long-term survivors of breast cancer Breast Cancer Research and Treatment 39:261–73
Ferrell, B. R., Dow, K. H., Leigh, S. et al. (1995). Quality of life in long-term cancer survivors Oncology Nursing Forum 22:915–22
Courneya, K. S., Friedenreich, C. M. (1997). Relationship between exercise pattern across the cancer experience and current quality of life in colorectal cancer survivors Journal of Alternative and Complementary Medicine 3:215–26
Courneya, K. S., Friedenreich, C. M. (1997). Relationship between exercise during treatment and current quality of life among survivors of breast cancer Journal of Psychosocial Oncology 15:35–57
Stanton, A. L., Danoff-Burg, S., Cameron, C. L. et al. (2000). Emotional expressive coping predicts psychological and physical adjustment to breast cancer Journal of Consulting and Clinical Psychology 68:875–82
Lee, W., McQuellon, R., Case, D. et al. (1999). Early quality of life assessment in men treated with permanent source interstitial brachytherapy for clinically localized prostate cancer Journal of Urology 162:403–6
Monga, U., Kerrigan, A., Thornby, J. et al. (1999). Prospective study of fatigue in localized prostate cancer patients undergoing radiotherapy Radiation and Environmental Biophysics 7:178–85
Robinson, J., Saliken, J., Donnelly, B. et al. (1999). Quality-of-life outcomes for men treated with cryosurgery for localized prostate carcinoma Cancer 86:1793–801
Tefilli, M. V., Gheiler, E. L., Tiguert, R. et al. (1998). Quality of life in patients undergoing salvage procedures for locally recurrent prostate cancer Journal of Surgical Oncology 69:156–61
Cella, D. F. (1995). Measuring quality of life in palliative care Seminars in Oncology 22:73–81
Bonomi, P., Kim, K. M., Fairclough, D. et al. (2000). Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial Journal of Clinical Oncology 18:623–31
Kelly, K., Crowley, J., Bunn, P. et al. (2001). Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-cell lung cancer: a Southwest Oncology Group Trial Journal of Clinical Oncology 19:3210–18
Schiller, J., Adak, S., Cella, D. et al. (2001). Topotecan versus observation after cisplatin plus etoposide in extensive-stage small-cell lung cancer: E7593 — A phase III trial of the Eastern Cooperative Oncology Group Journal of Clinical Oncology 19:2114–22
Smith, E., Hann, D., Ahles, T. et al. (2001). Dyspnea, anxiety, body consciousness, and quality of life in patients with lung cancer Journal of Pain Symptom Management 21:323–9
Cotton, S. P., Levine, E. G., Fitzpatrick, C. M., Dold, K. H., Targ, E. (1999). Exploring the relationships among spiritual well-being, quality of life, and psychological adjustment in women with breast cancer Psycho-Oncology 8:429–38
Shapiro, S. L., Lopez, A. M., Schwartz, G. E. et al. (2001). Quality of life and breast cancer: relationship to psychosocial variables Journal of Clinical Psychology 57:501–19
Thongprasert, S., Sanguanmitra, P., Juthapan, W. et al. (1999). Relationship between quality of life and clinical outcomes in advanced non-small cell lung cancer: best supportive care (BSC) versus BSC plus chemotherapy Lung Cancer 24:17–24
Ferrell, B. R., Grant, M., Funk, B. et al. (1997). Quality of life in breast cancer. Part I: Physical and social well-being Cancer Nursing 20:398–408
Whedon, M., Stearns, D., Mills, L. E. (1995). Quality of life of long-term adult survivors of autologous bone marrow transplantation Oncology Nursing Forum 22:1527–35
Derogatis, L. R., Spence, P. (1982). The Brief Symptom Inventory (BSI) Administration, Scoring and Procedures Manual — I. Baltimore, MD: Clinical Psychometric Research
Grassi, L., Rosti, G. (1996). Psychosocial morbidity and adjustment to illness among long-term cancer survivors Psychosomatics 37:523–32
Radloff, L. (1977). The CES-D Scale: A self-report depression scale for research in the general population Applied Psychological Measurement 1:385–401
Horowitz, M., Wilner, N., Alvarez, W. (1979). Impact of event scale: a measure of subjective stress Psychosomatic Medicine 41:209–18
Zilberg, N. J., Weiss, D. S., Horowitz, M. J. (1982). Impact of event scale: a cross-validation study and some empirical evidence supporting a conceptual model of stress response syndromes Journal of Consulting Clinical Psychology 50:407–14
McBride, C. M., Clipp, E., Peterson, B. L. et al. (2000). Psychological impact of diagnosis and risk reduction among cancer survivors Psycho-Oncology 9:418–27
Herr, H. W., Kornblith, A. B., Ofman, U. (1993). A comparison of the quality of life of patients with metastatic prostate cancer who received or did not receive hormonal therapy Cancer 71:1143–50
Watson, M., Greer, J. Y., Inayat, Q. et al. (1988). Development of a questionnaire measure of adjustment to cancer: the MAC scale Psychology Medicine 18:203–9
McNair, D. M., Lorr, M., Droppleman, L. F. (1971). EITS manual for the Profile of Mood States. San Diego, CA: Educational & Industrial Testing Service 1971/1981
Mast, M. E. (1995). Definition and measurement of quality of life in oncology nursing research: review and theoretical implications Oncology Nursing Forum 22:957–64
Schwartz, A. L. (1999). Fatigue mediates the effects of exercise on quality of life Quality of Life Research 8:529–38
Derogatis, L. R. (1986). The psychosocial adjustment to illness scale (PAIS) Journal of Psychosomatic Research 30:77–91
Derogatis, L., Lopez, M. (1983). The Psychosocial Adjustment to Illness Scale (PAIS& PAIS-SR): Administration, Scoring, & Procedures Manual I. Baltimore, MD: Clinical Psychometric Research
Bekkers, M. J. T. M., van Knippenberg, F. C. E., van Dulmen, A. M. et al. (1997). Survival and psychosocial adjustment to stoma surgery and nonstoma bowel resection: a 4-year follow-up Journal of Psychosomatic Research 42:235–44
Olweny, C. L., Juttner, C. A., Rofe, P. et al. (1993). Long-term effects of cancer treatment and consequences of cure: cancer survivors enjoy quality of life similar to their neighbours European Journal of Cancer 29A:826–30
Carter, B. J. (1993). Long-term survivors of breast cancer. A qualitative descriptive study Cancer Nursing 16:354–61
Dunn, J., Steginga, S. K. (2000). Young women's experience of breast cancer: defining young and identifying concerns Psycho-Oncology 9:137–46
Ferrell, B. R., Grant, M. M., Funk, B. et al. (1997). Quality of life in breast cancer survivors as identified by focus groups Psycho-Oncology 6:13–23
Ferrell, B. R., Grant, M. M., Funk, B. M. et al. (1998). Quality of life in breast cancer survivors: implications for developing support services Oncology Nursing Forum 25:887–95
Fredette, S. L. (1995). Breast cancer survivors: concerns and coping Cancer Nursing 18:35–46
Ganz, P. A., Zebrack, B. (2001). Long-term impact of cancer therapy in adults. In American Society of Clinical Oncology Educational Book, 37th Annual Meeting of the American Society of Clinical Oncologists, ed. C. Perry. Alexandria,VA
Langelier, K. M., Sullivan, C. F. (1998). Breast talk in breast cancer narratives Qualitative Health Research 8:76–94
Loescher, L. J., Clark, L., Atwood, J. R. et al. (1990). The impact of the cancer experience on long-term survivors Oncology Nursing Forum 17:223–9
Pelusi, J. (1997). The lived experience of surviving breast cancer Oncology Nursing Forum 24:1343–53
Taylor, E. J. (2000). Transformation of tragedy among women surviving breast cancer Oncology Nursing Forum 27:781–8
Utley, R. (1999). The evolving meaning of cancer for long-term survivors of breast cancer Oncology Nursing Forum 26:1519–23
Wyatt, G., Kurtz, M. E., Liken, M. (1993). Breast cancer survivors: An exploration of quality of life issues Cancer Nursing 16:440–8
Davis, C. S., Zinkand, J. E., Fitch, M. I. (2000). Cancer treatment induced menopause: meaning for breast and gynecological cancer survivors Cancer Oncology Nursing Journal 10:14–21
Ferrans, C. E. (1994). Quality of life through the eyes of survivors of breast cancer Oncology Nursing Forum 21:1645–51
Ferrell, B. R., Grant, M., Schmidt, G. et al. (1992). The meaning of quality of life for bone marrow transplant survivors. Part 1: The impact of bone marrow transplant on quality of life Cancer Nursing 15:153–60
Ferrell, B. R., Grant, M., Schmidt, G. M. et al. (1992). The meaning of quality of life for bone marrow transplant survivors. Part 2: Improving quality of life for bone marrow transplant survivors Cancer Nursing 15:247–53
Dow, K. H., Ferrell, B. R., Haberman, M. R. et al. (1999). The meaning of quality of life in cancer survivorship Oncology Nursing Forum 26:519–28
Clark, E. (1993). The linkage of research and practice in oncology Advances in Medical Psychotherapy 6: 215–26
Somerfield, M., Curbow, B. (1992). Methodological issues and research strategies in the study of coping with cancer Social Science and Medicine 34:1203–16
Zebrack, B. J., Chesler, M. A. (2001). A psychometric analysis of the Quality of Life-Cancer Survivors (QOL-CS) in survivors of childhood cancer Quality of Life Research 10:319–29
Fayers, P. M., Machin, D. (2000). Quality of Life: Assessment, Analysis and Interpretation. Chichester: John Wiley & Sons
Wilson, I. B., Cleary, P. D. (1995). Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes Journal of the American Medical Association 273:59–65
Borghede, G., Karlsson, J., Sullivan, M. (1997). Quality of life in patients with prostatic cancer: results from a Swedish population study Journal of Urology 158:1477–85
Giaccone, G., Splinter, T., Debruyne, C. et al. (1998). Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer Journal of Clinical Oncology 16:2133–41
Zabora, J., Brintzenhofeszoc, K., Curbow, B. et al. (2001). The prevalence of psychological distress by cancer site Psycho-Oncology 10:19–28
Schwartz, C., Daltroy, L., Brandt, U. et al. (1992). A psychometric analysis of the Mental Adjustment to Cancer Scale Psychological Medicine 22:203–10
Merluzzi, T., Martinez-Sanchez, M. (1997). Factor structure of the Psychological Adjustment to Illness Scale (Self-Report) for persons with cancer Psychological Assessment 9:269–76
Whynes, D. K., Neilson, A. R. (1997). Symptoms before and after surgery for colorectal cancer Quality of Life Research 6:61–6
Katz, S. (1963). Studies of illness in the aged — the Index of ADL: a standardized measure of biological and psychosocial function Journal of the American Medical Association 185:914–19
Ranson, M., Davidson, N., Nicolson, M. et al. (2000). Randomized trial of paclitaxel plus supportive care versus supportive care for patients with advanced non-small-cell lung cancer Journal of the National Cancer Institute 92:1074–80
Souhami, R., Spiro, S., Rudd, R. et al. (1997). Five-day oral etoposide treatment for advanced small-cell lung cancer: randomized comparison with intravenous chemotherapy Journal of the National Cancer Institute 89:577–80
Bradburn, N. M. (1969). The Structure of Psychological Well-being. Chicago, IL: Aldine
Bradburn, N. M., Caplovitz, D. (1965). Reports on Happiness: A Pilot Study of Behavior Related to Mental Health. Chicago, IL: Aldine
Greaves-Otte, J. G. W., Greaves, J., Kruyt, P. M. et al. (1991). Problems at social re-integration of long-term cancer survivors European Journal of Cancer 27:178–81
Zigmond, A. S., Snaith, R. P. (1983). The hospital anxiety and depression scale Acta Psychiatrica Scandinavica 67:361–70
Okuyama, T., Tanaka, K., Akechi, T. et al. (2001). Fatigue in ambulatory patients with advanced lung cancer: prevalence, correlated factors, and screening Journal of Pain Symptom Management 22:554–64
Lerman, C., Trock, B., Rimer, B. et al. (1991). Psychological and behavioral implications of abnormal mammograms Annals of Internal Medicine 114:657–61
Weathers, F. W., Huska, J. A., Keane, T. M. (1991). The PTSD Checklist-Civilian Version (PCL-C). Boston, MA: National Center for PTSD/Boston VA Medical Center
Andrykowski, M. A., Cordova, M. J. (1998). Factors associated with PTSD symptoms following treatment for breast cancer: test of the Andersen Model Journal of Traumatic Stress 11:189–203
Cordova, M. J., Studts, J. L., Hann, D. M. et al. (2000). Symptom structure of PTSD following breast cancer Journal of Traumatic Stress 13:301–19
Smith, M. Y., Redd, W., DuHamel, K. et al. (1999). Validation of the PTSD Checklist-Civilian Version in survivors of bone marrow transplantation Journal of Traumatic Stress 12:485–99
Spanier, G. B. (1976). Measuring dyadic adjustment: New scales for assessing the quality of marriage and similar dyads Journal of Marriage and the Family 38:15–28
Litwin, M., Lubeck, D., Stoddard, M. et al. (2001). Quality of life before death for men with prostate cancer: results from the CaPSURE database Journal of Urology 165:871–5

Reference Title: REFERENCES

Reference Type: reference-list

Foley, K. M., Gelband, H. (ed.) (2001). Institute of Medicine and National Research Council: Improving Palliative Care for Cancer Summary and Recommendations. Washington, DC: National Academy Press
World Health Organization Division of Mental Health (1993). WHO-QOL Study Protocol: The Development of the World Health Organization Quality of Life Assessment Instrument (MNG/PSF/93.9). Geneva, Switzerland: World Health Organization
American Society of Clinical Oncology (1996). Outcomes of cancer treatment for technology assessment and cancer treatment guidelines Journal of Clinical Oncology 14:671–9
Franks, P. J., Salisbury, C., Bosanquet, N. et al. (2000). The level of need for palliative care: a systematic review of the literature Palliative Medicine 14(2):93–104
Holland, J. C., Chertkov, L. (2001). Clinical practice guidelines for the management of psychosocial and physical symptoms of cancer. In Institute of Medicine and National Research Council: Improving Palliative Care for Cancer Summary and Recommendations, ed. K. M. Foley, H. Gelband, pp. 7-1–7-60. Washington, DC: National Academy Press
McCahill, L., Ferrell, B. R., Virani, R. (2001). Improving cancer care at the end of life Lancet Oncology 2:103–8
Cleeland, C. S. (2001). Cross-cutting research issues: a research agenda for reducing distress of patients with cancer. In Institute of Medicine and National Research Council: Improving Palliative Care for Cancer Summary and Recommendations, ed. K. M. Foley, H. Gelband, pp. 8-1–8-85. Washington, DC: National Academy Press
King, C. R., Hinds, P. S. (1998). Quality of Life from Nursing and Patient Perspectives: Theory, Research, Practice. Sudbury, MA: Jones and Bartlett Publishers, Inc
Breitbart, W., Payne, D. K. (1998). Pain. In Psycho-Oncology, ed. J. C. Holland, pp. 450–67. New York: Oxford University Press
Cherny, N. (1998). Cancer pain: principles of assessment and syndromes. In Principles and Practice of Supportive Oncology, ed. A. Berger, R. K. Portenoy, D. E. Weissman, pp. 3–43. Philadelphia, PA: Lippincott-Raven Publishers
Dean, G. E., Anderson, P. A. (2001). Fatigue. In Textbook of Palliative Nursing, ed. B. R. Ferrell, N. Coyle, pp. 91–100. New York: Oxford University Press
Greenberg, D. B. (1998). Fatigue. In Psycho-Oncology, ed. J. C. Holland, pp. 485–93. New York: Oxford University Press
Portenoy, R. K. (2000). Physical symptom management in the terminally ill. In Handbook of Psychiatry in Palliative Medicine, ed. H. M. Chochinov, W. Breitbart, pp. 99–129. New York: Oxford University Press
Portenoy, R. K., Itri, L. M. (1999). Cancer-related fatigue: guidelines for evaluation and management Oncologist 4:1–10
Portenoy, R. K., Lesage, P. (1999). Management of cancer pain Lancet 353(9165):1695–700
Berger, A. M., Portenoy, R. K., Weissman, D. E. (1998). Principles and Practice of Supportive Oncology. Philadelphia, PA: Lippincott-Raven Publishers
Doyle, D., Hanks, G. W. C., MacDonald, E. (Ed.) (1998). Oxford Textbook of Palliative Medicine, (2nd edition). New York: Oxford University Press
National Comprehensive Cancer Network and American Cancer Society (NCCN/ACS) (2001). Patient Guidelines for the Treatment of Cancer Pain. Atlanta, GA: American Cancer Society
American Pain Society (APS) Quality Care Committee (1998). Quality improvement guidelines for the treatment of acute pain and cancer pain Journal of the American Medical Association 274:1874–80
World Health Organization (1986). Cancer Pain Relief. Geneva, Switzerland: World Health Organization
World Health Organization (1996). Report of the WHO Expert Committee on Cancer Pain Relief and Active Supportive Care: Cancer Pain Relief with a Guide to Opioid Availability. Technical Series 804, 2nd edition. Geneva: World Health Organization
World Health Organization (1998). Symptom Relief in Terminal Illness. Geneva, Switzerland: World Health Organization
Cella, D. F. (1998). Quality of life. In Psycho-Oncology, ed. J. C. Holland, pp. 1135–46. New York: Oxford University Press
Cella, D. F., Tulsky, D. S., Gray, G. et al. (1993). The Functional Assessment of Cancer Therapy Scale: development and validation of the general measure Journal of Clinical Oncology 11:570–9
Ferrell, B. R. (1996). Pain: how patients and families pay the price. In Pain Treatment Centers at a Crossroads: A Practical and Conceptual Reappraisal. Progress in Pain Management, Vol. 7, ed. M. J. M. Cohen, J. N. Campbell, pp. 229–37. Seattle, WA: International Association for the Study of Pain
Ferrell, B. R. (1998). The family. In Oxford Textbook of Palliative Medicine (2nd edition), ed. D. Doyle, G. W. C. Hanks, N. MacDonald, pp. 909–17. New York: Oxford University Press
Ferrell, B. R., Borneman, T. (1999). Pain and suffering at the end of life (EOL) for older patients and their families Generations XⅫI(1):12–17
Ferrell, B. R., Wisdom, C., Schneider, C. (1989). Quality of life as an outcome variable in the management of cancer pain Cancer 63:2321–7
Holland, J. C. (ed.) (1998). Psycho-Oncology. New York: Oxford University Press
Die-Trill, M. (1998). The patient from a different culture. In Psycho-Oncology, ed. J. C. Holland, pp. 857–66. New York: Oxford University Press
Die-Trill, M., Holland, J. C. (1993). Cross-cultural differences in the care of patients with cancer: A review General Hospital Psychiatry 15:21–30
Payne, R. (2000). At the end of life, color still divides The Washington Post, February 15, p.15
Morris, J. N., Mor, V., Goldberg, R. J., Sherwood, S., Greer, D. S., Hiris, J. (1986). The effect of treatment setting and patient characteristics on pain in terminal cancer patients: a report of the national hospice study Journal of Chronic Diseases 39(1):27–35
Morris, J. N., Suissa, S., Sherwood, S., Wright, S. M., Gree, D. (1986). Last days: a study of the quality of life of terminally ill cancer patients Journal of Chronic Diseases 39(1):47–62
Davies, B. (2001). Supporting families in palliative care. In Textbook of Palliative Nursing, ed. B. R. Ferrell, N. Coyle, pp. 363–73. New York: Oxford University Press
Ferrell, B. R. (2001). Pain observed: the experience of pain from the family caregiver's perspective Clinics in Geriatric Medicine 17(3):595–609
Ferrell, B. R., Rivera, L. M. (1995). Cancer pain: impact on elderly patients and their family caregivers. In Chronic Pain in Old Age: An Integrated Biopsychosocial Perspective, ed. R. Roy. Toronto: University of Toronto Press
Ferrell, B. R., Rivera, L. M. (1997). Cancer pain education for patients Seminars in Oncology Nursing 13(1):42–8
Emanuel, E. J., Fairclough, D. L., Slutsman, J., Emanuel, L. L. (2000). Understanding economic and other burdens of terminal illness: the experience of patients and their caregivers Annals of Internal Medicine 132(6):451–9
Levine, C. (Ed.) (2000). Always on Call: When Illness Turns Families into Caregivers. New York: United Hospital Fund of New York
O'Connell, L. J. (1996). Changing the culture of dying. A new awakening of spirituality in America heightens sensitivity to the needs of dying persons Health Progress 77(6):6–20
Steinhauser, K. E., Christakis, N. A., Clipp, E. C., McNeilly, M., McIntyre, L., Tulsky, J. A. (2000). Factors considered important at the end of life by patients, family, physicians, and other care providers Journal of the American Medical Association 284(19):2476–82
Snyder, this volume, Chapter 16, pp. 329–345
Cella, D. F. (1995). Measuring quality of life in palliative care Seminars in Oncology 22(2 Suppl. 3):73–8
Breitbart, W., Jaramillo, J. R., Chochinov, H. M. (1998). Palliative and terminal care. Psycho-Oncology, ed. J. C. Holland, pp. 437–49. New York: Oxford University Press
Curt, G. A. (2000). Impact of fatigue on quality of life in oncology patients Seminars in Hematology 37(4 Suppl. l6):14–17
Ferrell, B. R., Coyle, N. (2001). Textbook of Palliative Nursing. New York: Oxford University Press
Breitbart, W. C., Cohen, K. R. (1998). Delirium. In Psycho-Oncology, ed. J. C. Holland, pp. 564–75. New York: Oxford University Press
Bruera, E., Franco, J. J., Maltoni, M., Watanabe, S., and Suarez-Almazor, M. (1995). Changing pattern of agitated impaired mental status in patients with advanced cancer: association with cognitive monitoring, hydration, and opioid rotation Journal of Pain and Symptom Management 10:287–91
Bruera, E., Miller, L., McCallion, J. et al. (1992). Cognitive failure in patients with terminal cancer: a prospective study Journal of Pain and Symptom Management 7(4):192–5
Bruera, E., Neumann, C. M. (1998). Management of specific symptom complexes in patients receiving palliative care Canadian Medical Association Journal 158:1717–26
Chochinov, H. M., Breitbart, W. (Ed.) (2000). Handbook of Psychiatry in Palliative Medicine. New York: Oxford University Press
Walch, S. E., Ahles, T. A., Saykin, A. J. (1998). Neuropsychological impact of cancer and cancer treatment. In Psycho-Oncology, ed. J. C. Holland, pp. 500–8. New York: Oxford University Press
Breitbart, W. C., Wein, S. E. (1998). Metabolic Disorders and Neuropsychiatric Symptoms. In Psycho-Oncology, ed. J. C. Holland, pp. 639–52. New York: Oxford University Press
Passik, S. D., Breitbart, W. (1993). Psychiatric and psychological approaches to cancer pain. In Management of Cancer Pain, ed. E. Arbit, pp. 151–77. Mount Kisko, NY: Futura Publishing Company
Pereira, J., Hanson, J., Bruera, E. (1997). The frequency and clinical course of cognitive impairment in patients with terminal cancer Cancer 69:835–41
Ferrell, B. R., Grant, M., Rhiner, M., Padilla, G. V. (1992). Home care: maintaining quality of life for patient and family Oncology 6(2):136–40
Ferrell, B. R., Grant, M., Chan, J., Ahn, C., Ferrell, B. A. (1995). The impact of cancer pain education on family caregivers of elderly patients Oncology Nursing Forum 22(8):1211–18
Fox, B. H. (1998). Psychosocial factors in cancer incidence and prognosis. In Psycho-Oncology, ed. J. C. Holland, pp. 110–24. New York: Oxford University Press
Gavrin, J., Chapman, C. R. (1995). Clinical management of dying patients Western Journal of Medicine 163(3):268–77
Zabora, J., Brintzenhofeszoc, K., Curbow, B., Hooker, C., Piantadosa, S. (2001). The prevalence of psychological distress by cancer site Psycho-Oncology 10:9–28
Zabora, J. R., Loscalzo, M. J. (1996). Comprehensive psychosocial programs: a prospective model of care Oncology Issues 1:14–18
Benson, H. (1984). Beyond the Relaxation Response. New York: Times Books
Benson, H. (1996). Timeless Healing: The Power of Biology and Belief. New York: Simon and Schuster
Jenkins, R. A., Pargament, K. I. (1995). Religion and spirituality as resources for coping with cancer Journal of Psychosocial Oncology 13 (1/2):51–74
Johnston-Taylor, E. (2001). Spiritual Care: Nursing Theory, Research, and Practice. Upper Saddle River, NJ: Prentice Hall
Larson, D. B., Greenwold-Molano, M. A. (1995). Are religion and spirituality clinically relevant in health care? Mind/Body Medicine 1:147–57
Matthews, D. A., Larson, D. B. (1995). The Faith Factor: An Annotated Bibliography of Clinical Research on Spiritual Subjects, Volume 3. Bethesda, MD: National Institute for Healthcare Management
Koenig, H., Idler, E., Kasl, S. et al. (1999). Religion, spirituality, and medicine: a rebuttal to skeptics International Journal of Psychiatry in Medicine 29(2):123–31
Pargament, K. A. (1997). The Psychology of Religion and Coping. New York: Guilford Press
Johnston-Taylor, E. (2001). Spiritual Assessment. In Textbook of Palliative Nursing, ed. B. R. Ferrell, N. Coyle, pp. 397–406. New York: Oxford University Press
Kemp, C. (2001). Spiritual Care Interventions. In Textbook of Palliative Nursing, ed. B. R. Ferrell, N. Coyle, pp. 407–14. New York: Oxford University Press
Wenzl, C. (2001). The role of the nurse chaplain: a personal reflection. In Textbook of Palliative Nursing, ed. B. R. Ferrell, N. Coyle, pp. 425–34. New York: Oxford University Press
Borneman, T., Brown-Slatzman, K. (2001). Meaning in illness. In Textbook of Palliative Nursing, ed. B. R. Ferrell, N. Coyle, pp. 415–24. New York: Oxford University Press
Lynn, J. (2001). Serving patients who may die soon and their families: The role of hospice and other services Journal of the American Medical Association 285(7):925–32
Field, M. J., Cassel, C. K. (Ed.) (1997). Approaching Death: Improving Care at the End of Life. Washington, DC: National Academy Press
Lynn, J., Teno, J. M., Phillips, R. S. et al. (1997). Perceptions by family members of the dying experience of older and seriously ill patients Annals of Internal Medicine 126:97–106
Teno, J. (2000). Toolkit of Instruments to Measure End of Life Care. http://www.chcr.brown.edu/pcoc/. Last accessed on September 11, 2004
Teno, J. (2001). Quality of care and quality indicators for end-of-life cancer care: hope for the best, yet prepare for the worst. In Improving Palliative Care for Cancer: Summary and Recommendations, ed. K. M. Foley and H. Gelband, pp. 3-1–3-49. Washington, DC: National Academy Press
Guo, H., Fine, P. G., Mendoza, T. R., Cleeland, C. S. (2001). A preliminary study of the utility of the brief hospice inventory Journal of Pain and Symptom Management 22(2):637–48
Aaronson, N. K., Ahmedzai, S., Bergman, B. et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology Journal of the National Cancer Institute 85:365–76
Ferrans, C. E., Powers, M. J. (1985). Quality of Life Index: development and psychometric properties Advances in Nursing Science 8:5–24
Finkelstein, D. M., Cassileth, B. R., Bonomi, P. D. et al. (1988). A pilot study of the functional living index-cancer (FLIC) scale for the assessment of quality of life for metastatic lung cancer patients American Journal of Clinical Oncology 11:630–3
McMillan, S. C. (1996). Quality of life in hospice patients Oncology Nursing Forum 22:1401–9
Cohen, S. R., Mount, B. M., Bruera, E. et al. (1997). Validity of the McGill Quality of Life Questionnaire in the palliative care setting: a multi-centre Canadian study demonstrating the importance of the existential domain Palliative Medicine 11:3–20
Cohen, S. R., Mount, B. M., Strobel, M. G. et al. (1995). The McGill Quality of Life Questionnaire: a measure of quality of life appropriate for people with advanced disease. A preliminary study of validity and acceptability Palliative Medicine 9:207–19
Ware, J. E., Sherbourne, C. D. (1992). The MOS 36-item short form health survey (SF-36): conceptual framework and item selection Medical Care 30(6):473–83
Byock, I. R. (1995). Missoula-VITAS Quality of Life Index: Version-25S. Missoula, MT: VITAS Healthcare Corporation
Byock, I., Merriman, M. P. (1998). Measuring quality of life for patients with terminal illness: the Missoula VITAS quality of life index Palliative Medicine 12:231–44
Greer, D. S., Mor, V., Sherwood, S. et al. (1984). National Hospice Study Final Report. Providence, RI: Brown University
Padilla, G. V., Presant, G., Grant, M. M. et al. (1983). Quality of life index for patients with cancer Research Nursing in Health 6:117–26
Andresen, E. M., Rothenberg, B. M., Kaplan, R. M. (1998). Performance of a self-administered mailed version of the Quality of Well-Being (QWB-SA) questionnaire among older adults Medical Care 36:1349–60
Bergner, M., Bobbitt, R., Carter, W. B., Gilson, B. S. (1981). The Sickness Impact Profile: development and final revision of a health status measure Medical Care 19(8):787–805
Moinpour, C. M., Hutchinson, F., Hayden, K. et al. (1990). Quality of life assessment in Southwest Oncology Group trials Oncology (Huntington) 4:79–93
Spitzer, W. O., Dobson, A. J., Hall, J. et al. (1981). Measuring the quality of life of cancer patients: a concise QL-index for use by physicians Journal of Chronic Diseases 34:585–97
Erickson, this volume, Chapter 3
Feeny, this volume, Chapter 4
O'Boyle, C. A., Waldron, D. (1997). Quality of life issues in palliative medicine Journal of Neurology 244 (Suppl. 4):S18–25
Portenoy, R. K., Thaler, H. T., Kornblith, A. B. et al. (1994). The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics, and distress European Journal of Cancer 30A:1326–36
Cohen, S. R., Mount, B. M., Tomas, J. N., Mount, L. F. (1996). Existential well-being is an important determinant of quality of life. Evidence from the McGill Quality of Life Questionnaire Cancer 77:576–86
O'Connor, A. P., Wicker, C. A., Germino, B. B. (1990). Understanding the cancer patient's search for meaning Cancer Nursing 13:167–75
Reed, P. G. (1987). Spirituality and well being in terminally ill hospitalized adults Research Nursing in Health 10:335–44
Yalom, I. D. (1980). Existential Psychotherapy. New York: Basic Books
Tierney, R. M., Horton, S. M., Hannan, T. J., Tierney, W. M. (1998). Relationships between symptom relief, quality of life, and satisfaction with hospice care Palliative Medicine 12:333–44
Bruera, E., Kuehn, N., Miller, M. J. et al. (1991). The Edmonton Symptom Assessment System (ESAS): A simple method for the assessment of palliative care patients Journal of Palliative Care 7:6–9
Ferrell, B. R., Grant, M., Padilla, G., Vemuri, S., Rhiner, M. (1991). The experience of pain and perceptions of quality of life: validation of a conceptual model The Hospice Journal 7(3):9–24
Ferrell, B. R., Dow, K. H., Grant, M. (1995). Measurement of the quality of life in cancer survivors Quality of Life Research 4:523–31
Juarez, G., Ferrell, B. R., Borneman, T. (1998a). Influence of culture on cancer pain management in Hispanic patients (Part I) Cancer Practice 6(Part 5):262
Juarez, G., Ferrell, B. R., Borneman, T. (1998b). Perceptions of quality of life in Hispanic patients (Part II) Cancer Practice 6(Part 6):318
Seidman, A. D., Portenoy, R. K., Yao, T. J. et al. (1995). Quality of life in phase II trials: a study of methodology and predictive value in patients with advanced breast cancer treated with paclitaxel plus granulocyte colony-stimulating factor Journal of the National Cancer Institute 87:1316–22
Ingham, J. M., Seidman, A., Yao, T. -J. et al. (1996). The importance of frequent pain measurement in a cancer clinical trial: a lesson for quality of life assessment Quality of Life Research 5:503–7
Osoba, D., Zee, B., Pater, J. et al. (1994). Psychometric properties and responsiveness of the EORTC Quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer Quality of Life Research 3:353–64
Osoba, D., Aaronson, N., Zee, B. et al. (1997). Modification of the EORTC QLQ-C30 (version 2.0) based on content validity and reliability testing in large samples of patients with cancer. The Study on Quality of Life of the EORTC and the Symptom Control and Quality of Life Committees of the NCI of Canada Clinical Trials Group Quality of Life Research 6:103–8
Cella, D. F., Tulsky, D. S. (1990). Measuring quality of life today: Methodological aspects Oncology 4(5):29–38
Ferrell, B. R. (1995). The impact of pain on quality of life: a decade of research Nursing Clinics of North America 30(4):609–24
Spilker, B. (1996). Quality of Life and Pharmacoeconomics in Clinical Trials (2nd Edition). New York: Raven Press
Frank-Stromborg, M., Olsen, S. J. (1997). Instruments for Clinical Health-Care Research (2nd Edition). Sudbury, MA: Jones and Bartlett Publishers
Lynn, J., O'Mara, A. (2001). Reliable, high-quality, efficient end-of-life care for cancer patients: economic issues and barriers. In Improving Palliative Care for Cancer: Summary and Recommendations, ed. K. M. Foley, H. Gelband, pp. 2-1–2-45. Washington, DC: National Academy Press
Holland, J. C. (1999). NCCN practice guidelines for the management of psychosocial distress Oncology 13(5A):113–47
Cella, D. F., Bonimi, A. E. (1996). The Functional Assessment of Cancer Therapy (FACT) and Functional Assessment of HIV Infection (FAHI) quality of life measurement systems. In Quality of Life and Pharmacoeconomics in Clinical Trials (2nd Edition), ed. B. Spilker, pp. 203–14. New York: Raven Press
Casarett, D., Ferrell, B. R., Kirschling, J. et al. (2001). NHPCO Task Force on Ethics of Hospice Participation in Research Journal of Palliative Medicine 4(4):441–9
Baer, W. L., Hanson, J. C. (2000). Families perception of the added value of hospice in the nursing home Journal of American Geriatric Society 48(8):879–82
McCorkle, R., Robinson, L., Nuameh, I., Lev, E., Benoliel, J. Q. (1998). The effects of home nursing care for patients during terminal illness on the bereaved's psychological distress Nursing Research 47(1):2–10
Payne, S., Smith, P., Dean, S. (1999). Identifying the concerns of informal carers in palliative care Palliative Medicine 13(1):37–44
Eich, E., Reeves, J. L., Jaeger, B., Graff-Radford, S. B. (1985). Memory for pain: relation between past and present intensity Pain 23:375–9
Eich, E., Reeves, J. L., Katz, R. L. (1985). Anesthesia, amnesia, and the memory/awareness distinction Anesthesia and Analgesia 64:1143–8
Jamison, R. N., Reeves, J. L., Salovey, P., Pearson, R. (1990). Symposium on pain memory: clinical and cognitive issues Proceedings of the Ninth Annual Meeting of the American Pain Society 1:1
Aucoin-Gallant, G. (1999). Description of caregiver's educational needs and the degree of their dissatisfaction Canadian Oncology Nursing 9(4):165–7, 170–4
Hickman, S. E., Tilden, V. P., Tolle, S. W. (2001). Family reports of dying patients' distress: the adaptation of a research tool to assess global symptom distress in the last week of life Journal of Pain and Symptom Management 22(1):565–74
Ferrell, B. R., Grant, M. (2001). Nursing research. In Textbook of Palliative Nursing, ed. B. R. Ferrell, N. Coyle, pp. 701–12. New York: Oxford University Press
American Medical Association (1998). EPEC: Educating Physicians in End of Life Care. Chicago, IL: American Medical Association
Loscalzo, M. (1996). Psychological approaches to the management of pain in patients with advanced cancer Hematology/Oncology Clinics of North America 10(1):139–55
Loscalzo, M., Jacobsen, P. B. (1990). Practical behavioral approaches to effective management of pain and distress Journal of Psychosocial Oncology 8(2/3):139–69
Grant, M., Ferrell, B. R., Rivera, L., Lee, J. (1995). Unscheduled readmissions for uncontrolled symptoms: a health care challenge for nurses Nursing Clinics of North America 30(4):673–82
Eischens, M. J., Elliott, B. A., Elliott, T. E. (1998). Two hospice quality of life surveys: a comparison American Journal of Hospice and Palliative Care 15(3):143–8
Chang, V. T., Hwang, S. S., Feuerman, M. (2000). Validation of the Edmonton Symptom Assessment Scale Cancer 88(9):2164–71
Chang, V. T., Hwang, S. S., Feuerman, M., Kasimis, B. S., Thaler, H. T. (2000). The Memorial Symptom Assessment Scale Short Form (MSAS-SF): reliability and validity Cancer 89(5):1163–71
Collins, J. J., Devine, T. D., Dick, G. S. et al. (2002). The measurement of symptoms on young children with cancer. The validation of the Memorial Symptom Assessment Scale in children aged 7–12 Journal of Pain and Symptom Management 23(1):10–16

Reference Title: REFERENCES

Reference Type: reference-list

Leigh, S. (1996). Defining our destiny. In Cancer Survivor's Almanac: Charting the Journey, ed. B. A. Hoffman, pp. 261–71. Minneapolis, MN: Chronimed Publishing
Schneider, M. (2002). Quality of life (Editorial) CancerFutures, March 2002, p. 1
Leitman, R. (1995). Perspectives on prostate cancer treatments, awareness, attitudes and relationships In A Study of Patients and Urologists, p. 3. Lewis Harris and Associates, July 31—August 17, 1995
Zebrack, B. (2000). How you can achieve quality of life after a cancer diagnosis. Coping, March/April 2000, p. 13
Hughes, M. K. (1997). Sexuality issues of the cancer survivor Coping, March/April: 51
Hughes, M. K. (1996). Sexuality issues: keeping your cook Oncology Nursing Forum 23 (10):1595–600
D'Amico, A. V., Whittington, R., Malkowicz, S. B. et al. (1998). Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer Journal of the American Medical Association 280 (11):969–74
Leigh, S. A., Williams, J. E., Jr., Stoval, E. (1998). Survivorship: from the moment of diagnosis Cancer 83 (Suppl. 8):1710–13

Reference Title: REFERENCES

Reference Type: reference-list

Agency for Healthcare Research and Quality National Healthcare Quality Report — Summary. Available at http://ahrq.gov/qual/nhqr03/nhqrsum03.htm. Last accessed on September 25, 2004
Donabedian, A. (1966). Evaluating the quality of medical care Milbank Memorial Fund Quarterly: Health and Sociology 4:166
Aharony, L., Strasser, S. (1993). Patient satisfaction: what we know about and what we still need to explore Medical Care Review 50:49–79
Borras, J. M., Sanchez-Hernandez, A., Navarro, M. et al. (2001). Compliance, satisfaction, and quality of life of patients with colorectal cancer receiving home chemotherapy or outpatient treatment: a randomized controlled trial British Medical Journal 322:1–5
Cassileth, B. R., Lusk, E. J., Walsh, W. P. et al. (1990). The satisfaction and psychosocial status of patients during treatment for cancer Journal of Psychosocial Oncology 4: 47–57
DiMatteo, M. R., Sherbourne, C. D., Hays, R. D. et al. (1993). Physicians' characteristics influence patients' adherence to medical treatment: results from the medical outcomes study Health Psychology 12:93–102
Gilson, L., Alilio, M., Heggenhougen, K. (1996). Community satisfaction with primary health care services: an evaluation undertaken in the Morogoro region of Tanzania Social Science and Medicine 39:767–80
Loblaw, D. A., Bezjak, A., Bunston, T. (1999). Development and testing of a visit-specific patient satisfaction questionnaire: the Princess Margaret Hospital satisfaction with doctor questionnaire Journal of Clinical Oncology 17: 1931–8
Cleary, P. D., McNeil, B. J. (1988). Patient satisfaction as an indicator of quality care Inquiry 25:25–36
Fitzpatrick, R. (1991). Surveys of patient satisfaction: I — Important general considerations British Medical Journal 302:887–9
Haas, M. (1999). The relationship between expectations and satisfactions: a qualitative study of patients' experiences of surgery for gynecological cancer Blackwell Science Ltd 2: 51–60
World Health Organization (2000). The World Health Report 2000. Geneva, Switzerland: World Health Organization
Ong, L. M. L., de Haes, J. C. J. M., Hoos, A. M. et al. (1995). Doctor-patient communication: a review of the literature Social Science and Medicine 40:903–18
Hall, J. A., Roter, D. L., Katz, N. R. (1988). Meta-analysis of correlates of provider behavior in medical encounters Medical Care 26:657
Linder-Pelz, S., Struening, E. L. (1985). The multidimensionality of patient satisfaction with a clinic visit Journal of Community Health 10:42–54
Sitzia, J., Wood, N. (1997). Patient satisfaction: a review of issues and concepts Social Science and Medicine 45: 1829–43
Ware, J. E., Snyder, M. K., Wright, W. R. et al. (1983). Defining and measuring patient satisfaction with medical care Evaluation and Program Planning 6:247–63
Avis, M., Bond, M., Arthur, A. (1997). Questioning patient satisfaction: an empirical investigation in two outpatient clinics Social Science and Medicine 44:85–92
Williams, S. J., Calnan, M. (1991). Convergence and divergence: assessing criteria of consumer satisfaction across general practice, dental and hospital care settings Social Science and Medicine 33: 707–16
Hall, J. A., Dornan, M. C. (1990). Patient sociodemographic characteristics as predictors of satisfaction with medical care: a meta-analysis Social Science and Medicine 30: 811–18
Wiggers, J. H., Donovan, K. O., Redman, S. et al. (1990). Cancer patient satisfaction with care Cancer 66:610–16
Cole, F. L., Mackey, T., Lindenberg, J. (1999). Quality improvement: psychometric evaluation of patient satisfaction with nurse practitioner care instrument Journal of the American Academy of Nurse Practitioners 11:471–5
Widmark-Peterson, V., von Essen, L., Sjoden, P. O. (1998). Perceptions of caring: patients' and staff's association to CARE-Q behaviors Journal of Psychosocial Oncology 16:75–96
Young, W. B., Minnick, A. F., Marcantonio, R. (1996). How wide is the gap in defining quality care? Journal of Nursing Administration 26:15–20
Attkisson, C. C., Roberts, R. E., Pascoe, G. C. (1983). The evaluation ranking scale: clarification of methodological and procedural issues Evaluation and Program Planning 6:349–58
Gustafson, D. H., Arora, N. J., Nelson, E. C., Boberg, E. W. (2001). Increasing understanding of patient needs during and after hospitalization Journal of Quality Improvement 27:81–92
Ware, J. E., Hays, R. D. (1988). Methods for measuring patient satisfaction with specific medical encounters Medical Care 26:393–402
Harris-Kojetin, L. D., Fowler, F. J., Brown, J. A. et al. (1999). The use of cognitive testing to develop and evaluate CAHPS 1.0 Core Survey items Medical Care 37: MS10–2
McCusker, J. (1984). Development of scales to measure satisfaction and preferences regarding long-term and terminal care Medical Care 22:476–93
Kristjanson, L. J., Leis, A., Koop, P. M. et al. (1997). Family members' care expectations, care perceptions, and satisfaction with advanced cancer care: results of a multi-site pilot study Journal of Palliative Care 13:5–13
Hernandez, L., Chang, C. H., Cella, D. et al. (2000). Development and validation of the satisfaction with pharmacist scale Pharmacotherapy 20:837–43
Aaronson, this volume, Chapter 20
Fakhoury, W., McCarthy, M., Addington-Hall, J. (1996). Determinants of informal caregivers' satisfaction with services for dying cancer patients Social Science and Medicine 42:721–31
Linder-Pelz, S. (1982). Toward a theory of patient satisfaction Social Science and Medicine 16:577–82
de Silva, A. (2000). A framework for measuring responsiveness. GPE Discussion Paper # 32. Geneva, Switzerland: World Health Organization
Gustafson, D. H., Otis-Taylor, J., Thompson, S. et al. (1993). Assessing the needs of breast cancer patients and their families Quality Management in Health Care 2:6–17
Haas, M. (1999). A critique of patient satisfaction Health Information Management 29:9–13
Linder-Pelz, S. (1982). Social psychological determinants of patient satisfaction: a test of five hypotheses Social Science and Medicine 16:583–9
Knudtson, N. (2000). Patient satisfaction with nurse practitioner service in a rural setting Journal of the American Academy of Nurse Practitioners 12:405–12
La Monica, E. L., Oberst, M. T., Madea, A. R. et al. (1986). Development of a patient satisfaction scale Research in Nursing and Health 9:43–50
Miaskowski, C., Nichols, R., Brody, R. et al. (1994). Assessment of patient satisfaction utilizing the American Pain Society's quality assurance standards on acute and cancer-related pain U. S. Cancer Pain Relief Committee 9:5–11
McKinley, R. K., Roberts, C. (2001). Patient satisfaction with out of hours primary medical care Quality in Health Care 10:23–8
Peck, B. M., Asch, D. A., Goold, S. D. et al. (2001). Measuring patient expectations: does the instrument affect satisfaction or expectations? Medical Care 39:100–8
Rogers, A., Saffron, K., Addington-Hall, J. (2000). ‘All the services were excellent. It is when the human element comes in that things go wrong’: Dissatisfaction with hospital care in the last year of life Journal of Advanced Nursing 31: 768–74
Williams, B. (1994). Patient satisfaction: a valid concept? Social Science and Medicine 38:509–16
Thomas, L. H., Bond, S. (1996). Measuring patients' satisfaction with nursing: 1990–1994 Journal of Advanced Nursing 23:747–56
Oberst, M. (1984). Patients' perceptions of care: measurement of quality and satisfaction Cancer 53:2366–75
Dougall, A., Russell, A., Rubin, G. et al. (2000). Rethinking patient satisfaction: patient experiences of an open access flexible sigmoidoscopy service Social Science 50: 53–63
Grunfeld, E., Fitzpatrick, R., Mant, D. et al. (1999). Comparison of breast cancer patient satisfaction with follow-up in primary care vs. specialist care: results from a randomized controlled trial British Journal of General Practice 49:705–10
Pellino, T. A., Ward, S. E. (1998). Perceived control mediates the relationship between pain severity and patient satisfaction Journal of Pain and Symptom Management 15:110–16
Cleary, P. D. (1998). Satisfaction may not suffice! A commentary on ‘A patient's perspective’ International Journal of Technology Assessment in Health Care 14:35–7
Ward, S. E., Gordon, D. (1994). Application of the American Pain Society quality assurance standards Pain 56:299–306
Williams, B., Coyle, J., Healy, D. (1998). The meaning of patient satisfaction: an explanation of high reported levels Social Science and Medicine 47:351–9
Carr-Hill, R. A. (1992). The measurement of patient satisfaction Journal of Public Health Medicine 14:236–49
Zaslavsky, A. M., Zaborski, L., Ding, L. et al. (2001). Adjusting performance measures to ensure equitable plans comparison Health Care Financing Review 22:109–126
Hall, J. A., Milburn, M. A., Epstein, A. M. (1993). A causal model of health status and satisfaction with medical care Medical Care 31:84–94
Crofton, C., Lubalin, J. M., Darby, C. (1997). Foreword Medical Care. 37:MS 1–9
Bernhart, M. H., Wiadnyana, I. G. P., Haryoko, W. et al. (1999). Patient satisfaction in developing countries Social Science and Medicine 48:989–96
Fitzpatrick, R. (1991). Surveys of patient satisfaction: II — designing a questionnaire and conducting a survey British Medical Journal 302:1129–32
McCracken, L. M., Klock, P. A., Mingay, D. J. et al. (1997). Assessment of satisfaction with treatment for chronic pain U.S. Cancer Pain Relief Committee 14:292–9
Cleary, P. D., Edgman-Levitan, S., Roberts, M. et al. (1991). Patients evaluate their hospital care: a national survey Health Affairs 10:254–67
Cleary, P. D., Edgman-Levitan, S., Mc Mullen, W. et al. (1992). The relationship between reported problems and patient summary evaluations of hospital care Quality Review Bulletin 18:53–9
Medigovich, K., Porock, D., Kristjanson, L. J. et al. (1999). Predictors of family satisfaction with an Australian palliative home care service: a test of discrepancy theory Journal of Palliative Care 15:48–56
Sitzia, J., Wood, N. (1999). Development and evaluation of a questionnaire to assess patient satisfaction with chemotherapy nursing care European Journal of Oncology Nursing 3:126–40
Sitzia, J., Wood, N. (1998) Development and evaluation of a questionnaire to assess patient satisfaction with chemotherapy nursing care European Journal of Oncology Nursing 2:142–53
Bredart, A., Razavi, D., Delvaux, N. et al. (1988). A comprehensive assessment of satisfaction with care for cancer patients Support Care Center 6:518–23
Bredart, A., Razavi, D., Robertson, C. et al. (1999). A comprehensive assessment of satisfaction with care: preliminary psychometric analysis in an oncology institute in Italy Annals of Oncology 10:839–46
Loeken, K., Steine, S., Sandvik, L. et al. (1997). A new instrument to measure patient satisfaction with mammography Medical Care 35:731–41
Cleary, P. D., Edgman-Levitan, S., Roberts, M. et al. (1991). Patients evaluate their hospital care: a national survey Health Affairs 10:254–67
Hays, R. D., Shaul, J. A., Williams, V. S. L. et al. (1997). Psychometric properties of the CAHPS survey measures Medical Care (Suppl.) 37: MS22–31
Hargraves, J. L., Hays, R. D., Cleary, P. D. (2001). Psychometric properties of the Consumer Assessment of Health Plans (CAHPS) 2.0 Adult Core Survey Health Services Research 38(6 Part 1):1509–27

Reference Title: REFERENCES

Reference Type: reference-list

Maslow, A. (1943). A theory of human motivation Psychology Review 50:370–96
Langley, G., Nolan, K., Nolan, T. et al. (1996). The Improvement Guide. San Francisco: Jossey-Bass
Berwick, D. (1997). The total customer relationship in health care: broadening the bandwidth The Joint Commission Journal On Quality Improvement 23:245–50
Ross, C., Steward, C., Sinacore, J. M. (1993). The importance of patient preferences in the measurement of health care satisfaction Medical Care 31:138–49
Suchman, A. L., Markakis, K., Beckman, H. B. et al. (1997). A model of empathic communication in the medical interview Journal of the American Medical Association 277:678–82
Guadagnoli, E., Ward, P. (1998). Patient participation in decision-making Social Science and Medicine 47:329–39
Frosch, D. L., Kaplan, R. M. (1999). Shared decision making in clinical medicine: past research and future directions American Journal of Preventive Medicine 17:285–94
Charles, C., Gafni, A., Whelan, T. (1999). Decision making in the physician-patient encounter: revisiting the shared treatment decision-making model Social Science and Medicine 49:651–61
Maguire, P. (1999). Improving communication with cancer patients European Journal of Cancer 35:1415–22
Cull, A., Stewart, M., Altman, D. (1995). Assessment of and intervention for psychosocial problems in routine oncology practice British Journal of Cancer 72:229–35
Osoba, D. (1996). Rationale for the timing of health related HRQOL assessments in oncological palliative therapy Cancer Treatment Review 22A:69–73
Ford, S., Fallowfield, L., Lewis, S. (1996). Doctor-patient interactions in oncology Social Science and Medicine 42:1511–19
Holland, J. C., Almanza, J. (1999). Giving bad news: is there a kinder, gentler way? Cancer 86:738–40
Kim, M. K., Alvi, A. (1999). Breaking the bad news of cancer: the patient's perspective Laryngoscope 109:1064–7
Sabo, D. (1990). Men, death anxiety and denial. In Clinical Sociological Perspectives of Illness and Loss, ed. D. Clark, J. Fritz, P. Rieder, pp. 71–84. Philadelphia, PA: Charles Press
Peters-Golden, H. (1982). Varied perceptions of social support in the illness experience Social Science and Medicine 16:463–91
Northouse, L., Peters-Golden, H. (1993). Cancer and the family: strategies to assist spouses Seminars in Oncology Nursing 9:74–82
Cegala, D. J. (1997). A study of doctors' and patients' communication during a primary care consultation: implications for communication training Journal of Health Communication 2:169–94
Northouse, L. (1988). Social support in patients and husbands adjustment to breast cancer Nursing Research 37:91–5
Northouse, P., Northouse, L. (1987). Communication and cancer: Issues confronting patients, health professionals and caregivers Journal of Psychosocial Oncology 5:17–46
Vitaliano, P. (1997). Physiological and physical concomitants of caregiving; introduction to special issue Annals of Behavioral Medicine 19:75–7
Schulz, R., Beach, S. (1999). Caregiving as a risk factor for mortality Journal of the American Medical Association 282:2215–19
Morris, J., Sussa, S., Sherwood, S. et al. (1986). Last days: a study of the HRQOL of terminally ill cancer patients Journal of Chronic Disease 39:47–62
Ward, S., Goldberg, N., Miller-McCauley, V. et al. (1993). Patient-related barriers to management of cancer pain Pain 52:319–24
Bretsher, M., Rummons, R., Sloan J. et al. (1999). HRQOL in hospice patients Psychosomatics 40:309–13
Silveira, M., De Piero, A., Gerrity, M. et al. (2000). Patients knowledge of options at the end of life Journal of the American Medical Association 284:2483–8
Institute of Medicine (1997). Approaching Death: Improving Care at the End of Life, ed. M. Field, C. Cassel. Washington, DC: Institute of Medicine
Lawton, M. (2000). The End of Life: Scientific and Social Issues (Annual Review of Gerontology and Geriatrics). New York: Springer
Mor, V., Masterson-Allen, S., Houts, P. et al. (1992). The changing needs of patients with cancer at home Cancer 69:829–38
Northouse, L. (1988). A longitudinal study of the adjustment of patients and husbands to breast cancer Oncology Nurses Forum 16:511–16
Ell, K., Nishimoto, R., Mantell, J. et al. (1988). Longitudinal analysis of psychological adaptation among family members of patients with cancer Journal of Psychosomatic Research 32:429–38
Wilson, S., Morse, J. (1991). Living with a wife undergoing chemotherapy Image 23: 78–84
Wilkerson, S. (1991). Factors which influence how nurses communicate with cancer patients Journal of Advanced Nursing 16:677–88
Gustafson, D. (1991). Expanding on the role of patient as customer Quality Review Bulletin 17:324–5
Ferrans, this volume, Chapter 2
Marvel, M. K., Epstein, R. M., Flowers, K. et al. (1999). Soliciting the patient's agenda: have we improved? Journal of the American Medical Association 281:283–7
Grobe, M. E., Ahmann, D. L., Ilstrup, D. M. (1982). Needs assessment for advance cancer patients and their families Oncology Nursing Forum 9:26–30
Longman, A. J., Atwood, J. R., Sherman, J. B. et al. (1992). Care needs of home-based cancer patients and their caregivers Cancer Nursing 15:182–90
Thomas, S., Glynne Jones, R., Chait, I. (1997). Is it worth the wait? A survey of patients' satisfaction with an oncology outpatient clinic European Journal of Cancer Care in England 6:50–8
Davis, S. W., Quinn, S., Fox, L. et al. (1988). Satisfaction among cancer outpatients Programs for Clinical Biological Research 278:227–32
Darby, this volume, Chapter 14
Schag, C. C., Heinrich, R. L., Ganz, P. A. (1983). Cancer Inventory of Problem Situations: an instrument for assessing cancer patients' rehabilitation needs Journal of Psychosocial Oncology 1:11–24
Schag, C. C., Ganz, P. A., Heinrich, R. L. (1991). Cancer Rehabilitation Evaluation System-Short Form (CARES-SF). A cancer specific rehabilitation and quality of life instrument Cancer 15:1406–13
Gates, M. F., Lackey, N. R., White, M. R. (1995). Needs of hospice and clinic patients with cancer Cancer Practice 3:226–32
Foot, G., Sanson-Fisher, R. (1995). Measuring the unmet needs of people living with cancer Cancer Forum 19:131–5
Bonevski, B., Sanson-Fisher, R., Girgis, A. et al. (2000). Evaluation of an instrument to assess the needs of patients with cancer Cancer 88:217–25
McCusker, J. (1984). Development of scales to measure satisfaction and preferences regarding long-term and terminal care Medical Care 22:476–93
Tamburini, M., Gangeri, L., Brunelli, C. et al. (2000). Assessment of hospitalized cancer patients' needs by the Needs Evaluation Questionnaire Annals of Oncology 11:31–7
Coyle, N., Goldstein, L., Passik, S. et al. (1996). Development and validation of a patient needs assessment tool (PNAT) for oncology clinicians Cancer Nursing 19:81–92
Derdiarian, A. K. (1986). Informational needs of recently diagnosed cancer patients Nursing Research 36:276–81
Mesters, I., Borne van den, B., Boer, M. D. et al. (2001). Measuring information needs among cancer patients Patient Education and Counseling 43:253–62
Boberg, E., Gustafson, D., Hawkins, R. (2002). Assessing the unmet information, support and care delivery needs of men with prostate cancer Patient Education and Counseling 49 (3):233–42
Galloway, S., Graydon, J., Harrison, D. et al. (1997). Informational needs of women with a recent diagnosis of breast cancer: development and initial testing of a tool Journal of Advanced Nursing 25:1175–83
McCarthy, M., Higginson, I. (1991). Clinical audit by a palliative care team Palliative Medicine 5:215–21
Ellershaw, J. E., Peat, S. J., Boys, L. C. (1995). Assessing the effectiveness of a hospital palliative care team Palliative Medicine 9:145–52
Emanuel, L. L., Alpert, H. R., Baldwin, D. C. et al. (2000). What terminally ill patients care about: toward a validated construct of patients' perspectives Journal of Palliative Medicine 3:419–31
Kristjanson, L. J., Atwood, J., Degner, L. F. (1995). Validity and reliability of the Family Inventory of Needs (FIN): measuring the care needs of families of advanced cancer patients Journal of Nursing Measurement 3:109–26
Kipatrick, M. G., Kristjanson, L. J., Tataryn, D. (1998). Measuring the information needs of husbands of women with breast cancer: validity and reliability of the Family Inventory of Needs-Husbands Oncology Nursing Forum 25:1347–51
Kristjanson, L. J. (1993). Validity and reliability testing of the FAMCARE scale: Measure Family Satisfaction with Advance Cancer Care Social Science and Medicine 36:693–701
Chalmers, K. I., Luker, K. A., Leinster, S. J. et al. (2001). Information and support needs of women with primary relatives with breast cancer: development of the Information and Support Needs Questionnaire Journal of Advance Nursing 35:497–507
Prigerson, H. G., Maciejewski, P. K., Reynolds, C. F. et al. (1995). Inventory of complicated grief: a scale to measure maladaptive symptoms of loss Psychiatry Research 59:65–79
Lev, E. L., Munro, B. H., McCorkle, R. (1993). A shortened version of an instrument measuring bereavement International Journal of Nursing Studies 30:213–26
Gustafson, D. H., Arora, N. K., Nelson, E. C. et al. (2001). Increasing understanding of patient needs during and after hospitalization The Joint Commission Journal on Quality Improvement 27:81–92
Reise, this volume, Chapter 21
Miller, M. (1995). Coefficient alpha: a basic introduction from the perspectives of classical theory and structural equation modeling Structural Equation Modeling 2:255–73
Novick, M., Lewis, C. (1967). Coefficient alpha and the reliability of composite measurements Psychometrika 32:1–13
Siegel, K., Palamara, M., Karus, D. et al. (1992). Reducing the prevalence of unmet needs for concrete services of patients with cancer Cancer 69:1873–83
Flanagan, J. (1954). The critical incident technique Psychology Bulletin 51:327–58
Craig, T. J., Comstock, G. W., Geiser, P. B. (1974). Quality of survival in breast cancer care — control comparison Cancer 33:1451–7
Fieldman, J. G., Gardner, B., Carter, A. C. et al. (1989). Relationship of race to functional status among breast cancer patients after surgery Journal of Surgical Oncology 11:333–9
Lehmann, J. F., Delisa, J. A., Warren, C. G. et al. (1978). Cancer rehabilitation: assessment of need, development and evaluation of a model of care Archives of Physical Medicine and Rehabilitation 58:410–19
Mor, V., Guadagnoli, E., Wool, M. (1987). An examination of the concrete service needs of advanced cancer patients Journal of Psychosocial Oncology 5:1–17
Hilerman, J., Ackerman, N., Hassanein, R. (1992). Identifying the needs of home caregivers of patients with cancer Oncology Nursing Forum 19:771–7
Leis, A., Kristjanson, L., Koop, P. et al. (1997). Family health and the palliative care trajectory: a cancer research agenda Prevention et Controle en Cancerologie 1:352–60
Galloway, S. (1994). Meeting information needs of women with breast cancer (Abstract) Canadian Oncology Nursing Journal 14:29
Graf, M. A., Tanner, D. D., Swinyard, W. R. (1993). Optimizing the delivery of patient and physician satisfaction: a conjoint analysis approach Health Care Management Review 18:34–43
Green, P. E., Srinivasan, V. (1978). Conjoint analysis in customer research: issues and outlook Journal of Customer Research 5:103–23
Green, P. E. (1974). On the design of choice experiments involving multifactor alternatives Journal of Customer Research 1:61–8
Huber, G. P. (1974). Multiattribute utility models: a review of field and field-like studies Management Science 20:1393–402
Green, P. E. (1984). Hybrid conjoint analysis: an expository review Journal of Marketing Research 21:155–9

Reference Title: REFERENCES

Reference Type: reference-list

Lim, Y. M., Luna, I., Caromwell, S. L. et al. (1996). Toward a cross-cultural understanding of family caregiving burden Western Journal of Nursing Research 18:252–66
Nijboer, C., Tempelaar, R., Sanderman, R. et al. (1998). Cancer and caregiving: the impact on the caregiver's health Psycho-Oncology 7:3–13
Ohaeri, J. U., Campbell, O. B., Ilesanmi, A. O. et al. (1999). The psychosocial burden of caring for some Nigerian women with breast cancer and cervical cancer Social Science and Medicine 49:1541–9
Schott-Baer, D., Fisher, L., Gregory, C. (1995). Dependent care, caregiver burden, hardiness and self-care agency of caregivers Cancer Nursing 18:299–305
Schott-Baer, D. (1993). Dependent care, caregiver burden, and self-care agency of spouse caregivers Cancer Nursing 16:230–6
Buehler, J. A., Lee, H. J. (1992). Exploration of home care resources for rural families with cancer Cancer Nursing 15:299–308
Carey, P. J., Oberst, M. T., McCubbin, M. A. et al. (1991). Appraisal and caregiving burden in family members caring for patients receiving chemotherapy Oncology Nursing Forum 18:1341–8
Ferrell, B. R., Grant, M., Borneman, T. et al. (1999). Family caregiving in cancer pain management Journal of Palliative Medicine 2:185–95
Gilbar, O. (1999). Gender as a predictor of burden and psychological distress of elderly husbands and wives of cancer patients Psycho-Oncology 8:287–94
Given, C. W., Stommel, M., Given, B. et al. (1993). The influence of cancer patients' symptoms and functional states on patients' depression and family caregivers' reaction and depression Health Psychology 12:277–85
Harrison, J., Haddad, P., Maguire, P. (1995). The impact of cancer on key relatives: a comparison of relative and patient concerns European Journal of Cancer 31A:1736–40
Oberst, M. T., Thomas, S., Gass, K. et al. (1989). Caregiving demands and appraisal of stress among family caregivers Cancer Nursing 12:209–15
Pasacreta, J. V., Barg, F., Nuamah, I. et al. (2000). Participant characteristics before and 4 months after attendance at a family caregiver cancer education program Cancer Nursing 23:295–303
Rabins, P. V., Fitting, M. D., Eastham, J. et al. (1990). The emotional impact of caring for the chronically ill Psychosomatics 31:331–6
Rusinak, R. L., Murphy, J. F. (1995). Elderly spousal caregivers: knowledge of cancer care, perceptions of preparedness, and coping strategies Journal of Gerontological Nursing 21:33–41
Siegel, K., Raveis, V. H., Houts, P. et al. (1991). Caregiver burden and unmet patient needs Cancer 68:1131–40
Siegel, K., Raveis, V. H., Mor, V., Houts, P. (1991). The relationship of spousal caregiver burden to patient disease and treatment-related conditions Annals of Oncology 2:511–16
Stommel, M., Given, C. W., Given, B. (1990). Depression as an overriding variable in explaining caregiver burdens Journal of Aging and Health 2:81–102
Weitzner, M. A., Jacobsen, P. B., Wagner, H., Jr. et al. (1999). The caregiver quality of life index-cancer (CQOLC) scale: development and validation of an instrument to measure quality of life of the family caregiver of patients with cancer Quality of Life Research 8:55–63
Weitzner, M. A., Knutzen, R. (1998). The impact of pituitary disease on the family caregiver and overall family functioning Psychotherapy and Psychosomatics 67:181–8
Weitzner, M. A., McMillan, S. C. (1999). The caregiver quality of life index-cancer (CQOLC) scale: revalidation in a home hospice setting Journal of Palliative Care 15:13–20
Weitzner, M. A., Meyers, C. A., Steinbruecker, S. et al. (1997). Developing a care giver quality-of-life instrument: preliminary steps Cancer Practice 5:25–31
Blanchard, C. G., Albrecht, T. L., Ruckdeschel, J. C. (1997). The crisis of cancer: psychological impact on family caregivers Oncology 11:189–94
Blood, G. W., Simpson, K. C., Dineen, M. et al. (1994). Spouses of individuals with laryngeal cancer: caregiver strain and burden Journal of Communication Disorders 27:19–35
Ferrell, B. R., Ferrell, B. A., Rhiner, M. et al. (1991). Family factors influencing cancer pain management Postgraduate Medical Journal 67(Suppl. 2):S64–9
Ferrell, B. R., Grant, M., Chan, J. et al. (1995). The impact of cancer pain education on family caregivers of elderly patients Oncology Nursing Forum 22:1211–18
Given, B. A., Given, C. W., Helms, E. et al. (1997). Determinants of family care giver reaction: new and recurrent cancer Cancer Practice 5:17–24
Given, B., Stommel, M., Collins, C. et al. (1990). Responses of elderly spouse caregivers Research in Nursing and Health 13:77–85
Given, C. W., Given, B. A., Stommel, M. et al. (1999). The impact of new demands for assistance on caregiver depression: tests using an inception cohort The Gerontologist 39:76–85
Juarez, G., Ferrell, B. R. (1996). Family and caregiver involvement in pain management Clinics in Geriatric Medicine 12:531–47
Kozachik, S. L., Given, C. W., Given, B. A. et al. (2001). Improving depressive symptoms among caregivers of patients with cancer: results of a randomized clinical trial Oncology Nursing Forum 28:1149–57
Kurtz, M. E., Given, B., Kurtz, J. C. et al. (1994). The interaction of age, symptoms, and survival status on physical and mental health of patients with cancer and their families Cancer 74:2071–8
Kurtz, M. E., Kurtz, J. C., Given, C. W. et al. (1997). Predictors of postbereavement depressive symptomatology among family caregivers of cancer patients Support Care in Cancer 5:53–60
Kurtz, M. E., Kurtz, J. C., Given, C. W. et al. (1995). Relationship of caregiver reactions and depression to cancer patients' symptoms, functional states and depression — a longitudinal view Social Science and Medicine 40:837–46
McMillan, S. C., Mahon, M. (1994). The impact of hospice services on the quality of life of primary caregivers Oncology Nursing Forum 21:1189–95
Ohaeri, J. U., Campbell, O. B., Ilesanmi, A. et al. (1999). The opinion of caregivers of some women with breast and cervical cancer on aspects of the disease West African Journal of Medicine 18:6–12
Raveis, V. H., Karus, D. G., Siegel, K. (1998). Correlates of depressive symptomatology among adult daughter caregivers of a parent with cancer Cancer 83:1652–63
Summers, N., Dawe, U., Stewart, D. A. (2000). A comparison of inpatient and outpatient ASCT Bone Marrow Transplantation 26:389–95
Toseland, R. W., Blanchard, C. G., McCallion, P. (1995). A problem solving intervention for caregivers of cancer patients Social Science and Medicine 40:517–28
Weitzner, M. A., Haley, W. E., Chen, H. (2000). The family caregiver of the older cancer patient Hematology/Oncology Clinics of North America 14:269–81
Weitzner, M. A., McMillan, S. C., Jacobsen, P. B. (1999). Family caregiver quality of life: differences between curative and palliative cancer treatment settings Journal of Pain and Symptom Management 17:418–28
Holden, C. M. (1991). Anorexia in the terminally ill cancer patient: the emotional impact on the patient and the family The Hospice Journal 7:73–84
Payne, S., Smith, P., Dean, S. (1999). Identifying the concerns of informal carers in palliative care Palliative Medicine 13:37–44
Stetz, K. M. (1989). The relationship among background characteristics, purpose in life, and caregiving demands on perceived health of spouse caregivers Scholarly Inquiry for Nursing Practice 3:133–53
Watt-Watson, J., Graydon, J. (1995). Impact of surgery on head and neck cancer patients and their caregivers Nursing Clinics of North America 30:659–71
Pohl, J. M., Given, C. W., Collins, C. E. et al. (1994). Social vulnerability and reactions to caregiving in daughters and daughters-in-law caring for disabled aging parents Health Care for Women International 15:385–95
Yates, P. (1999). Family coping: issues and challenges for cancer nursing Cancer Nursing 22:63–71
Kramer, B. J. (1997). Gain in the caregiving experience: where are we? what next? Gerontologist 37:218–32
Ferrell, B. R., Rhiner, M., Cohen, M. Z. et al. (1991). Pain as a metaphor for illness. Part I: impact of cancer pain on family caregivers Oncology Nursing Forum 18:1303–9
Smeenk, F. W. J. M., De Witte, L. P., Van Haastregt, J. C. M. et al. (1998). Transmural care of terminal cancer patients: effects on the quality of life of direct caregivers Nursing Research 47:129–36
Ferrell, B. R., Cohen, M. Z., Rhiner, M. et al. (1991). Pain as a metaphor for illness. Part II: family caregivers' management of pain Oncology Nursing Forum 18:1315–21
Nijboer, C., Triemstra, M., Tempelaar, R. et al. (1999). Measuring both negative and positive reactions to giving care to cancer patients: psychometric qualities of the caregiver reaction assessment (CRA) Social Science and Medicine 48:1259–69
Given, C. W., Given, B., Stommel, M., Collins, C. et al. (1992). The caregiver reaction assessment (CRA) for caregivers to persons with chronic physical and mental impairments Research in Nursing and Health 15:271–83
Picot, S. J. F., Youngblut, J., Zeller, R. (1997). Development and testing of a measure of perceived caregiver rewards in adults Journal of Nursing Measurement 5:33–52
Given, B., Given, C. W. (1992). Patient and family caregiver reaction to new and recurrent breast cancer Journal of the American Medical Women's Association 47:201–6, 12
Lyles, J., King, S., Given, B. A. et al. (1990). Social interaction, instrumental support, and family caregiver perception of support Behavior, Health, and Aging 1:105–20
Curt, G. A. (2000). The impact of fatigue on patients with cancer: overview of FATIGUE 1 and 2 The Oncologist 5 (Suppl. 2):9–12
Lang, D. A., Neil-Dwyer, G., Garfield, J. (1999). Outcome after complex neurosurgery: the caregiver's burden is forgotten Journal of Neurosurgery 91:359–63
Fakhoury, W., McCarthy, M., Addington-Hall, J. (1996). Determinants of informal caregivers' satisfaction with services for dying cancer patients Social Science and Medicine 42:721–31
Jensen, S., Given, B. (1993). Fatigue affecting family caregivers of cancer patients Supportive Care in Cancer 1:321–5
Jensen, S., Given, B. A. (1991). Fatigue affecting family caregivers of cancer patients Cancer Nursing 14:181–7
King, S., Collins, C., Given, B. et al. (1991). Institutionalization of an elderly family member: reactions of spouse and nonspouse caregivers Archives of Psychiatric Nursing 5:323–30
Lawton, M. P., Kleban, M. H., Moss, M. et al. (1989). Measuring caregiver appraisal Journal of Gerontology 44:61–71

Reference Title: REFERENCES

Reference Type: reference-list

Sugarbaker, P. H., Barofsky, I., Rosenberg, S. A., Gianola, F. J. (1986). Quality of life assessment of patients in extremity sarcoma clinical trials Surgery 91:17–23
Hicks, J. E., Lampert, M. H., Gerber, L. H., Glastein, E., Danoff, J. (1985). Functional outcome update in patients with soft tissue sarcoma undergoing wide local excision and radiation (Abstract). Archives of Physical Medicine and Rehabilitation 66:542–3
Brown, M. L., Lipscomb, J., Snyder, C. (2001). The burden of illness of cancer: economic cost and quality of life Annual Review of Public Health 22:91–113
Revicki, D. A., Rothman, M., Luce, B. (1992). Health-related quality of life assessment and the pharmaceutical industry Pharmacoeconomics 1:294–408
Slevin, M. L., Stubbs, L., Plant, H. J. et al. (1990). Attitude to chemotherapy: comparing views British Medical Journal 300:1458–60
Brinkley, D. (1985). Quality of life in cancer trialsBritish Medical Journal 291:685–6
Moinpour, C., Feigl, P., Metch, B. et al. (1989). Quality of life endpoints in cancer clinical trials: review and recommendations Journal of the National Cancer Institute 81:485–95
Gotay, C. C., Korn, E. L., McCabe, M. S., Moore, T. D., Cheson, B. D. (1992). Quality of life assessment in cancer treatment protocols: research issues in protocol development Journal of the National Cancer Institute 84:575–9
Hillner, B. E., Smith, T. J. (1998). Does a clinical trial warrant an economic analysis? (Editorial) Journal of the National Cancer Institute 90:724–5
O'Brien, this volume, Chapter 25
Hornbrook, this volume, Chapter 24
Bungay, K. M., Boyer, J. G., Steinwald, A. B., Ware, J. E. (1996). Health-related quality of life: an overview. In Principles of Pharmacoeconomics (2nd Edition), ed. J. L. Bootman, R. J. Townsend, W. F. McGhan, pp. 128–48. Cincinnati, OH: Harvey Whitney Books Company
Fairclough, D. L. (2002). Design and Analysis of Quality of Life Studies in Clinical Trials. Boca Raton, FL: Chapman and Hall/CRC
Sprangers, M. A. G., Aaronson, N. K. (1992). The role of health care providers and significant others in evaluating the quality of life of patients with chronic diseases: a review Journal of Clinical Epidemiology 45:743–60
Rothman, M. L., Hedrick, S. C., Bulcroft, K. A., Hickam, D. H., Rubinstein, L. Z. (1991). The validity of proxy-generated scores as measures of patient health status Medical Care 29:115–24
Sneeuw, K. C. A., Aaronson, N. K., Sprangers, M. A. G., Detmar, S. B., Wever, L. D. V., Schornagel, J. H. (1998). Comparison of patient and proxy EORTC QLQ-C30 ratings in assessing the quality of life of cancer patients Journal of Clinical Epidemiology 51:617–31
Novella, J. L., Jochum, C., Jolly, D., Morrone, I., Ankri, J., Bureau, F., Blanchard, F. (2001). Agreement between patient' and proxies' reports of quality of life in Alzheimer's disease Quality of Life Research 10:443–52
Epstein, A. M., Hall, J. A., Togretti, J. et al. (1989). Using proxies to evaluate quality of life Medical Care 27(Suppl.): S91–8
Nelson, L. M., Longstreth, W. T., Koepsel, T. D., van Belle, G. (1990). Proxy respondents in epidemiologic research Epidemiology Reviews 12:71–89
Farrow, D. C., Samet, J. M. (1990). Comparability of information provided by elderly cancer patients regarding health and functional status, social network and life events Epidemiology 1:370–6
Groenvold, M., Klee, M. C., Sprangers, M. A. G., Aaronson, N. K. (1997). Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement Journal of Clinical Epidemiology 50:441–50
Fitzsimmons, D., George, S., Payne, S., Johnson, C. D. (1990). Differences in perceptions of quality of life issues between health professionals and patient with pancreatic cancer Psycho-Oncology 8:135–43
Gabriel, S. E., Kneeland, T. S., Melton, L. J., Moncur, M. M., Ettiger, B., Tosteson, A. N. A. (1999). Health-related quality of life in economic evaluations for osteoporosis: whose values should we use? Medical Decision Making 19:141–8
Llewellyn-Thomas, H., Sutherland, H. J., Tibshirani, R. et al. (1984). Describing health states. Methodologic issues in obtaining values for health states Medical Care 22:543–52
Patrick, D. L., Sittampalam, Y., Somerville, S. M. et al. (1985). A cross-cultural comparison of health status values American Journal of Public Health 75:1402–7
Balaban, D. J., Sagi, P. C., Goldfarb, N. I., Mettler, S. (1986). Weights for scoring the quality of well-being instrument among rheumatoid arthritics. A comparison to general population weights Medical Care 24:973–80
Sackett, D. L., Torrance, G. (1978). The utility of different health states as perceived by the general public Journal of Chronic Disease 31:697–704
Schipper, H. (1990). Guidelines and caveats for quality of life measurement in clinical practice and research Oncology 4:51–7
Wiklund, I., Dimenas, E., Wahl, M. (1990). Factors of importance when evaluating quality of life in clinical trials Controlled Clinical Trials 11:169–79
TeVelde, A., Sprangers, M. A., Aaronson, N. K. (1996). Feasibility, psychometric performance and stability across modes of administration of the CARES-SF Annals of Oncology 7:381–90
Kissinger, P., Rice, J., Farley, T. et al. (1999). Application of computer-assisted interviews to sexual behavior research American Journal of Epidemiology 149:950–4
Turner, C. F., Ku, L., Rogers, S. M. et al. (1998). Adolescent sexual behavior, drug use, and violence: increased reporting with computer survey technology Science 280:867–73
Skinner, H. A., Allen, B. A. (1983). Does the computer make a difference? Computerized versus face-to-face versus self-report assessment of alcohol, drug and tobacco use Journal of Consulting Clinical Psychology 51:267–75
Weinberger, M., Oddone, E. Z., Samsa, G. P. et al. (1996). Are HRQOL measures affected by the mode of administration? Journal of Clinical Epidemiology 49:135–40
Cella, D. F. (1995). Methods and problems in measuring QOL. Support Care in Cancer 3:11–22
McHorney, D. A., Kosinski, M., Ware, J. E. (1994). Comparison of the cost and quality of norms for the SF-36 health survey collected by mail versus telephone interview: results from a national survey Medical Care 32:551–67
Leidy, N. K., Elixhauser, A., Rentz, A. M. et al. (1999) Telephone validation of the QOL in epilepsy inventory-89 (QOLIE-89) Epilepsia 40:97–106
Gasquet, I., Falissard, B., Ravaud, P. (2001). Impact of reminders and methods of questionnaire distribution on patient response to mail-back satisfaction survey Journal of Clinical Epidemiology 54:1174–80
Velikova, G., Wright, E. P., Smith, A. B. et al. (1999). Automated collection of quality of life data: a comparison of paper and computer-touchscreen questionnaires Journal of Clinical Oncology 17:998–1000
Kleinman, L., Leidy, N. K., Crawley, J., Bonomi, A., Schoenfeld, P. (2001). A comparative trial of paper-and-pencil versus computer administration of the QOL in Reflux and Dyspepsia (QOLRAD) questionnaire Medical Care 39:181–9
Buxton, J., White, M., Osoba, D. (1998). Patients' experiences using a computerized program with a touch-sensitive video monitor for the assessment of health-related quality of life Quality of Life Research 7:513–19
Yarnold, P. R., Stewart, M. J., Stille, F. C. et al. (1996). Assessing functional status of elderly adults via microcomputer Perception and Motor Skills 82:689–90
Crawley, J. A., Bleinman, L., Dominitz, J. (2000). User preferences for computer administration of quality of life instruments Drug Information Journal 34:137–44
Burke, K. C., Baker, J. H., Hillis, A. (1995). Test-retest reliability in psychiatric patients of the SF-36 health survey International Journal of Methods in Psychological Research 5:189–94
Drummond, H. E., Gosh, S., Ferguson, A. et al. (1995). Electronic quality of life questionnaires: a comparison of pen-based electronic questionnaires with conventional paper in a gastrointestinal study Quality of Life Research 4:21–6
O'Connor, K. P., Hallam, R. S., Hinchliffe, R. (1989). Evaluation of a computer interview system for use with neuro-otology patients Clinical Otolaryngology 14:3–9
American Psychological Association (1986). Guidelines of Computer Based Tests and Interpretation (p. 18). American Psychological Association
Hopwood, P., Harvey, A., Davies, J., Stephens, R. J. et al. (1997). Survey of the Administration of Quality of Life Questionnaires in three multicentre randomised trials in cancer European Journal of Cancer 90:49–57
Fairclough, D. L., Cella, D. F. (1996). A Cooperative Group report on quality of life research: lessons learned. Eastern Cooperative Oncology Group (ECOG) Journal of the National Cancer Institute 40:73–5
Young, T., Maher, J. (1999). Collecting quality of life data in EORTC clinical trials — what happens in practice? Psycho-Oncology 8, 260–3
Cella, D. F., Skeel, R. T., Bonomi, A. E. (1993). Policies and Procedures Manual. Eastern Cooperative Oncology Group Quality of Life Subcommittee, Boston MA. (Unpublished)
Brooks, M. M., Jenkins, L. S., Schron, E. B., Steinberg, J. S., Cross, J. A., Paeth D. S. (1998). Quality of life at baseline: is assessment after randomization valid? Medical Care 36:1515–19
Fairclough, D. L. (1996). Quality of life in cancer clinical trials: now that we have the data, what do we do? Journal of Applied Statistical Science 4:253–69
Curren, D., Fayers, P., Molenbergerghs, G., Machin, D. (1998). Analysis of incomplete quality of life data in clinical trials. In Quality of Life Assessment in Clinical Trials: Methods and Practice, ed. M. Staquet, R. Hays, P. Fayers, pp. 249–80. Oxford: Oxford University Press
Korn, E. L., O'Fallon, J. (1990). Statistical considerations. Statistics Working Group. In Quality of Life Assessment in Cancer Clinical Trials, Report on Workshop on Quality of Life Research in Cancer Clinical Trials, Division of Cancer Prevention and Control. Bethesda, MD: National Cancer Institute
Heyting, A., Tolboom, J. T. B. M., Essers, J. G. A. (1992). Statistical handling of dropouts in longitudinal clinical trials Statistics in Medicine 11:2043–61
Gould, A. L. (1980). A new approach to the analysis of clinical drug trials with withdrawals Biometrics 36:721–27
Jennrich, R. I., Schluchter, M. D. (1986). Unbalanced repeated-measures models with structured covariance matrices Biometrics 42:805–20
Laird, N. M. (1988). Missing data in longitudinal studies Statistics in Medicine 7:305–15
Little, R. J. A. (1995). Modeling the dropout mechanism in repeated-measures studies Journal of the American Statistical Association 90:1112–21
Zwinderman, A. H. (1992). Statistical analysis of longitudinal quality of life data with missing measurements Quality of Life Research 1:219–24
Wu, M. C., Bailey, K. R. (1988). Analyzing changes in the presence of informative right censoring caused by death and withdrawal Statistics in Medicine 7:337–46
Wu, M. C., Carroll, R. J. (1988). Estimation and comparison of changes in the presence of informative right censoring by modeling the censoring process Biometrics 44:175–88
Mori, M., Woodworth, G. G., Woolson, R. F. (1992). Application of empirical Bayes inference to estimation of rate of change in the presence of informative right censoring Statistics in Medicine 11:621–31
Diggle, P. J., Kenward, M. G. (1994). Informative dropout in longitudinal data analysis (with discussion) Applied Statistics 43:49–93
Schluchter, M. D. (1992). Methods for the analysis of informatively censored longitudinal data Statistics in Medicine 11:1861–70
DeGruttola, V., Tu, X. M. (1994). Modeling progression of CD4-lymphocyte count and its relationship to survival time Biometrics 50:1003–14
Rubin, D. B. (1987). Multiple Imputation for Nonresponse in Surveys. New York: John Wiley
Rubin, D. B., Schenker, N. (1991). Multiple imputation in health-care data bases: an overview and some applications Statistics in Medicine 10:585–98
Schafer, J. L. (1998). Analysis of Incomplete Multivariate Data. London: Chapman and Hall
Crawford, S. L., Tennstedt, S. L., McKinlay, J. B. (1995). A comparison of analytic methods for non-random missingness of outcome data Journal of Clinical Epidemiology 48:209–19
Lavori, P. W., Dawson, R., Shera, D. (1995). A multiple imputation strategy for clinical trials with truncation of patient data Statistics in Medicine 14:1913–25
Fairclough, D. L. (2002). Multiple imputation for non-random missing data in longitudinal studies of health-related quality of life. In Statistical Methods for Quality of Life Studies: Design, Measurement and Analysis, ed. M. Mesbah, B. F. Cole, M.-L. T. Lee. Boston: Kluwer Academic Publishers, pp. 323–37
Fairclough, D. L., Peterson, H., Cella, D., Bonomi, P. (1998). Comparison of model based methods dependent on the missing data mechanism in two clinical trials of cancer therapy Statistics in Medicine 17:781–96

Reference Title: REFERENCES

Reference Type: reference-list

Sloan, J. A., Varricchio, C. (2001). Quality of life endpoints in prostate chemoprevention trials Urology 57:235–40
Juni, P., Altman, D. G., Egger, M. (2001). Systematic reviews in health care: assessing the quality of controlled clinical trials British Medical Journal 323(7303):42–6
Pocock, S. L. (1996). Clinical Trials. New York, NY: John Wiley & Sons
Altman, D. G., Goodman, S. N., Schroter, S. (2002). How statistical expertise is used in medical research Journal of the American Medical Association 287(21):2817–20
Fairclough, D. L. (1997). Summary measures and statistics for comparison of quality of life in a clinical trial of cancer therapy Statistics in Medicine 16:1197–209
Albert, P. S. (1999). Longitudinal data analysis (repeated measures) in clinical trials Statistics in Medicine 18(13):1707–32
Chassany, O., Sagnier, P., Marquis, P. et al. (2002). Patient reported outcomes: the example of health related quality of life — a European guidance for the improved integration of HRQOL assessment in the drug regulatory process Drug Information Journal 36:209–38
Spilker, B. (ed.) (1996). Quality of Life and Pharmacoeconomics in Clinical Trials. New York, NY: Lippincott Raven
Sloan, J. A., Loprinzi, C. L., Novotny, P. J. et al. (2001). Methodologic lessons learned from hot flash studies Journal of Clinical Oncology 19:4280–90
Loprinzi, C. L., Sloan, J. A., Rowland, Jr., K. M. (2003). Methodologic issues regarding cancer anorexia/cachexia trials. In Research and Palliative Care: Methodologies and Outcomes, R. K. Portenoy, E. Bruera, eds. Oxford: Oxford University Press, pp. 25–40
Burris, H. A., Moore, M. J., Andersen, J. et al. (1997). Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial Journal of Clinical Oncology 15(6):2403–13
Marubini, E., Valsecchi, M. G. (1995). Analyzing Survival Data from Clinical Trials and Observational Studies. New York, NY: John Wiley & Sons
Aaronson, N. K. (1991). Methodological issues in assessing the quality of life of cancer patients Cancer 67:844–50
Cella, D. F. (1996). Quality of life outcomes: measurement and validation Oncology 10:233–46
Cox, D. R., Fitzpatrick, R. (1992). Quality-of-life assessment: can we keep it simple? Journal of Research Statistical Society 155:353–93
Lara-Munoz, C., Feinstein, A. R. (1999). How should quality of life be measured? Journal of Investigative Medicine 47(1):17–24
Leplege, A., Hunt, S. (1997). The problem of quality of life in medicine Journal of the American Medical Association 278(1):47–50
Fayers, P. M., Hopwood, P., Harvey, A. et al. (1997). Quality of life assessment in clinical trials — guidelines and a checklist for protocol writers: the U.K. Medical Research Council experience European Journal of Cancer 33:20–8
Moinpour, C. M., Feigl, P., Metch, B. et al. (1991). Quality of life end points in cancer clinical trials: review and recommendations Journal of National Cancer Institute 81:485–95
Sloan, J. A., Novotny, P. J., Loprinzi, C. L. (1998). Analyzing quality of life endpoints in clinical trials via the SAS system Proceedings of SAS Users Group International (SUGI) 23:1213–18
Sloan, J. A., Loprinzi, C. L., Kuross, S. A. et al. (1998). Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer Journal of Clinical Oncology 16:3662–73
Sloan, J. A., O'Fallon, J. R., Suman, V. J. et al. (1998). Incorporating quality of life measurement in oncology clinical trials Proceedings of the American Statistical Association: 282–7
Hambleton, R. K. (2000). Emergence of item response modeling in instrument development and data analysis Medical Care 38(9 Suppl.):II60–5
Cella, D., Chang, C. H. (2000). A discussion of item response theory and its applications in health status assessment Medical Care 38(9 Suppl.):II66–72
McHorney, C. A., Cohen A. S. (2000). Equating health status measures with item response theory: illustrations with functional status items Medical Care 38(9 Suppl.):II43–59
Jenkinson, C., Fitzpatrick, R., Garratt, A. et al. (2001). Can item response theory reduce patient burden when measuring health status in neurological disorders? Results from Rasch analysis of the SF-36 physical functioning scale (PF-10) Journal of Neurology, Neurosurgery and Psychiatry 71(2):220–4
Ware, J. E., Bjorner, J. B., Kosinski, M. (2000). Practical implications of item response theory and computerized adaptive testing: a brief summary of ongoing studies of widely used headache impact scales Medical Care 38(9 Suppl.):II73–82
Scott, N. W., McPherson, G. C., Ramsay, C. R. et al. (2002). The method of minimization for allocation to clinical trials: a review Controlled Clinical Trials 23(6):662–4
Therneau, T. (1993). How many stratification factors is too many to use in a randomisation plan? Controlled Clinical Trials 14:98–108
Loprinzi, C. L., Kugler, J. W., Sloan, J. A. et al. (1999). Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia Journal of Clinical Oncology 17(10):3299–306
Sloan, J. A., Loprinzi, C. L., Laurine, J. A. et al. (2001). A simple stratification factor for survival in advanced cancer patients: the Good/Bad/Uncertain index Journal of Clinical Oncology 20:1491–8
Guyatt, G., Osoba, D., Wu, A. et al. (2002). Methods to explain the clinical significance of health status measures Mayo Clinic Proceedings 77:371–83
Cella, D., Bullinger, M., Scott, C. et al. (2002). Group versus individual approaches to understanding the clinical significance of differences or changes in quality of life Mayo Clinic Proceedings 77:384–92
Sloan, J., Aaronson, N., Cappelleri, J. et al. (2002). Assessing the clinical significance of single items relative to summated scores Mayo Clinic Proceedings 77:479–87
Frost, M., Bonomi, A., Ferrans, C. et al. (2002). Patient, clinician and population perspectives on determining the clinical significance of quality of life scores Mayo Clinic Proceedings 77:488–94
Sprangers, M., Moinpour, C., Moynihan, T. et al. (2002). Assessing meaningful change over time in quality of life: a users' guide for clinicians Mayo Clinic Proceedings 77:561–71
Symonds, T., Berzon, R., Marquis, P. et al. (2002). The clinical significance of QOL results: practical considerations for specific audiences Mayo Clinic Proceedings 77:572–83
Osoba, D., Rodrigues, G., Myles, J. et al. (1998). Interpreting the significance of changes in health-related quality of life scores Journal of Clinical Oncology 16:139–44
Sloan, J. A., Vargas-Chanes, D., Kamath, C. C. et al. (2003). Detecting worms, ducks, and elephants: a simple approach for defining clinically relevant effects in quality-of-life measures. Journal of Cancer and Integrative Medicine 1(1): 41–7
Cohen, J. (1988). Statistical Power Analysis for the Behavioral Sciences. Hillsdale, NJ: Lawrence Erlbaum Associates
Sloan, J. A., Dueck, A. (2004). Issues for statisticians in conducting analyses and translating results for quality of life end points in clinical trials. Journal of Biopharmaceutical Statistics 14(1):73–96
Sloan, J. A., Novotny, P. J., Loprinzi, C. L. et al. (1997). Graphical and analytical tools for the analysis of two-period crossover clinical trials Proceedings of SAS Users Group International (SUGI) 22:1312–17
Norman, G. R., Sloan, J. A., Wyrwich, K. W. (2003). Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation Medical Care 41(5): 582–92
Gould, A. L. (2001). Sample size re-estimation: recent developments and practical considerations Statistics in Medicine 20(17–18):2625–43
O'Brien, P. C. (1984). Procedures for comparing samples with multiple endpoints Biometrics 40:1079–87
Loprinzi, C. L., Kugler, J. W., Sloan, J. A. et al. (2000). Venlafaxine in management of hot flashes in survivors of breast cancer: a randomized controlled trial Lancet 356:2059–63
Benjamini, Y., Hochberg, Y. (1995). Controlling the false discovery rate: a practical and powerful approach to multiple testing Journal of the Royal Statistical Society, Series B, Methodological 57:289–300
Loehlin, J. C. (1992). Latent Variable Models. Hillsdale, NJ: Lawrence Erlbaum and Associates
Fairclough, this volume, Chapter 17
McGinnis, W., Loprinzi, C. L., Buskirk, S. et al. (1997). Placebo-controlled trial of sucralfate for inhibiting radiation-induced esophagitis Journal of Clinical Oncology 15:1239–43
Lachin, J. M. (2000). Statistical considerations in the intent-to-treat principle Controlled Clinical Trials 21(3):167–89
Horne, A. D., Lachenbruch, P. A., Goldenthal, K. L. (2000). Intent-to-treat analysis and preventive vaccine efficacy Vaccine 19(2–3):319–26
Martenson, J. A., Bollinger, J. W., Sloan, J. A. et al. (2000). Sucralfate in the prevention of treatment-induced diarrhea in patients receiving pelvic radiation therapy: A North Central Cancer Treatment Group Phase III double-blind placebo-controlled trial Journal of Clinical Oncology 18:1239–45
Vickers, A. J., Altman, D. G. (2001). Analysing controlled trials with baseline and follow up measurements British Medical Journal 323:1123–4
Cheung, Y. B. (2001). Adjustment for selection bias in cohort studies: an application of a probit model with selectivity to life course epidemiology Journal of Clinical Epidemiology 54(12):1238–43
Gerstein, D. R., Johnson, R. A. (2000). Nonresponse and selection bias in treatment follow-up studies Substance Use and Misuse 35(6–8):971–1014
Grasdal, A. (2001). The performance of sample selection estimators to control for attrition bias Health Economics 10(5):385–98
Grimes, D. A., Schulz, K. F. (2002). Bias and causal associations in observational research Lancet 359(9302):248–52
Oglesby, L., Rotko, T., Krutli, P. et al. (2000). Personal exposure assessment studies may suffer from exposure-relevant selection bias Journal of Exposure Analysis and Environmental Epidemiology 10(3):251–66
Potosky, A. L., Legler, J., Albertsen, P. C. et al. (2000). Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study Journal of the National Cancer Institute 92(19):1582–92
Maddala, G. S. (1994). Limited Dependent and Quantitative Variables in Econometrics. Cambridge: Cambridge University Press
Sloan, J. A., Loprinzi, C. L., Novotny, P. J. et al. (2000). Sex differences in fluorouracil-induced stomatitis Journal of Clinical Oncology 18:412–20
Sloan, J. A., Goldberg, R. M., Sargent, D. J. et al. (2001). Women experience greater toxicity with fluorouracil-based chemotherapy for colorectal cancer Journal of Clinical Oncology 19:3539–46
Bentler, P. M., Stein, J. A. (1992). Structural equation models in medical research Statistical Methods Medical Research 1(2):159–81
Burgess, A. P., Carretero, M., Ellington, A. et al. (2000). The role of personality, coping style and social support in health-related quality of life in HIV infection Quality of Life Research 9(4):423–37
de Boer, A., Spruijt, R. J., de Haes, J. C. (1998). Disease-specific quality of life: is it one construct? Quality of Life Research 7(2):135–42
Larsson, G., Larsson, B. W., Munck, I. M. (1998). Refinement of the questionnaire ‘quality of care from the patient's perspective’ using structural equation modeling Scandinavian Journal of the Caring Sciences 12(2):111–18
Lehert, P. (2001). Quality-of-life assessment in comparative therapeutic trials and causal structure considerations in peripheral occlusive arterial disease Pharmacoeconomics 19(2):121–30
Palta, M., Lin, C. Y. (1999). Latent variables, measurement error and methods for analysing longitudinal binary and ordinal data Statistics in Medicine 18(4):385–96
Cole, B. F., Gelber, R. D., Kirkwood, J. M. et al. (1996). Quality-of-life-adjusted survival analysis of interferon alfa-2b adjuvant treatment of high-risk resected cutaneous melanoma: an Eastern Cooperative Oncology Group study Journal of Clinical Oncology 14(10):2666–73
Cole, B. F., Solal-Celigny, P., Gelber, R. D. et al. (1996). Quality-of-life-adjusted survival analysis of interferon alfa-2b treatment for advanced follicular lymphoma: an aid to clinical decision making Journal of Clinical Oncology 16(7):2339–44
Gelber, R. D., Goldhirsch, A., Cavalli, F. (1991). Quality-of-life-adjusted evaluation of adjuvant therapies for operable breast cancer. The International Breast Cancer Study Group Annals of Internal Medicine 114(8):621–8
Gelber, R. D., Goldhirsch, A., Cole, B. F. (1993). Evaluation of effectiveness: Q-TWiST. The International Breast Cancer Study Group Cancer Treatment Reviews 19(Suppl. A):73–84
Goldhirsch, A., Gelber, R. D., Simes, R. J. et al. (1989). Costs and benefits of adjuvant therapy in breast cancer: a quality-adjusted survival analysis Journal of Clinical Oncology 7(1):36–44
Sloan, J. A., Sargent, D. J., Lindman, J. et al. (2002). A new graphic for quality adjusted life years (Q-TWiST) survival analysis: the Q-TWiST plot Quality of Life Research 11(1):37–45
Sloan, J. A., Bonner, J. A., Hillman, S. L. et al. (2002). A quality-adjusted reanalysis of a Phase III trial comparing once-daily thoracic radiation vs. twice-daily thoracic radiation in patients with limited-stage small-cell lung cancer(1) International Journal of Radiation Oncology, Biology, and Physics 52(2):371–81
Moayyedi, P., Wardman, M., Toner, J. et al. (2002). Establishing patient preferences for gastroenterology clinic reorganization using conjoint analysis European Journal of Gastroenterology Hepatology 14(4):429–33
Ryan, M., Shackley, P. (1995). Assessing the benefits of health care: how far should we go? Quality Health Care 4(3):207–13
Ryan, M., Farrar, S. (2000). Using conjoint analysis to elicit preferences for health care British Medical Journal 320(7248):1530–3
Hays, R. D., Morales, L. S., Reise, S. P. (2000). Item response theory and health outcomes measurement in the 21st century Medical Care 38(9 Suppl.):II28–42
Revicki, D. A., Cella, D. F. (1997). Health status assessment for the twenty-first century: item response theory, item banking and computer adaptive testing Quality of Life Research 6(6):595–600
Teresi, J. A., Kleinman, M., Ocepek-Welikson, K. (2000). Modern psychometric methods for detection of differential item functioning: application to cognitive assessment measures Statistics in Medicine 19(11–12):1651–83
Briggs, A. H. (1999). A Bayesian approach to stochastic cost-effectiveness analysis Health Economics 8(3):257–61
Fryback, D. G., Chinnis, J. O., Ulvila, J. W. (2001). Bayesian cost-effectiveness analysis. An example using the GUSTO trial International Journal of Technology Assessment in Health Care 17(1):83–97
Fryback, D. G., Stout, N. K., Rosenberg, M. A. (2001). An elementary introduction to Bayesian computing using WinBUGS International Journal of Technology Assessment in Health Care 17(1):98–113
Hornberger, J. (2001). Introduction to Bayesian reasoning International Journal of Technology Assessment in Health Care 17(1):9–16
Luce, B. R., Shih, Y. C., Claxton, K. (2001). Introduction. Bayesian approaches to technology assessment and decision making International Journal of Technology Assessment in Health Care 17(1):1–5
Winkler, R. L. (2001). Why Bayesian analysis hasn't caught on in healthcare decision making International Journal of Technology Assessment in Health Care 17(1):56–66
Degner, L., Sloan, J. A. (1995). Symptom distress in newly diagnosed ambulatory cancer patients and as a predictor of survival in lung cancer Journal of Pain and Symptom Management 10:1–8
Schwartz, C. E., Sprangers, M. A. (1999). Methodological approaches for assessing response shift in longitudinal health-related quality-of-life research Social Science and Medicine 48:1531–48
Sprangers, M. A., Van Dam, F. S., Broersen, J. et al. (1999). Revealing response shift in longitudinal research on fatigue — the use of the thentest approach Acta Oncologica 38:709–18
Reise, this volume, Chapter 21
Wilson, this volume, Chapter 23
Hambleton, this volume, Chapter 22
Vail, A., Hornbuckle, J., Spiegelhalter, D. J. et al. (2001). Prospective application of Bayesian monitoring and analysis in an “open” randomized clinical trial Statistics in Medicine 20:3777–87
Cleeland, C. S., Mendoza, T. R., Wang, X. S. et al. (2000). Assessing symptom distress in cancer patients: the M. D. Anderson Symptom Inventory Cancer 89:1634–46
Fairclough, D. L., Fetting, J. H., Cella, D. et al. (1999). Quality of life and quality-adjusted survival for breast cancer patients receiving adjuvant therapy Quality of Life Research 8:723–31
Potosky, A. L., Reeve, B. B., Legler, J. L. et al. (2002). Quality of life following localized prostate cancer treatment initially with androgen deprivation therapy or no therapy Journal of the National Cancer Institute 94:430–9
Stockler, M. R., Osoba, D., Corey, P. et al. (1999). Convergent, discriminative, and predictive validity of the PROSQOLI assessment and comparison with analogous scales from the EORTC QLQ-C30 and a trial-specific module Journal of Clinical Epidemiology 52:653–66
Esper, P., Mo, F., Chodak, G. et al. (1997). Measuring quality of life in men with prostate cancer using the Functional Assessment of Cancer Therapy-Prostate Instrument Urology 50:920–8
Kemmler, G., Holzner, B., Kopp, M. et al. (1999). Comparison of two quality-of-life instruments for cancer patients: the Functional Assessment of Cancer Therapy-General and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30 Journal of Clinical Oncology 17:2932–40
Hakamies-Blomquist, L., Luoma, M., Sjostrom, J. et al. (2000). Quality of life for patients with metastatic breast cancer receiving either docetaxel or sequential methotrexate and 5-fluorouracil. A multi-center randomised phase III trial by the Scandinavian Breast Group European Journal of Cancer 36:1411–17
Moinpour, C. M., Lovato, L. C., Thompson, I. M. et al. (2000). Profile of men randomized to the prostate cancer prevention trial: baseline health-related quality of life, urinary and sexual functioning, and health behaviors Journal of Clinical Oncology 18:1942–53
McLachlan, S.-A., Allenby, A., Matthews, J. et al. (2001). Randomized trial of coordinated psychosocial interventions based on patient self-assessments versus standard care to improve the psychosocial functioning of patients with cancer Journal of Clinical Oncology 19:4117–25
Coates, A. S., Hurny, C., Peterson, H. F. et al. (2000). Quality-of-life scores predict outcome in metastatic but not early breast cancer Journal of Clinical Oncology 18:3768–74
Doyle, C., Crump, M., Pintilie, M. et al. (2001). Does palliative chemotherapy palliate? Evaluation of expectations, outcomes, and costs in women receiving chemotherapy for advanced ovarian cancer Journal of Clinical Oncology 9:1266–74
Zee, B. C. (1998). Growth curve model analysis for quality of life data Statistics in Medicine 17:757–66
Curran, D., Aaronson, N., Standaert, B. et al. (2000). Summary measures and statistics in the analysis of quality of life data: an example from an EORTC-NCIC-SAKK locally advanced breast cancer study European Journal of Cancer 36:834–44
Bernhard, J., Cella, D. F., Coates, A. S. et al. (1998). Missing quality of life data in cancer clinical trials: serious problems and challenges Statistics in Medicine 17:517–32
Madalinska, J. B. et al. (2001). Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer Journal of Clinical Oncology 19:1619–28
Bland, J. M., Altman, D. G. (1995). Comparing two methods of clinical measurement: a personal history International Journal of Epidemiology 24(Suppl.):S7–14
Lee, C. W., Chi, K. N. (2000). The standard of reporting of health-related quality of life in clinical cancer trials Journal of Clinical Epidemiology 53:451–8

Reference Title: REFERENCES

Reference Type: reference-list

Simon, R. (1993). Design and conduct of clinical trials. In Cancer. Principles and Practice of Oncology, (Fourth Edition), ed. V. T. DeVita Jr., S. Hellman, S. Rosenberg, pp. 416–40. Philadelphia, PA: JB Lippincott Co
Warr, D., McKinney, S., Tannock, I. (1984). Influence of measurement error on assessment of response to anticancer chemotherapy: proposal for new criteria of tumor response Journal of Clinical Oncology 2:1041–6
Cook, D. J., Guyatt, G. H., Laupacis, A., Sackett, D. L. (1992). Rules of evidence and clinical recommendation on the use of antithrombotic agents Chest 102 (Suppl. 4):305S–11S
Sackett, D. L. (1993). Rules of evidence and clinical recommendations for the management of patients Canadian Journal of Cardiology 9:487–9
Sackett, D. L., Cook, D. J. (1993). Can we learn anything from small trials? Annals of the New York Academy of Sciences 703:25–31
Franklin, H. R., Simonetti, G. P., Dubbelman, A. C. et al. (1994). Toxicity grading systems. A comparison between the WHO scoring system and the Common Toxicity Criteria when used for nausea and vomiting Annals of Oncology 5:113–17
Karnofsky, D. A., Abelman, W. H., Craver, L. F., Burchenal, J. H. (1948). The use of nitrogen mustards in the palliative treatment of carcinoma Cancer 1:634–56
Zubrod, C. G., Schneiderman, M., Frei, E. III. et al. (1960). Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide Journal of Chronic Diseases 11:7–33
Ware, J. E. Jr., (1991). Measuring functioning, well-being, and other generic health concepts. In Effect of Cancer on Quality of Life, ed. D. Osoba, pp. 7–23. Boca Raton, FL: CRC Press
Slevin, M. L., Plant, H., Lynch, D., Drinkwater, J., Gregory, W. M. (1988). Who should measure quality of life, the doctor or the patient? British Journal of Cancer 57:109–12
Sneeuw, K. C. A., Aaronson, N. K., Sprangers, M. A. G., Detmar, S. B., Wever, L. D. V., Schornagel, J. H. (1998). Comparison of patient and proxy EORTC QLQ-C30 ratings in assessing the quality of life of cancer patients. Journal of Clinical Epidemiology 51:617–31
Osoba, D., Rusthoven, J. J., Turnbull, K. A., Evans, W. K., Shepherd, F. A. (1998). Combination chemotherapy with bleomycin, etoposide, and cisplatin in metastatic non-small-cell lung cancer. Journal of Clinical Oncology 3:1478–85
Stephens, R. J., Hopwood, P., Girling, D. J. (1999). Defining and analysing symptom palliation in cancer clinical trials: a deceptively difficult exercise. British Journal of Cancer 79:533–44
Savage, C., Pater, J. L., Tu, D., Norris, B. (2002). He said/she said: how well do common toxicity criteria and quality of life agree on patient symptoms? Proceedings of the American Society of Clinical Oncology 21:382a (abstract 1540)
Osoba, D. (1991). Measuring the effect of cancer on quality of life. In Effect of Cancer on Quality of Life, ed. D. Osoba, pp. 25–40. Boca Raton, FL: CRC Press
Osoba, D., Aaronson, N. K., Till, J. E. (1999) A practical guide for selecting quality-of-life measures in clinical trials and practice. In Effect of Cancer on Quality of Life, ed. D. Osoba, pp. 89–104. Boca Raton, FL: CRC Press
Guyatt, G. H., Veldhuzen Van Zanten, S. J. O., Feeny, D. H., Patrick, D. L.. (1989). Measuring quality of life in clinical trials: a taxonomy and review. Canadian Medical Association Journal 140:1441–8
Jaeschke, R., Guyatt, G. D., Cook, D. (1992). Quality of life instruments in the evaluation of new drugs. Pharmacoeconomics 1:84–94
Osoba, D. (1995). Measuring the effect of cancer on health-related quality of life Pharmacoeconomics 7:308–19
Mackworth, N., Fobair, P., Prados, M. D. (1992). Quality of life self-reports from 100 brain tumor patients: comparisons with Karnofsky Performance Scores Journal of Neuro-Oncology 14:243–53
Schaafsma, J., Osoba, D. (1994). The Karnofsky performance status scale re-examined: a cross-validation with the EORTC-C30 Quality of Life Research 3:413–24
Hjermstad, M. J., Fayers, P. M., Bjordal, K., Kaasa, S. (1998). Health related quality of life in the general Norwegian population assessed by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire: the QLQ-C30(+3). Journal of Clinical Oncology 16:1188–96
Klee, M., Roenvald, M., Machin, D. (1997). Quality of Life of Danish women: population-based norms for the EORTC QLQ-C30. Quality of Life Research 6:27–34
Michelson, H., Bolund, C., Nilsson, B., Brandberg, Y. (2000). Health-related quality of life measured by the EORTC QLQ-C30 — reference values from a large sample of the Swedish population. Acta Oncologica 39:477–84
Gandek, B., Ware, J. E., Aaronson, N. K. et al. (1998). Tests of data quality, scaling assumptions, and reliability of the SF-36 in eleven countries: results from the IQOLA project. Journal of Clinical Epidemiology 51:1149–58
Fayers, P., Weeden, S., Curran, D. (1998). EORTC QLQ-C30 Reference Values. Brussels: EORTC Quality of Life Study Group, EORTC Data Centre
Allen-Mersch, T. G., Earlam, S., Fordy, C., Abrams, K., Houghton, J. (1994). Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases Lancet 344:1255–60
Clavel, M., Soukop, M., Greenstreet, Y. C. A., (1993). Improved control of emesis and quality of life with ondansetron in breast cancer Oncology 50:180–5
Coates, A., Gebski, V., Bishop, J. F. et al. (1987). Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies. New England Journal of Medicine 317:1490–5
Osoba, D., Brada, M., Yung, W. K. A., Prados, M. (2000). Health-related quality of life in patients treated with temozolomide versus procarbazine for recurrent glioblastoma multiforme. Journal of Clinical Oncology 18:1481–91
Osoba, D., Brada, M., Yung, W. K. A., Prados, M. (2000). Health-related quality of life in patients with anaplastic astrocytoma during treatment with temozolomide. European Journal of Cancer 36:1788–95
Osoba, D., Northfelt, D. W., Budd, D. W., Himmelberger, D. (2001). Effect of treatment on health-related quality of life in AIDS-related Kaposi's sarcoma; a randomized trial of pegylated liposomal doxorubicin versus doxorubicin, bleomycin and vincristine. Cancer Investigation 19:573–80
Murray, N., Livingston, R. B., Shepherd, F. A. et al. (1999). Randomized study of CODE versus alternating CAV/EP for extensive-stage small-cell lung cancer: An intergroup study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology Group. Journal of Clinical Oncology 17:2300–8
Hürny, C., Bernhard, J., Coates, A. S. et al. (1996). Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancer. International Breast Cancer Study Group. Lancet 347:1279–84
Fairclough, D. L., Fetting, J. H., Cella, D., Wonson, W., Moinpour, C. M. (1999). Quality of life and quality adjusted survival for breast cancer patients receiving adjuvant chemotherapy. Eastern Cooperative Oncology Group (ECOG). Quality of Life Research 8:723–31
Osoba, D. (1999). What has been learned from measuring health-related quality of life in clinical oncology. European Journal of Cancer 35:1565–70
Cutler, D. M., Richardson, E. (1997). Measuring the health of the U.S. population. In Brookings Papers on Economic Activity: Microeconomics, ed. M. C. Bailey, P. C. Reiss, C. Winston, pp. 217–71. Washington, DC: Brookings Institute
Osoba, D., Zee, B., Sadura, A., Pater, J., Quirt, I. (1993). Measurement of quality of life in an adjuvant trial of gamma interferon versus levamisole in malignant melanoma. In Adjuvant Therapy of Cancer VII, ed. S. E. Salmon, pp. 412–16. Philadelphia, PA: JB Lippincott Co
Coates, A., Gebski, V., Signorini, D. et al. (1992). Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group. Journal of Clinical Oncology 10:1833–8
Coates, A., Porzsolt, F., Osoba, D. (1997). Quality of life in oncology practice: prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy. European Journal of Cancer 33:1025–30
Coates, A. S., Hürny, C., Peterson, H. F. et al. (2000). Quality-of-life scores predict outcome in metastatic but not early breast cancer. Journal of Clinical Oncology 18:3768–74
Coates, A. S., Thomson, D., McLeod, G. R. M. et al. (1993). Prognostic value of quality of life scores in a trial of chemotherapy with or without interferon in patients with metastatic malignant melanoma. European Journal of Cancer 29A:1731–4
Earlam, S., Glover, C., Fordy, C., Burke, D., Allen-Mersh, T. G. (1996). Relation between tumour size, quality of life, and survival in patients with colorectal liver metastases. Journal of Clinical Oncology 14:171–5
Kaasa, S., Mastekaasa, A., Lund, E. (1989). Prognostic factors for patients with inoperable non-small cell lung cancer, limited disease. Radiotherapy Oncology 15:235–42
Ganz, P. A., Lee, J. J., Siau, J. (1991). Quality of life assessment. An independent prognostic variable for survival in lung cancer. Cancer 67:3131–5
Blazeby, J. M., Brookes, S. T., Alderson, D. (2001). The prognostic value of quality of life scores during treatment for oesophageal cancer. Gut 49:227–30
Dancey, J., Zee, B., Osoba, D. et al. (1997). Quality of life scores: an independent prognostic variable in a general population of cancer patients receiving chemotherapy. Quality of Life Research 6:151–8
Herndon, J. E. Jr.,, Fleishman, S., Kornblith, A. B., Kosty, M., Green, M. R., Holland, J. (1999). Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma? Cancer 85:333–40
Medical Research Council Working Party (1993). A randomized trial of three or six courses of etoposide, cyclophosphamide, methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer. (SCLC) II: quality of life. British Journal of Cancer 68:1157–66
Tannock, I. F., Osoba, D., Stockler, M. R. et al. (1996). Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer; a Canadian randomized trial with palliative end points. Journal of Clinical Oncology 14:1756–64
Osoba, D., Tannock, I. F., Ernst, S., Neville, J. (1999). Health-related quality of life in men with metastatic prostate cancer treated by prednisone alone or mitoxantrone and prednisone. Journal of Clinical Oncology 17:1654–63
Demetri, G. D., Kris, M., Wade, J., Degos, L., Cella, D. (1998). Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Journal of Clinical Oncology 16:3412–25
Rowland, K. M. Jr.,, Loprinzi, C. L., Shaw, E. G. et al. (1996). Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate in extensive-stage small-cell lung cancer: a North Central Cancer Treatment Group Study. Journal of Clinical Oncology 14:135–41
Simons, J. P., Aaronson, N. K., Vansteenkiste, J. F. et al. (1996). Effects of medroxyprogesterone acetate on appetite, weight, and quality of life in advanced-stage non-hormone-sensitive cancer: a placebo-controlled multicentre study. Journal of Clinical Oncology 14:1077–84
Bruera, E., Ernst, S., Hagen, N. et al. (1998). Effectiveness of megestrol acetate in patients with advanced cancer: a randomized, double-blind, crossover study. Cancer Prevention and Control 2:74–8
Porter, A. T., McEwan, A. J. B., Powe, J. E. et al. (1993). Results of a randomized phase III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer. International Journal of Radiation Oncology, Biology, and Physics 25:805–13
Seymour, M. T., Slevin, M. L., Kerr, D. J. et al. (1996). Randomized trial assessing the addition of interferon α-2a to fluorouracil and leucovorin in advanced colorectal cancer. Journal of Clinical Oncology 14:2282–8
Ganz, P. A. (2001). Impact of tamoxifen adjuvant therapy on symptoms, functioning, and quality of life. Journal of the National Cancer Institute Monograph 30:130–4
Moinpour, C. M., Lovato, L. C., Thompson, I. M. et al. (2000). Profile of men randomized to the prostate cancer prevention trial: baseline health-related quality of life, urinary and sexual functioning, and health behaviors. Journal of Clinical Oncology 18:1942–53
Hays, R. D., Anderson, R., Revicki, D. (1993). Psychometric considerations in evaluating health-related quality of life measures. Quality of Life Research 2:441–9
Hays, R. D., Anderson, R. T., Revicki, D. (1998). Assessing reliability and validity of measurement in clinical trials. In Quality of Life Assessment in Clinical Trials, ed. M. J. Staquet, R. D. Hays, P. M. Fayers, pp. 169–23. Oxford: Oxford University Press
Revicki, D. A., Kaplan, R. M. (1993). Relationship between psychometric and utility-based approaches to the measurement of health-related quality of life. Quality of Life Research 2:477–87
Torrance, G. W. (1986). Measurement of health state utilities for economic appraisal. Journal of Health Economics 5:1–30
Torrance, G. W., Feeny, D. (1989). Utilities in quality-adjusted life years. International Journal of Technology Assessment in Health Care 5:559–75
Kaplan, R. M., Feeny, D., Revicki, D. A. (1993). Methods for assessing relative importance in preference based outcome measures. Quality of Life Research 2:467–75
Feeny, this volume, Chapter 4
O'Brien, this volume, Chapter 25
Detmar, S., Muller, M. J., Schornagel, J. H., Wever, L. D., Aaronson, N. K. (2002). The role of health-related quality of life considerations in palliative chemotherapy treatment decisions Journal of Clinical Oncology 20:1056–62
Levine, M. N., Gafni, A., Markham, B., MacFarlane, D. (1992). A bedside decision instrument to elicit a patient's preference concerning adjuvant chemotherapy for breast cancer. Annals of Internal Medicine 117:53–8
Whelan, T. J., Levine, M. N., Gafni, A. et al. (1995). Breast irradiation postlumpectomy: development and evaluation of a decision instrument. Journal of Clinical Oncology 13:847–53
Osoba, D. (2002). A taxonomy of the uses of health-related quality of life (HRQOL) instruments in cancer care and the clinical meaningfulness of the results. Medical Care 40 (Suppl. 3):S31–8
Detmar, S. B., Aaronson, N. K. (1998). Quality of life assessment in daily clinical oncology practice: a feasibility study. European Journal of Cancer 34:1181–6
Velikova, G., Brown, J. M., Smith, A. B., Selby, P. J. (2002). Computer-based quality of life questionnaires may contribute to doctor—patient interactions in oncology. British Journal of Cancer 86:51–9
Murray, C. J. L., Lopez, A. D. (1997). Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 349:1436–42
World Health Organization (2000). The World Health Report 2000: Health Systems: Improving Performance. Geneva: World Health Organization
Goldie, A. J., Kuntz, K. M., Weinstein, M. C., Freedberg, K. A., Palefsky, J. M. (2000). Cost-effectiveness of screening for anal squamous intraepithelial lesions and anal cancer in human immunodeficiency virus-negative homosexual and bisexual men. American Journal of Medicine 108:634–41
Neilson, A. R., Whynes, D. K. (1995). Cost-effectiveness of screening for colorectal cancer: a simulation model. IMA Journal of Mathematically Applied Medical Biology 12:355–67
Norum, J. (2000). Adjuvant cyclophosphamide, methotrexate, fluorouracil (CMF) in breast cancer — is it cost-effective? Acta Oncologica 39:33–9
Brown, M. L, Lipscomb, J., Snyder, C. (2001). The burden of illness in cancer: economic cost and quality of life. Annual Review of Public Health 22:91–113
Lydick, E., Epstein, R. S. (1993). Interpretation of quality of life changes. Quality of Life Research 2:221–6
Osoba, D., Rodrigues, G., Myles, J., Zee, B., Pater, J. (1998). Interpreting the significance of changes in health-related quality-of-life scores. Journal of Clinical Oncology 16:139–44
Bernhard, J., Gelber, R. D., ed. (1998). Workshop on Missing Data in Quality of Life Research in Cancer Clinical Trials: Practical and Methodological Issues. Statistics of Medicine 17:511–796
Fairclough, D. L. (2002). Design and Analysis of Quality of Life Studies in Clinical Trials. Boca Raton, FL: Chapman & Hall/CRC
Sloan, this volume, Chapter 18, pp. 362–85
Cohen, J. (1977). Statistical Power Analysis for the Behavioural Sciences. New York: Academic Press
Kazis, L. E., Anderson, J. J., Meenan, R. F. (1989). Effect sizes for interpreting changes in health status. Medical Care 27 (Suppl. 3):S178–89
King, M. T. (1996). The interpretation of scores from the EORTC Quality of Life Questionnaire QLQ-C30. Quality of Life Research 5:555–67
Jacobson, N. S., Roberts, L. J., Berns, S. B., McGlinchey, J. B. (1999). Methods for defining and determining the clinical significance of treatment effects: description, application and alternatives. Journal of Consulting Clinical Psychology 67:300–7
Salsburg, D. S., Turner, R. S. (1992). Defining clinically meaningful units of change for health outcome research. Quality of Life Newsletter 3:1
Wyrwich, K., Nienaber, N. A., Tierney, W., Wolinsky, F. (1999). Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life. Medical Care 37:469–78
Wyrwich, K., Tierney, W., Wolinsky, F. (1999). Further evidence supporting a SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life. Journal of Clinical Epidemiology 52:861–73
Wyrwich, K. W., Wolinsky, F. G. (2000). Identifying meaningful intra-individual change standards for health-related quality of life measures. Journal of Evaluating Clinical Practice 6:39–45
Jaeschke, R., Singer, J., Guyatt, G. H. (1989). Measurement of health status. Ascertaining the minimal clinically important difference. Controlled Clinical Trials 10:407–15
Juniper, E. D., Guyatt, G. H., Willan, A., Griffith, L. E. (1994). Determining a minimal important change in a disease-specific quality of life questionnaire. Journal of Clinical Epidemiology 47:81–7
Ware, J. E., Keller, S. D. (1996). Interpreting general health measures. In Quality of Life and Pharmacoeconomics in Clinical Trials, ed. B. Spilker, pp. 445–60. Philadelphia, PA: Lippincott-Raven
Guyatt, G., Osoba, D., Wu, A., Wyrwich, K., Norman, G. and the Clinical Significance Consensus Meeting Group (2002). Methods to explain the clinical significance of health status measures. Mayo Clinic Proceedings 77:371–83
Cella, D., Hahn, E., Dineen, K. (2002). Meaningful change in cancer-specific quality of life scores: differences between improvement and worsening. Quality of Life Research 11:207–21
Cohen, R. S., Mount, B. M. (2000). Living with cancer: “Good” days and “bad” days — what produces them? Cancer 89:1854–65
Ringash, G. J., Redelmeier, D. A., O'Sullivan, B., Bezjak, A. A. (1999). Asymmetry of good and bad minimal important differences in quality of life for laryngeal cancer patients. Quality of Life Research 8:604 (abstract 214)
Rodrigues, G., Bezjak, A., Osoba, D. et al. (2000). Measuring patient perception of health-related quality-of-life changes using the Subjective Significance Questionnaire. Quality of Life Research 9:256 (abstract 1404)
Ross, M. (1989). Relation of implicit theories to the construction of personal histories. Psychological Reviews 96:341–7
Norman, G. R., Stratford, P., Regehr, G. (1997). Methodological problems in the retrospective computation of responsiveness to change: the lesson of Cronbach. Journal of Clinical Epidemiology 50:869–79
Sneeuw, K., Muller, M., Aaronson, N. (2000). Interpreting the significance of changes in EORTC QLQ-C30 and COOP/WONCA scores. Quality of Life Research 9:256 (abstract 1416)
Sprangers, M. A. G., Schwartz, C. E. (1999). Integrating response shift into health-related quality of life research: a theoretical model. Social Science and Medicine 48:1507–15
Sprangers, M. A. G., Schwartz, C. E. (1999). The challenge of the response shift for quality-of-life based clinical oncology research (Editorial). Annals of Oncology 10:747–9
Jansen, S. J. T., Stiggelbout, A. M., Nooij, E. M., Noordijk, E. M., Kievit, J. (2000). Response shift in quality of life measurement in early-stage breast cancer patients undergoing radiotherapy. Quality of Life Research 9:603–15
Osoba, D., Brada, M., Prados, M. D., Yung, W. K. A., (2000). Effect of disease burden on health-related quality of life in patients with malignant gliomas. Neuro-Oncology 2: 221–8
Hornbrook, this volume, Chapter 24
Cella, D., Bullinger, M., Scott, C., Gorkin, L., Barofsky, I., and the Clinical Significance Consensus Meeting Group. (2002). Group versus individual approaches to understanding the clinical significance of differences or changes in quality of life. Mayo Clinic Proceedings 77:384–92
Sloan, J. A., Aaronson, N., Cappelleri, J. C., Fairclough, D. L., Varricchio, C., and the Clinical Significance Consensus Meeting Group. (2002). Assessing the clinical significance of single items relative to summated scores. Mayo Clinic Proceedings 77:479–87
Frost, M. H., Bonomi, A. E., Ferrans, C. E., Wong, G. Y., Hays, R. D., and the Clinical Significance Consensus Meeting Group. (2002). Patient, clinician and population perspectives on determining the clinical significance of quality-of-life scores. Mayo Clinic Proceedings 77:488–94
Symonds, T., Berzon, R., Marquis, P., Rummans, T., and the Clinical Significance Consensus Meeting Group (2002). The clinical significance of quality-of-life results: practical considerations for specific audiences. Mayo Clinic Proceedings 77:572–83
Fayers, P., Machin, D. (2000). Quality of Life: Assessment, Analysis and Interpretation. Chichester: John Wiley & Sons
Sprangers, M. A. G., Moinpour, C., Moynihan, T. J., Patrick, D. L., Revicki, D. A., and the Clinical Significance Consensus Meeting Group. (2002). Assessing meaningful change over time in quality of life: a users' guide for clinicians. Mayo Clinic Proceedings 77:561–71
Osoba, D. (1998). Guidelines for measuring health-related quality of life in clinical trials. In Quality of Life Assessment in Clinical Trials, ed. M. J. Staquet, R. D. Hays, P. M. Fayers, pp. 19–35. Oxford: Oxford University Press
Staquet, M., Berzon, R., Osoba, D., Machin, D. (1996). Guidelines for reporting results of quality of life assessments in clinical trials. Quality of Life Research 5:496–502
Guyatt, G. H., Juniper, E. F., Walter, S. D., Griffith, L. E., Goldstein, R. S. (1998). Interpreting treatment effects in randomised trials. British Medical Journal 316:690–3
Nunnally, J. C., Bernstein, I. H. (1994). Psychometric Theory (3rd Edition), pp. 264–5. New York, NY: McGraw-Hill, Inc
Revicki, D. A., Cella, D. F. (1997). Health status assessment for the twenty-first century: item response theory, item banking and computer adaptive testing. Quality of Life Research 6:595–600
Revicki, D. A., Osoba, D., Fairclough, D. et al. (2000). Recommendation on health-related quality of life research to support labeling and promotional claims in the United States. Quality of Life Research 9:887–900
Leidy, N. K., Revicki, D. A., Geneste, B. (1999). Recommendations for evaluating the validity of quality of life claims for labeling and promotion. Value in Health 2:113–27
Ganz, P. A. (1995). Impact of quality of life outcomes on clinical practice. Oncology 9 (Suppl. 11):61–5
Osoba, D., Till, J. E., Pater, J. L., Young, J. R. (1995). Health-related quality of life: measurement and clinical application. A workshop report. Canadian Journal of Oncology 5:338–431

Reference Title: REFERENCES

Reference Type: reference-list

Schipper, H., Clinch, J., McMurray, A. et al. (1984). Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation Journal of Clinical Oncology 2:472–83
Ganz, P. A., Schag, C. A., Lee, J. J. et al. (1992). The CARES: a generic measure of health-related quality of life for patients with cancer Quality of Life Research 1:19–29
Schag, C. A., Ganz, P. A., Heinrich, R. L. (1991). Cancer Rehabilitation Evaluation System—short form (CARES-SF). A cancer specific rehabilitation and quality of life instrument Cancer 68:1406–13
de Haes, J. C., van Knippenberg, F. C., Neijt, J. P. (1990). Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist British Journal of Cancer 62:1034–8
Aaronson, N. K., Ahmedzai, S., Bergman, B. et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology Journal of the National Cancer Institute 85:365–76
Cella, D. F., Tulsky, D. S., Gray, G. et al. (1993). The Functional Assessment of Cancer Therapy scale: development and validation of the general measure Journal of Clinical Oncology 11:570–9
Erickson, this volume, Chapter 3
Clinch, J. (1996). The Functional Living Index-Cancer: ten years later. In Quality of Life and Pharmacoeconomics in Clinical Trials (2nd Edition), ed. B. Spilker, pp. 215–25. New York: Lippincott-Raven
Goh, C. R., Lee, K. S., Tan, T. C. et al. (1996). Measuring quality of life in different cultures: translation of the Functional Living Index for Cancer (FLIC) into Chinese and Malay in Singapore Annals of the Academy of Medicine of Singapore 25:323–34
Eguchi, K., Fukutani, M., Kanazawa, M. et al. (1992). Feasibility study on quality-of-life questionnaires for patients with advanced lung cancer Japanese Journal of Clinical Oncology 22:185–93
Forjaz, M. J., Guarnaccia, C. A. (2001). A comparison of Portuguese and American patients with hematological malignancies: a cross-cultural survey of health-related quality of life Psycho-Oncology 10:251–8
King, M. T., Dobson, A. J., Harnett, P. R. (1996). A comparison of two quality-of-life questionnaires for cancer clinical trials: the functional living index—cancer (FLIC) and the quality of life questionnaire core module (QLQ-C30) Journal of Clinical Epidemiology 49:21–9
Mercier, M., Bonneterre, J., Schraub, S. et al. (1998). The development of a French version of a questionnaire on the quality of life in cancerology (Functional Living Index-Cancer: FLIC) Bulletin du Cancer 85:180–6
Canales, S., Ganz, P. A., Coscarelli, C. A. (1995). Translation and validation of a quality of life instrument for Hispanic American cancer patients: methodological considerations Quality of Life Research 4:3–11
te Velde, A., Sprangers, M. A., Aaronson, N. K. (1996). Feasibility, psychometric performance, and stability across modes of administration of the CARES-SF Annals of Oncology 7:381–90
Rustoen, T., Moum, T., Wiklund, I. et al. (1999). Quality of life in newly diagnosed cancer patients Journal of Advanced Nursing 29:490–8
de Haes, J. C., Olschewski, M. (1998). Quality of life assessment in a cross-cultural context: use of the Rotterdam Symptom Checklist in a multinational randomised trial comparing CMF and Zoladex (Goserlin) treatment in early breast cancer Annals of Oncology 9:745–50
Kramer, J. A., Curran, D., Piccart, M. et al. (2000). Randomised trial of paclitaxel versus doxorubicin as first-line chemotherapy for advanced breast cancer: quality of life evaluation using the EORTC QLQ-C30 and the Rotterdam symptom checklist European Journal of Cancer 36:1488–97
Agra, Y., Badia, X. (1998). Spanish version of the Rotterdam Symptom Check List: cross-cultural adaptation and preliminary validity in a sample of terminal cancer patients Psycho-Oncology 7:229–39
Ravaioli, A., Buda, P., Fava, C. et al. (1996). Assessment of the RSCL quality of life instrument during chemotherapy in an Italian setting Quality of Life Research 5:491–5
Paci, E. (1992). Assessment of validity and clinical application of an Italian version of the Rotterdam Symptom Checklist Quality of Life Research 1:129–34
Fallowfield, L. J. (1995). Assessment of quality of life in breast cancer Acta Oncologica 34:689–94
Ganz, P. A., Desmond, K. A., Leedham, B. et al. (2002). Quality of life in long-term, disease-free survivors of breast cancer; a follow-up study Journal of the National Cancer Institute 94:39–49
Ganz, P. A., Schag, A. C., Lee, J. J. et al. (1992). Breast conservation versus mastectomy. Is there a difference in psychological adjustment or quality of life in the year after surgery? Cancer 69:1729–38
Kiebert, G. M., de Haes, J. C., van de Velde, C. J. (1991). The impact of breast-conserving treatment and mastectomy on the quality of life of early-stage breast cancer patients: a review Journal of Clinical Oncology 9:1059–70
Cull, A., Sprangers, M., Bjordal, K. et al. (2002). EORTC Quality of Life Group Translation Procedures. Brussels: European Organization for Research and Treatment of Cancer
Zhao, H., Kanda, K. (2000). Translation and validation of the standard Chinese version of the EORTC QLQ-C30. Quality of Life Research 9:129–37
Kobayashi, K., Takeda, F., Teramukai, S. et al. (1998). A cross-validation of the European Organization for Research and Treatment of Cancer QLQ-C30 (EORTC QLQ-C30) for Japanese with lung cancer European Journal of Cancer 34:810–5
Petersen, M. A., Groenvold, M., Bjorner, J. et al. (2003). Use of differential item functioning analysis to assess the equivalence of translations of a questionnaire Quality of Life Research 12(4):373–85
Reise, this volume, Chapter 21
Hambleton, this volume, Chapter 22
Apolone, G., Filiberti, A., Cifani, S. et al. (1998). Evaluation of the EORTC QLQ-C30 questionnaire: a comparison with SF-36 Health Survey in a cohort of Italian long-survival cancer patients Annals of Oncology 9:549–57
Arraras, J. I., Arias, F., Tejedor, M. et al. (2002). The EORTC QLQ-C30 (version 3.0) quality of life questionnaire: validation study for Spain with head and neck cancer patients Psycho-Oncology 11:249–56
Kaasa, S., Bjordal, K., Aaronson, N. et al. (1995). The EORTC core quality of life questionnaire (QLQ-C30): validity and reliability when analysed with patients treated with palliative radiotherapy European Journal of Cancer 31A:2260–3
Osoba, D., Zee, B., Pater, J. et al. (1994). Psychometric properties and responsiveness of the EORTC Quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer Quality of Life Research 3:353–64
Ringdal, G. I., Ringdal, K. (1993). Testing the EORTC Quality of Life Questionnaire on cancer patients with heterogeneous diagnoses Quality of Life Research 2:129–40
Ringdal, K., Ringdal, G. I., Kaasa, S. et al. (1999). Assessing the consistency of psychometric properties of the HRQoL scales within the EORTC QLQ-C30 across populations by means of the Mokken Scaling Model Quality of Life Research 8:25–43
McLachlan, S. A., Devins, G. M., Goodwin, P. J. (1999). Factor analysis of the psychosocial items of the EORTC QLQ-C30 in metastatic breast cancer patients participating in a psychosocial intervention study Quality of Life Research 8:311–17
Ford, E. M., Havstad, S. L., Kart, C. S. (2002). Assessing the reliability of the EORTC QLQ-C30 in a sample of older African American and Caucasian adults Quality of Life Research 10:533–41
Hjermstad, M. J., Fayers, P. M., Bjordal, K. et al. (1998). Health-related quality of life in the general Norwegian population assessed by the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire: the QLQ = C30 (+3) Journal of Clinical Oncology 16:1188–96
Schwarz, R., Hinz, A. (2001). Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population European Journal of Cancer 37:1345–51
Gotay, C. C., Holup, J. L., Pagano, I. (2002). Ethnic differences in quality of life among early breast and prostate cancer survivors Psycho-Oncology 11:103–13
Osoba, D., Aaronson, N., Zee, B. et al. (1997). Modification of the EORTC QLQ-C30 (version 2.0) based on content validity and reliability testing in large samples of patients with cancer. The Study Group on Quality of Life of the EORTC and the Symptom Control and Quality of Life Committees of the NCI of Canada Clinical Trials Group. Quality of Life Research 6:103–8
Montazeri, A., Harirchi, I., Vahdani, M. et al. (1999). The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): translation and validation study of the Iranian version Supportive Care in Cancer 7:400–6
Hjermstad, M. J., Fossa, S. D., Bjordal, K. et al. (1995). Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire Journal of Clinical Oncology 13:1249–54
Kemmler, G., Holzner, B., Kopp, M. et al. (1999). Comparison of two quality-of-life instruments for cancer patients: the functional assessment of cancer therapy-general and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30 Journal of Clinical Oncology 17:2932–40
Kopp, M., Schweigkofler, H., Holzner, B. et al. (2000). EORTC QLQ-C30 and FACT-BMT for the measurement of quality of life in bone marrow transplant recipients: a comparison European Journal of Haematology 65:97–103
Groenvold, M., Klee, M. C., Sprangers, M. A. et al. (1997). Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement Journal of Clinical Epidemiology 50:441–50
Klee, M., Groenvold, M., Machin, D. (1997). Quality of life of Danish women: population-based norms of the EORTC QLQ-C30 Quality of Life Research 6:27–34
Michelson, H., Bolund, C., Nilsson, B. et al. (2000). Health-related quality of life measured by the EORTC QLQ-C30—reference values from a large sample of Swedish population Acta Oncologica 39:477–84
Fayers, P., Weeden, S., Curran, D. (1998). EORTC QLQ-C30 Reference Values. Brussels: European Organization for Research and Treatment of Cancer
Bonomi, A. E., Cella, D. F., Hahn, E. A. et al. (1996). Multilingual translation of the Functional Assessment of Cancer Therapy (FACT) quality of life measurement system Quality of Life Research 5:309–20
Lent, L., Hahn, E., Eremenco, S. et al. (1999). Using cross-cultural input to adapt the Functional Assessment of Chronic Illness Therapy (FACIT) scales Acta Oncologica 38:695–702
Cella, D., Hernandez, L., Bonomi, A. E. et al. (1998). Spanish language translation and initial validation of the functional assessment of cancer therapy quality-of-life instrument Medical Care 36:1407–18
Cella, D. F., McCain, N. L., Peterman, A. H. et al. (1996). Development and validation of the Functional Assessment of Human Immunodeficiency Virus Infection (FAHI) quality of life instrument Quality of Life Research 5:450–63
Ward, W. L., Hahn, E. A., Mo, F. et al. (1999). Reliability and validity of the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) quality of life instrument Quality of Life Research 8:181–95
Wan, G. J., Counte, M. A., Cella, D. F. et al. (1999). The impact of socio-cultural and clinical factors on health-related quality of life reports among Hispanic and African-American cancer patients Journal of Outcome Measurement 3:200–15
Dapueto, J. J., Francolino, C., Gotta, I. et al. (2001). Evaluation of the Functional Assessment of Cancer Therapy-General Questionnaire (FACT-G) in a South American Spanish speaking population Psycho-Oncology 10:88–92
Yu, C. L., Fielding, R., Chan, C. L. et al. (2000). Measuring quality of life of Chinese cancer patients: a validation of the Chinese version of the Functional Assessment of Cancer Therapy-General (FACT-G) scale Cancer 88:1715–27
Mullin, V., Cella, D., Chang, C. H. et al. (2000). Development of three African language translations of the FACT-G Quality of Life Research 9:139–49
Pandey, M., Thomas, B. C., Ramdas, K. et al. (2002). Quality of life in breast cancer patients: validation of a FACT-B Malayalam version Quality of Life Research 11:87–90
Fallowfield, L. J., Leaity, S. K., Howell, A. et al. (1999). Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT-B Breast Cancer Research and Treatment 55:189–99
Flaherty, J. A., Gaviria, F. M., Pathak, D. et al. (1988). Developing instruments for cross-cultural psychiatric research Journal of Nervous and Mental Disease 176:257–63
Guillemin, F., Bombardier, C., Beaton, D. (1993). Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines Journal of Clinical Epidemiology 46:1417–32
Hays, R. D., Anderson, R., Revicki, D. (1993). Psychometric considerations in evaluating health-related quality of life measures Quality of Life Research 2:441–9
Herdman, M., Fox-Rushby, J., Badia, X. (1998). A model of equivalence in the cultural adaptation of HRQoL instruments: the universalist approach Quality of Life Research 7:323–35
Hui, C., Triandis, H. C. (1985). Measurement in cross-cultural psychology: a review and comparison of strategies Cross Cultural Psychology 16:131–52
Stewart, A. L., Napoles-Springer, A. (2000). Health-related quality-of-life assessments in diverse population groups in the United States Medical Care 38:II102–24
Cella, D., Chang, C. H., Lai, J. S. et al. (2002). Advances in quality of life measurements in oncology patients Seminars in Oncology 29:60–8
Bjordal, K., Kaasa, S., Mastekaasa, A. (1994). Quality of life in patients treated for head and neck cancer: a follow-up study 7 to 11 years after radiotherapy International Journal of Radiation Oncology, Biology, and Physics 28:847–56
Bjordal, K., de Graeff, A., Fayers, P. M. et al. (2000). A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group. European Journal of Cancer 36:1796–807
McLachlan, S. A., Devins, G. M., Goodwin, P. J. (1998). Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (QLQ-C30) as a measure of psychosocial function in breast cancer patients European Journal of Cancer 34:510–17

Reference Title: REFERENCES

Reference Type: reference-list

McHorney, C. A., Cohen, A. S. (2000). Equating health status measures with item response theory: illustrations with functional status items Medical Care 38:43–59
Ware, J. E., Bjorner, J. B., Kosinski, M. (2000). Practical implications of item response theory and computerized adaptive testing: a brief summary of ongoing studies of widely used headache impact scales Medical Care 38:73–83
Medical Outcomes Trust (1991). Medical Outcomes Trust: Improving Medical Outcomes from the Patient's Point of View. Boston, MA: Medical Outcomes Trust
van der Linden, W. J., Hambleton, R. K. (ed.) (1997). Handbook of Modern Item Response Theory. New York: Springer
Hambleton, this volume, Chapter 22
Wilson, this volume, Chapter 23
McHorney, Cook, this volume, Invited Paper B
Hays, R. D., Morales, L. S. (2001). The RAND-36 measure of health-related quality of life Annals of Medicine 33:350–7
Hays, R. D., Sherbourne, C. D., Mazel, R. M. (1993). The RAND 36-item Health Survey 1.0. Health Economics 2:217–27
Ware, J. E., Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36), conceptual framework and item selection Medical Care 30:473–83
Morales, L. S., Cunningham, W. E., Brown, J. A. et al. (1999). Are Latinos less satisfied with communication by health care providers? Journal of General Internal Medicine 14:409–17
Bock, R. D. (1997). A brief history of item response theory Educational Measurement: Issues and Practice 16:21–33
Lord, F. M. (1980). Applications of Item Response Theory to Practical Testing Problems. Hillsdale, NJ: Lawrence Erlbaum Associates
Wright, B. D. (1997). A history of social science measurement Educational Measurement: Issues and Practice 16:33–45
Rasch, G. (1960). Probabilistic Models for Some Intelligence and Attainment Tests. Copenhagen: Denmarks Paedagogiske Institute
Mellenbergh, G. J. (1994). A unidimensional latent trait model for continuous item responses Multivariate Behavioral Research 29:223–36
Samejima, F. (1969). Estimation of latent ability using a response pattern of graded scores Psychometric Monograph, No. 17
Masters, G. N. (1982). A Rasch model for partial credit scoring Psychometrika 47:149–74
Masters, G. N., Wright, B. D. (1996). The partial credit model. In Handbook of Modern Item Response Theory, ed. W. J. van der Linden, R. K. Hambleton. New York: Springer
Andrich, D. (1978). Application of a psychometric model to ordered categories which are scored with successive integers Applied Psychological Measurement 2:581–94
Muraki, E., Bock, R. D. (1997). PARSCALE: IRT Based Test Scoring and Item Analysis for Graded Open-ended Exercises and Performance Tasks. Chicago: Scientific Software
Cooke, D. J., Michie, C. (1997). An item response theory analysis of the Hare psychopathy checklist — revised Psychological Assessment 9:3–14
Drasgow, F., Parsons, C. (1983). Applications of unidimensional item response theory models to multidimensional data Applied Psychological Measurement 7:189–99
Reckase, M. D. (1979). Unifactor latent trait models applied to multifactor tests: results and implications Journal of Educational Statistics 4:207–30
Hattie, J. (1985). Methodology review: assessing unidimensionality of tests and items Applied Psychological Measurement 9:139–64
Reise, S. P., Waller, N. G. (2001). Dichotomous IRT models. In Advances in Measurement and Data Analysis, ed. F. Drasgow, Schmitt, pp. 88–122. Williamsburg, VA: Jossey-Bass
McLeod, L. D., Swygert, K. A., Thissen, D. (2001). Factor analysis for items scored in two categories. In Test Scoring, ed. D. Thissen, H. Wainer, pp. 141–86. Mahwah, NJ: Lawrence Erlbaum Associates
Waller, N. G. (2000). Micro FACT 2.0 User's Manual. St. Paul, MN: Assessment Systems Corporation
McDonald, R. P. (1981). The dimensionality of tests and items British Journal of Mathematical and Statistical Psychology 34:100–17
Chen, W., Thissen, D. (1997). Local dependence indexes for item pairs using item response theory Journal of Educational and Behavioral Statistics 22:265–89
Yen, W. M. (1984). Effects of local item dependence on the fit and equating performance of the three-parameter logistic model Applied Psychological Measurement 8:125–45
Embretson, S. E., Reise, S. P. (2000). Item Response Theory for Psychologists. Mahwah, NJ: Lawrence Erlbaum Associates
Baker, F. B. (1992). Item Response Theory Parameter Estimation Techniques. New York: Marcel Dekker, Inc
Kingston, N., Dorans, N. (1985). The analysis of item-ability regressions: an exploratory IRT model-fit tool Applied Psychological Measurement 9:281–8
McKinley, R., Mills, C. (1985). A comparison of several goodness-of-fit statistics Applied Psychological Measurement 9:49–57
Hambleton, R. K., Robin, F., Xing, D. (2000). Item response models for the analysis of educational and psychological test data. In H. E. A. Tinsley, S. D. Brown (ed.), Handbook of Applied Multivariate Statistics and Mathematical Modeling, pp. 553–85. San Diego, CA: Academic Press
Orlando, M., Thissen, D. (2000). Likelihood-based item-fit indices for dichotomous item response theory models Applied Psychological Measurement 24:50–64
Rogers, H., Hattie, J. (1987). A Monte Carlo investigation of several person and item-fit statistics for item response models Applied Psychological Measurement 11:47–57
Mislevy, R. J., Bock, R. D. (1989). BILOG 3: Item Analysis and Test Scoring with Binary Logistic Models. Mooresville, IN: Scientific Software
Meijer, R. R., Sijtsma, K. (1995). Detection of aberrant item score patterns: a review of recent developments Applied Measurement in Education 8:261–72
Reise, S. P., Waller, N. G. (1993). Traitedness and the assessment of response pattern scalability Journal of Personality and Social Psychology 65:143–51
Zickar, M. J., Drasgow, F. (1996). Detecting faking on a personality instrument using appropriateness measurement Applied Psychological Measurement 20:71–88
Embretson, S. E. (1996). The new rules of measurement. Psychological Assessment 8:341–9
Cronbach, L. J. (1951). Coefficient alpha and the internal structure of tests Psychometrika 16:297–334
Dodd, B. G., DeAyala, R. J. (1994). Item information as a function of threshold values in the rating scale model. In Objective Measurement: Theory and Practice, ed. M. Wilson, Vol. 2, pp. 201–317. Norwood, NJ: Ablex
Flaugher, R. (2000). Item pools. In Computerized Adaptive Testing: A Primer (2nd Edition), ed. H. Wainer, N. J. Dorans, D. Eignor et al., pp. 37–60. Mahwah, NJ: Lawrence Erlbaum Associates
Orlando, M., Sherbourne, C. D., Thissen, D. (2000). Summed-score linking using item response theory: application to depression measurement Psychological Assessment 12:354–9
Vale, D. C. (1986). Linking item parameters onto a common scale Applied Psychological Measurement 10:133–44
Wainer, H., Eignor, D. (2000). Caveats, pitfalls, and unexpected consequences of implementing large-scale computerized testing. In Computerized Adaptive Testing: A Primer (2nd Edition), H. Wainer, N. J. Dorans, D. Eignor et al., pp. 37–60. Mahwah, NJ: Lawrence Erlbaum Associates
Weiss, D. J. (1985). Adaptive testing by computer Journal of Consulting and Clinical Psychology 53:774–89
Drasgow, F., Olson-Buchanan, J. B. (1999). Innovations in Computerized Assessment. Mahwah, NJ: Lawrence Erlbaum Associates
Wainer, H., Dorans, N. J., Eignor, D. et al. (2000). Computerized Adaptive Testing: A Primer (2nd Edition). Mahwah, NJ: Lawrence Erlbaum Associates
van der Linden, W. J., Glas, C. A. W. (2000). Computerized Aadaptive Testing: Theory and Practice. London: Kluwer Academic Publishers
Bjorner, J. B., Kreiner, S., Ware, J. E. et al. (1998). Differential item functioning in the Danish translation of the SF-36 Journal of Clinical Epidemiology 51:1189–202
Gandek, B., Ware Jr., J. E., Neil, K. A. et al. (1998). Tests of data quality, scaling assumptions, and reliability of the SF-36 in eleven countries: results from the IQOLA project Journal of Clinical Epidemiology 51:1149–58
Millsap, R. E., Everson, H. T. (1993). Methodology review: statistical approaches for assessing measurement bias Applied Psychological Measurement 17:297–334
Zimowski, M. F., Muraki, E., Mislevy, R. J. et al. (1996). BILOG-MG: Multiple-group IRT Analysis and Test Maintenance for Binary Items. Chicago: Scientific Software
Kim, S., Cohen, A. (1998). Detection of differential item functioning under the graded response model with the likelihood ratio test Applied Psychological Measurement 22:345–55
Raju, N. S. (1988). The area between two item characteristic curves Psychometrika 53:495–502
Reise, S. P., Smith, L., Furr, R. M. (2001). Invariance on the NEO PI-R Neuroticism Scale Multivariate Behavioral Research 36:83–110
Thissen, D., Steinberg, L., Gerrard, M. (1986). Beyond group-mean differences: the concept of item bias Psychological Bulletin 99:118–28
Reise, S. P., Widaman, K. F., Pugh, R. H. (1993). Confirmatory factor analysis and item response theory: two approaches for exploring measurement invariance Psychological Bulletin 114:352–66
Holland, P. W., Wainer, H. (1993). Differential Item Functioning. Hillsdale, NJ: Lawrence Erlbaum Associates
Yen, W. M. (1986). The choice of scale for educational measurement: an IRT perspective Journal of Educational Measurement 23:299–325
Thissen, D., Orlando, M. (2001). Item response theory for items scored in two categories. In Test Scoring, ed. D. Thissen, H. Wainer, pp. 73–140. Mahwah, NJ: Lawrence Erlbaum Associates
Cella, D., Chang, C. (2000). A discussion of item response theory and its applications in health status assessment Medical Care 9:66–72
Santor, D. A., Ramsay, J. O. (1998). Progress in the technology of measurement: applications of item response models Psychological Assessment 10:345–59
Embretson, S. E. (1996). Item response theory models and spurious interaction effects in factorial ANOVA designs Applied Psychological Measurement 20:201–12

Reference Title: REFERENCES

Reference Type: reference-list

Reise, this volume, Chapter 21
Ware, J. E., Snyder, M. K., Wright, W. R. (1976). Development and Validation of Scales to Measure Patient Satisfaction with Medical Care Services: Volume I, Part A. Review of Literature, Overview of Methods, and Results Regarding Construction of Scales. NTIS Publication No. PB 288-329. Springfield, VA: National Technical Information Service
Ware, J. E., Snyder, M. K., Wright, W. R. (1976). Development and Validation of Scales to Measure Patient Satisfaction with Medical Care Services: Vol. I, part B. Results Regarding the Construction of the Patient Satisfaction Questionnaire and Measures of Other Health Care Perceptions. NTIS Publication No. PB 288–330. Springfield, VA: National Technical Information Service
Tarlov, A. R., Ware, J. E., Greenfield, S. et al. (1989). Medical outcomes study: an application of methods for evaluating the results of medical care Journal of the American Medical Association 262:907–13
Marshall, G. N., Hays, R. D., Sherbourne, C. D. et al. (1993). The structure of patient satisfaction with outpatient medical care Psychological Assessment 5(4):477–83
Samejima, F. (1969). Estimation of latent ability using a response pattern of graded scores. Psychometrika Monograph 17, Richmond, VA: William Byrd Press
Muraki, E., Bock, R. D. (1993). PARSCALE: IRT-based Test Scoring and Item Analysis for Graded and Open-ended Exercises and Performance Tasks. Chicago: Scientific Software International
Hambleton, R. K. (1989). Principles and selected applications of item response theory. In Educational Measurement, (3rd Edition), ed. R. L. Linn, pp. 147–200. New York: Macmillan
Rogers, H. J. (1996). POLYFIT [software program]. Amherst, MA: University of Massachusetts School of Education
Embretson, S. E., Reise, S. P. (2000). Item Response Theory for Psychologists. Mahwah, NJ: Lawrence Erlbaum Publishers
Hambleton, R. K., Robin, F., Xing, D. (2000). Item response models for the analysis of educational and psychological test data. In Handbook of Applied Multivariate Statistics and Mathematical Modeling, ed. H. E. A. Tinsley, S. D. Brown, pp. 553–85. San Diego, CA: Academic Press
Hambleton, R. K., Swaminathan, H., Rogers, H. J. (1991). Fundamentals of Item Response Theory. Newbury Park, CA: Sage
Nichol, M. B., Sengupta, N., Globe, D. R. (2001). Evaluating quality-adjusted life years: estimation of the health utility index (HUI2) from the SF-36 Medical Decision Making 21:105–12
Wilson, this volume, Chapter 23
McHorney, Cook, this volume, Invited Paper B

Reference Title: REFERENCES

Reference Type: reference-list

Aaronson, N. K., Ahmedzai, S., Bergman, B. et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology Journal of the National Cancer Institute 85:365–76
Cella, D. F., Tulsky, D. S., Gray, G. et al. (1993). The Functional Assessment of Cancer Therapy scale: development and validation of the general measure Journal of Clinical Oncology 11:570–9
Ware, J. E., Gandek, B. (1998). Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project Journal of Clinical Epidemiology 51:903–12
McHorney, C. A., Ware, J. E., Lu, J. F. R. et al. (1994). The MOS 36-Item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions and reliability across diverse patient groups Medical Care 32(4):40–66
Wilson, M. (2001). On choosing a model for measuring. Paper presented at the International Conference on Objective Measurement 3, Chicago, IL
Masters, G. N., Adams, R. A., Wilson, M. (1990). Charting student progress. In International Encyclopedia of Education: Research and Studies. Supplementary Volume 2, ed. T. Husen, T. N. Postlethwaite, pp. 628–34. Oxford: Pergamon Press
Raczek, A. E., Ware, J. E., Bjorner, J. B. et al. (1998). Comparison of Rasch and summated rating scales constructed from the SF-36 Physical Functioning items in seven countries: Results from the IQOLA Project Journal of Clinical Epidemiology 51:1203–11
Masters, G. N., Wilson, M. (1997). Developmental Assessment. Berkeley Evaluation and Assessment Research Center Research Report. University of California, Berkeley. (see http://bear.soe.berkeley.edu/)
Patton, M. Q. (1980). Qualitative Evaluation Methods. Beverly Hills, CA: Sage
Reise, this volume, Chapter 21
Rasch, G. (1960). Probabilistic Models for Some Intelligence and Attainment Tests. Copenhagen: Danmarks Paedogogiske Institut. [also, 1980 University of Chicago Press, Chicago]
Andrich, D. (1978). A rating formulation for ordered response categories Psychometrika 43:561–73
Masters, G. N. (1981). A Rasch model for partial credit scoring Psychometrika 47:149–74
Samejima, F. (1969). Estimation of Latent Ability Using a Response Pattern of Graded Scores. Psychometrika Monograph Supplement No. 17
Hambleton, R. K., Swaminathan, H., Rogers, H. J. (1991). Fundamentals of Item Response Theory. Newbury Park: Sage
Hambleton, this volume, Chapter 22
American Educational Research Association, American Psychological Association, National Council for Measurement in Education. (1999). Standards for Educational and Psychological Testing. Washington, DC: American Educational Research Association
Reckase, M. D. (1972). Development and Application of a Multivariate Logistic Latent Trait Model. Unpublished doctoral dissertation, Syracuse University, Syracuse, NY
Sympson, J. B. (1978). A model for testing with multidimensional items. In Proceedings of the 1977 Computerized Adaptive Testing Conference, ed. D. J. Weiss, pp. 82–98. Minneapolis: University of Minnesota, Dept. of Psychology, Psychometric Methods Program
Adams, R. J., Wilson, M. (1995). Formulating the Rasch model as a mixed coefficients multinomial logit. In Objective Measurement: Theory into Practice. Volume III, ed. G. Engelhard & M. Wilson, pp. 143–66. Norwood, NJ: Ablex
Adams, R., Wilson, M., Wang, W. (1997). The multidimensional random coefficient multinomial logit model Applied Psychological Measurement 21(1):1–23
Davey, T., Hirsch, T. M. (1991). Concurrent and consecutive estimates of examinee ability profiles. Paper presented at the Annual Meeting of the Psychometric Society, New Brunswick, NJ
Briggs, D. C., Wilson, M. (2003). An introduction to multidimensional measurement using Rasch models Journal of Applied Measurement 4(1):87–100
Wang, W. (2000). Direct estimation of correlations among latent traits within IRT Framework. MPR-online 4(1) 47–70. (http://www.mpr-online.de/)
Wang, W., Wilson, M. (1996). Comparing open-ended items and performance-based items using item response modeling. In Objective Measurement: Theory into Practice, Volume III, ed. G. Engelhard, M. Wilson pp. 167–94. Norwood, NJ: Ablex
Wang, W., Wilson, M., Adams, R. J. (1997). Rasch models for multidimensionality between and within items. In Objective Measurement: Theory into Practice, Volume IV, ed. M. Wilson, G. Engelhard, K. Draney, pp. 139–56. Norwood, NJ: Ablex
Wang, W., Wilson, M., Adams, R. J. (1998). Measuring individual differences in change with Rasch models Journal of Outcome Measurement 2(3):240–65
Wu, M., Adams, R. J., Wilson, M. (1998). ACERConQuest. Hawthorn, Australia: ACER Press
Paek, I., Peres, D., Wilson, M. (2002). Constructing one scale to describe two statewide exams. Paper presented at the International Objective Measurement Workshop, New Orleans, LA
Brady, M. J., Cella, D. F., Mo, F. et al. Reliability and validity of the Functional Assessment of Cancer Therapy — Breast Quality of Life Instrument Journal of Clinical Oncology 15:974–86
Feeny, this volume, Chapter 4
Muthén, L. K., Muthén, B. O. (1998). M-Plus User's Guide. Los Angeles: Muthén & Muthén
Muthén, B. O., Khoo, S. T. (1998). Longitudinal studies of achievement growth using latent variable modeling Learning and Individual Differences, Special issue: Latent growth curve analysis 10:73–101
SAS Institute Inc. (1999). SAS OnlineDoc (Version 8) [software manual on CD-ROM]. Cary, NC: SAS Institute Inc
Pellegrino, J., Glaser, R., Chudowsky, N. (ed.) (2001). Knowing What Students Know: The Science and Design of Educational Assessment. Washington, DC: National Academy Press
De Boeck, P., Wilson, M. (2004). Explanatory Item Response Models. New York: Springer-Verlag

Reference Title: REFERENCES

Reference Type: reference-list

Hodgson, T. A., Meiners, M. R. (1982). Cost of illness methodology: a guide to current practices and procedures Milbank Memorial Fund Quarterly/Health and Society 60(3):429–62
Hodgson, T. A. (1983). The state of the art of cost-of-illness estimates Advances in Health Economics and Health Service Research 4:129–64
Rice, D. P., Hodgson, T. A., Kopstein, A. N. (1985). The economic costs of illness: a replication and update Health Care Financing Review 7(1):61–80
Hodgson, T. A. (1994). Costs of illness in cost-effectiveness analysis. A review of the methodology Pharmacoeconomics 6:536–52
Gold, M. R., Siegel, J. E., Russell, L. B. et al. (1996). Cost-Effectiveness in Health and Medicine. New York: Oxford University Press
Drummond, M. F., O'Brien, B., Stoddart, G. L. et al. (1997). Methods for the Economic Evaluation of Health Care Programmes, (2nd Edition). Oxford: Oxford University Press
Rice, D. P., Hodgson, T. A. (1981). Social and economic implications of cancer in the United States Vital and Health Statistics, Series 3 20:1–43
Brown, M. L. (1990). The national economic burden of cancer: an update Journal of the National Cancer Institute 82(23):1811–14
Evans, W. K., Will, B. P., Berthelot, J. M. et al. (1995). The cost of managing lung cancer in Canada Oncology (Huntington) 9(11 Suppl):147–53
Schuette, H. L., Tucker, T. C., Brown, M. L. et al. (1995). The costs of cancer care in the United States: implications for action Oncology (Huntington) 9(11 Suppl):19–22
Brown, M. L., Lipscomb, J., Snyder, C. (2001). The burden of illness of cancer: economic cost and quality of life Annual Review of Public Health 22:91–113
Koopmanschap, M. A., van Roijen, L., Bonneux, L. et al. (1994). Current and future costs of cancer European Journal of Cancer 30A(1):60–5
Gross, C. P., Anderson, G. F., Powe, N. R. (1999). The relation between funding by the National Institutes of Health and the burden of disease New England Journal of Medicine 17;340(24):1881–7
Forbes, J. F. (1997). The incidence of breast cancer: the global burden, public health considerations Seminars in Oncology 24(1 Suppl. 1):S20–35
Young, T. K., Kliewer, E., Blanchard, J. et al. (2000). Monitoring disease burden and preventive behavior with data linkage: cervical cancer among aboriginal people in Manitoba, Canada American Journal of Public Health 90(9):1466–8
Wunsch-Filho, V., de Camargo, E. A. (2001). The burden of mouth cancer in Latin America and the Caribbean: epidemiologic issues Seminars in Oncology 28(2):158–68
Merrill, R. M., Weed, D. L. (2001). Measuring the public health burden of cancer in the United States through lifetime and age-conditional risk estimates Annals of Epidemiology 8:547–53
Satcher, D. (2001). The unequal burden of cancer Cancer 91(1 Suppl.):205–7
Longman, A. J., Braden, C. J., Mishel, M. H. (1996). Side effects burden in women with breast cancer Cancer Practice 4(5):274–80
Longman, A. J., Braden, C. J., Mishel, M. H. (1999). Side-effects burden, psychological adjustment, and life quality in women with breast cancer: pattern of association over time Oncology Nursing Forum 26(5):909–15
Mandelblatt, J. S., Bierman, A. S., Gold, K. et al. (2001). Constructs of burden of illness in older patients with breast cancer: a comparison of measurement methods Health Services Research 36(6 Pt 1):1085–107
Nijboer, C., Tempelaar, R., Sanderman, R. et al. (1998). Cancer and caregiving: the impact on the caregiver's health Psycho-Oncology 7(1):3–13
Munkres, A., Oberst, M. T., Hughes, S. H. (1992). Appraisal of illness, symptom distress, self-care burden, and mood states in patients receiving chemotherapy for initial and recurrent cancer Oncology Nursing Forum 19(8):1201–9
Luce, B. R., Manning, W. G., Siegel, J. E. et al. (1996). Estimating costs in cost-effectiveness analysis. In Cost Effectiveness in Health and Medicine, ed. M. Gold, J. E. Siegel, L. B. Russell, M. C. Weinstein, pp. 176–213. New York: Cambridge University Press
Ubel, P. A. (2000). Pricing Life. Cambridge, MA: MIT Press
Ubel, P. A., Richardson, J., Menzel, P. (2000). Societal value, the person trade-off, and the dilemma of whose values to measure for cost-effectiveness analysis Health Economics 9:127–36
National Heart, Lung, and Blood Institute. Fact Book for Fiscal Year 2002. Bethesda, MD, 2002. Available at: http://www.nhlbi.nih.gov/about/02factbk.pdf. Last accessed on September 12, 2004
Max, W., Rice, D. P., Sung, H. Y. et al. (2002). The economic burden of prostate cancer, California, 1998 Cancer 94(11):2906–13
Seifeldin, R., Hantsch, J. J. (1999). The economic burden associated with colon cancer in the United States Clinical Therapeutics 21(8):1370–9
Evans, W. K. (1998). Cost-effectiveness of vinorelbine alone or vinorelbine plus cisplatin for stage IV NSCLC Oncology (Huntington) 12(3, Suppl. 4):18–25
Wirt, D. P., Giles, F. J., Oken, M. M. et al. (2001). Cost-effectiveness of interferon alfa-2b added to chemotherapy for high-tumor follicular non-Hodgkin's lymphoma Leukemia and Lymphoma 40(5–6):565–79
Ramsey, S. D., Moinpour, C. M., Lovato, L. C. et al. (2002). Economic analysis of vinorelbine plus cisplatin versus paclitaxel plus carboplatin for advanced non-small-cell lung cancer Journal of the National Cancer Institute 94(4):291–7
Du, W., Touchette, D., Vaitkevicius, V. K. et al. (2000). Cost analysis of pancreatic carcinoma treatment Cancer 89(9):1917–24
Warren, J. L., Brown, M. L., Fay, M. P. et al. (2002). Costs of treatment for elderly women with early-stage breast cancer in fee-for-service settings Journal of Clinical Oncology 20(1):307–16
Brown, M. L., Riley, G. F., Potosky, A. L. et al. (1999). Obtaining long-term disease specific costs of care: application to Medicare enrollees diagnosed with rectal cancer Medical Care 37(12):1249–59
Fireman, B. H., Quesenberry, C. P., Somkin, C. P. et al. (1997). Cost of care for cancer in a health maintenance organization Health Care Financing Review 18(4):51–76
Taplin, S. H., Barlow, W., Urban, N. et al. (1995). Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care. Journal of the National Cancer Institute 87(6):417–26
Hodgson, T. A., Cohen, A. J. (1999). Medical care expenditures for selected circulatory diseases: opportunities for reducing national health expenditures Medical Care 37 (11):994–1012
Etzioni, R., Urban, N., Baker, M. (1996). Estimating the costs attributable to a disease with application to ovarian cancer Journal of Clinical Epidemiology 49:95–103
Etzioni, R., Ramsey, S. D., Berry, K. et al. (2001). The impact of including medical care costs when estimating the costs attributable to a disease: a colorectal cancer case study Health Economics 10:245–56
Hornbrook, M. C., Hurtado, A. V., Johnson, R. E. (1985). Health care episodes: definition, measurement and use Medical Care Review 42:163–218
Hornbrook, M. C. (1995). Definition and measurement of episodes of care in clinical and economic studies. In Cost Analysis Methodology for Clinical Practice Guidelines Conference Proceedings, ed. M. L. Grady, K. A. Weis, AHCPR Publication No. 95–0001, pp. 15–40. Rockville, MD: US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research
Steinwachs, D. M. (1992). Episode of care framework: utility for medical effectiveness research. Medical Effectiveness Research Data Methods, M. Grady, ed. AHCPR Publication No. 92–0056. Rockville, MD: US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research
Rosen, A. K., Mayer-Oakes, A. (1998). Developing a tool for analyzing medical care utilization of adult asthma patients on indemnity and managed care plans: can an episode of care framework be used? American Journal of Medical Quality 13(4):203–12
Rosen, A. K., Houchens, R. L., Gibson, T. B. et al. (1998). Developing episodes of care for adult asthma patients: a cautionary tale American Journal of Medical Quality 13(1):25–35
Rosen, A. K., Mayer-Oakes, A. (1999). Episodes of care: theoretical frameworks versus current operational realities Joint Commission Journal of Quality Improvement 25(3):111–28
Ettner, S. L., Hermann, R., Tang, H. (1999). Differences between generalists and mental health specialists in the psychiatric treatment of Medicare beneficiaries Health Services Research 34:737–60
Ward, M. M., Javitz, H. S., Smith, W. M. et al. (2000). A comparison of three approaches for attributing hospitalizations to specific diseases in cost analyses International Journal of Technology Assessment in Health Care 16(1):125–36
Weed, L. J. (1968). Medical records that guide and teach New England Journal of Medicine 278(11):593–600
Weed, L. J. (1971). The problem oriented record as a basic tool in medical education, patient care and clinical research Annals of Clinical Research 3(3):131–4
Reinstein, L. (1977). Problem-oriented medical record: experience in 238 rehabilitation institutions Archives of Physical Medicine and Rehabilitation 58(9):398–401
Fernow, L. A., Mackie, C., McColl, I. et al. (1978). The effect of problem-oriented medical records on clinical management controlled for patient risks Medical Care 16(6):476–87
Lloyd, S. C. (1984). Computer-generated progress notes in an automated POMR Journal of Medical Systems 8(102):35–42
Hornbrook, M. C., Goodman, M. J., Fishman, P. A. et al. (1998). Health-based payment and computerized patient record systems Effective Clinical Practice 1(2):66–72
Hornbrook, M. C., Goodman, M. J., Fishman, P. A. et al. (1998). Building health plan databases to risk-adjust outcomes and payments International Journal for Quality in Health Care 10(6):531–8
DiGianni, L. M., Garber, J. E., Winer, E. P. (2002). Complementary and alternative medicine use among women with breast cancer Journal of Clinical Oncology 20(18 Suppl.):34S–8S
Medical Economics Staff (2002). 200 Red Book. Montvale, NJ: Thomsen Medical Economics. Inc. See http://www.medec.com/html/products/productdetail/redbook.html, last accessed March 21, 2003
Physician Payment Review Commission (1990). Annual Report to Congress 1990. Washingon, DC: US Government Printing Office
Birenbaum, L. K., Clarke-Steffen, L. (1992). Terminal care costs in childhood cancer Pediatric Nursing 18(3):285–8
Moore, K. (1998). Out-of-pocket expenditures of outpatients receiving chemotherapy Oncology Nursing Forum 25(9):1615–20
Agency for Healthcare Research & Quality. Medical Expenditure Panel Survey. Available at http://www.ahrq.gov/data/mepsix.htm. Last accessed on September 12, 2004
Friedman, B., De La Mare, J., Andrews, R. et al. (2002). Practical options for estimating cost of hospital inpatient stays Journal of Health Care Finance 29:1–13
Hsiao, W. C., Braun, P., Dunn, D. L. et al. (1992). An overview of the development and refinement of the Resource-Based Relative Value Scale. The foundation for reform of U.S. physician payment Medical Care 30(11 Suppl.):NS1–12
Berlin, M. F., Faber, B. P., Berlin, L. M. et al. (1997). RVU costing applications Healthcare Financial Management 51(11):73–4, 76
Grimaldi, P. L. (2002). Medicare fees for physician services are resource-based Journal of Health Care Finance 28(3):88–104
Bronstein, J. M., Adams, E. K. (2002).Rural-urban differences in health risks, resource use and expenditures within three state Medicaid programs: implications for Medicaid managed care Journal of Rural Health 18(1):38–48
Fries, B. E., Schneider, D. P., Foley, W. J. et al. (1989). Case-mix classification of Medicare residents in skilled nursing facilities: resource utilization groups (RUG-T18) Medical Care 27(9):843–58
Fries, B. E. (1990). Comparing case-mix systems for nursing home payment Health Care Financing Review 11(4):103–19
Fries, B. E., Schneider, D. P., Foley, W. J. et al. (1994). Refining a case-mix measure for nursing homes: resource utilization groups (RUG-III) Medical Care 32(7):668–85
Carpenter, G. I., Main, A., Turner, G. F. (1995). Casemix for the elderly inpatient: resource utilization groups (RUGs) validation project. Casemix for the Elderly Inpatient Working Group Age and Ageing 24(1):5–13
Loeve, F., Brown, M. L., Boer, R. et al. (2000). Endoscopic colorectal cancer screening: a cost-saving analysis Journal of the National Cancer Institute 92(7):557–63
Tsao, H., Rogers, G. S., Sober, A. J. (1998). An estimate of the annual direct cost of treating cutaneous melanoma Journal of the American Academy of Dermatology 38(5 Pt 1):669–80
Grover, S. A., Coupal, L., Zowall, H. et al. (2000). The clinical burden of prostate cancer in Canada: forecasts from the Montreal Prostate Cancer Model Canadian Medical Association Journal 162(7):977–83
O'Brien, this volume, Chapter 25
Fairclough, this volume, Chapter 17
Miller, L. L., Hornbrook, M. C., Archbold, P. G. et al. (1996). Development of use and cost measures in a nursing intervention for family caregivers and frail elderly patients Research in Nursing and Health 19(4):273–85
Chochinov, H. M., Kristjanson, L. (1998). Dying to pay: the cost of end-of-life care Journal of Palliative Care 14(4):5–15
Emanuel, E. J., Fairclough, D. L., Slutsman, J. et al. (2000). Understanding economic and other burdens of terminal illness: the experience of patients and their caregivers Annals of Internal Medicine 132(6):451–9
Arno, P. S., Levine, C., Memmott, M. M. (1999). The economic value of informal caregiving Health Affairs (Millwood) 18(2):182–8
Hayman, J. A., Langa, K. M., Kabeto, M. U. et al. (2001). Estimating the cost of informal caregiving for elderly patients with cancer Journal of Clinical Oncology 19(13):3219–25
Harrow, B. S., Tennstedt, S. L., McKinlay, J. B. (1995). How costly is it to care for disabled elders in a community setting? Gerontologist 35(6):803–13
Goldman, D. P., Schoenbaum, M. L., Potosky, A. L. et al. (2001). Measuring the incremental cost of clinical cancer research Journal of Clinical Oncology 19(1):105–10
Hahn, R. W. (ed.). Risks, Costs, and Lives Saved: Getting Better Results from Regulation. New York: Oxford University Press
McGarity, T. O., Ruttenberg, R. (1997). Counting the cost of health, safety, and environmental regulation Texas Law Review 80:1997–2058
Harrington, W., Morgenstern, R. D. (2000). On the accuracy of regulatory cost estimates Journal of Policy Analysis and Management 19:297–318
Morganstern, R. D., Pizer, W. A., Shih, J. S. (2001). The cost of environmental protection The Review of Economics and Statistics 83:732–8
Joshi, S., Krishnan, R., Lave, L. (2001). Estimating the hidden costs of environmental regulation The Accounting Review 76:171–98
Freeman, A. M. (2002). Environmental policy since earth day I: what do we know about the benefits and costs? Agricultural and Resource Economics Review 31:1–14
Feeny, this volume, Chapter 4
Murphy, K. M., Topel, R. H. (2003). The Economic Value of Medical Research. In Exceptional Returns: the Economic Value of America's Investment in Medical Research, ed. R. H. Topel, K. M. Murphy. Chicago, IL: University of Chicago Press
Nord, E. (1999). Cost-value Analysis in Health Care. Cambridge: Cambridge University Press
Nord, E., Pinto, J. L., Richardson, J. et al. (1999). Incorporating societal concerns for fairness in numerical valuations of health programmes Health Economics 8:25–39
Harberger, A. C. (1978). On the use of distributional weights in social cost—benefit analysis Journal of Political Economy 86(2), Part 2, S87–S120
Boardman, A. E., Greenberg, D. H., Vining, A. R. et al. (1996). Cost—Benefit Analysis: Concepts and Practice, pp. 37–47. Prentice Hall, Upper Saddle River, NJ

Reference Title: REFERENCES

Reference Type: reference-list

Woden, A. C. T. (1990). Guidelines for the pharmaceutical industry on preparation of submissions to the Pharmaceutical Benefits Advisory Committee: including submissions involving economic analysis. Commonwealth of Australia: Department of Health, Housing and Community Services
Ontario Ministry of Health (1994). Ontario Guidelines for Economic Analysis of Pharmaceutical Products. Toronto: Drug Programs Branch
Sculpher, M., Drummond, M., O'Brien, B. (2001). Effectiveness, efficiency and NICE British Medical Journal 322(7292):943–4
Gold, M. R., Siegel, J. E., Russell, L. B. et al. (1996). Cost-effectiveness in Health and Medicine. Oxford: Oxford University Press
National Institute for Clinical Excellence (2000). Guidance on the Use of Taxanes for the Treatment of Breast Cancer. Technology Appraisal No. 6
Drummond, M. F., O'Brien, B. J., Stoddart, G. L. et al. (1997). Methods for Economic Evaluation of Health Care Programmes (2nd Edition). Oxford: Oxford University Press
Schulman, K., Glick, H., Yabroff, R. et al. (1995). Introduction to clinical economics: assessment of cancer therapies Journal of the National Cancer Institute Monographs 19:1–9
National Cancer Institute and American Society of Clinical Oncology (1998). Integrating economic analysis into cancer clinical trials: The National Cancer Institute — American Society of Clinical Oncology economics workbook Journal of the National Cancer Institute Monographs 24:1–28
Briggs, A. H., O'Brien, B. J. (2001). The death of cost-minimisation analysis? Health Economics 10:179–84
Pashko, S., Johnson, D. H. (1992). Potential cost savings of oral versus intravenous etoposide in the treatment of small cell lung cancer Pharmacoeconomics 1:293–7
Jaakkimainen, L., Goodwin, P., Pater, J. et al. (1990). Counting the costs of chemotherapy in a National Cancer Institute of Canada randomized trial in non-small cell lung cancer Journal of Clinical Oncology 8(8):1301–9
Feeny, this volume, Chapter 4
Hayman, J. A., Hillner, B. E., Harris, J. et al. (1998). Cost-effectiveness of routine radiation therapy following conservative surgery for early-stage breast cancer Journal of Clinical Oncology 16(3):1022–9
Weeks, J. (1996). Taking quality of life into account in health economic analyses Journal of the National Cancer Institute Monographs 20:23–7
Earle, C. C., Chapman, R. H., Baker, C. S. et al. (2000). Systematic overview of cost-utility assessments in oncology Journal of Clinical Oncology 18(18):3302–17
O'Brien, B., Gafni, A. (1996). When do the “dollars” make sense? Toward a conceptual framework for contingent valuation studies in health care Medical Decision Making 16:288–9
Diener, A., O'Brien, B., Gafni, A. (1998). Health care contingent valuation studies: a review and classification of the literature Health Economics 7:313–26
Ortega, A., Dranitsaris, G., Puodziunas, A. L. (1998). What are cancer patients willing to pay for prophylactic epoetin alfa? Cancer 83:2588–96
O'Brien, B., Goeree, R., Gafni, A. et al. (1998). Assessing the value of a new pharmaceutical: a feasibility study of contingent valuation in managed care Medical Care 36(370):384
Petitti, D. B. (1994). Meta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis: Methods for Quantitative Synthesis in Medicine. New York: Oxford University Press
Weinstein, M. C., Fineberg, H. V., Elstein, A. S. et al. (1980). Clinical Decision Analysis. Philadelphia: W.B. Saunders Company
Marshall, D. A., Simpson, K. N., Earle, C. C. et al. (2001). Economic decision analysis model of screening for lung cancer European Journal of Cancer 37:1759–67
Detsky, A. S. (1989). Are clinical trials a cost-effective investment Journal of the American Medical Association 262:1795–800
Naglie, G., Krahn, M. D., Naimark, D. et al. (1997). Primer on medical decision analysis: Part 2 — Estimating probabilities and utilities Medical Decision Making 17:136–41
Naimark, D., Krahn, M. D., Naglie, G. et al. (1997). Primer on medical decision analysis: Part 5 — Working with Markov processes Medical Decision Making 17:152–9
Sonnenberg, F. A., Beck, J. R. (1993). Markov models in medical decision making: a practical guide Medical Decision Making 13:322–38
Briggs, A. H., Sculpher, M. J. (1998). An introduction to Markov modelling for economic evaluation Pharmacoeconomics 13(4):397–409
Hillner, B. E., Smith, T. J. (1991). Efficacy and cost-effectiveness of adjuvant chemotherapy in women with node-negative breast cancer New England Journal of Medicine 324:160–8
Weinstein, M. C., O'Brien, B., Hornberger, J. et al. for the ISPOR Task Force on Good Research Practices — Modeling Studies (2003). Principles of good practice for decision analytic modeling in health-care evaluation. Value in Health 6(1):9–17
United States General Accounting Office (1992). Cross Design Synthesis: A New Strategy for Medical Effectiveness Research, pp. 1–121, Washington, DC: General Accounting Office/PEMD-92-18
Sculpher, M., Fenwick, E., Claxton, K. (2000). Assessing quality in decision analytic cost-effectiveness models Pharmacoeconomics 17:461–77
Brennan, A., Akehurst, R. (2000). Modeling in health economic evaluation. What is its place? What is its value? Pharmacoeconomics 17(5):445–9
Weinstein, M., Toy, E. L., Sandberg, E. A. et al. (2001). Modeling for health care and other policy decisions: uses, roles, and validity Value in Health 4(5):348–61
McCabe, C., Dixon, S. (2000). Testing the validity of cost-effectiveness models Pharmacoeconomics 17(5):501–13
Grover, S. A., Coupal, L., Zowall, H. et al. (2000). The economic burden of prostate cancer in Canada: forecasts from the Montreal Prostate Cancer Model Canadian Medical Association Journal 162(7):987–92
Drummond, M. (1995). Economic analysis alongside clinical trials: practical considerations Journal of Rheumatology 22:1418–19
Bennett, C. L., Golub, R., Waters, T. M. et al. (1997). Economic analyses of Phase II Cooperative Cancer Group clinical trials: are they feasible? Cancer Investigation 15(3):227–36
Bennett, C. L., Waters, T. M. (1997). Economic analyses in clinical trials for cooperative groups: operational considerations Cancer Investigation 15(5):448–53
Schulman, K., Dorsainvil, D., Yabroff, K. R. et al. (1998). Prospective economic evaluation accompanying a trial of GM-CSF/IL-3 in patients undergoing autologous bone marrow transplantation for Hodgkin's and non-Hodgkin's lymphoma. IL-3 BMT Study Team Bone Marrow Transplantation 21(6):607–14
O'Brien, B. (1996). Economic evaluation of pharmaceuticals: Frankenstein's monster or vampire of trials? Medical Care 34(12):DS99–DS108
Buxton, M. J., Drummond, M. F., van Hout, B. A. et al. (1996). Modelling in economic evaluation: an unavoidable fact of life Health Economics 6:217–27
Slamon, D. J., Leyland, J., Shak, S. et al. (2001). Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2 New England Journal of Medicine 344(11):783–92
Bucher, H. C., Guyatt, G. H., Griffith, L. E. et al. (1997). The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials Journal of Clinical Epidemiology 50(6):683–91
Freemantle, N., Drummond, M. (1997). Should clinical trials with concurrent economic analyses be blinded? Journal of the American Medical Association 277(21):1677
Ness, R. M., Holmes, A. M., Klein, R. et al. (2000). Cost-utility of one-time colonoscopic screening for colorectal cancer at various ages American Journal of Gastroenterology 95(7):1800–11
Pharoah, P., Freemantle, N., Mason, J. (1998). Economic benefit analysis of primary prevention with pravastatin. Modelling economic benefits after such long term treatment is inappropriate British Medical Journal 316(7139):1241–2
Eddy, D. M., Hasselblad, V., Shachter, R. (1990). An introduction to a Bayesian method for meta-analysis — the confidence profile method Medical Decision Making 10:15–23
Briggs, A. H. (2000). Handling uncertainty in cost-effectiveness models Pharmacoeconomics 17(5):479–500
Briggs, A., Sculpher, M., Buxton, M. (1994). Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis Health Economics 3(2):95–104
Doubilet, P., Begg, C. B., Weinstein, M. C. et al. (1985). Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach Medical Decision Making 5(2):157–77
Briggs, A. H., O'Brien, B. J., Blackhouse, G. (2002). Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies Annual Review of Public Health 23:377–401
Briggs, A. H., Goeree, R., Blackhouse, G. et al. (2002). Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease Medical Decision Making 22(4):290–308
Briggs, A. H., Wonderling, D. E., Mooney, C. Z. (1997). Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation Health Economics 6(4):327–40
Willan, A., O'Brien, B. J. (1996). Confidence intervals for cost-effectiveness ratios in clinical trials: A new method using Fieller's Theorem Health Economics 5:297–305
Willan, A. R., O'Brien, B. J. (1999). Sample size and power issues in estimating incremental cost-effectiveness ratios from clinical trials data Health Economics 8(3):203–11
Stinnett, A. A., Mullahy, J. (1998). Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis Medical Decision Making 18(Suppl.):S65–80
Stinnett, A. A., Paltiel, A. D. (1997). Estimating CE ratios under second-order uncertainty: the mean ratio versus the ratio of means Medical Decision Making 17(4):483–9
Tambour, M., Zethraus, N., Johannesson, M. (1998). A note on confidence intervals in cost-effectiveness analysis International Journal of Technology Assessment in Health Care 14:467–71
Hornberger, J. (2001). Introduction to Bayesian reasoning International Journal of Technology Assessment in Health Care 17(1):9–16
Spiegelhalter, D. J., Myles, J. P., Jones, D. R. et al. (2000). Bayesian methods in health technology assessment: a review Health Technology Assessment 4(38):1–129
Gelman, A., Carlin, J. B., Stern, H. S. et al. (1995). Bayesian Data Analysis. London: Chapman & Hall
Claxton, K. (1999). The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies Journal of Health Economics 18(3):341–64
Zivin, J. G. (2001). Cost-effectiveness analysis with risk aversion Health Economics 10(6):499–508
O'Brien, B. J. (2000). Building uncertainty into cost-effectiveness rankings: portfolio risk-return tradeoffs and implications for decision rules Medical Care 38(5):460–8
Felli, J. C., Hazen, G. B. (1998). Sensitivity analysis and the expected value of perfect information Medical Decision Making 18(1):95–109
Claxton, K., Neumann, P. J., Araki, S. et al. (2000). Bayesian value-of-information analysis. An application to a policy model of Alzheimer's disease International Journal of Technology Assessment in Health Care 17(1):38–55
Claxton, K., Neumann, P. J., Araki, S. et al. (2001). Bayesian value-of-information analysis. An application to a policy model of Alzheimer's disease International Journal of Technology Assessment in Health Care 17(1):38–55
Hirth, R. A., Chernew, M. E., Miller, E. et al. (2000). Willingness-to-pay for Quality-Adjusted Life Year: In search of a standard Medical Decision Making 20:332–42

Reference Title: REFERENCES

Reference Type: reference-list

Sloan, this volume, Chapter 18
O'Brien, this volume, Chapter 25
Reise, this volume, Chapter 21
National Cancer Policy Board, Institute of Medicine (1999). Ensuring Quality Cancer Care, ed. M. Hewitt, J. V. Simone. Washington, DC: National Academy Press
National Cancer Policy Board, Institute of Medicine (2000). Enhancing Data Systems to Improve the Quality of Cancer Care, ed. M. Hewitt, J. V. Simone. Washington, DC: National Academy Press
National Cancer Institute. “Surveillance, Epidemiology, and End Results (SEER) Program.” Available at http://seer.cancer.gov. Last accessed September 9, 2004
Centers for Disease Control and Prevention. “National Program of Cancer Registries.” Available at http://www.cdc.gov/cancer/npcr/. Last accessed September 9, 2004
Commission on Cancer, American College of Surgeons. “National Cancer Data Base (NCDB).” Available at http://www.facs.org/dept/cancer/ncdb/. Last accessed September 9, 2004
National Cancer Institute. “SEER Pattern of Care/Quality of Care Studies.” Available at http://www.healthservices.cancer.gov/surveys/poc. Last accessed September 9, 2004
National Cancer Institute. “Rapid Response Surveillance Studies.” Available at http://outcomes.cancer.gov/methods/quality/seer-rrss.html. Last accessed September 9, 2004
Potosky, A. L., Harlan, L. C., Stanford, J. L. et al. (1999). Prostate cancer practice patterns and quality of life: the Prostate Cancer Outcomes Study Journal of the National Cancer Institute 91(20):1719–24
National Cancer Institute. “SEER-Medicare Linked Data Base.” Available at http://healthservices.cancer.gov/seermedicare/. Last accessed September 9, 2004
Edge, S. B., Fritz, A., Clutter, G. G. et al. (1999). A unified cancer stage collection system: preliminary report from the Collaborative Stage Task Force/American Joint Committee on Cancer Journal of Registry Management 26(2):57–61
Ayanian, J. Z., Zaslavsky, A. M., Fuchs, C. F. et al. (2003). Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort Journal of Clinical Oncology 21:1293–300
Hillner, B., McDonald, K., Desch, C. et al. (1998). A comparison of patterns of care of nonsmall cell lung carcinoma patients in a younger and Medigap commercially insured cohort Cancer 83(9):1930–7
Surveillance Implementation Group (1999). Cancer Surveillance Research Implementation Plan. National Cancer Institute, National Institutes of Health. Available at http://dccps.nci.nih.gov/DCCPS/SIG. Last accessed September 9, 2004
National Cancer Institute. “Breast and Ovarian Cancer Family Registries.” Available at http://epi.grants.cancer.gov/BCFR/index.html. Last accessed on April 26, 2003
National Cancer Institute. “Colon Cancer Family Registries.” Available at http://epi.grants.cancer.gov/CCFR/index.html. Last accessed on April 26, 2003
Gilda Radner Familial Ovarian Cancer Registry (located at Roswell Park Cancer Institute, Buffalo, NY). Available at http://www.ovariancancer.com/. Last accessed on April 26, 2003
Ballard-Barbash, R., Taplin, S. H., Yankaskas, B. C. et al. (1997). Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database American Journal of Radiology 169:1001–8
Bach, P. B., Cramer, L. D., Warren, J. L. et al. (1999). Racial differences in the treatment of early-stage lung cancer New England Journal of Medicine 341(16):1198–205
Schrag, D., Cramer, L. D., Bach, P. B. et al. (2001). Age and adjuvant chemotherapy use after surgery for stage II colon cancer Journal of the National Cancer Institute 93(11):850–7
Warren, J. L., Feuer, E., Potosky, A. L. et al. (1999). Use of Medicare hospital and physician data to assess breast cancer incidence Medical Care 37(5):445–56
Cooper, G. S., Yuan, Z., Stange, K. C. et al. (1999). The utility of Medicare claims data for measuring cancer stage Medical Care 37(7):706–11
Bradley, C. J., Given, C. W., Robert, C. (2002). Race, socioeconomic status, and breast cancer treatment and survival Journal of the National Cancer Institute 94(7):490–6
McKee, M. D., Cropp, M. D., Hyland, A. et al. (2002). Provider case volume and outcome in the evaluation and treatment of patients with mammogram-detected breast carcinoma Cancer 95:704–12
Doebbeling, B. N., Wyant, D. K., McCoy, K. D. et al. (1999). Linked insurance-tumor registry database for health services research Medical Care 37(11):1105–15
CyberAtlas Staff. “U.S. doctors behind in adoption of electronic records.” Harris Interactive. Available at http://cyberatlas.internet.com/markets/healthcare/article/0,10110_897031,00.html. Last accessed September 9, 2004
U.S. Department of Veterans Affairs. “Information about VIReC (VA Information Resource Center).” Available at http://www1.va.gov/hsrd/fr/loi/virec.htm. Last accessed September 9, 2004
Etzioni, R., Urban, N., Baker, M. (1996). Estimating the costs attributable to a disease with application to ovarian cancer Journal of Clinical Epidemiology 49(1):95–103
Donaldson, M. S. (2004). Taking stock of health-related quality-of-life measurement in oncology practice in the United States. Journal of the National Cancer Institute Monograph 33:155–67
Rehm, S., Kraft, S. (2001). Electronic medical records: the FPM vendor survey Family Practice Management 8:45–54
Centers for Medicare & Medicaid Services (DHHS). “MedQuest.” Available at http://cms.hhs.gov/medquest. Last accessed September 9, 2004
Ayanian, J. Z., Chrischilles, E. A., Wallace, R. B. et al. (2004). Understanding cancer treatment and outcomes: the Cancer Care Outcomes Research and Surveillance Consortium. Journal of Clinical Oncology 22:2992–6
Board on Health Care Services, Institute of Medicine (2003). Key Capabilities of an Electronic Health Record System, Board on Health Care Services. Washington, DC: National Academy Press
National Cancer Institute. “What is the Health Interview Survey?”. Available at http://appliedresearch.cancer.gov/surveys/nhis/ Last accessed on September 4, 2004
Freedman, A. N., Graubard, B. I., Rao, S. R. et al. (2003). Estimates of the number of U.S. women who could benefit from Tamoxifen for breast cancer chemoprevention Journal of the National Cancer Institute 95:526–32
National Cancer Institute. “What is the California Health Interview Survey?” Available at http:/appliedresearch.cancer.gov/surveys/chis/. Last accessed September 9, 2004
Centers for Disease Control and Prevention. “Behavioral Risk Factor Surveillance System.” Available at http://www.cdc.gov/brfss/. Last accessed on September 27, 2004
National Center for Health Statistics. “National Health and Nutrition Examination.” Available at http://www.cdc.gov/nchs/nhanes/htm. Last accessed September 9, 2004
National Cancer Institute. “What Is the TUS-CPS?” Available at http://riskfactor.cancer.gov/studies/tus-cps/. Last accessed on September 9, 2004
Centers for Medicare & Medicaid Services. “Medicare Health Outcomes Survey.” Available at http://cms.hhs.gov/surveys/hos/. Last accessed September 9, 2004
Baker, F., Haffer, S. C., Denniston, M. (2003). Health-related quality of life of cancer and noncancer patients in Medicare managed care Cancer 97:674–81
Goldstein, E., Cleary, P. D., Langwell, K. M. et al. (2001). Medicare managed care CAHPS®: a tool for performance improvement Health Care Financing Review 22(3):101–7
Darby, this volume, Chapter 14
Ganz, Goodwin, this volume, Chapter 5
Moinpour, Provenzale, this volume, Chapter 8
Earle, Weeks, this volume, Chapter 7
Litwin, Talcott, this volume, Chapter 6
Zebrack, Cella, this volume, Chapter 11
Ferrell, this volume, Chapter 12
Snyder, this volume, Chapter 16
Feeny, this volume, Chapter 4
Erickson, this volume, Chapter 3
Gustafson, this volume, Chapter 15
National Cancer Institute. “What is the Health, Eating, Activity, and Lifestyle (HEAL) Study?” Available at http://appliedresearch.cancer.gov/surveys/heal. Last accessed on September 9, 2004
American Cancer Society. Research Program and Funding — Behavioral Research Center. Available at http://www.cancer.org/docroot/RES/RES_0.asp. Last accessed on September 27, 2004
National Cancer Institute. A pilot evaluation of the Consumer Assessment of Health Plans instrument in a cancer population. Available at http://outcomes.cancer.gov/methods/quality/seer_rrss.html. Last accessed on September 13, 2004
Center for Demographic Studies (Duke University). “The National Long Term Care Survey (NLTCS).” Available at http://www.nltcs.eds.duke.edu/index.htm. Last accessed September 9, 2004
National Cancer Institute. “What is the Physician Survey on Cancer Susceptibility Testing?” Available at http://riskfactor.cancer.gov/studies/physician/. Last accessed September 9, 2004
National Cancer Institute. “National Survey of Colorectal Cancer Screening Practices.” Available at http://healthservices.cancer.gov/surveys/colorectal/. Last accessed September 9, 2004
Sickles, E. A., Wolverton, D. E., Dee, K. E. (2002). Performance parameters for screening and diagnostic mammography: specialist and general radiologists Radiology 224:861–9
Brown, M. L., Fintor, L. (1995). The use of mobile units to deliver screening mammography services in the United States: results from the National Survey of Mammography Facilities Radiology 195:529–32
National Center for Health Statistics. “National Hospital Discharge Survey Description.” Available at http://www.cdc.gov/nchs/about/major/hdasd/nhdsdes.htm. Last accessed September 9, 2004
Agency for Healthcare Research and Quality. “Healthcare Cost and Utilization Project (HCUP): 1988–2000: a Federal-State Industry Partnership in Health Data.” Available at http://www.ahrq.gov/data/hcup/. Last accessed September 9, 2004
Quality Resource Systems, Inc. “The Area Resource File System” (maintained under contract from the Bureau of Health Professions, U.S. Health Resources and Services Administration). Available at http://www.arfsys.com/. Last accessed September 9, 2004
National Center for Health Statistics. “What is the National Ambulatory Medical Care Survey?” Available at http://www.cdc.gov/namcs/. Last accessed September 9, 2004
Agency for Healthcare Research and Quality. “Medical Expenditure Panel Survey (MEPS).” Available at http://www.meps.ahrq.gov. Last accessed September 9, 2004
Centers for Medicare & Medicaid Services. “Medicare Current Beneficiary Survey: Overview.” Available at http://www.cms.hhs.gov/MCBS/default.asp. Last accessed September 9, 2004
Thorpe, K. E., Howard, D. (2003). Health insurance and spending among cancer patients. Health Affairs. Available at http://www.healthaffairs.org/WebExclusives.php and also summarized in volume 22, number 3 (May/June):12
Centers for Medicare & Medicaid Services. “The Minimum Data Set 2.0.” Information Site. Available at http://www.cms.hhs.gov/medicaid/mds20/. Last accessed September 9, 2004
Centers for Medicare & Medicaid Services. “OASIS Overview.” Available at http://www.cms.hhs.gov/oasis/hho.view.asp. Last accessed on September 9, 2004
Institute for Social Research, University of Michigan. “Study of Assets and Health Dynamics Among the Oldest Old (AHEAD). Available at http://hrsonline.isr.umich.edu/. Last accessed September 9, 2004
Soldo, B. J., Hurd, M. D., Rodgers, W. L. et al. (1997). Asset and Health Dynamics among the oldest old: an overview of the AHEAD Study Journal of Gerontology B: Psychological Science and Social Science 52B:1–20
Hayman, J. A., Langa, K. M., Kabeto, M. U. et al. (2001). Estimating the cost of informal caregiving for elderly patients with cancer Journal of Clinical Oncology 19:3219–25
Hornbrook, this volume, Chapter 24
Willis, Reeve, Barofsky, this volume, Invited Paper C
Selby, J. V. (1997). Linking automated databases for research in managed care settings Annals of Internal Medicine 127:719–24
Wagner, E. H., Thompson, R. S. (1988). Cancer prevention and HMOs Cancer Investigation 6(4):453–9
Hartmann, L. C., Schaid, D. J., Woods, J. E. et al. (1999). Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer New England Journal of Medicine 340(2):77–84
U.S. Indian Health Service. “EHR Overview, Site Planning and Schedule.” Available at http://www.ihs.gov/generalweb/webapps/ehr/save/index.asp. Last accessed September 9, 2004
U.S. Department of Veterans Affairs. “Quality Enhancement Research Initiative,” available at http://www1.va.hsrd/research/queri/ and “Colorectal Cancer Quality Enhancement Research Initiative,” http://www.hsrd.minneapolis.med.va.gov/CRC/CRCHome.asp. Last accessed on July 5, 2003
Schneider, E. C., Epstein, A. M., Malin, J. L. et al. (2004). Developing a system to assess the quality of cancer care: ASCO's National Initiative on Cancer Care Quality. Journal of Clinical Oncology 22:2985–91
National Cancer Institute. “Breast Cancer Surveillance Consortium.” Available at http://breastscreening.cancer.gov. Last accessed on September 9, 2004
National Cancer Institute. “HMO Cancer Research Network.” Available at http://crn.cancer.gov. Last accessed September 9, 2004
National Comprehensive Cancer Network. “Oncology Outcomes Database.” Available at http://www.nccn.org/professionals/outcomes_database.asp. Last accessed September 9, 2004
National Cancer Institute. “Cancer Therapy Evaluation Program.” Available at http://CTEP.cancer.gov. Last accessed September 9, 2004
National Cancer Institute. “Community Clinical Oncology Program.” Available at http://www3.cancer.gov/prevention/ccop/. Last accessed September 9, 2004
Day, R., Ganz, P. A., Costantino, J. P. et al. (1999). Health-related quality of life and tamoxifen in breast cancer prevention: a report from the National Surgical Adjuvant Breast and Bowel Project P-1 Study Journal of Clinical Oncology 17(9):2659–69
Schink, J. C., Weller, E., Harris, L. S. et al. (2001). Outpatient taxol and carboplatin chemotherapy for suboptimally debulked epithelial carcinoma of the ovary results in improved quality of life: an Eastern Cooperative Group phase II study (E2E93) Cancer Journal 7(2):155–64
Cella, D., Eton, D. T., Fairclough, D. L. et al. (2002). What is clinically meaningful change (CMC) on the Functional Assessment of Cancer Therapy — Lung (FACT-L) questionnaire? An analysis of data from ECOG 5592 Journal of Clinical Epidemiology 55:286–95
Wenzel, L. B., Donnelly, J. P., Fowler, J. M. et al. (2002). Resilience, reflection, and residual stress in ovarian cancer survivorship: a Gynecologic Oncology Group study Psycho-Oncology 11:142–53
Gotay, C. C., Moinpour, C. M., Moody-Thomas, S. et al. (2000). Behavioral science research in the cooperative group setting: the Southwest Oncology Group experience Journal of the National Cancer Institute 92:1381–7
Hutchins, L. F., Unger, J. M., Crowley, J. J. et al. (1999). Underrepresentation of patients 65 years of age or older in cancer-treatment trials New England Journal of Medicine 341(27):2061–7
National Cancer Institute. “Policies and Guidelines Relating to the Cancer-Center Support Grant.” Available at http://www3.cancer.gov/cancercenters/ccsg_comp_pt1_1to2.html. Last accessed September 9, 2004
National Cancer Institute. “The Nation's Investment in Cancer Research: A Plan and Budget Proposal for Fiscal Year 2005.” Available at http://plan.cancer.gov. Last accessed on September 13, 2004
Agency for Healthcare Research and Quality. “Primary Care Practice-Based Research Networks: Fact Sheet.” Available at http://www.ahrq.gov/research/pbrnfact.htm. Last accessed on September 9, 2004
Agency for Healthcare Research and Quality. “Integrated Delivery System Research Network (IDSRN): Field Partnerships to Conduct and Use Research.” Available at http://www.ahrq.gov/research/dsrn.htm. Last accessed September 9, 2004
U.S. Office of Civil Rights. “Office for Civil Rights — HIPAA. Medical Privacy — National Standards to Protect the Privacy of Personal Health Information.” Available at http://www.hhs.gov/ocr/hipaa. Last accessed on September 9, 2004
National Institutes of Health. “Protecting Personal Health Information in Research: Understanding the HIPAA Privacy Rule.” Available at http://privacyruleandresearch.nih.gov. Last accessed on September 9, 2004

Reference Title: REFERENCES

Reference Type: reference-list

Barofsky, I., Sugarbaker, P. (1990). Cancer. In Quality of Life Assessments in Clinical Trials, ed. B. Spilker, pp. 419–40. New York: Raven
Karnofsky, D., Abelman, W., Craver, L. et al. (1948). The use of the nitrogen mustards in the palliative treatment of carcinoma Cancer 1:634–56
Kiebert, G., Curran, D., Aaronson, N. (1998). Quality of life as an endpoint in EORTC clinical trials Statistics in Medicine 17:561–9
Litwin, Talcott, this volume, Chapter 6
Ganz, Goodwin, this volume, Chapter 5
Moinpour, Provenzale, this volume, Chapter 8
Earle, Weeks, this volume, Chapter 7
Osoba, this volume, Chapter 19
Leidy, N., Revicki, D., Geneste, B. (1999). Recommendations for evaluating the validity of quality of life claims for labeling and promotion Value in Health 2:113–27
Revicki, D., Osoba, D., Fairclough, D. et al. (2000). Recommendations on health-related quality of life research to support labeling and promotional claims in the United States Quality of Life Research 9:887–900
Johnson, J. R., Temple, R. (1985). Food and Drug Administration requirements for approval of new anticancer drugs Cancer Treatment Reports 69:1155–7
Beitz, J. (1999). Quality-of-life end points in oncology drug trials Oncology 13:1439–42
F-D-C Reports. (2002). Oncologic NDA approval standards: FDA asks “what stands behind” response rate. Pink Sheet 64:34–5
American Society for Clinical Oncology (1996). Outcomes of cancer treatment for technology assessment and cancer treatment guidelines Journal of Clinical Oncology 14:671–9
Berzon, R. (1998). Understanding and using health-related quality of life instruments within clinical research studies. In Quality of Life Assessment in Clinical Trials: Methods and Practice, ed. M. Staquet, R. Hays, P. Fayers, pp. 3–18. New York: Oxford University Press
Revicki, D. A. (2000). The added value of health-related quality of life evidence: is safety and efficacy enough? Presented at the annual meeting of the International Society for Quality of Life Research, Vancouver, British Columbia, Canada
Food and Drug Administration (1998). Guidance for Industry: Fast Track Drug Development Programs — Designation, Development and Application Review. Available at: http://www.fda.gov/cder/guidance. Accessed September 9, 2004
Aaronson, N., Cull, A., Kaasa, S. et al. (1996). The European Organization for Research and Treatment of Cancer (EORTC) modular approach to quality of life assessments in oncology: an update. In Quality of Life and Pharmacoeconomics in Clinical Trials (2nd Edition), ed. B. Spilker, pp. 179–90. Philadelphia, PA: Lippincott-Raven
Cella, D., Bonomi, A. (1996). The Functional Assessment of Cancer Therapy (FACT) and Functional Assessment of HIV Infection (FAHI) quality of life measurement system. In Quality of Life and Pharmacoeconomics in Clinical Trials, (2nd Edition), ed. B. Spilker, pp. 203–14. Philadelphia, PA: Lippincott-Raven
Clinch, J. J. (1996). The Functional Living Index-Cancer: ten years later. In Quality of Life and Pharmacoeconomics in Clinical Trials, (2nd Edition), ed. B. Spilker, pp. 215–25. Philadelphia, PA: Lippincott-Raven
Padilla, G., Grant, M., Ferrell, B., Presant, C. (1996). Quality of Life-Cancer. In Quality of Life and Pharmacoeconomics in Clinical Trials, (2nd Edition), ed. B. Spilker, pp. 301–8. Philadelphia, PA: Lippincott-Raven
Osoba, D. (1999). What has been learned from measuring health-related quality of life in clinical oncology? European Journal of Cancer 35:1565–70
Osoba, D. (1999). Quality of life instruments in oncology European Journal of Cancer 35:1571–80
McCabe, M. S., Shoemaker, D., Temple, R. J. et al. (1996). Regulatory perspectives on quality of life issues. In Quality of Life and Pharmacoeconomics in Clinical Trials, (2nd Edition), ed. B. Spilker, pp. 569–74. Philadelphia, PA: Lippincott-Raven
Beitz, J., Gnecco, C., Justice, R. (1996). Quality of life endpoints in cancer clinical trials Journal of the National Cancer Institute Monographs 20:7–9
Bergner, M. (1989). Quality of life, health status, and clinical research Medical Care 27(Suppl.):S148–56
Ferrans, this volume, Chapter 2
Patrick, D. L., Erickson, P. (1993). Health Status and Health Policy. New York: Oxford University Press
Schipper, H., Clinch, J. J., Olweny, C. L. (1996). Quality of life studies: definitions and conceptual issues. In Quality of Life and Pharmacoeconomics in Clinical Trials, (2nd Edition), ed. B. Spilker, pp. 11–24. Philadelphia, PA: Lippincott-Raven
World Health Organization (1958). The First Ten Years of the World Health Organization. Geneva: World Health Organization
Cella, D., Tulsky, D. (1990). Measuring quality of life today: methodological aspects Oncology 5:29–38
Gill, T. M., Feinstein, A. R. (1994). A critical appraisal of the quality of quality-of-life measurements Journal of the American Medical Association 272:619–26
Leplege, A., Hunt, S. (1997). The problem of quality of life in medicine Journal of the American Medical Association 278:47–50
Acquadro, C., Berzon, R., Leidy, N. K. et al. for the PRO Harmonization Group (2004). Incorporating the patient's perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001. Value in Health 6(5):522–31
Food and Drug Administration Modernization Act, 1997. Available at: http://www.fda.gov/cder/guidance. Accessed September 9, 2004
Smith, N. D. (1993). Quality of life studies from the perspective of an FDA reviewing statistician Drug Information Journal 27:617–23
Food and Drug Administration. (2000). Guidance to Industry: Content and Format of the Adverse Reactions Section of Labeling for Human Prescription Drugs and Biologics. Available at: http://www.fda.gov/cder/guidance. Accessed September 9, 2004
Morris, L. A., Miller, D. (2002). The regulation of patient reported outcome claims: need for a flexible standard Value in Health 5:372–81
Burke, L. B. (2000). Acceptable evidence for pharmaceutical advertising and labeling. Presented at Drug Information Association Workshop on Pharmacoeconomic and Quality of Life Labeling and Marketing Claims. New Orleans, Louisiana
Federal Trade Commission. (1984). Policy statement regarding Advertising Substantiation Program Federal Register 49(50):30999–1001
Santanello, N. C., Baker, D., Cappelleri, J. C. et al. (2002). Regulatory issues for health-related quality of life — PhRMA Health Outcomes Committee Workshop, 1999 Value in Health 5:14–25
Revicki, D. A., Rothman, M., Luce, B. (1992). Health-related quality of life assessment and the pharmaceutical industry Pharmacoeconomics 1:394–408
National Institutes of Health Consensus Development Panel. (2001). National Institutes of Health Consensus Development Conference Statement: Adjuvant therapy for breast cancer, November 1–3 Journal of the National Cancer Institute 93:979–89
Morris, L. A., Beckett, T., Lechter, K. (1996). A marketing perspective: theoretical underpinnings. In Quality of Life and Pharmacoeconomics in Clinical Trials, (2nd Edition), ed. B. Spilker, pp. 541–8. Philadelphia, PA: Lippincott-Raven
Jack, W. (1991). Pharmaceutical differentiation through quality of life measurement: a case study Journal of Pharmaceutical Marketing Management 10:33–53
Burke, L. B. (2000). Regulatory issues in the use of patient reported outcomes in drug labeling and advertising. Presented at the Health-Related Quality of Life Workshop. Rockville, MD: Center for Drug Evaluation and Research, Food and Drug Administration
Camptosar (Irinotecan hydrochloride) Injection Package Insert. Kalamazoo, MI: Pharmacia & Upjohn Company, 2000
Cunningham, D. C., Pyrhonen, S., James, R. D. et al. (1998). Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer Lancet 352:1413–18
Rougier, P., Van Cutsem, E., Bajetta, E. et al. (1998). Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer Lancet 352:1407–12
Casodex®(Bicalutamide tablets) Package Insert. Wilmington, DE: AstraZeneca Pharmaceuticals, 2000
Schellhammer, P., Sharifi, R., Block, N. et al. (1996). Maximal androgen blockade for patients with metastatic prostate cancer: outcome of a controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy. Casodex Combination Study Group Urology 47(1A Suppl):54–60
Schellhammer, P., Sharifi, R., Block, N. et al. (1995). A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate cancer Casodex Combination Study Group. Urology 45:745–52
Gemzar (Gemcitabine HCI) for Injection Package Insert. Indianapolis, IN: Eli Lilly and Company, 1998
Cardenal, F., Lopez-Cabrerizo, M. P., Anton, A. et al. (1999). Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer Journal of Clinical Oncology 17:12–18
Sandler, A. B., Nemunaitis, J., Denham, C. et al. (2000). Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer Journal of Clinical Oncology 18:122–30
Navelbine (vinorelbine tartrate) Injection Package Insert. Research Triangle Park, NC: GlaxoWellcome Inc., 2000
LeChavalier, T., Brisgand, D., Douillard, J. Y. et al. (1994). Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients Journal of Clinical Oncology 12:360–7
Wozniak, A. J., Crowley, J. L., Balcerzak, S. P. et al. (1998). Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group Study Journal of Clinical Oncology 16:2459–65
Crawford, J., O'Rourke, M., Schiller, J. H. et al. (1996). Randomized trial of vinorelbine compared with flourouracil plus leucovorin in patients with stage IV non-small-cell lung cancer Journal of Clinical Oncology 14:2774–84
Taxol® (paclitaxel) Injection Package Insert. Princeton, NJ: Bristol-Myers Squibb Co., 2000
Bonomi, P., Kim, K. M., Fairclough, D. et al. (2000). Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial Journal of Clinical Oncology 18:623–31
Giaccone, G., Splinter, T. A. W., Debruyne, C. et al. (1998). Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer Journal of Clinical Oncology 16:2133–41
Thyrogen (thyrotropin alfa) for Injection Package Insert. Cambridge, MA: Genzyme Corporation, 1999
Haugen, B. R., Pacini, F., Reiners, C. et al. (1999). A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer Journal of Clinical Epidemiology and Metabolism 81:3877–85
Ladenson, P. W., Braverman, L. E., Mazzaferri, E. L. et al. (1997). Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma New England Journal of Medicine 337:888–95
Aredia (pamidronate disodium) for Injection Package Insert. East Hanover, NJ: Novartis Pharmaceutical Co., 1999
Theriault, R. L., Lipton, A., Hortobagyi, G. N. et al. (1999). Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: a randomized, placebo-controlled trial Journal of Clinical Oncology 17:846–54
Hortobagyi, G. N., Theriault, R. L., Lipton, A. et al. (1998).Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate Journal of Clinical Oncology 16:2038–44
King, M. T. (1996). The interpretation of scores from the EORTC Quality of Life Questionnaire QLQ-C30 Quality of Life Research 5:555–67
Tannock, I. F., Osoba, D., Stockler, M. R. et al. (1996). Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points Journal of Clinical Oncology 14:1756–64
Osoba, D., Tannock, I. F., Ernst, S. et al. (1999). Health-related quality of life in men with metastatic prostate cancer treated by prednisone alone or mitoxantrone and prednisone Journal of Clinical Oncology 17:1654–63
Demetri, G. D., Kris, M., Wade, J. et al. (1998). Quality-of-life benefit in chemotherapy patients treated with epoetin alpha is independent of disease response or tumor type: results from a prospective community oncology study Journal of Clinical Oncology 16:3412–25
Rowland, K. M., Loprinzi, C. L., Shaw, E. G. et al. (1996). Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate in extensive-stage small-cell lung cancer: a North Central Cancer Treatment Group study Journal of Clinical Oncology 14:135–41
Simons, J. P. F., Aaronson, N. K., Vansteenkiste, J. F. et al. (1996). Effects of medroxyprogesterone acetate on appetite, weight, and quality of life in advanced-stage non-hormone-sensitive cancer: a placebo-controlled multicentre study Journal of Clinical Oncology 14:1077–84
Bruera, E., Ernst, S., Hagen, N. et al. (1998). Effectiveness of megestrol acetate in patients with advanced cancer: a randomized, double-blind, crossover study Cancer Prevention and Control 2:74–8
Medical Research Council Working Party (1993). A randomized trial of three or six courses of etoposide, cyclophosphamide, methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer. II: quality of life British Journal of Cancer 68:1157–66
Osoba, D., Brada, M., Yung, W. K. et al. (2000). Health-related quality of life in patients treated with temozolomide versus procarbazine for recurrent glioblastoma multiforme Journal of Clinical Oncology 18:1481–91
Osoba, D., Brada, M., Yung, W. K. et al. (2000). Health-related quality of life in patients with anaplastic astrocytoma during treatment with temozolomide European Journal of Cancer 36:1788–95
Seymour, M. T., Slevin, M. L., Kerr, D. J. et al. (1996). Randomized trial assessing the addition of interferon alpa-2a to flourouracil and leucovorin in advanced colorectal cancer Journal of Clinical Oncology 14:2282–8
Osoba, D., Northfelt, D. W., Budd, D. W. et al. (2001). Effect of treatment on health-related quality of life in AIDS-related Kaposi's sarcoma: a randomized trial of pegylated liposomal doxorubicin versus doxorubicin, bleomycin and vincristine Cancer Investigation 19:573–80
Coates, A., Gebski, V., Bishop, J. F. et al. (1987). Improving the quality of life during chemotherapy for advanced breast cancer: a comparison of intermittent and continuous treatment strategies New England Journal of Medicine 317:1490–5
Tannock, I. F., Boyd, N. F., DeBoer, G. et al. (1988). A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancer Journal of Clinical Oncology 6:1377–87
Fairclough, D. L., Fetting, J. H., Cella, D. et al. (1999). Quality of life and quality adjusted survival for breast cancer patients receiving adjuvant therapy Quality of Life Research 8:723–31
Levine, M., Guyatt, G., Gent, M. et al. (1988). Quality of life in stage II breast cancer: an instrument for clinical trials Journal of Clinical Oncology 6:1798–810
Kaasa, S., Mastekaasea, A., Lund, E. (1989). Prognostic factors for patients with inoperable non-small cell lung cancer, limited disease Radiotherapy Oncology 15:235–42
Ganz, P., Lee, J., Siau, J. (1991). Quality of life assessment: an independent prognostic variable for survival in lung cancer Cancer 67:3131–5
Coates, A., Grebski, V., Signorini, D. et al. (1992). Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer Australian New Zealand Breast Cancer Trials Group. Journal of Clinical Oncology 10:1833–8
Earlam, S., Glover, C., Fordy, C. et al. (1996). Relation between tumor size, quality of life, and survival in patients with colorectal liver metastases Journal of Clinical Oncology 14:171–5
Coates, A., Porzsolt, F., Osoba, D. (1997). Quality of life in oncology practice: prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy European Journal of Cancer 33:1025–30
Dancey, J., Zee, B., Osoba, D. et al. (1997). Quality of life scores: an independent prognostic variable in a general population of cancer patients receiving chemotherapy Quality of Life Research 6:151–8
Coates, A., Hurny, C., Peterson, H. et al. (2000). Quality-of-life scores predict outcome in metastatic but not early breast cancer Journal of Clinical Oncology 18:3768–74
Langendijk, J. A., Aaronson, N. K., ten Velde, G. P. et al. (2000). Pretreatment quality of life of inoperable non-small cell lung cancer patients referred for primary radiotherapy Acta Oncology 39:949–58
Blazeby, J. M., Brookes, S. T., Alderson, D. (2001). The prognostic value of quality of life scores during treatment for oesophageal cancer Gut 49:227–30
Bezjak, A., Ng, P., Skeel, R. et al. (2001). Oncologists' use of quality of life information: results from a survey of Eastern Cooperative Oncology Group physicians Quality of Life Research 10:1–13
Chassany, O., Sagnier, P., Marquis, P. et al. for the European Regulatory Issues on Quality of Life Assessment Group (2002). Patient-reported outcomes: the example of health-related quality of life — a European guidance document for the improved integration of health-related quality of life assessment in the drug regulatory process Drug Information Journal 36:209–18
Scientific Advisory Committee of the Medical Outcomes Trust (2002). Assessing health status and quality-of-life instruments: attributes and review criteria Quality of Life Research 11:193–205
Hays, R. D., Anderson, R. T., Revicki, D. A. (1998). Assessing reliability and validity of measurements in clinical trials. In Quality of Life Assessment in Clinical Trials: Methods and Practice, eds. M. Staquet, R. Hays, P. Fayers, pp. 169–82. New York, NY: Oxford University Press
Guyatt, G. H., Kirshner, B., Jaeschke, R. (1992). Measuring health status: what are the necessary measurement properties? Journal of Clinical Epidemiology 45:1341–5
Guyatt, G., Osoba, D., Wu, A., Wyrwich, K., Norman, G. and the Clinical Significance Consensus Meeting Group (2002). Methods to explain the clinical significance of health status measures Mayo Clinic Proceedings 77:371–83
Cella, D., Bullinger, M., Scott, C. et al. and the Clinical Significance Consensus Meeting Group (2002). Group versus individual approaches to understanding the clinical significance of differences or changes in quality of life Mayo Clinic Proceedings 77:384–92
Sprangers, M., Moinpour, C., Moynihan, T. et al. and the Clinical Significance Consensus Meeting Group (2002). Assessing meaningful change over time in quality of life: a users' guide for clinicians Mayo Clinic Proceedings 77:561–71
Sloan, J., Aaronson, N., Cappelleri, J. et al. and the Clinical Significance Consensus Meeting Group (2002). Assessing the clinical significance of single items relative to summated scores Mayo Clinic Proceedings 77:479–87
Hambleton, R., Robin, F., Xing, D. (2000). Item response models for the analysis of educational and psychological test data. In Handbook of Applied Multivariate Statistics and Mathematical Modeling, eds. H. Tinsley, S. Brown. San Diego: Academic Press
Embretson, S., Reise, S. (2001). Item Response Theory for Psychologists. Mahwah, NJ: Lawrence Erlbaum Associates
Reise, this volume, Chapter 21
Hambleton, this volume, Chapter 22
Wilson, this volume, Chapter 23
Hays, R., Morales, L., Reise, S. (2000). Item response theory and health outcomes measurement in the 21st century Medical Care 38(Suppl. II):II-28–42
Fairclough, D. (1998). Methods of analysis for longitudinal studies of health-related quality of life. In Quality of Life Assessment in Clinical Trials: Methods and Practice, ed. M. Staquet, R.Hays, P. Fayers, pp. 227–45. New York, NY: Oxford University Press
Curran, D., Fayers, P., Molenberghs, G. et al. (1998). Analysis of incomplete quality of life data in clinical trials. In Quality of Life Assessment in Clinical Trials: Methods and Practice, ed. M. Staquet, R. Hays, P. Fayers, pp. 249–80. New York, NY: Oxford University Press
Fayers, P., Machin, D. (2000). Quality of Life: Assessment, Analysis and Interpretation. New York: John Wiley & Sons
Fairclough, D. (2002). Design and Analysis of Quality of Life Studies in Clinical Trials. Boca Raton, FL: Chapman Hall/CRC Press
Mesbah, M., Cole, B. (ed.) (2002). Statistical Methods for Quality of Life Studies: Design, Measurement, and Analysis. Amsterdam: Kluwer Academic Publishers
Hedeker, D., Gibbons, R. (1997). Applications of random-effects pattern mixture models for missing data in longitudinal studies Psychological Methods 2:64–78
Revicki, D., Gold, K., Buckman, D. et al. (2001). Imputing physical function scores missing owing to mortality: results of a simulation comparing multiple techniques Medical Care 39:61–71
Luce, B., Shih, Y. C. T., Claxton, A. (2001). Special Section: Bayesian approaches to technology assessment and decision making International Journal of Technology Assessment in Health Care 17(1):1–125

Reference Title: REFERENCES

Reference Type: reference-list

Lipscomb, et al., this volume, Chapter 1
Lohr, K. N. (for the Scientific Advisory Committee of the Medical Outcomes Trust) (2002). Assessing health status and quality-of-life instruments: attributes and review criteria Quality of Life Research 11:193–205
Ganz, Goodwin, this volume, Chapter 5
Moinpour, Provenzale, this volume, Chapter 8
Earle, Weeks, this volume, Chapter 7
Litwin, Talcott, this volume, Chapter 6
Ferrell, this volume, Chapter 12
Snyder, this volume, Chapter 16
Erickson, this volume, Chapter 3
Darby, this volume, Chapter 14
Gustafson, this volume, Chapter 15
Zebrack, Cella, this volume, Chapter 11
Potosky, A. L., Harlan, L. C., Stanford, J. L. et al. (1999). Prostate cancer practice patterns and quality of life: the Prostate Cancer Outcomes Study Journal of the National Cancer Institute 91(20):1719–24
Gotay, C. (2004). Assessing cancer-related quality of life across a spectrum of applications. Journal of the National Cancer Institute Monograph 33:126–33
Spilker, this volume, Invited Paper A
Fairclough, this volume, Chapter 17
Sloan, this volume, Chapter 18
Aaronson, this volume, Chapter 20
Hambleton, this volume, Chapter 22
Mandelblatt, Selby, this volume, Chapter 10
Holland, J. C. (2003). Psychological care of patients: psycho-oncology's contribution (American Cancer Society Award lecture). Journal of Clinical Oncology 21 (23 Suppl.): 253s–65s
Ferrans, this volume, Chapter 2
Fayers, P. M., Machin, D. (2002). Quality of Life: Assessment, Analysis and Interpretation. Chichester: John Wiley & Sons
Reise, S., this volume, Chapter 21
Hornbrook, this volume, Chapter 24
Williams, this volume, Chapter 13
Willis et al., this volume Invited Paper C
Barry, Dancey, this volume, Chapter 9
Schwartz, C. E., Sprangers, M. A. G. (2000). Adaptation to Changing Health: Response Shift in Quality-of-Life Research. Washington, DC: American Psychological Association
Sprangers, M. A. G., Schwartz, C. E. (1999). Integrating response shift into health-related quality of life research: a theoretical model Social Science and Medicine 48:1507–15
Patrick, D. L., Kinne, S., Engleberg, R. A. et al. (2000). Functional status and perceived quality of life in adults with and without chronic conditions Journal of Clinical Epidemiology 53:779–85
Osoba, this volume, Chapter 19
Sloan, J. A., Cella, D., Frost, M. H. et al. (2002). Assessing clinical significance in measuring oncology patient quality of life: introduction to the symposium, content overview, and definition of terms Mayo Clinic Proceedings 77:367–70
Dowie, J. (2002). Decision validity should determine whether a generic or condition-specific HRQOL measure is used in health care decisions Health Economics 11:1–8
Wasson, J. H. (2003). Office practice today: as good as it gets? tomorrow: as good as it can be? International Society for Quality of Life Research, 10th Annual Conference, Prague, Czech Republic
Gotay, C. C., Wilson, M. E. (1998). Use of quality of life outcome assessments in current cancer clinical trials Evaluation and the Health Professions 21:157–78
Gotay, C. C. (2003). Quality of life assessment in cancer clinical research: current status and a look to the future Expert Review of Pharmacoeconomics and Outcomes Research 3:479–86
Lindley, C., Vasa, S., Sawyer, W. T. et al. (1998). Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer Journal of Clinical Oncology 16:1380–7
Slevin, M. L., Stubbs, L., Plant, H. J. et al. (1990). Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public British Medical Journal 300:1458–60
Wilson, this volume, Chapter 23
McHorney, Cook, this volume, Invited Paper B
Feeny, this volume, Chapter 4
O'Brien, this volume, Chapter 25
Donaldson, M. S. (2004). Taking stock of health-related quality-of-life measurement in oncology practice in the United States Journal of the National Cancer Institute Monograph 33:155–67
Barofsky, I., Sugarbaker, P. H. (1990). Cancer. In Quality of Life Assessments in Clinical Trials, ed. B. Spilker, pp. 419–39. New York: Raven Press
Sugarbaker, P. H., Barofsky, I., Rosenberg, S. A. (1982). Quality of life assessment in patients with extremity sarcoma clinical trials Surgery 91:17–23
Clauser, S. B. (2004). Use of cancer performance measures in population health: a macro-level perspective Journal of the National Cancer Institute Monograph 33:142–54
Revicki, this volume, Chapter 27
Copley-Merriman et al. this volume, Invited Paper D
Johnson, J. R., Williams, G., Pazdur, R. (2003). End points and United States Food and Drug Administration approval of oncology drugs Journal of Clinical Oncology 21:1404–11
Lipscomb J., Snyder C. F. (2002). The outcomes of cancer outcomes research: focusing on the National Cancer Institute's quality-of-care initiative Medical Care 40 [supplement]:III:3–10
National Cancer Institute. “Improving the quality of cancer care” in The Nation's Investment in Cancer Research: a Plan and Budget Document for Fiscal Year 2005. Available at http://plan.cancer.gov. Last accessed on September 18, 2004
National Institutes of Health. “Dynamic Assessment of Patient-Reported Chronic Disease Outcomes.” NIH Roadmap Initiative RFA-AR-04–007, released November 18, 2003. Available at http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-04-011.html. Last accessed on September 18, 2004
Gotay, Lipscomb, this volume, Chapter 26

Reference Title: REFERENCES

Reference Type: reference-list

Spilker, B. (ed.) (1996). Quality of Life and Pharmacoeconomics in Clinical Trials (2nd Edition). Philadelphia, PA: Lippincott-Raven
Weinstein, M. C., Toy, E. L., Sandberg, E. A. et al. (2001). Modeling for public policy decisions: uses, roles and validity Value in Health 4:348–61
Mullins, C. D., Ogilvie, S. D. (1998). Emerging standardization in pharmacoeconomics Clinical Therapeutics 20:1194–202
Pritchard, C. (2001). Pharmacoeconomic guidelines around the world. In Spectrum Reimbursement, Pharmacoeconomics, and Disease Management Issue 5, pp. 5–1 to 5–12. Waltham, MA: Decision Resources Inc

Reference Title: REFERENCES

Reference Type: reference-list

White, K. L. (1967). Improved medical care statistics and the health services system Public Health Reports 82 (10):847–54
Trask, J. (1935). Vital Statistics. In Preventive Medicine and Hygiene, ed. M. Rosenau, pp. 1175–220. New York, NY: D. Appleton-Century Company
Cumming, H. (1936). Chronic disease as a public health problem The Milbank Memorial Fund Quarterly 14:125–31
Hailman, D. (1941). Health status of adults in the productive ages Public Health Reports 56:2071–87
Collins, S. (1949). Sickness Surveys. In Administrative Medicine, ed. H. Emerson, pp. 511–35. New York: Thomas Nelson & Sons
Logan, W., Brooke, E. (1953). The Survey of Sickness 1943 to 1952 Studies on Medical and Population Subjects 12:1–43
Sheldon, M. (1935). A physical achievement record Journal of Health and Physical Education 30: 1
Deaver, G., Brown, M. (1945). Physical Demands of Daily Life: An Objective Scale for Rating the Orthopedically Exceptional. New York, NY: Institute for the Crippled and Disabled
Bennett, R., Stephens, H. (1949). Functional testing and training The Physical Therapy Review 29 (3):99–107
Moskowitz, E., McCann, C. B. (1957). Classification of disability in the chronically ill and aging Journal of Chronic Diseases 5(3):342–6
Mahoney, F., Wood, O., Barthel, D. (1958). Rehabilitation of chronically ill patients Southern Medical Journal 51:605–9
Staff of the Benjamin Rose Hospital (1959). Multidisciplinary studies of illness in aged persons: II. A new classification of functional status in activities of daily living Journal of Chronic Diseases 19(1):55–62
US Department of Health, Education, and Welfare (1964). Health survey procedure: Concepts, questionnaire development, and definitions in the health interview survey Vital and Health Statistics: Programs and Collection Procedures 1(2):1–66
Hoffer, C. R., Schuler, E. A. (1948). Measurement of health needs and health care American Sociological Review 13:719–24
Brodman, K., Erdmann, A., Wolff, H. (1949). The Cornell Medical Index Journal of the American Medical Association 140(6):530–4
Souelem, O. (1955). Mental patients' attitudes toward mental hospitals Journal of Clinical Psychology 11:181–5
Klopfer, W. G., Wylie, A. A., Hillson, J. S. (1956). Attitudes toward mental hospitals Journal of Clinical Psychology 12:361–5
Hecker, J., Lewis, C. E. (1965). Factors determining attitudes towards medical care — study of a metropolitan area Journal of the Kansas Medical Society 66:123–8
McHorney, C. (2002). Use of item response theory to link three modules of functional status items from the Asset and Health Dynamics among the Oldest Old Study Archives of Physical Medicine and Rehabilitation 83(3):383–94
Task Force for the Handbook of Psychiatric Measures (2000). Handbook of Psychiatric Measures. Washington, DC: American Psychiatric Association
McHorney, C. (1997). Generic health measurement: past accomplishments and a measurement paradigm for the 21st century Annals of Internal Medicine 127:743–50
McHorney, C. (1999). Health status assessment methods for adults: past accomplishments and future challenges Annual Review of Public Health 20:309–35
Bowling, A. (2001). Measuring Disease: A Review of Disease-Specific Quality of Life Measurement Scales (2nd Edition). Buckingham: Open University Press
McHorney, C. A. (2001). Prospects and Problems Associated with Item Banking and Computerized Adaptive Testing in Cancer Clinical Trials. National Cancer Institute, Cancer Outcomes Working Group Symposium, February 2001, Bethesda, MD
Gulliksen, H. (1950). Theory of Mental Tests. New York: John Wiley & Sons
Lord, F. M., Novick, M. R. (1968). Statistical Theories of Mental Test Scores. Reading, MA: Addison-Wesley Publishing Company
Hambleton, R., Swaminathan, H. (1985). Item Response Theory: Principles and Applications. Boston, MA: Kluwer Nijoff Publishing
McHorney, C., Cohen, A. (2000). Equating health status measures with item response theory: illustrations with functional status items Medical Care 38 (9, Suppl. II):II43–59
Cleary, P. D. (1996). Future directions of quality of life research. In Quality of Life and Pharmacoeconomics in Clinical Trials (2nd Edition), ed. B. Spilker, pp. 73–8. Philadelphia, PA: Lippincott-Raven
Hambleton, R. (2000). Emergence of item response modeling in instrument development and data analysis Medical Care 38(9):II60–5
Teresi, J. (2001). Statistical methods for examination of differential item functioning (DIF) with applications to cross-cultural measurement of functional, physical and mental health Journal of Mental Health and Aging 7(1):31–40
Lord, F. M. (1980). Applications of Item Response Theory to Practical Testing Problems. Hillsdale, NJ: Lawrence Erlbaum Associates
Baker, F. (1992). Item Response Theory: Parameter Estimation. New York: Springer-Verlag
Gill, T. M., Feinstein, A. R. (1994). A critical appraisal of the quality of quality-of-life measurements Journal of the American Medical Association 272(8):619–26
Leplege, A., Hunt, S. (1997). The problem of quality of life in medicine Journal of the American Medical Association 278(1):47–50
World Health Organization (1947). Chronicle of the World Health Organization 1(1–2):13
Ahmed, P., Kolker, A. (1973). The role of indigenous medicine in WHO's definition of health. In Toward A New Definition of Health: Psychosocial Dimensions, ed. P. Ahmed, G. Coelgo, pp. 113–28. New York: Plenum Press
Stewart, A. L., Ware, J. E. (1992). Measuring Functioning and Well-Being: The Medical Outcomes Study Approach. Durham, NC: Duke University Press
Meenan, R. F., Gertman, P. M., Mason, J. H. (1980). Measuring health status in arthritis Arthritis and Rheumatism 23(2):146–52
Roland, M., Morris, R. (1983). A study of the natural history of back pain part I: development of a reliable and sensitive measure of disability in low-back pain Spine 8(2):141–4
Wu, A. W., Rubin, H. R., Mathews, W. C. et al. (1991). A health status questionnaire using 30 items from the Medical Outcomes Study: preliminary validation in persons with early HIV infection Medical Care 29 (8):786–98
Ingersoll, G., Marrero, D. (1991). A modified quality-of-life measure for youths: psychometric properties The Diabetes Educator 17(2):114–18
Marks, G. B., Dunn, S. M., Woolcock, A. J. (1992). A scale for the measurement of quality of life in adults with asthma Journal of Clinical Epidemiology 45(5):461–72
Hyland, M., Bott, J., Singh, S. et al. (1994). Domains, constructs and the development of the breathing problems questionnaire Quality of Life Research 3:245–56
McHorney, C., Bricker, D., Kramer, A. et al. (2000). The SWAL-QOL outcomes tool for oropharyngeal dysphagia in adults: I. Conceptual foundation and item development Dysphagia 15:115–21
McHorney, C. Methodological and psychometric issues in health status assessment across populations and applications. In Advances in Medical Sociology, Vol. 5, ed. G. L. Albrecht, R. Fitzpatrick, pp. 281–304. Stamford, CT: JAI Press
McHorney, C. A., Ware, J. E., Lu, J. F. R. et al. (1994). The MOS 36-item short-form health survey (SF-36): III. Tests of data quality, scaling assumptions and reliability across diverse patient groups Medical Care 32(1):40–66
Jobe, J. B., Mingay, D. J. (1990). Cognitive laboratory approach to designing questionnaires for surveys of the elderly Public Health Reports 105(5):518–24
Lessler, J. (1995). Choosing questions that people can understand and answer Medical Care 33 (4 Suppl.):AS203–8
Weitzner, M., Meyers, C., Steinbruecker, S. et al. (1997). Developing a care giver quality-of-life instrument Cancer Practice 5(1):25–31
Moore, K. N., Estey, A. (1999). The early post-operative concerns of men after radical prostatectomy Journal of Advanced Nursing 29(5):1121–9
Hobart, J., Lamping, D., Fitzpatrick, R. et al. (2001). The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure Brain 124:962–73
Kadam, U. T., Croft, P., McLeod, M. et al. (2001). A qualitative study on patients' views on anxiety and depression British Journal of General Practice 51(466):375–80
Ware, N., Tugenberg, T., Dickey, B. et al. (1999). An ethnographic study of the meaning of continuity of care in mental health services Psychiatric Services 50(3):395–400
Angel, R., Frisco, M. (2001). Self-assessments of health and functional capacity among older adults Journal of Mental Health and Aging 7(1):119–35
De Geest, S., Abraham, I., Gemoets, H. et al. (1994). Development of the long-term medication behaviour self-efficacy scale: qualitative study for item development Journal of Advanced Nursing 19:233–8
Porter, E. (1995). A phenomenological alternative to the “ADL Research Tradition” Journal of Aging and Health 7(1):24–45
Krasner, D. (1998). Painful venous ulcers: themes and stories about their impact on quality of life Ostomy/Wound Management 44(9):38–49
Koch, T., Webb, C., Williams, A. (1995). Listening to the voices of older patients: an existential-phenomenological approach to quality assurance Journal of Clinical Nursing 4:185–93
Spies, J., Coyne, K., Guaou, N. et al. (2002). The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata Obstetrics and Gynecology 99(2):290–300
Lerner, D., Amick, B., Rogers, W. et al. (2001). The Work Limitations Questionnaire Medical Care 39(1):72–85
Wu, A., Fink, N., Cagney, K. et al. (2001). Developing a health-related quality-of-life measure for end-stage renal disease: The CHOICE Health Experiences Questionnaire American Journal of Kidney Diseases 37(1):11–21
Juniper, E. F., Guyatt, G. H., Epstein, R. S. et al. (1992). Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials Thorax 47:76–83
Wilde, B., Larsson, G., Larsson, M. et al. (1994). Quality of care: development of a patient-centred questionnaire based on a grounded theory model Scandinavian Journal of the Caring Sciences 8:39–48
Launois, R., Reboul-Marty, J., Henry, E. (1996). Construction and validation of a quality of life questionnaire in chronic lower limb venous insufficiency (CIVIQ) Quality of Life Research 5:539–54
Rubin, H., Jenckes, M., Fink, N. et al. (1997). Patient's view of dialysis care: development of a taxonomy and rating of importance of different aspects of care American Journal of Kidney Diseases 30(6):793–801
Cronin, L., Guyatt, G., Griffith, L. et al. (1998). Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS) Journal of Clinical Endocrinology and Metabolism 83(6):1976–87
Jabine, T., Straf, M., Tanue, J. et al. (1984). Cognitive Aspects of Survey Methodology. Washington, DC: National Academy Press
Fienberg, S., Loftus, E., Tanur, J. (1985). Cognitive aspects of health survey methodology: an overview Milbank Memorial Fund Quarterly 63(3):547–64
Lessler, J. T., Sirken, M. G. (1985). Laboratory-based research on the cognitive aspects of survey methodology: the goals and methods of the National Center for Health Statistics study Milbank Memorial Fund Quarterly. Health and Society 63(3):565–81
Loftus, E., Fienberg, S., Tanur, J. (1985). Cognitive psychology meets the national survey American Psychologist 40(2):175–80
Jobe, J. B., Mingay, D. J. (1989). Cognitive research improves questionnaires American Journal of Public Health 79(8):1053–5
Bergner, M., Bobbitt, R. A., Pollard, W. E. et al. (1976). The Sickness Impact Profile: validation of a health status measure Medical Care 14(1):57–67
Ware, J., Kosinski, M., Bayliss, M. et al. (1995). Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: Summary of results from the MOS Medical Care 33 (4 Suppl.):AS264–79
Bozzette, S., Hays, R., Berry, S. et al. (1994). A perceived health index for use in persons with advanced HIV disease: derivation, reliability, and validity Medical Care 32(7):716–31
Bozzette, S. A., Hays, R. D., Berry, S. H. et al. (1995). Derivation and properties of a brief health status assessment instrument for use in HIV disease Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 8(3):253–65
Devinsky, O., Vickrey, B., Cramer, J. et al. (1995). Development of the quality of life in epilepsy inventory Epilepsia 36(11):1089–104
Vickery, B., Hays, R., Garooni, R. et al. (1995). A health-related quality of life measure for multiple sclerosis Quality of Life Research 4:187–206
Revicki, D., Sorensen, S., Wu, A. (1998). Reliability and validity of physical and mental health summary scores from the Medical Outcomes Study HIV health survey Medical Care 36(2):126–37
Varni, J., Seid, M., Kurtin, P. (2001). Peds QL 4.0: Reliability and validity of the pediatric quality of life inventory version 4.0 generic core scales in healthy and patient populations Medical Care 39(8):800–12
Simon, G., Revicki, D., Grothaus, L. et al. (1998). SF-36 summary scores. Are physical and mental health truly distinct? Medical Care 36(4):567–72
Rubenach, S., Shadbolt, B., McCallum, J. et al. (2002). Assessing health-related quality of life following myocardial infarction: is the SF-12 useful? Journal of Clinical Epidemiology 55:306–9
Fairclough, D. (1997). Summary measures and statistics for comparisons of quality of life in a clinical trial of cancer therapy Statistics in Medicine 16:1197–209
Beusterien, K., Nissenson, A., Port, F. K. et al. (1996). The effects of recombinant human erythropoietin on functional health and well-being in chronic dialysis patients Journal of the American Society of Nephrology 7(5):763–73
Jenkinson, C., Gray, A., Doll, H. et al. (1997). Evaluation of index and profile measures of health status in a randomized controlled trial Medical Care 35(11):1109–18
Ruhland, J., Shields, R. (1997). The effects of a home exercise program on impairment and health-related quality of life in persons with chronic peripheral neuropathies Physical Therapy 77(10):1026–39
Gartsman, G., Brinker, M., Khan, M. et al. (1998). Self assessment of general health status in patients with five common shoulder conditions Journal of Shoulder and Elbow Surgery 7(3):228–37
Gartsman, G., Khan, M., Hammerman, S. (1998). Arthroscopic repair of full-thickness tears of the rotator cuff Journal of Bone and Joint Surgery 80-A (6):832–40
Wiklund, I., Junghard, O., Grace, E. et al. (1998). Quality of life in reflux and dyspepsia patients. Psychometric documentation of a new specific questionarie (QOLRAD) European Journal of Surgery 583(Suppl.):41–9
Reuben, D. B., Frank, J. C., Hirsch, S. H. et al. (1999). A randomized clinical trial of outpatient comprehensive geriatric assessment coupled with an intervention to increase adherence to recommendations Journal of the American Geriatrics Society 47:269–76
Revicki, D., Crawley, J., Zodet, M. et al. (1999). Complete resolution of heartburn symptoms and health-related quality of life in patients with gastro-oesophageal reflux disease Alimentary Pharmacology and Therapeutics 13:1621–30
Stavem, K., Erikssen, J., Boe, J. (1999). Performance of a short lung-specific health status measure in outpatients with chronic obstructive pulmonary disease Respiratory Medicine 93:467–75
Taylor, S., Taylor, A., Foy, M. et al. (1999). Responsiveness of common outcome measures for patients with low back pain Spine 24:1805–12
Adler, D., Bungay, K., Cynn, D. et al. (2000). Patient-based health status assessments in an outpatient psychiatry setting Psychiatric Services 51(3):341–8
Hughes, S., Weaver, F., Giobbie-Hurder, A. et al. (2000). Effectiveness of team-managed home-based primary care: a randomized multicenter trial Journal of the American Medical Association 284(22):2877–85
Mayo, N., Wood-Dauphinee, S., Cote, R. et al. (2000). There's no place like home: an evaluation of early supported discharge for stroke Stroke 31:1016–23
Nortvedt, M. W., Riise, T., Myhr, K.-M. et al. (2000). Performance of the SF-36, SF-12 and RAND-36 summary scales in a multiple sclerosis population Medical Care 38(10): 1022–8
Hobart, J., Freeman, J., Lamping, D. et al. (2001). The SF-36 in multiple sclerosis: why basic assumptions must be tested Journal of Neurology, Neurosurgery, and Psychiatry 71(3):363–70
Roznowski, M., Tucker, L., Humphreys, L. (1991). Three approaches to determining the dimensionality of binary items Applied Psychological Measurement 15(2):109–27
US Department of Health and Human Services. Healthy People 2010 [Web Page]. Available at http://www.healthypeople.gov/document/. Accessed September 18, 2004
National Institutes of Health. Addressing Health Disparities: The NIH Program of Action. Available at http://healthdisparities.nih.gov/whatare.html. Accessed September 18, 2004
McKinlay, J. B., McKinlay, S. M., Beaglehole, R. (1989). A review of the evidence concerning the impact of medical measures on recent mortality and morbidity in the United States International Journal of Health Services 19(2):181–208
Evans, R., Stoddart, G. (1992). Producing health, consuming health care Social Science and Medicine 35:1347–63
U.S. Department of Health and Human Services. (1979). Risks to good health. Healthy People — the Surgeon General's Report on Health Promotion and Disease Prevention. Hyattsville, MD: U.S. Department of Health and Human Services, Public Health Service, Office of the Assistant Secretary for Health and Surgeon General, (PHS) 79–55071
McHorney, C. (1999). Concepts and Measurement of Health Status and Health-Related Quality of Life. In The Handbook of Social Studies in Health & Medicine, ed. G. L. Albrecht, R. Fitzpatrick, S. Scrimshaw, pp. 339–58. London: Sage
Blaxter, M. (1987). Evidence on inequality in health from a national survey Lancet 2(8549):30–3
House, J. S., Kessler, R. C., Regula, A. (1990). Age, socioeconomic status, and health Milbank Memorial Fund Quarterly 68(3):383–412
Arber, S., Ginn, J. (1993). Gender and inequalities in health in later life Social Science and Medicine 36(1):33–46
Guralnik, J. M., Land, K. C., Blazer, D. et al. (1993). Educational status and active life expectancy among older blacks and whites New England Journal of Medicine 329(2):110–16
Sorlie, P., Backlund, E., Keller, J. (1995). US mortality by economic, demographic, and social characteristics: the national longitudinal mortality study American Journal of Public Health 85(7):949–56
Schoenbaum, M., Waidmann, T. (1997). Race, socio-economic status, and health: accounting for race differences in health Journal of Gerontology 52B(Special Issue):61–73
Kind, P., Dolan, P., Gudex, C. et al. (1998). Variations in population health status: results from a United Kingdom national questionnaire survey British Medical Journal 316:736–41
Adams, P., Hendershot, G. E., Marano, M. (1999). Current Estimates from the National Health Interview Survey, 1996. Data from the National Health Survey; Vol. 10. Hyattsville, MD: U.S. Department of Health and Human Services; (PHS) 99–1528
Stewart, A., Napoles-Springer, A. (2000). Health-related quality-of-life assessments in diverse population groups in the United States Medical Care 38(9, Suppl.):II-102–24
Day, J. (1996). Population Projections of the United States by Age, Sex, Race, and Hispanic Origin: 1995 to 2050. Washington, DC: US Government Printing Office
Liang, J. (2001). Assessing cross-cultural comparability in mental health among older adults Journal of Mental Health and Aging 7(1):21–30
Herdman, M., Fox-Rushby, J., Badia, X. (1997). ‘Equivalence’ and the translation and adaptation of health-related quality of life questionnaires Quality of Life Research 6:237–47
Byrne, B., Campbell, T. (1999). Cross-cultural comparisons and the presumption of equivalent measurement and theoretical structure. A look beneath the surface Journal of Cross-Cultural Psychology 30(5):555–74
Kleinman, A. (1977). Depression, somatization and the new cross-cultural psychiatry Social Science and Medicine 11:3–10
Flaherty, J., Gaviria, F., Pathak, D. et al. (1988). Developing instruments for cross-cultural psychiatric research Journal of Nervous and Mental Disease 176 (5):257–63
Pelto, P., Pelto, G. (1997). Studying knowledge, culture, and behavior in applied medical anthropology Medical Anthropology Quarterly 11(2):147–63
Lutner, R., Foizen, M., Stocking, C. (1991). The automated interview versus the personal interview Anesthesiology 75:394–400
Rozensky, R., Honor, L., Rasinski, K. et al. (1986). Paper-and-pencil versus computer-administered MMPIs: a comparison of patients' attitudes Computers in Human Behavior 2:111–16
Greist, J., Klein, M., Erdman, H. et al. (1987). Comparison of computer- and interviewer-administered versions of the Diagnostic Interview Schedule Hospital and Community Psychiatry 38(12):1304–11
Kobak, K., Reynolds, W., Rosenfeld, R. et al. (1990). Development and validation of a computer-administered version of the Hamilton Depression Rating Scale Psychological Assessment 2(1):56–63
Baer, L., Brown-Beasley, M., Sorce, J. et al. (1993). Computer-assisted telephone administration of a structured interview for obsessive-compulsive disorders American Journal of Psychiatry 150:1737–8
Kobak, K., Reynolds, W., Greist, J. (1993). Development and validation of a computer-administered version of the Hamilton Anxiety Scale Psychological Assessment 5(4):487–92
Baer, L., Jacobs, D. G., Cukor, P. et al. (1995). Automated telephone screening survey for depression Journal of the American Medical Association 273(24):1943–4
Roizen, M. F., Coalson, D., Hayward, R. S. A. et al. (1992). Can patients use an automated questionnaire to define their current health status? Medical Care 30(5 Suppl.):MS74–84
Newell, S., Girgis, A., Sanson-Fisher, R. et al. (1997). Are touch-screen computer surveys acceptable to medical oncology patients? Journal of Psychosocial Oncology 15 (2):37–46
Taenzer, P., Speca, M., Atkinson, M. et al. (1997). Computerized quality-of-life screening in an oncology clinic Cancer Practice 5(3):168–75
Buxton, J., White, M., Osoba, D. (1998). Patients' experiences using a computerized program with a touch-sensitive video monitor for the assessment of health-related quality of life Quality of Life Research 7:513–17
McBride, J., Anderson, R., Bahnson, J. (1999). Using a hand-held computer to collect data in an orthopedic outpatient clinic Medical Care 37(7):647–51
Velikova, G., Wright, E. P., Smith, A. B. et al. (1999). Automated collection of quality-of-life data: a comparison of paper and computer touch-screen questionnaires Journal of Clinical Oncology 17(3):998–1007
Lofland, J., Schaffer, M., Goldfarb, N. (2000). Evaluating health-related quality of life: cost comparison of computerized touch-screen technology and traditional paper systems Pharmacotherapy 20(11):1390–5
Taenzer, P., Bultz, B., Carlson, L. et al. (2000). Impact of computerized quality of life screening on physician behavior and patient satisfaction in lung cancer outpatients Psycho-Oncology 9:203–13
Carlson, L., Speca, M., Hagen, N. et al. (2001). Computerized quality of life screening in a cancer pain clinic Journal of Palliative Care 17 (1):46–52
Ernst, M., Doucette, W., Dedhiya, S. et al. (2001). Use of point-of-service health status assessments by community pharmacists to identify and resolve drug-related problems in patients with musculoskeletal disorders Pharmacotherapy 21(8):988–97
Brodie, M., Fournoy, R., Altman, D. et al. (2000). Health information, the internet, and the digital divide Health Affairs 19(6):255–65
Burstin, H. (2000). Traversing the digital divided Health Affairs 19(6):245–9
Ree, M. (1993). Foreword: Differential Item Functioning (DIF): A perspective from the Air Force Human Resources Laboratory. In Differential Item Functioning, ed. P. Holland, H. Wainer, pp. ⅺ–ⅻ. Hillsdale, NJ: Lawrence Erlbaum Associates
Hambleton, R. (2001). The next generation of the ITC test translation and adaptation guidelines European Journal of Psychological Assessment 17(3):164–72
Teresi, J., Cross, P., Golden, R. (1989). Some applications of latent trait analysis to the measurement of ADL Journal of Gerontology 44(5):S196–204
Groenvold, M., Bjorner, J. B., Klee, M. C. et al. (1995). Test for item bias in a quality of life questionnaire Journal of Clinical Epidemiology 48(6):805–16
Avlund, K., Era, P., Davidsen, M. et al. (1996). Item bias in self-reported functional ability among 75-year-old men and women in three Nordic localities Scandinavian Journal of Social Medicine 24(3):206–17
Kempen, G., Miedema, I., Ormel, J. et al. (1996). The assessment of disability with the Groningen Activity Restriction Scale Conceptual framework and psychometric properties Social Science and Medicine 43(11):1601–10
Spector, W., Fleishman, J. (1998). Combining activities of daily living with instrumental activities of daily living to measure functional disability Journal of Gerontology 53(1):S46–57
Custers, J., Hiujtink, H., van der Net, J. et al. (2000). Cultural differences in functional status measurement: analyses of person fit according to the Rasch model Quality of Life Research 9:571–8
Wolfe, F., Hawley, D., Goldenberg, D. et al. (2000). The assessment of functional impairment in fibromyalgia (FM): Rasch analyses of 5 functional scales and the development of the FM Health Assessment Questionnaire Journal of Rheumatology 27(8):1989–99
Jagger, C., Arthur, A., Spiers, N. et al. (2001). Patterns of onset of disability in activities of daily living Journal of the American Geriatric Society 49(4):404–9
Teresi, J. A., Golden, R. R., Cross, P. et al. (1995). Item bias in cognitive screening measures: Comparisons of elderly White, Afro-American, Hispanic and high and low education subgroups Journal of Clinical Epidemiology 48(4):473–83
Teresi, J., Kleinman, M., Ocepek, K. (2000). Modern psychometric methods for detection of differential item functioning: application to cognitive assessment measures Statistics in Medicine 19:1651–83
Teresi, J., Kleinman, M., Ocepek-Welikson, K. et al. (2000). Applications of item response theory to the examination of the psychometric properties and differential item functioning of the comprehensive assessment and referral evaluation dementia diagnostic scale among samples of Latino, African American, and white non-latino elderly Research on Aging 22(6):738–73
Teresi, J., Holmes, D., Ramirez, M. et al. (2001). Performance of cognitive tests among different racial/ethnic and education groups: findings of differential item functioning and possible item bias Journal of Mental Health and Aging 7(1):79–89
Bjorner, J. B., Kreiner, S., Ware, J. E. (1998). Differential item functioning in the Danish translation of the SF-36 Journal of Clinical Epidemiology 51(11):1189–202
Collins, W., Raju, N., Edwards, J. (2000). Assessing differential functioning in a satisfaction scale Journal of Applied Psychology 85(3):451–61
Morales, L., Reise, S., Hays, R. (2000). Evaluating the equivalence of health care ratings by whites and Hispanics Medical Care 38(5):517–27
Schaeffer, N. (1988). An application of item response theory to the measurement of depression. In Sociological Methodology, ed. C. Clogg, pp. 271–307. San Francisco, CA: Jossey-Bass
Ellis, B. B., Minsel, B., Becker, P. (1989). Evaluation of attitude survey translations: an investigation using item response theory International Journal of Psychology 24:665–84
Ellis, B. E., Kimmell, H. (1992). Identification of unique cultural response patterns by means of item response theory Journal of Applied Psychology 77(2):177–84
Stommel, M., Given, B., Given, C. et al. (1993). Gender bias in the measurement properties of the Center for Epidemiologic Studies Depression Scale (CES-D) Psychiatry Research 49:239–50
Dancer, L., Anderson, A., Derlin, R. (1994). Use of log-linear models for assessing differential item functioning in a measure of psychological functioning Journal of Consulting and Clinical Psychology 62(4):710–17
Flannery, W., Reise, S., Widaman, K. (1995). An item response theory analysis of the general and academic scales of the Self-Description Questionnaire II Journal of Research in Personality 29:168–88
Hammond, S. (1995). An IRT investigation of the validity of non-patient analogue research using the Beck Depression Inventory European Journal of Psychologic Assessment 11(1):14–20
Huang, C., Church, A., Katigbak, M. (1997). Identifying cultural differences in items and traits Journal of Cross-Cultural Psychology 28(2):192–218
Panter, A., Swygert, K., Dahlstrom, W. et al. (1997). Factor analytic approaches to personality item-level data Journal of Personality Assessment 68(3):561–89
Suh, T., Gallo, J. (1997). Symptom profiles of depression among general medical service users compared with specialty mental health service users Psychological Medicine 27:1051–63
Coelho, V., Strauss, M., Jenkins, J. (1998). Expression of symptomatic distress by Puerto Rican and Euro-American patients with depression and schizophrenia Journal of Nervous and Mental Disease 186(8):477–83
DeRoos, Y., Allen-Meares, P. (1998). Application of Rasch analysis: exploring differences in depression between African-American and white children Journal of Social Science Research 23(3/4):93–107
Gallo, J., Cooper-Patrick, L., Lesikar, S. (1998). Depressive symptoms of whites and African Americans aged 60 years and older Journal of Gerontology 53B(5):P277–86
Santor, D., Ramsay, J. (1998). Progress in the technology of measurement: applications of item response models Psychological Assessment 10(1):345–59
Smith, L., Reise, S. (1998). Gender differences on negative affectivity: an IRT study of differential item functioning on the multidimensional personality questionnaire stress reaction scale Journal of Personality and Social Psychology 75(5):1350–62
Christensen, H., Jorm, A., MacKinnon, A. et al. (1999). Age differences in depression and anxiety symptoms: A structural equation modeling analysis of data from a general population sample Psychological Medicine 29(2): 325–39
Cooke, D., Michie, C. (1999). Psychopathy across cultures: North America and Scotland compared Journal of Abnormal Psychology 108(1):58–68
Grayson, D., Mackinnon, A., Jorm, A. (2000). Item bias in the Center for Epidemiologic Studies Depression scale: effects of physical disorders and disability in an elderly community sample Journal of Gerontology 55B(5):P273–82
Waller, N., Thompson, J., Wenk, E. (2000). Using IRT to separate measurement bias from true group differences on homogeneous and heterogeneous scales: An illustration with the MMPI Psychological Methods 5(1):125–46
Azocar, F., Arean, P., Miranda, J. et al. (2001). Differential item functioning in a Spanish translation of the Beck Depression Inventory Journal of Clinical Psychology 57:355–65
Santor, D., Coyne, J. (2001). Evaluating the continuity of symptomology between depressed and nondepressed individuals Journal of Abnormal Psychology 110(2):216–25
Drasgow, F., Hulin, C. (1987). Cross-cultural measurement Interamerican Journal of Psychology 21(1–2):1–24
Walstad, W. B., Robson, D. (1997). Differential item functioning and male-female differences on multiple-choice tests in economics Journal of Economic Education 28(2): 155–71
Guarnaccia, P. (1996). Anthropological perspectives: the importance of culture in the assessment of quality of life. In Quality of Life and Pharmacoeconomics in Clinical Trials, (2nd Edition), ed. B. Spilker, pp. 523–7. Philadelphia, PA: Lippincott-Raven
Rogler, L. (1989). The meaning of culturally sensitive research in mental health American Journal of Psychiatry 146(3):296–303
McHorney, C. A., Ware, J. E., Rogers, W. et al. (1992). The validity and relative precision of MOS short- and long-form health status scales and Dartmouth COOP Charts: Results from the Medical Outcomes Study Medical Care 30(Suppl.):MS253–65
McHorney, C., Tarlov, A. (1995). The use of health status measures for individual patient level applications: problems and prospects Quality of Life Research 3(1):43–4
McHorney, C. (1996). Measuring and monitoring general health status in elderly persons: practical and methodological issues in using the SF-36 health survey The Gerontologist 38(5):571–83
Haley, S. M., McHorney, C. A., Ware, J. E. (1994). Evaluation of the MOS SF-36 physical functioning scale (PF-10): I. Unidimensionality and reproducibility of the Rasch item scale Journal of Clinical Epidemiology 47(6):671–84
Prieto, L., Alonso, J., Lamarca, R. et al. (1998). Rasch measurement for reducing the items of the Nottingham Health Profile Journal of Outcome Measurement 2(4):285–301
Finch, M., Kane, R., Philp, I. (1995). Developing a new metric for ADLs Journal of the American Geriatrics Society 43:877–84
Grimby, G., Andrén, E., Holmgren, E. et al. (1996). Structure of a combination of functional independence measure and instrumental activity measure items in community-living persons: a study of individuals with cerebral palsy and spina bifida Archives of Physical Medicine and Rehabilitation 77:1109–14
Nordenskiold, U. (1996). Daily Activities in Women with Rheumatoid Arthritis. Goteborg, Sweden: Goteborg University
Doble, S. E., Fisher, A. G. (1998). The dimensionality and validity of the older Americans resource services (OARS) activities of daily living (ADL) scale Journal of Outcome Measurement 2(1):4–24
Grimby, G., Andren, E., Daving, Y. et al. (1998). Dependence and perceived difficulty in daily activities in community-living stroke survivors 2 years after stroke Stroke 29:1843–9
Carter, J., Wilkinson, L. (1984). A latent trait analysis of the MMPI Multivariate Behavioral Research 19:385–407
Steinberg, L., Thissen, D. (1995). Item response theory in personality research. In Personality, Research, Methods, and Theory: a Festschrift Honoring Donald W. Fisk, ed. P. E. Shrout, S. T. Fisk, pp. 161–81. Hillsdale, NJ: Lawrence Erlbaum Associates
Gray-Little, B., Williams, V., Hancock, T. (1997). An item response theory analysis of the Rosenberg Self-Esteem Scale Personality and Social Psychology Bulletin 23(5):443–51
Payne, S. (1951). The Art of Asking Questions. Princeton, NJ: Princeton University Press
Wesman, A. (1971). Writing the test item. In Educational Measurement, ed. R. Thorndike, pp. 81–129. Washington, DC: American Council on Education
Andrich, D. (1995). Distinctive and incompatible properties of the common classes of IRT models for graded responses Applied Psychological Measurement 19(1):101–19
Wright, B., Masters, G. (1982). Rating Scale Analysis. Chicago, IL: MESA Press
Gibbons, R., Clark, D., Cavanaugh, S. et al. (1985). Application of modern psychometric theory in psychiatric research Journal of Psychiatric Research 19(1):43–55
Steinberg, L. (1994). Context and serial-order effects in personality measurement: limits on the generality of measuring changes the measure Journal of Personality and Social Psychology 66(2):341–9
Kirisci, L., Clark, D., Moss, H. (1996). Reliability and validity of the State-Trait Anxiety Inventory for Children in adolescent substance abusers: Confirmatory factor analysis and item response theory Journal of Child and Adolescent Substance Abuse 5(3):57–69
Kirisci, L., Moss, H., Tarter, R. (1996). Psychometric evaluation of the situational confidence questionnaire in adolescents: fitting a graded item response model Addictive Behaviors 21(3):303–17
Cooke, D. J., Michie, C. (1997). An item response theory analysis of the Hare psychopathy checklist-revised Psychological Assessment 9(1):3–14
Kim, Y., Pilkonis, P. A. (1999). Selecting the most informative items in the IIP scales for personality disorders: an application of item response theory Journal of Personality Disorders 13(2):157–74
Waller, N. (1999). Searching for structure in the MMPI. In The New Rules of Measurement, ed. S. Embretson, S. Hershberger, pp. 185–217. Mahwah, NJ: Lawrence Erlbaum Associates
Marshall, G., Orlando, M., Jaycox, L. et al. (2002). Development and validation of a modified version of the Peritraumatic Dissociative Experiences Questionnaire Psychological Assessment 14(2):123–34
Masters, G. (1982). A Rasch model for partial credit scoring Psychometrika 47(2):149–74
Kolen, M., Brennan, R. (1995). Test Equating: Methods and Practices. New York: Springer-Verlag
Feuer, M., Holland, P., Green, B. et al. (1999). Uncommon Measures: Equivalence and Linkage among Educational Tests. Washington, DC: National Academy Press
Reise, S., Henson, J. (2000). Computerization and adaptive administration of the NEO PI-R Psychological Assessment 7(4):347–67
Green, B. F. (1983). The promise of tailored tests. In Principles of Modern Psychological Measurement, ed. H. Wainer, S. Messick, pp. 69–80. Hillsdale, NJ: Lawrence Erlbaum Associates
Hambleton, R. K., Jones, R. W. (1993). Comparison of classical test theory and item response theory and their applications to test development Education Measurement: Issues and Practice Fall:38–47
Waller, N., Reise, S. (1989). Computerized adaptive personality assessment: an illustration with the Absorption Scale Journal of Personality and Social Psychology 57(6):1051–8
Koch, W. R., Dodd, B. G., Fitzpatrich, S. J. (1990). Computerized adaptive measurements of attitudes Measurement and Evaluation in Counseling and Development 23:20–30
Dodd, B., De Ayala, R., Koch, W. R. (1995). Computerized adaptive testing with polytomous items Applied Psychological Measurement 19(1):5–22
Hambleton, R., Slater, S. (1997). Item response theory models and testing practices: current international status and future directions European Journal of Psychological Assessment 13(1):21–8
Shapiro, M. (1994). Is the spirit of capitalism undermining the ethics of health services research? Health Services Research 28(6):661–72

Reference Title: REFERENCES

Reference Type: reference-list

McHorney, Cook, this volume, Invited Paper B
Zebrack, Cella, this volume, Chapter 11
Darby, this volume, Chapter 14
Cohen, S. R., Leis, A. (2002). What determines the quality of life of terminally ill cancer patients from their own perspective? Journal of Palliative Care 18(1):48–58
Ferrans, this volume, Chapter 2
Ganz, Goodwin, this volume, Chapter 5
Erickson, this volume, Chapter 3
Centers for Disease Control and Prevention (2000). Measuring Healthy Days. Atlanta, GA: CDC
Jobe, J. B., Mingay, D. J. (1991). Cognition and survey measurement: history and overview Applied Cognitive Psychology 5:175–92
Tourangeau, R., Rips L. J., Rasinski, K. (2000). The Psychology of Survey Response. Cambridge: Cambridge University Press
Willis, G. B. (1994). Cognitive Interviewing and Questionnaire Design: A Training Manual. Hyattsville, MD: National Center for Health Statistics: Cognitive Methods Staff, Working Paper No. 7
van der Veer, K., Hak, T., Jansen, H. (2002). The Three-Step Test-Interview (TSTI): An observational instrument for pre-testing self-completion questionnaires. Paper presented at the International Conference on Questionnaire Development, Evaluation, and Testing Methods (QDET), Charleston, SC
Jobe, J. (2003). Cognitive psychology and self reports: models and methods Quality of Life Research, 12(3):219–27
Lessler, J. T. (1995). Choosing questions that people can understand and answer Medical Care 33(4, Suppl.):AS203–8
Willis, G. B., Schechter, S. (1997). Evaluation of cognitive interviewing techniques: do the results generalize to the field? Bulletin de Methodologie Sociologique 55:40–66
Mullin, P. A., Lohr, K. N., Bresnahan, B. W. et al. (2000). Applying cognitive design principles to formatting HRQOL instruments Quality of Life Research 9(1):13–27
Harris-Kojetin, L. D., Fowler, F. J., Brown, J. A. et al. (1999). The use of cognitive testing to develop and evaluate CAHPS(R) 1.0 core survey items Medical Care 37(3, Suppl.): MS10–MS21
Sehulster, J. R. (1994). Health and self: paths for exploring cognitive aspects underlying self-report of health status. In Proceedings of the 1993 NCHS Conference on the Cognitive Aspects of Self-Reported Health Status, ed. S. Schechter, pp. 89–105. Hyattsville, MD: National Center for Health Statistics, Cognitive Methods Staff Working Paper Series, No. 10
Fowler, F. J. (1995). Improving Survey Questions: Design and Evaluation. Thousand Oaks, CA: Sage
Aaronson, N. K., Ahmedzai, S., Bergman, B. et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology Journal of the National Cancer Institute 85(5):365–76
Beatty, P., Schechter, S. (1998). Questionnaire Evaluation and Testing in Support of the Behavioral Risk Factor Surveillance System (BRFSS), 1992–1998. Hyattsville, MD: National Center for Health Statistics, Cognitive Methods Staff Working Paper No. 26
Schechter, S., Beatty, P., Willis, G. B. (1999). Asking survey respondents about health status: judgment and response issues. In Cognition, Aging, and Self-reports, ed. N. Schwarz, D. Park, B. Knauper, S. Sudman, pp. 265–83. Washington, DC: Psychology Press
Fayers, P. M., Machin, D. (2000). Quality of Life: Assessment, Analysis and Interpretation. Chichester: John Wiley & Sons
Barofsky, I. (1996). Cognitive aspects of quality of life assessment. In Quality of Life and Pharmacoeconomics in Clinical Trials (2nd Edition), ed. B. Spilker, pp. 107–15. New York: Lippincott-Raven Press
Gotay, C. C. (1996). Trial-related quality of life: using quality-of-life assessment to distinguish among cancer therapies Journal of the National Cancer Institute Monographs 20:1–6
Groenvold, M., Klee, M. C., Sprangers, M. A. G. et al. (1997). Validation of the EORTC QLQ-C30 Quality of Life Questionnaire through combined qualitative and quantitative assessment of patient-observer agreement Journal of Clinical Epidemiology 50(4):441–50
Willis, G. B., Lessler, J. (1999). The BRFSS-QAS: A Guide for Systematically Evaluating Survey Question Wording. Research Triangle Park, NC: Research Triangle Institute
Litwin, M. S., McNaughton-Collins, M., Fowler, F. J. et al. (1999). The National Institutes of Health Chronic Prostatitis Symptom Index: development and validation of a new outcome measure Journal of Urology 162:369–75
Willis, G. B. (1994). Results of NCHS Cognitive Testing: 1995 Year 2000 Objectives Questionnaire. Hyattsville, MD: National Center for Health Statistics
Lepore, S. J., Eton, D. T. (2000). Response shifts in prostate cancer patients: an evaluation of suppressor and buffer models. In Adaptation to Changing Health: Response Shifts in Quality-of-Life Research, ed. C. E. Schwartz, M. A. G. Sprangers, pp. 37–51. Washington, DC: American Psychological Association
Abeles, N. (1998). What Practitioners Should Know About Working with Older Adults. Washington, DC: American Psychological Association
Beatty, P. (2002). The dynamics of cognitive interviewing. Paper presented at the International Conference on Questionnaire Development, Evaluation, and Testing Methods (QDET), Charleston, SC
Zebrack, B. (2000). Quality of life of long-term survivors of leukemia and lymphoma Journal of Psychosocial Oncology 18(4):39–59
US Bureau of the Census (1993). Protocol for Pretesting Demographic Surveys at the Census Bureau. Suitland, MD: U.S. Bureau of the Census
Esposito, J. L., Rothgeb, J. M. (1997). Evaluating survey data: making the transition from pretesting to quality assessment. In Survey Measurement and Process Quality, ed. L. Lyberg et al., pp. 541–71. New York, NY: John Wiley & Sons
Reise, this volume, Chapter 21
Panter, A. T., Reeve, B. B. (2002). Assessing tobacco beliefs among youth using item response theory models Drug and Alcohol Dependence 68:521–39
Lankenau, B. H., Hennessy, C. H., Moriarty, D. G. et al. (1995). Health-related Quality of Life: A New Approach to Measuring the Health Status of a Population. Paper presented at Ninth World Productivity Congress, Istanbul, Turkey
Aaronson, this volume, Chapter 20
Quittner, A. L., Sweeny, S., Watrous, M. et al. (2000). Translation and linguistic validation of a disease-specific quality of life measure for cystic fibrosis Journal of Pediatric Psychology 25(6):403–14

Reference Title: REFERENCES

Reference Type: reference-list

Lindley, C., Vasa, S., Sawyer, W. T. et al. (1998). Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer Journal of Clinical Oncology 16(4):1380–7
Bezjak, A., Ng, P., Skeel, R. et al. (2001). Oncologists' use of quality of life information: results of a survey of Eastern Cooperative Oncology Group physicians Quality of Life Research 10(1):1–13
de Haes, J. C. J. M., van Knippenberg, F. C. E., Neijt, J. P. (1990). Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist British Journal of Cancer 62:1034–8
Chang, V. T., Hwang, S. S., Feuerman, M. et al. (2000). The Memorial Symptom Assessment Scale Short Form Cancer 89:1162–71
Aaronson, N. K., Ahmedzai, S., Bergman, B. et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology Journal of the National Cancer Institute 85(5):365–76
Cella, D. F., Tulsky, D. S., Gray, G. et al. (1993). The Functional Assessment of Cancer Therapy Scale: development and validation of the general measure Journal of Clinical Oncology 11(3):570–9
Acquandro, C. (2001). Important issues in patient reported outcomes (PROs) research. Quality of Life Newsletter, MAPI Research Institute, No. 27
PDR@ Electronic Library Copyright (©) 2002 Medical Economics Company, Inc
Khayat, D. (2000). The main causes of quality of life in cancer patients International Journal of Pharmaceutical Medicine 14:70–3
Sabbatini, P. (2000). Treating cancer symptoms improves quality of life: Part I: treatment of anemia and fatigue International Journal of Pharmaceutical Medicine 14:88–91
Roila, F., Cortesi, E. (2001). Quality of life as a primary end point in oncology Annals of Oncology 12 (Suppl. 3):S3–6
Ahles, T. A., Saykin, A. (2001). Cognitive effects of standard-dose chemotherapy in patients with cancer Cancer Investigation 19(8):812–20
Van Dam, F. S. A. M., Schagen, S. B., Muller, J. M. et al. (1998). Impairment of cognitive function in women receiving adjuvant treatment for high risk breast cancer: high dose versus standard dose chemotherapy Journal of the National Cancer Institute 90(3):210–18
Wienie, M. H., Diets, E. R. (1995). Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer Psycho-Oncology 4:61–6
Schagen, S. B., van Dam, F. S. A. M., Muller, M. J. et al. (1999). Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma Cancer 85(3):640–50
Ahles, T. A., Saykin, A., Furstenber, C. et al. (2002). Cognitive impact of standard-dose chemotherapy in long-term survivors of breast cancer and lymphoma Journal of Clinical Oncology 20(2):485–93
Santanello, N. C., Baker, D., Cappelleri, J. C. et al. (2002). Regulatory issues for health-related quality of life — PhRMA Health Outcomes Committee Workshop, 1999 Value in Health 5:14–25
Chassany, O., Sagnier, P., Marquis, P. et al for the European Regulatory Issues on Quality of Life Assessment Group (2002). Patient-reported outcomes: The example of health-related quality of life — A European guidance document for the improved integration of health-related quality of life assessment in the drug regulatory process Drug Information Journal 36:209–18
Curran, D., Fayers, P. M., Molenberghs, G. et al. (1998). Analysis of incomplete quality of life data in clinical trials. In Quality of Life Assessment in Clinical Trials: Methods and Practice, ed. M. J. Staquet, R. D. Hays, P. M. Fayers, pp. 249–80. New York, NY: Oxford University Press
Fairclough, D. L. (2002). Design and Analysis of Quality of Life Studies in Clinical Trials. New York: Chapman & Hall/CRC
Zhang, J., Quan, H., Ng, J. et al. (1997). Some statistical methods for multiple endpoints in clinical trials Controlled Clinical Trials 18:204
Guyatt, G. H., Osoba, D., Wu, A. W. et al. (2002). Methods to explain the clinical significance of health status measures Mayo Clinic Proceedings 77:371–83
Osoba, D., Rodrigues, G., Myles, J. et al. (1998). Interpreting the significance of changes in health-related quality-of-life scores Journal of Clinical Oncology 16:139–44
Cella, D., Eton, D. T., Fairclough, D. L. et al. (2002). What is a clinically meaningful change on the Functional Assessment of Cancer Therapy-Lung (FACT-L) Questionnaire? Results from Eastern Cooperative Oncology Group (ECOG) Study 5592 Journal of Clinical Epidemiology 55:285–95
Harrell, F. E., Jr., Shih, Y. C. (2001). Using full probability models to compute probabilities of actual interest to decision makers International Journal of Technology Assessment in Health Care 17:17–26
Hornberger, J. (2001). Introduction to Bayesian reasoning International Journal of Technology Assessment in Health Care 17:9–16
Spiegelhalter, D. J., Myles, J. P., Jones, D. R. et al. (1999). An introduction to Bayesian methods in health technology assessment British Medical Journal 319:508–12
Sheingold, S. H. (2001). Can Bayesian methods make data and analyses more relevant to decision makers? A perspective from Medicare. 2001 International Journal of Technology Assessment in Health Care 17:114–22
Winkler, R. L. (2001). Why Bayesian analysis hasn't caught on in healthcare decision making International Journal of Technology Assessment in Health Care 17:56–66
International Conference on Harmonization. Statistical Principles for Clinical Trials, 1998. Available at: www.ich.org/pdfifpma/e9.pdf Accessed October 31, 2002
Fryback, D. G., Stout, N. K., Rosenberg, M. A. (2001). An elementary introduction to Bayesian computing using WinBUGS International Journal of Technology Assessment in Health Care 17:98–113
Fryback, D. G., Chinnis, J. O. Jr., Ulvila, J. W. (2001). Bayesian cost-effectiveness analysis: An example using the GUSTO trial International Journal of Technology Assessment in Health Care 17:83–97
Briggs, A. H. (2001). A Bayesian approach to stochastic cost-effectiveness analysis: an illustration and application to blood pressure control in type 2 diabetes International Journal of Technology Assessment in Health Care 17:69–82
Claxton, K., Neumann, P. J., Araki, S. et al. (2001). Bayesian value-of-information analysis: an application to a policy model of Alzheimer's disease International Journal of Technology Assessment in Health Care 17:38–55
Spiegelhalter, D. J., Myles, J. P., Jones, D. R. et al. (2000). Health Technology Assessment 4:1–130
O'Hagan, A. O., Stevens, J. W., Montmartin, J. (2000). Inference for the cost-effectiveness acceptability curve and cost-effectiveness ratio Pharmacoeconomics 17:339–49
O'Hagan, A. O., Stevens, J. W., Montmartin, J. (2001). Bayesian cost-effectiveness analysis from clinical trial data Statistics in Medicine 20:733–53
Hay, J., Jackson, J., Luce, B. et al. (1999). Panel 2: Methodological issues in conducting pharmacoeconomic evaluations — modeling studies Value in Health 2(2):78–81
Meyer, J. A. (2002). Assessing the Impact of Pharmaceutical Innovation: A Comprehensive Framework. Washington, DC: New Directions for Policy
Tengs, T. O., Adams, M. E., Pliskin, J. S. et al. (1995). Five-hundred life-saving interventions and their cost-effectiveness Risk Analysis 15:360–90
Lichtenberg, F. R. (2001). Are the benefits of newer drugs worth their cost? Evidence from the 1996 MEPS Health Affairs 20:241–51
Weinstein, M. C., Siegel, J. E., Gold, M. R. et al. (1996). Recommendations of the Panel on Cost-Effectiveness in Health and Medicine Journal of the American Medical Association 276:1253–8
Meltzer, D. (1997). Accounting for future costs in medical cost-effectiveness analysis Journal of Health Economics 16:33–64
Hutton, J., Brown, R., Borowitz, M. et al. (1996). A new decision model for cost-utility comparisons of chemotherapy in recurrent metastatic breast cancer Pharmacoeconomics 9:8–22
Nuitjen, M., McCormick, J., Waibel, F. et al. (2000). Economic evaluation of letrozole in the treatment of advanced breast cancer in postmenopausal women in Canada Value in Health 3:31–9
Weinstein, M. C., Toy, E. L., Sandberg, E. A. et al. (2001). Modeling for health care and other policy decisions Value in Health 4:348–61
Brown, M., Glick, H. A., Harrell, F. et al. (1998). Integrating economic analysis into cancer clinical trials: the National Cancer Institute — American Society of Clinical Oncology economics workbook National Cancer Institute Monographs 24:1–28
Hornbrook, this volume, Chapter 24
O'Brien, this volume, Chapter 25
Bennett, C. L., Smith, T. J., George, S. L. et al. (1995). Free-riding and the prisoner's dilemma: problems in funding economic analyses of phase III cancer clinical trials Journal of Clinical Oncology 9:2457–63
National Institute for Clinical Excellence (2000). Guidance on the Use of Taxanes for Breast Cancer, Technology Appraisal Guidance No. 6, June 2000. London: National Institute for Clinical Excellence
National Institute for Clinical Excellence (2001). Guidance on the Use of Docetaxel, Paclitaxel, Gemcitabine and Vinorelbine for the Treatment of Non-Small Cell Lung Cancer, Technology Appraisal Guidance No. 26, June 2001. London: National Institute for Clinical Excellence
National Institute for Clinical Excellence (2001). Guidance on the Use of Topotecan for the Treatment of Advanced Ovarian Cancer, Technology Appraisal Guidance No. 28, August 2001. London: National Institute for Clinical Excellence